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Abstract 
 
How and why depression confers greater risk of impaired adaptation following coronary artery 
bypass graft (CABG) surgery is not well understood. This PhD aimed to address these issues by: 
developing and piloting a longitudinal study (the ARCS study) in order to track the recovery of 
patients undergoing CABG surgery; and conducting an extended version of the ARCS study on 
which to test the association between pre-operative depression and post-operative recovery 
and the underlying social-behavioural, cognitive and biological pathways. Outcomes were 
studied in the early and short term, namely three to five days (216 participants) and two 
months (154 participants) following surgery.  The results indicated that greater pre-operative 
depression symptoms were predictive of poorer recovery, including longer in-hospital stays, 
greater emotional distress, physical symptoms and pain in the early term, and greater 
emotional distress, physical symptoms and pain and impaired health status in the short term, 
independent of demographic and disease severity factors (all p <0.05). Some associations were 
limited to subtypes of depression symptoms. Specifically, somatic/affective, but not total or 
cognitive/affective, depression symptoms were predictive of short-term outcomes. Mediators 
of the depression-recovery relationship were tested. Social support and behavioural factors 
were not shown to be mediators, but instead physical activity, body mass index and smoking 
status all had independent effects on recovery. Cognitive mediation was shown, with greater 
pre-operative negative illness perceptions mediating the relationship between pre-operative 
depression symptoms and post-operative anxiety and physical symptoms in the early term, 
and affective pain and physical symptoms in the short term.  Biological mediation was not 
shown: although depression symptoms were related to neuroendocrine and inflammatory 
patterns suggestive of poorer physical functioning, these patterns did not consistently relate to 
recovery. Further work is needed to translate these findings into new ways to approach the 
measurement, diagnosis and treatment of depressed cardiac surgery patients. 
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Chapter 1. Literature review (I): Coronary heart disease and 
depression 
1.1 Introduction 
This chapter will describe the literature relating to the diagnosis and treatment of coronary 
heart disease (CHD) and depression, as separate and co-morbid disease states. The literature 
showing a relationship between depression and poor cardiac outcomes will be described, in 
relation to two patient groups: myocardial infarction (MI) and coronary artery bypass graft 
(CABG) surgery patients.   
An electronic search of the literature was conducted in four online databases: 
PubMed, PsycINFO, EMBASE and SCOPUS, and a bibliography search was conducted to identify 
any previously missed papers. Much of the literature discussed in this chapter can be found in 
our review (Poole, Dickens, & Steptoe, 2011). 
1.2 Coronary heart disease 
1.2.1 Pathogenesis 
Cardiovascular disease (CVD) is an umbrella term, referring to all diseases affecting the 
circulatory system, the most prevalent of which is CHD, also known as ischaemic heart disease 
or coronary artery disease. Atherosclerosis is the primary pathological process which underlies 
CHD and is a life-long process by which fatty deposits (atheroma) lead to the narrowing of the 
coronary arteries. Atherosclerosis begins in childhood, with changes gradually occurring 
throughout adolescence and young adulthood (Berenson et al., 1989) due to the cumulative 
effect of several known risk factors (Craig & Mindell, 2008; Williams, 2008). These risk factors 
can be divided into behavioural factors such as physical inactivity, tobacco use, excessive 
alcohol consumption and poor diet, biological factors such as male gender, older age and 
genetic predisposition, clinical factors including hypertension, diabetes, obesity and 
hyperlipidaemia, social factors including low educational status and low socioeconomic status, 
and psychological factors such as depression. The majority of people will remain in an 
asymptomatic disease state for many years. 
Atherosclerosis was once thought to be a cholesterol storage disease but is now 
understood to be an inflammatory disorder capable of affecting all medium- and large-sized 
blood vessels in the cardiovascular system (Libby, Ridker, & Hansson, 2011; Libby, Ridker, & 
Maseri, 2002). Appendix 1 shows the cell structure of a human artery. In response to certain 
biological catalysts such as, among others, bacterial products, dyslipidaemia, and pro-
inflammatory cytokines associated with excess adiposity, the expression of adhesion molecules 
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that promote the sticking of blood leukocytes to the inner surface of the endothelium is 
increased. Once these cells have migrated to the arterial intima, an immune and inflammatory 
response is initiated leading to migration of smooth muscle cells (the endogenous cells of the 
arterial wall) from the tunica media into the intima. These cells proliferate, forming a complex 
extracellular matrix which, principally via the action of proteoglycans, can bind lipoproteins, 
prolong their residence in the intima and make them susceptible to modification via oxidation 
and glycation. These changes to lipoproteins sustain the inflammatory response and as a result 
they are engulfed by monocytes. The oxidised-low density lipoproteins accumulate in the 
macrophages, creating ‘foam cells’. Foam cells form the fatty streaks of atheroma in the 
intima. As the lesion progresses a fibrous cap forms, consisting primarily of smooth muscle 
cells and collagen. Simultaneously, underneath this cap, the macrophages die, resulting in the 
lipid-rich necrotic core of the atherosclerotic plaque. As cells and lipids continue to accumulate 
in the lesion, the plaque enlarges, bulging into the artery lumen. Over time, the fibrous cap 
begins to thin and fissures may appear on the surface of the plaque. If the plaque ruptures, the 
lipid fragments and cellular debris leak through into the lumen triggering the formation of a 
thrombus. For an up to date review of atherosclerosis pathogenesis see Weber & Noels (2011). 
The clinical manifestations of CHD as a result of atherogenesis include: ACS, namely MI 
and unstable angina, and angina pectoris. MI refers to the occlusion of one of the coronary 
arteries by a thrombus following the rupture of an atherosclerotic plaque; the resulting oxygen 
shortage can lead to damage or death of heart tissue. Angina pectoris is a chronic condition 
characterised by chest pain on exertion caused by a lack of oxygen supply to the heart muscle 
due to stenosis (i.e. narrow atherosclerotic arteries). Unstable angina is distinct from angina 
pectoris in that symptoms occur more frequently and for a longer duration; aetiologically, 
unstable angina is different as it is caused by a thrombus resulting in partial occlusion of a 
coronary artery.  
1.2.2 Prevalence 
CVD represents a major public health challenge both globally and nationally. Recently, the 
World Health Organisation (WHO) published an update on the global status of CVD (Mendis, 
Puska, & Norrving, 2011). This report stated that worldwide, in 2008, CVD accounted for 30% 
of deaths from all causes (i.e. 17.3 million deaths), equivalent to the death rate from 
communicable, nutritional and maternal and perinatal conditions combined. Moreover, CVD is 
not just a disease of the very old, being the leading cause of death, globally, for persons less 
than 70 years of age.  In terms of the global disease burden (DALYs1), 10% is attributable to 
                                                          
1
 DALYs: Disability Adjusted Life Years. The sum of years of potential life lost due to premature mortality and the years of 
productive life lost due to disability. 
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CVD. Furthermore, projections of global CVD mortality rates are set to rise by 17% between 
2006 and 2015 (WHO, 2005). 
 
 
 
FIGURE 1.1: DEATHS BY CAUSE (A) MEN AND (B) WOMEN, 2009, UK 
 
Despite downward trends in mortality rates over the past 50 years, CVD remains the 
biggest killer in the UK, accounting for almost 180,000 deaths in 2009, nearly half of which 
were due to CHD (Scarborough, Wickramasinghe, Bhatnager, & Rayner, 2011). This makes CHD 
the biggest single cause of death in the UK, accounting for approximately one-fifth of all deaths 
CHD - 18%
Stroke - 7%
Other CVD - 8%
Cancer - 31%
Respiratory disease - 13%
All other causes - 23%
CHD - 12%
Stroke - 11%
Other CVD - 10%
Cancer - 26%
Respiratory disease - 14%
All other causes - 27%
A 
B 
25 
 
in men and one eighth of all deaths in women (Figure 1.1). CHD is also the leading cause of 
premature death, accounting for just over 26,000 deaths of persons below the age of 75 years 
in 2009 (ibid).  
The economic implications of CHD are high. In 2006, CHD cost the UK health care 
system £3.2 billion, 73% of which was spent on hospital care (Scarborough et al., 2010). 
However, the true economic costs are thought to be much higher. When loss of production 
due to work absenteeism was considered, the UK spent a further £3.9 billion in 2006; in the 
same year the cost of providing informal care to CHD patients cost the UK £1.8 billion (ibid).  
1.2.3 Treatment  
Various treatment options exist for patients with CHD, including behaviour modification, 
prescription drugs and surgery. The UK National Institute of Clinical Excellence (NICE) provides 
a secondary prevention care plan for those patients with known CHD (Cooper et al., 2008). The 
first step in this plan recommends lifestyle advice to be given, where appropriate, to all 
patients regarding smoking cessation, diet and weight control, physical activity and alcohol 
reduction. The efficacy of non-pharmaceutical methods of CHD secondary prevention has been 
subject to recent review (Müller-Riemenschneider et al., 2010). Evidence suggests that 
increasing physical activity levels can be effective at reducing mortality, but there is a scarcity 
of high-quality research investigating the effect of smoking cessation and diet modification 
programmes on mortality reduction in CHD patients. A recent longitudinal examination of 
smoking status in over 4500 post-ACS patients has begun to address this issue (Boggon et al., 
in press).  These authors reported that smoking cessation advice, while advocated by NICE, 
was only provided by general practitioners (GPs) to 24% of patients after ACS. Moreover, those 
patients who did quit conferred benefits in terms of both reduced mortality risk and reduced 
risk of major adverse cardiac events. More high quality research is needed to further enhance 
our understanding of the effect of behavioural modification on cardiac risk.  
The second step in the NICE care plan is to discuss with patients their CVD risk (i.e. the 
risk of a cardiovascular event occurring) and management options through the use of drugs. 
Since the 1980s there has been a marked increase in the number of medicines prescribed for 
the management of CHD in the UK. In 2008 alone, there were 266 million prescriptions for CVD 
treatments (Scarborough et al., 2010). The NICE guidelines outline medication options to 
include statins, antihypertensives and antiplatelet agents, and for those patients post-MI, 
beta-blockers and angiotensin converting enzyme (ACE) inhibitors.  
 The UK Department of Health published a National Service Framework for CHD in 
2000, with the aim to modernise CHD services over a 10-year period. One of the standards 
presented in this report was to address the problem of under-provision of revascularisation in 
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the UK (Department of Health, 2000). According to these guidelines, revascularisation should 
be considered for those individuals with angina pectoris, unstable angina or those who have 
survived an MI, who meet the criteria for angiography based on evidence of persisting 
extensive ischaemia and/or angina that is unresponsive to optimal drug therapy and lifestyle 
advice. If angiogram shows significant narrowing of the left main coronary artery, three 
coronary arteries, or two coronary arteries including the proximal left anterior descending 
coronary artery, and the benefits of surgery outweigh the risks, then CABG surgery is 
recommended. Percutaneous coronary intervention (also called coronary angioplasty) with or 
without stenting, is the alternative revascularisation procedure offered to those patients who 
have an operable narrowing of one or two coronary arteries without significant narrowing of 
the left main stem. 
A large scale survey of cardiovascular prevention in Europe, EUROASPIRE III  (European 
Action on Secondary and Primary Prevention by Intervention to Reduce Events III), collected 
data from 76 centres across 22 countries in Europe in 2006-7 regarding the lifestyle, risk factor 
and therapeutic management of CHD patients (Kotseva et al., 2009).  Patients were identified 
retrospectively, following hospital admission for elective or emergency CABG or percutaneous 
transluminal coronary angioplasty, acute MI or acute myocardial ischaemia without infarction.  
In the UK, over 600 participants had their medical notes reviewed, 399 of whom underwent a 
physical examination and interview at least six months after their coronary event. At interview, 
20.1% of UK participants were smokers, 75.6% were overweight (body mass index [BMI] ≥ 
25kg/m2) and 47.4% had elevated blood pressure (systolic blood pressure ≥140 mmHg and/or 
diastolic blood pressure ≥90mmHg). These results show that despite the NICE guidelines, a 
large number of CHD patients do not achieve therapeutic targets for secondary prevention.  
1.3 Depression 
1.3.1 Diagnosis and pathogenesis 
Depression is not an illness with discrete boundaries, encompassing an array of symptoms and 
having a heterogeneous diagnosis. Indeed there is little consensus amongst clinicians and 
researchers about how best to categorise depressive disorders (Wakefield, 2011). Two main 
classification systems are used to diagnose depressive disorders: the International Statistical 
Classification of Diseases and Related Health Problems - 10th revision (ICD-10) and the 
Diagnostic and Statistical Manual of Mental Disorders – 4th edition (DSM-IV); this latter system 
terms the disorder ‘major depression’ (see Table 1.1 for a list of the DSM-IV diagnostic 
criteria). Both systems require a series of symptoms to be present most days for at least two 
weeks and at least one of these symptoms must include low mood or loss of interest and 
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pleasure; the ICD-10 also includes loss of energy as one of the key diagnostic symptoms. 
Further symptoms also need to be reported, such as feelings of guilt/worthlessness, appetitive 
changes, sleep disruption, suicidal ideation, loss of concentration and psychomotor agitation 
or retardation. The ICD-10 requires at least four out of ten symptoms and the DSM-IV requires 
at least five out of nine symptoms to be present to meet a diagnosis.  
 
TABLE 1.1: DSM-IV-TR CRITERIA FOR MAJOR DEPRESSIVE EPISODE  
(Adapted from: American Psychiatric Association, 2000) 
A. Five (or more) of the following symptoms have been present during the same two-week period 
and represent a change from previous functioning; at least one of the symptoms is either (1) 
depressed mood or (2) loss of interest or pleasure.  
(1) Depressed mood most of the day, nearly every day. 
(2) Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly 
every day. 
(3) Significant weight loss when not dieting or weight gain, or decrease or increase in appetite 
nearly every day. 
(4) Insomnia or hypersomnia nearly every day. 
(5) Psychomotor agitation or retardation nearly every day.  
(6) Fatigue of loss of energy nearly every day.  
(7) Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly 
every day (not merely self-reproach or guilt about being sick). 
(8) Diminished ability to think or concentrate, or indecisiveness, nearly every day. 
(9) Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific 
plan, or a suicide attempt or a specific plan for committing suicide. 
B. The symptoms do not meet criteria for a Mixed Episode. 
C. The symptoms cause clinically significant distress or impairment in social, occupational, or other 
important areas of functioning.  
D. The symptoms are not due to the direct physiological effects of a substance (e.g. a drug of abuse, 
a medication) or a general medical condition (e.g. hypothyroidism). 
E. The symptoms are not better accounted for by Bereavement, i.e. after the loss of a loved one, 
the symptoms persist for longer than two months or are characterised by marked functional 
impairment, morbid preoccupation with worthlessness, suicidal ideation, psychotic symptoms, or 
psychomotor retardation. 
 
Conceptual problems with the nosology of depression become apparent when one 
considers that depression can present different symptom clusters in different individuals (e.g. 
somatic or cognitive symptom preponderance), it can manifest itself either as an excess or 
insufficiency of certain behaviours (e.g. hypersomnia or insomnia, weight gain or weight loss), 
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and symptoms of major depression overlap with other disorders including dysthymia, 
adjustment disorders and bipolar depression.  Moreover, recent critiques of depression have 
focussed on whether discrete subtypes of depression exist based on symptom patterns 
(Lichtenberg & Belmaker, 2010; Lux & Kendler, 2010). 
Severity of the depressive disorder is based both on the number and severity of an 
individual’s symptoms and the level of distress and impairment in normal functioning. 
However, it is now considered more appropriate to conceptualise depression as occurring 
along a continuum of severity, without discrete cut-offs for mild-moderate-severe (Lewinsohn, 
Solomon, Seeley, & Zeiss, 2000). Indeed, the NICE guidelines recognise the importance of sub-
clinical depression for causing considerable distress and disability. Sub-clinical depression 
refers to the presence of at least one key depressive symptom, but insufficient other 
symptoms to meet the full criteria for depression (National Collaborating Centre for Mental 
Health, 2010a).  
The aetiology of depression is as varied and multifactorial as the diagnosis, and is 
thought to originate from the interaction between genetic and environmental vulnerabilities 
including the experience of stressful life events, physical inactivity, obesity, female sex, 
smoking, alcohol consumption and low socioeconomic status. We still lack a clear 
understanding regarding the pathogenesis of depression, with several competing hypotheses 
currently under investigation (Ebmeier, Donaghey, & Steele, 2006; Nestler et al., 2002). There 
is the so-called monoamine hypothesis, which is based on deficiency in the biogenic amine 
system, principally serotonin and noradrenalin (Ressler & Nemeroff, 2000). Also, there is the 
hypothalamic pituitary adrenal (HPA) axis dysfunction theory, based on dysregulation of this 
system resulting in excess glucocorticoid production (Dinan, 1994; Pariante & Lightman, 2008). 
Other theories include the cognitive model centred on the role of dysfunctional self-schema 
(Clark & Beck, 2010), the neurogenesis hypothesis which posits that depression is precipitated 
by stress induced decreases in neurogenesis in the hippocampus (Jacobs, Van Praag, & Gage, 
2000), the inflammatory theory which emphasises the role of pro-inflammatory cytokines 
(Miller, Maletic, & Raison, 2009), the neurotrophic theory which implicates the role of growth 
factors such as brain derived neurotrophic factor (Altar, 1999), and the neurodegenerative 
hypothesis which recognises evidence of structural and volumetric changes to the 
hippocampus, amygdala, prefrontal cortex, anterior cingulate and basal ganglia in the brains of 
depressed patients (Maes et al., 2009).  In order to better understand the neurobiology of 
depression, researchers are now beginning to look for similarities across the models to create 
one unifying theory. In particular, is the role of glucocorticoids, which are central to the HPA 
axis dysfunction, inflammatory and neurodegenerative theories (Zunszain, Anacker, Cattaneo, 
Carvalho, & Pariante, 2011).  
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1.3.2 Prevalence 
Mental illness is now firmly on the world health agenda, with estimates suggesting that it 
accounted for approximately 11% of the global burden of disease in 1990, a figure which is 
predicted to rise to 15% by 2020 (WHO, 2001). Mood disorders are the most prevalent mental 
illness, of which the most common is major depressive disorder. Depression made the fourth 
largest contribution to the total global disease burden in 1990 and is predicted to become the 
second largest after CHD by 2020 (ibid). A systematic review of depression prevalence 
reported a one-year pooled prevalence of 4.1% and a lifetime prevalence of 6.7% for major 
depression (Waraich, Goldner, Somers, & Hsu, 2004).  
Depression is also a growing challenge for UK health services. In 2000, the Office for 
National Statistics conducted a survey of UK households on behalf of the Department of Health 
estimating that the point prevalence for a depressive episode among those aged 16 to 74 years 
was 2.3% for men and 2.8% for women (pooled point prevalence 2.6%) (Singleton, Bumpstead, 
O’Brien, Lee, & Meltzer, 2003).  
The consequences for the UK economy are high. In 2000, it was estimated that the 
cost of adult depression was more than £9 billion, £370 million of which was spent on 
treatment costs. An additional £8 billion was attributed to loss of earnings due to absenteeism, 
while loss of future earnings due to death by suicide was estimated at £562 million (Thomas & 
Morris, 2003). Another recent review was published by the King’s Fund to look at projected 
costs of depression expenditure within the UK from 2006 to 2026 (McCrone, Dhanasiri, Patel, 
Knapp, & Lawton-Smith, 2008). This review predicted the number of people with depression to 
rise by 17% by 2026, to 1.45 million, leading to a concomitant rise in the cost of services and 
lost employment over the same period from £7.5 billion to £12.2 billion.  Similar across both 
the Thomas and Morris and King’s Fund publications is that the health service costs are 
relatively minor in comparison to the indirect costs of depression. 
1.3.3 Treatment 
One of the main problems with treating depression is the poor identification of depression 
cases in primary care. This is in part accounted for by the failure of the individual to consult 
with their GP about mood symptoms (Meltzer et al., 2003) and in part explained by a failure of 
GPs to identify symptoms of depression, particularly among those presenting with mild 
symptoms (Goldberg, Privett, Ustun, Simon, & Linden, 1998; Thompson, Ostler, Peveler, Baker, 
& Kinmonth, 2001).  The NICE guidelines for depression (National Collaborating Centre for 
Mental Health, 2010a) recognise that some cases of depression will remit spontaneously 
without treatment, while other cases will recur and take a more chronic course; for a review of 
this literature see Richards (2011).  
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The current UK guidelines for treating depression follow a stepped care plan, in which 
treatment recommendations are based on the severity and chronicity of the depressive 
episode. For mild cases, watchful waiting is often prescribed in which patients are asked to 
return after two weeks for symptoms to be re-assessed. For more severe cases, possible 
treatment options include pharmacological interventions and psychological treatment, 
including cognitive behavioural therapy and counselling. Pharmacological treatments include 
use of tricyclic antidepressants and serotonin reuptake inhibitors (SSRIs), which work on the 
premise of monoamine neurotransmission deficiency causing depression.  However, these 
drugs are only modestly efficacious, with effect sizes reported to be 0.31 (95% confidence 
interval [CI], 0.27 to 0.35) for both published and unpublished trials (Turner, Matthews, 
Linardatos, Tell, & Rosenthal, 2008). Despite the treatment options available in primary care, 
some patients fail to respond to antidepressant treatment entirely, so-called ‘treatment 
resistant’ depression (Vieta & Colom, 2011).  Poor treatment response is further compounded 
by poor adherence to antidepressant medication, with estimates of non-adherence ranging 
from 10% to 60% (Lingam & Scott, 2002).   
Treatment of depression can be improved by using cognitive behavioural strategies as 
an adjunct to pharmacotherapy (Thase et al., 1997). Counselling or psychotherapy, where 
stress-management techniques and sometimes exercise are involved, tend to be less 
frequently prescribed than antidepressant drugs; however there is a growing body of evidence 
finding in support of their efficacy (Bower, Knowles, Coventry, & Rowland, 2011). Moreover, 
some authors suggest that such treatment strategies would actually be preferred by patients 
(Dwight-Johnson, Sherbourne, Liao, & Wells, 2000). In addition, there has been recent interest 
in the use of physical exercise as a treatment for mental illness (Blumenthal, 2011; Phillips, 
Kiernan, & King, 2003). Support for the mood-enhancing benefits of physical activity, both in 
terms of reducing negative mood symptoms (Poole, Hamer, Wawrzyniak, & Steptoe, 2011) and 
promoting positive wellbeing (Poole, Steptoe, et al., 2011), have been demonstrated recently 
in our own empirical studies and review (Hamer, Endrighi, & Poole, 2012).  
1.3.4 Depression in physical illness 
The full health implications of depressive disorders have only emerged in recent years and 
depression is now recognised as contributing to the onset and progression of physical illness 
(Steptoe, 2007). Moreover ‘mood disorder due to a general medical condition’ is a recognised 
subtype of depressive disorder within DSM-IV, in which major depressive disorder onsets as a 
direct physiological consequence of a physical illness; it is not merely a failure to adapt to the 
emotional burden of medical illness.  In the UK, NICE also recognises co-morbid depression in 
physical illness and has clinical management guidelines in place to improve treatment of these 
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patients (National Collaborating Centre for Mental Health, 2010b). However, NICE points out 
that depression in these patients is not a separate disorder with different symptoms or 
treatment requirements, but rather reflects the different contexts in which depression can 
manifest itself.  
 Depression in physical illness is highly prevalent. The WHO World Health Survey 
(Moussavi et al., 2007) sampled just fewer than 245.5 thousand participants from across 60 
countries, covering all regions of the world. They used the ICD-10 classification system to 
estimate depressive episode prevalence alone and in conjunction with four physical illnesses: 
diabetes, arthritis, angina, and asthma. They found that the one-year prevalence of a 
depressive episode co-morbid with diabetes was 9.3% (95% CI 7.3–11.3), for those with 
arthritis it was 10.7% (95% CI 9.1–12.3), for those with angina it was 15.0% (95% CI 12.9–17.2), 
and for those with asthma it was 18.1% (95% CI 15.9–20.3). In comparison, the healthy 
comparison group had a one-year prevalence of a depressive episode at just 3.2% (95% CI 3.0–
3.5). Moreover, a dose-response relationship seems to exist, whereby those participants with 
two or more physical illnesses had even greater risk, with nearly a quarter also having co-
morbid depression. With an ageing population and an ever-increasing rise in the prevalence of 
chronic illness, a concomitant rise in the diagnosis of co-morbid depression is expected 
(Moussavi et al., 2007). 
Several good quality reviews have now been published in this area, showing that 
depression can lead to physical illness onset. For example, a meta-analysis of longitudinal 
studies showed depressed individuals to be at 60% greater risk of developing type II diabetes 
than those without depression (Mezuk, Eaton, Albrecht, & Golden, 2008). Depression has also 
been implicated as a risk factor in cancer, with another recent meta-analysis of prospective 
studies revealing depression morbidity predicted a 29% increase in cancer incidence (Chida, 
Hamer, Wardle, & Steptoe, 2008). In addition, a systematic review of prospective cohort 
studies (Kuper, Marmot, & Hemingway, 2002) demonstrated that in individuals free from 
disease at baseline, the presence of depression symptoms was related to an increased risk of 
future cardiac events, both fatal and non-fatal, up to 40 years later (c.f. Ford et al., 1998). 
Moreover, depression has also been associated with an increase in disease progression in HIV 
patients (Leserman, 2008) and a greater risk of mortality in cancer (Satin, Linden, & Phillips, 
2009) and stroke (Ellis, Zhao, & Egede, 2010) patients. The subjective experience of disease 
burden is also different in depressed patients, with depressed patients experiencing more 
symptoms of their physical illness compared to their non-depressed counterparts (Katon, Lin, 
& Kroenke, 2007).  
Creed and Dickens note that methodological issues arise from the assessment of 
depression in those with a physical illness, primarily due to measurement problems caused by 
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the commonality of somatic symptoms in both depression and physical illness, for example 
sleep, fatigue and appetite changes (Creed & Dickens, 2007). Therefore, care must be taken 
when interpreting the results of these studies, taking into account this conceptual overlap.  
1.4 Depression and coronary heart disease 
1.4.1 Depression in acute coronary syndrome 
Co-morbid depression is commonly observed in patients suffering from CHD (Blumenthal, 
2008; Lett et al., 2004; Steptoe, 2007), and has been most widely studied in patients suffering 
from acute MI. A comprehensive literature review of hospitalised post-MI patients estimates 
the prevalence rate to be nearly 20% for major depression as measured using clinical 
interviews (Thombs et al., 2006). Prevalence varied from 7.3% (Hospital and Anxiety 
Depression Scale score [HADS] ≥11) to 31.1% (Beck Depression Inventory [BDI] score ≥10) 
when using standardised questionnaires measuring elevated depression symptomatology. 
Similar estimates have been reported more recently for both major and minor depression, 
again in post-MI patients (Carney & Freedland, 2008; Frasure-Smith & Lespérance, 2010). The 
association between depression and cardiovascular morbidity following ACS was first identified 
in the literature more than 15 years ago; Frasure-Smith and colleagues (Frasure-Smith, 
Lespérance, & Talajic, 1993) showed that major depression in patients recently admitted to 
hospital for MI was an independent risk factor for mortality at six months. This association has 
since been replicated in several studies (Brown, Stewart, Stump, & Callahan, 2011; Meijer et 
al., 2011, 2011; Nabi et al., 2010; van Melle et al., 2004). The association with recurrent cardiac 
disease is apparent not only for clinical depression, but for subclinical dysphoria and elevated 
symptoms of depression within the normal range (Bush et al., 2001; Lespérance, Frasure-
Smith, Talajic, & Bourassa, 2002). 
 Depression in CHD patients is associated with poorer quality of life after MI (Lane, 
Carroll, Ring, Beevers, & Lip, 2001), longer hospital stays and greater cardiac-related 
readmissions after MI (Frasure-Smith et al., 2000; Myers, Gerber, Benyamini, Goldbourt, & 
Drory, 2012), greater disease progression such as atherosclerosis in CABG patients (Wellenius, 
Mukamal, Kulshreshtha, Asonganyi, & Mittleman, 2008), and increased use of urgent and 
unscheduled care (Frasure-Smith et al., 2000; Kurdyak, Gnam, Goering, Chong, & Alter, 2008; 
Lauzon et al., 2003). Indeed in recognition of the prevalence and negative sequelae of 
depression in CHD, the American Heart Association now recommends routine screening for 
depression in all heart disease patients (Bigger & Glassman, 2010; Lichtman et al., 2008), but 
such guidelines have yet to be introduced in the UK. However, screening has yet to be shown 
to impact patient outcomes (Thombs et al., 2008).  
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There are several features of depression in CHD patients which add additional layers of 
complexity to our understanding of the relationship (Poole, Dickens, et al., 2011). The first 
unusual feature of the relationship between depression and CHD is that there appears to be a 
difference between those patients who are depressed before the occurrence of an ACS and 
those who develop depressive symptoms following the cardiac event. Several subtypes of 
depression in response to an ACS have been reported, differentiating patients according to the 
timing and recurrence of a depressive episode. Recent evidence indicates there is a stronger 
association with mortality and recurrent cardiac events in patients with new onset depression 
(post-ACS depressed with no prior history of depression; also called ‘incident’ depression). For 
example, in a prospective cohort study of 588 patients admitted to hospital with MI, Dickens 
and colleagues (Dickens et al., 2007, 2008) observed 167 cases of depression of which 96 had 
depression before their MI and 71 developed depression during the 12 months following their 
MI. Kaplan-Meier survival analysis showed that depression symptomatology from the week 
preceding MI did not confer risk of cardiac mortality, but new onset depression did (hazard 
ratio [HR] = 2.33, p = 0.038), even after controlling for a range of risk factors including age, 
history of angina prior to MI, Killip class, beta-blocker use on discharge, left ventricular ejection 
fraction (LVEF), use of antidepressant medication at baseline and serious cardiac events during 
12-month follow-up. Other studies have supported these findings (Carney et al., 2009; de 
Jonge, van den Brink, Spijkerman, & Ormel, 2006; Grace et al., 2005; Lespérance, Frasure-
Smith, & Talajic, 1996; Parker et al., 2008). By contrast, recent findings from the Sertraline 
Antidepressant Heart Attack Randomised Trial (SADHART) found that although major 
depression following hospital admission predicted mortality over the next seven years, timing 
of depression onset and a history of major depression did not (Glassman, Bigger, & Gaffney, 
2009).  
One explanation for this pattern of findings proposed by Spijkerman and colleagues 
(Spijkerman et al., 2005) and later Goodman and colleagues (Goodman, Shimbo, Haas, 
Davidson, & Rieckmann, 2008) is that new onset depression is associated with more severe 
coronary artery disease than is recurrent depression; however, the studies reported above (de 
Jonge et al., 2006; Dickens et al., 2007; Parker et al., 2008) all controlled for cardiac risk 
factors. It has been suggested that new onset depression has different risk factors to recurrent 
depression (Dickens et al., 2004), further indicating that it may be a distinct phenomenon. In 
particular, negative perceptions regarding one’s heart condition in the days following an MI 
(Dickens et al., 2008b) were associated with increased risk of developing depression. Other 
analyses have shown the greater cardiac risk associated with post-ACS depression may be in 
large part attributable to an increase in depressive symptoms following MI, rather than the 
prolongation of recurrent depressive symptoms from before the MI (Zuidersma, Ormel, 
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Conradi, & de Jonge, 2012). In particular these authors reported that each new depression 
symptom experienced post-MI carried an increased risk of new cardiac events of 15%, 
remaining significant even after adjusting for baseline disease severity and demographic 
confounders. This study did not distinguish new onset depression cases, but rather analysed 
the absolute number of depression symptoms experienced pre- and post-MI. A systematic 
review by the same research group suggested that due to the small number of studies 
published and the inconsistent findings, firm conclusions are difficult to draw about the risk of 
new onset depression cases over and above recurrent episodes (Zuidersma et al., 2011).  
Moreover, care needs to be taken when interpreting the literature in this area due to concerns 
over the measurement of incident depression. While a first-ever ACS can be established from 
medical notes, establishing a first-ever depressive episode is likely to be subject to recall bias 
and may not be objectively verifiable since some episodes may have escaped medical 
attention. In addition, it is not clear to what extent depression that onsets after an ACS differs 
from depression that onsets after a first-ever manifestation of CHD, such as angina. This 
distinction would have implications for understanding the direction of the causal direction, but 
has yet to be addressed in the literature. However, it seems the weight of evidence points 
towards new onset cases of depression carry at least as much, if not more, risk as chronic, 
recurrent depression.  
The second intriguing feature of the depression-CHD relationship concerns the 
symptom profile of patients with post-ACS depression who are at risk of future cardiac events. 
Some types of symptoms appear to be more “cardiotoxic” than others, with somatic symptoms 
being particularly damaging. Analyses performed on two large datasets comprising more than 
2000 patients compared three dimensions of depression symptoms derived from the BDI in 
relation to cardiovascular risk markers, mortality and readmissions over an average of 2.5 
years after ACS (De Jonge, Ormel, et al., 2006). Cox regression analyses found 
somatic/affective symptoms (e.g. fatigue, pessimism) to predict cardiovascular events and 
mortality, even after controlling for cardiac risk factors (LVEF, Killip class, and previous 
myocardial infarction), while cognitive/affective (e.g. social withdrawal, work difficulty) and 
appetitive symptoms (e.g. loss of appetite, weight loss) did not. Other studies have reported 
similar findings (Doyle, Conroy, McGee, & Delaney, 2010; Hoen et al., 2010; Linke et al., 2009; 
Martens, Hoen, Mittelhaeuser, de Jonge, & Denollet, 2010; McGowan et al., 2004) and this 
observation has been subject to recent discussion (Carney & Freedland, 2012; Ormel & de 
Jonge, 2011). Somatic depression symptoms have also been shown to be positively correlated 
to intima-media thickness of the carotid artery, a marker of atherosclerotic disease 
progression (Bus et al., 2011).  
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It should be noted that not all evidence supports this association. For example, an 
early study by Lespérance and colleagues (Lespérance et al., 1996) found that by removing 
appetite and sleep disturbance symptoms from analyses, depression was better able to predict 
mortality at six months. However, a key limitation of this study is its small sample size, with 
only 42 depressed patients being followed up at six months. It is also interesting that somatic 
symptoms of depression overlap with the concept of vital exhaustion, which is commonly 
defined as symptoms of excessive tiredness, increased irritability and a sense of 
demoralisation (Appels, Höppener, & Mulder, 1987). Vital exhaustion has been shown to be 
predictive of cardiac prognosis in MI and heart failure patients (Smith, Kupper, Denollet, & De 
Jonge, 2010). Although depression and vital exhaustion are generally understood to be 
separate constructs (Kopp, Falger, Appels, & Szedmak, 1998), in a recent study this was only 
observed in men and not women (Lindeberg, Rosvall, & Östergren, 2012). Another study used 
principal component analyses on questionnaire responses of 528 MI patients on the BDI and 
Maastricht Questionnaire (a measure of vital exhaustion) (Vroege, Zuidersma, & De Jonge, 
2012).  These authors showed strong conceptual overlap between the two scales, with all but 
two items from the Maastricht Questionnaire loading on the somatic/affective dimension of 
the BDI. Moreover, this somatic/affective dimension was able to predict recurrent events, but 
the cognitive/affective dimension was not. Due to these disparate findings, more research is 
needed to delineate the independent effect of vital exhaustion over and above depression, on 
the prognosis of ACS patients.  
 A third feature is that depression following ACS responds relatively poorly to standard 
treatment. The Enhancing Recovery In Coronary Heart Disease (ENRICHD) randomised 
controlled trial of cognitive-behavioural treatment versus usual case for depressed MI patients 
(Berkman et al., 2003), showed only a modest and poorly sustained difference in depression 
following treatment between the two groups. Although statistically significant, the 
improvement observed was only between 1.5 and 2.8 points depending on the scale used, 
which is of questionable clinical significance. Other randomised trials, such as SADHART, 
CREATE (Canadian Cardiac Randomised Evaluation of Antidepressant and Psychotherapy 
Efficacy) and MIND-IT (Myocardial Infarction and Depression Intervention Trial), have reported 
similarly modest treatment effects (SADHART: Glassman et al., (2002); CREATE: Lespérance et 
al., (2007); MIND-IT: van Melle et al., (2007)). Interestingly, in subgroup analyses in two of 
these trials (SADHART and CREATE), new onset depression showed poorer treatment response 
than recurrent depression (Glassman, Bigger, Gaffney, Shapiro, & Swenson, 2006; Habra et al., 
2010), which is in line with the evidence discussed earlier that timing of depression is key to 
cardiac outcomes. In a systematic review, Thombs and colleagues (Thombs et al., 2008) 
demonstrated only modest benefits to antidepressant treatment in cardiac patients with 
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hedges’ g effect sizes ranging from 0.20 to 0.38. High rates of placebo response as opposed to 
low treatment responses may in large part explain these results. Evidence also suggests that 
treatment resistant depression is linked to cardiac mortality (Carney & Freedland, 2009; de 
Jonge et al., 2007; Scherrer et al., 2012). 
 However, these findings should be interpreted in light of evidence from non-cardiac 
populations. Turner and colleagues (Turner et al., 2008) conducted a literature search of both 
published and unpublished data on antidepressant efficacy in psychiatric populations finding 
effect sizes that are comparable to the ENRICHD and SADHART results. This suggests both non-
cardiac and cardiac patients often respond poorly to standard treatment. One of the 
difficulties in determining whether cardiac patients respond less well to treatment is that 
many cases of depression resolve in the weeks following the event, making a treatment effect 
hard to demonstrate. The literature is suggestive of a reduced response to pharmacological 
and cognitive behavioural treatments following ACS, but further systematic studies are 
required to fully resolve this issue.  
 It can be argued that the form of depression in ACS that is particularly cardiotoxic is a 
distinct disorder from psychiatric depression. It comprises the three elements described, 
namely new onset, somatic/affective symptoms and limited responsiveness to treatment. This 
model presents one way in which we can interpret the differences in presentation of 
depression in ACS patients compared with their psychiatric counterparts. One important point 
to be borne in mind when summarising the literature in this field, relates to the issue of 
publication bias and the large number of papers published with positive findings. This is a 
consideration raised in a recent critique of the cancer prognosis literature (Kyzas, Denaxa-Kyza, 
& Ioannidis, 2007) in which 95.8% of 1575 original articles were found to report positive 
significant findings. This highlights the need for careful interpretation of published findings, so 
as not to overestimate the effect of prognostic markers. Several methods to examine 
publication bias exist, including the use of statistical techniques such as Egger’s method. 
Alternatively, meta-analyses could include published as well as unpublished datasets to 
estimate accurate effect sizes. While recent meta-analyses have made use of statistical 
techniques to demonstrate that publication bias is likely to be an issue in the depression-CHD 
literature (e.g. Nicholson, Kuper, & Hemingway, 2006), to date no meta-analyses have 
systematically studied the impact of including unpublished trials on effect estimates.  
Nevertheless, despite this controversy, research has continued to explore the 
depression-CHD relationship. It can be argued that by drawing on a greater range of cardiac 
populations we would be better able to understand the patterns of depression incidence in 
this patient group. Therefore, recent research has also begun to investigate these issues in 
cardiac surgery patients as well.  
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1.4.2 Depression in cardiac surgery  
1.4.2.1 Estimating depression prevalence 
CABG surgery is one of the most common revascularisation procedures used for CHD patients 
in the UK (Scarborough et al., 2010) and the USA (Lloyd-Jones et al., 2010) and is the treatment 
of choice for patients over 65 years of age and for patients with co-morbid conditions such as 
diabetes (Hlatky et al., 2009) and with multivessel disease (Biryukova et al., 2010; Mokadam et 
al., 2011). It is primarily used in patients for whom, due to the number, location and extent of 
coronary artery occlusions, MI is a significant risk. In addition, CABG may be used during or 
immediately following an MI in order to minimise damage to heart muscle. As such it is used 
both for the relief of symptoms and the improvement of life expectancy in patients suffering 
from CHD; it is not a cure for CHD (Van Domburg, Kappetein, & Bogers, 2009). CABG patients 
differ from an ACS population in that many patients requiring CABG have not had a prior MI 
but rather suffer from stable angina; some others will have no cardiac symptoms at all but may 
have another form of CVD such as cerebrovascular disease or peripheral arterial disease.  
Short-term survival rates following CABG are high; according to the Healthcare Commission, 
98.4% of first-time patients in the UK were successfully discharged from hospital in 2009 (Care 
Quality Commission, 2010).  
Two different surgical techniques can be used in CABG surgery: either on-pump or off-
pump. On-pump surgery involves cardioplegic arrest, using a cardiopulmonary bypass machine 
to keep blood flowing round the body. On the other hand, off-pump surgery is performed 
without cardiopulmonary bypass, mechanically stabilising the heart and using drugs to slow 
the patient’s heart rate. A systematic review of randomised controlled trials comparing on-
pump and off-pump CABG surgery techniques concluded that in the majority of studies, 
patients generally show improved health-related quality of life after CABG, irrespective of the 
surgery type (Jokinen, Hippeläinen, Turpeinen, Pitkänen, & Hartikainen, 2010). However, the 
reason why some patients fail to show these improvements is not clear and has yet to be fully 
accounted for in the literature. For example, Hawkes and Mortensen (Hawkes & Mortensen, 
2006) reported cross-cultural data showing that 27% of cardiac surgery patients have a 
clinically significant decline in quality of life at six-month follow-up compared to pre-surgery 
levels and this has been supported by others (Covinsky et al., 2008). Moreover, the impact of 
CABG on patients’ emotional adjustment is often less positive than might be expected for a 
surgery which aims to remove symptoms and promote wellbeing.  
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TABLE 1.2: PREVALENCE OF DEPRESSION BEFORE AND AFTER CABG SURGERY 
BDI: Beck Depression Inventory; CES-D: Center for Epidemiologic Studies Depression scale; DASS-D: 
Depression Anxiety Stress Scales- Depression subscale; DISH: Depression Interview and Structured Hamilton; 
HADS: Hospital and Anxiety Depression Scale; MINI: Mini International Neuropsychiatric Interview; PHQ-9: 
Patient Health Questionnaire- 9 item; SCL-90-R: Symptom Checklist- 90 items- Revised. 
Reference 
Sample 
size 
Surgical 
procedure 
Excluded 
those 
currently 
treated for 
depression? 
Design 
Depression 
measure 
Time in 
relation to 
CABG 
Prevalence 
Pre-CABG depression 
Baker et al. 
(2001) 
158 (118 
male, 40 
female) 
Urgent and 
elective, CABG 
+/- valve 
replacement 
No 
Cross-
sectional 
DASS-D 
1 day pre-
CABG 
15.2% 
depressed 
(DASS-
D≥10) 
Beresnevaitė et 
al. (2010) 
109 male 
CABG in 
isolation 
No 
Cross-
sectional 
SCL-90-R 
1 day pre-
CABG 
23% 
depressed 
(SCL-
90R≥71) 
Blumenthal et 
al. (2003) 
817 (596 
male, 
221 
female) 
Elective CABG 
in isolation 
 
Yes Prospective CES-D 
1 day pre-
CABG 
26% mild 
depression 
(CES-D 16–
26) 
 
12% 
moderate 
to severe 
depression 
(CES-D ≥27) 
Borowicz et al. 
(2002) (follow-
up study of 
McKhann et al. 
(1997) dataset) 
172 (134 
male, 38 
female) 
Elective first-
time or re-do 
CABG in 
isolation 
No Prospective CES-D 
≥1 day pre-
CABG 
32% 
depressed 
(CES-D≥16) 
Burg, 
Benedetto, 
Rosenberg, et 
al. (2003) 
89 male 
Urgent and 
elective, first-
time or re-do, 
CABG in 
isolation 
No Prospective BDI 
≤1 week 
pre-CABG 
28.1% 
depressed 
(BDI≥10) 
Dunkel et al. 
(2009) 
1238 CABG No 
Cross-
sectional 
PHQ-9 
1-3 days 
pre-CABG 
21.6% 
depressed 
(PHQ-9≥10) 
Krannich et al. 
(2007) 
142 Elective CABG No Prospective HADS 
2 days pre-
CABG 
25.8% 
depressed 
(HADS≥8) 
Langeluddecke, 
Fulcher, Baird, 
Hughes, & 
Tennant (1989) 
89 
Elective, first-
time CABG 
No Prospective CES-D 
2 days pre-
CABG 
36% 
depressed 
(CES-D>15) 
McKhann, 
Borowicz, 
Goldsborough, 
Enger, & Selnes 
(1997) 
124 (100 
male, 27 
female) 
Elective first-
time or re-do 
CABG in 
isolation 
No Prospective CES-D 
≥1 day pre-
CABG 
27.4% 
depressed 
(CES-D≥16) 
Mitchell et al. 
(2005) 
123 
Elective CABG 
in isolation 
No Prospective 
MINI 
 
 
BDI 
≤28 days 
pre-CABG 
28.2% 
depressed 
 
39% 
depressed 
(BDI≥10) 
 
39 
 
Oxlad & Wade 
(2006) 
119 (100 
male, 19 
female) 
Elective CABG 
+/- valve 
replacement 
No 
Cross-
sectional 
DASS-D 
90% 
between 2-
112 days 
pre-CABG 
14.3% 
depressed 
(DASS-
D≥10) 
Phillips-Bute et 
al. (2008) 
(sub-study of 
Blumenthal et 
al. (2003) 
cohort) 
427 (299 
male,  
128 
female) 
Elective on-
pump CABG in 
isolation 
Yes Prospective CES-D 
1 day pre-
CABG 
36.8% 
depressed 
(CES-D>16) 
Pirraglia, 
Peterson, 
Williams-Russo, 
Gorkin, & 
Charlson (1999) 
237 Elective CABG No Prospective CES-D 
1 day - 1 
week pre-
CABG 
43.1% 
depressed 
Timberlake et 
al. (1997) 
121 (109 
male, 12 
female) 
Elective CABG No Prospective BDI 
Pre-CABG 
(no time 
frame 
defined) 
37% 
depressed 
(BDI≥9) 
Tully, Baker, & 
Knight (2008) 
440 (360 
male, 90 
female) 
Elective, first-
time, on-pump 
CABG +/- valve 
replacement 
No 
Cross-
sectional 
DASS-D 
1 day - 1 
week pre-
CABG 
20% 
depressed 
(DASS-
D≥10) 
Yang et al. 
(2012) 
232 
Elective, first 
time CABG 
No Prospective PHQ-9 
≥3 days 
pre-CABG 
18.1% 
depressed 
(PHQ-9≥10) 
Post-CABG depression 
Blumenthal et 
al. (2003) 
555 
Elective CABG 
in isolation 
Yes Prospective CES-D 
6 months 
post-CABG 
20.5% 
depressed 
(CES-D≥16) 
Borowicz et al. 
(2002) (follow-
up study of 
McKhann et al. 
(1997) dataset) 
147 
 
 
 
128 
 
 
117 
First-time or re-
do CABG in 
isolation 
No Prospective CES-D 
1 month 
post-CABG 
 
1 year 
post-CABG 
 
5 years 
post-CABG 
28% 
depressed 
(CES-D≥16) 
 
21% 
depressed 
(CES-D≥16) 
 
16% 
depressed 
(CES-D≥16) 
Burg, 
Benedetto, 
Rosenberg, et 
al. (2003) 
89 male 
Urgent and 
elective, first-
time or re-do, 
CABG in 
isolation 
No Prospective BDI 
6 months 
post-CABG 
13.5% 
depressed 
(BDI>10) 
Connerney, 
Shapiro, 
McLaughlin, 
Bagiella, & 
Sloan (2001) 
309 (207 
male, 
102 
female) 
Urgent and 
elective, first-
time or re-do, 
CABG +/- valve 
replacement 
No 
Cross-
sectional 
Clinical 
interview 
(modified 
DSM-IV 
criteria) 
 
BDI 
4-10 days 
post-CABG 
 
20.4% 
depressed 
 
 
28% 
depressed 
(BDI≥10) 
 
 
 
 
40 
 
Doering et al. 
(2006) 
 
75 
female 
 
 
 
 
 
55 
female 
First-time CABG No Prospective DISH 
Prior to 
discharge 
post-CABG 
 
2-4 weeks 
post- 
discharge 
 
6 months 
post- 
discharge 
 
36% 
depressed 
 
 
 
16.4% 
depressed 
 
 
12.8% 
depressed 
 
Krannich et al. 
(2007) 
132 Elective CABG No Prospective HADS 
10 days 
post-CABG 
17.5% 
depressed 
(HADS≥8) 
Kustrzycki et al. 
(2012) 
37 
Elective on-
pump CABG 
No Prospective BDI 
8 years 
post-CABG 
37.8% 
depressed 
(BDI>13) 
Langeluddecke, 
Fulcher, Baird, 
Hughes, & 
Tennant (1989) 
89 
Elective, first-
time CABG 
No Prospective CES-D 
6 months 
post-CABG 
 
1 year post-
CABG 
26% 
depressed 
(CES-D>15) 
 
22% 
depressed 
(CES-D>15) 
McKhann, 
Borowicz, 
Goldsborough, 
Enger, & Selnes 
(1997) 
124 (100 
male, 27 
female) 
Elective first-
time or re-do 
CABG in 
isolation 
No Prospective CES-D 
1 month 
post-CABG 
 
1 year post 
CABG 
24.2% 
depressed 
(CES-D≥16) 
 
19.4% 
depressed 
(CES-D≥16) 
Mitchell et al. 
(2005) 
120 
Elective CABG 
in isolation 
No Prospective 
MINI 
 
 
 
BDI 
6-12 weeks 
post-CABG 
16.4% 
depressed 
 
30% 
depressed 
(BDI≥10) 
Phillips-Bute et 
al. (2008) (sub-
study of 
Blumenthal et 
al. (2003) 
cohort) 
420 
 
 
 
 
411 
Elective on-
pump CABG in 
isolation 
Yes Prospective CES-D 
6 months 
post-CABG 
 
 
1 year post 
CABG 
17% male, 
33% female 
depressed 
(CES-D>16) 
 
17% male, 
32% female 
depressed 
(CES-D>16) 
Pirraglia, 
Peterson, 
Williams-Russo, 
Gorkin, & 
Charlson (1999) 
219 Elective CABG No Prospective CES-D 
6 months 
post-CABG 
23.4% 
depressed 
(CES-D≥16) 
Timberlake et 
al. (1997) 
121 (109 
male, 12 
female) 
Elective CABG No Prospective BDI 
8 days 
post-CABG 
 
8 weeks 
post-CABG 
 
1 year post-
CABG 
50% 
depressed 
(BDI≥9) 
 
24% 
depressed 
(BDI≥9) 
 
23% 
depressed 
(BDI≥9) 
Yang et al. 
(2012) 
232 
Elective, first 
time CABG 
No Prospective PHQ-9 
6 months 
post-CABG 
18.1% 
depressed 
(PHQ-9≥10) 
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CABG has been shown to have negative emotional effects, and both severe depression 
in the clinical range and subclinical milder depression are common sequelae (Pignay-Demaria, 
Lespérance, Demaria, Frasure-Smith, & Perrault, 2003). Prevalence of depression has been 
found to vary widely both before and after CABG surgery; Table 1.2 summarises these studies. 
Before CABG the prevalence of depression has been shown to be between 14.3% and 43.1%, 
while after surgery estimates are between 12.8% and 50%. These prevalence data were used 
to calculate weighted means: on average 28.22% of patients were depressed pre-surgery and 
post-surgery 28.17% of patients were depressed. Therefore, overall estimates suggest similar 
prevalence rates both pre- and post-operatively; however, assessment timing is likely to 
influence the rate of post-operative depression, with the prevalence rate tending to peak 
shortly after surgery and declining in the succeeding months.  There may be several reasons 
for the variability across studies, namely issues with: measurement, study design and inclusion 
and exclusion criteria. 
The choice of measurement tool (e.g. questionnaire, clinical interview) presents 
several issues.  The cut-off implemented by researchers to determine caseness varies greatly 
between studies, even among those using the same instrument. In particular, the study by 
Timberlake and colleagues (Timberlake et al., 1997) used a cut-off of ≥9 on the BDI, which may 
in large part account for their finding of 50% depression cases in the days following surgery. 
This is a much higher estimate than others who also used the BDI found. Also related to 
measurement is the fact that the criteria for the different instruments vary, so prevalence may 
not be consistent, especially given the overlap between somatic depression symptoms and 
illness symptoms.  
The second broad issue with the prevalence data concerns the study design, which 
varies across studies. While the majority of studies cited have the advantage of using a 
prospective design, tracking patient’s depression symptoms from pre- to post-operative 
stages, several studies only report cross-sectional data (Baker, Schrader, & Knight, 2001; 
Beresnevaitė et al., 2010; Connerney, Shapiro, McLaughlin, Bagiella, & Sloan, 2001; Dunkel et 
al., 2009; Oxlad & Wade, 2006; Tully, Baker, & Knight, 2008). One of the principal issues 
surrounding cross-sectional data in cardiac patients is that little can be discovered about how 
depression progresses, for example whether it persists or resolves following surgery. Another 
issue with the study design is the timing of assessments. While the majority of studies assessed 
depression the day prior to surgery, the post-operative assessment point varies widely across 
studies, with some studies using assessments just days after surgery (Connerney et al., 2001; 
Doering, Magsarili, Howitt, & Cowan, 2006; Krannich et al., 2007; Timberlake et al., 1997) while 
others had much longer follow-ups of five (Borowicz et al., 2002) and eight (Kustrzycki et al., 
2012) years. This makes it difficult to directly compare the results across the different studies. 
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It is important to note that this latter study  (Kustrzycki et al., 2012) had a small sample of only 
37 participants, which limits the conclusions to be drawn from the data due to potential bias 
and risk of committing a type I or II error.   
The third general issue surrounds the use of study inclusion and exclusion criteria, 
namely the surgical procedure, the sex of participants and current treatment for depression. 
CABG surgery is often broadly defined in research studies to include elective and emergency 
cases, CABG in isolation or in conjunction with another procedure, first-time and re-do cases, 
and on-pump and off-pump. In reviewing the literature it is notable how ill-defined and 
unspecific the phrase ‘CABG surgery patients’ is used; few studies provided full details on the 
type of CABG surgery participants underwent. In addition, even if participants were 
characterised as, for example, elective cases, more detailed information is not provided, such 
as length of time spent on the waiting-list. Nor is it clear how long after a patient’s first 
manifestation of CHD the surgery was performed, which would provide an indication of the 
chronicity of the underlying cardiac disease. This information is necessary to make direct 
comparisons in prevalence rates since the sample demographic is likely to vary according to 
the type of procedure performed. Another inclusion criteria that varies across studies is the 
sex of participants, with some studies including only men (Beresnevaitė et al., 2010; Burg, 
Benedetto, Rosenberg, et al., 2003), one study including only women (Doering et al., 2006) and 
the remainder using mixed sex samples. Depression has been shown to be more common in 
female than male CABG surgery patients (Phillips-Bute et al., 2008), but some studies report 
mixed findings (Mitchell et al., 2005) and most studies report prevalence rates irrespective of 
sex, making it hard to disentangle the relationship entirely. Psychiatric history and current use 
of depression treatment is also inconsistently taken into account across studies, with only the 
studies by Blumenthal and colleagues (Blumenthal et al., 2003) and Phillips-Bute and 
colleagues (Phillips-Bute et al., 2008) excluding those participants being treated for depression 
at study entry, which may otherwise mask depression symptoms. Despite the methodological 
limitations making it difficult to draw robust conclusions, it seems clear that depression is 
commonly experienced by cardiac patients both before and after CABG surgery. 
1.4.2.2 Depression and cardiac morbidity 
Depressive symptoms after CABG have been shown to significantly increase the risk of graft 
disease progression (Wellenius et al., 2008) and hospital readmissions (Tully, Baker, Turnbull, 
& Winefield, 2008). In addition, depression has been associated with poorer functional 
recovery such as shorter walking distances (Doering, Moser, Lemankiewicz, Luper, & Khan, 
2005) and poorer physical recovery including more infections and impaired wound healing 
(Doering, Martínez-Maza, Vredevoe, & Cowan, 2008; Doering et al., 2005; Kendel et al., 2010). 
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In another study, Burg and colleagues (Burg, Benedetto, Rosenberg, & Soufer, 2003) found 
that patients who were depressed pre-surgery had higher levels of medical complications 
during the six months following surgery, and were more likely to report poor quality of life and 
worse recovery. Moreover, two years after surgery pre-surgery depression was linked to 
greater risk of death (Burg, Benedetto, & Soufer, 2003).   
Two landmark studies in the Lancet documented the impact of depression on survival 
following CABG. Blumenthal and colleagues (Blumenthal et al., 2003) studied 817 patients 
awaiting CABG for an average follow-up of 5.2 years. In models adjusting for age, sex, number 
of grafts, diabetes, smoking, LVEF, and previous MI, patients with pre-CABG depression had 
increased risk of death from all causes compared to those without depression. Specifically, 
these authors also reported a dose-response relationship such that severity of depression was 
predictive of mortality, with moderate to severe depression (n = 97) significantly increasing risk 
of all-cause mortality (HR 2.37, 95% CI 1.40-4.00, p = 0.001) while mild depression (n = 213) did 
not (HR 1.08, 95% CI 0.70-1.67, p = 0.723). In secondary analyses, event rates were analysed 
comparing the mortality rates between those patients who had pre-CABG depression but had 
remitted at six-month follow-up (10% of whom died), those who were never depressed (10% 
of whom died), those with new onset depression post-CABG (14% of whom died), and those 
who were persistently depressed (19% of whom died), indicating that there was a trend 
towards those with more severe depression (either persistent or new onset) being at greatest 
risk. However, due to the small event rate, further studies are required before firm conclusions 
can be drawn. Another limitation of this study includes the reliance on a questionnaire 
measure of depression, with no clinical diagnostic tool being used. The second study published 
was by Connerney and colleagues (Connerney et al., 2001) who used standard diagnostic 
interviews in 309 patients in the days following CABG assessing for both current and history of 
depression. Patients were followed up at six and 12 months. They found that post-CABG 
depression was an independent risk factor for cardiac events after controlling for other risk 
factors including disease severity. However, they did not distinguish between those with 
recurrent as opposed to new onset depression. In addition, this study only measured 
depression post-operatively and therefore the progression of depression symptoms over time 
was not able to be studied objectively.   
While there is extensive research using ACS patients, there is a distinct lack of research 
investigating depression to the same level of detail in CABG patients. For example, does 
depression with onset pre-CABG and post-CABG follow similar patterns to that observed in MI 
patients? Are some types of depression symptoms more cardiotoxic than others in CABG 
patients? Can depression in CABG patients be effectively treated? Taken together, these 
questions again ask whether depression in cardiac patients can be seen as distinct from that 
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observed in psychiatric populations. Depression in CABG patients remains relatively 
underexplored, indeed one of the few studies to date which has begun to address these issues 
has been published recently (Connerney, Sloan, Shapiro, Bagiella, & Seckman, 2010). In 
particular, these authors were interested in unpicking the relevance of depression symptom 
subtypes and depression onset in predicting cardiac mortality after CABG.  
In order, to distinguish between the different depression onset subtypes, a recent 
paper by Zuidersma and colleagues (Zuidersma et al., 2011, p.228) devised a schematic 
representation to neatly depict the different depression onset subtypes, which is displayed in 
Figure 1.2.  This figure shows how we can distinguish between first-ever depression as 
opposed to recurrent depression, post-CABG onset depression as compared to pre-CABG onset 
depression and incident (or new onset) depression versus non-incident depression.  
Depression as a consequence of a cardiac event refers to post-CABG onset and could be either 
first-ever (i.e. incident) or recurrent. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1.2: MODELS OF DEPRESSION IN CABG 
(Adapted from: Zuidersma et al., 2011, p.228) 
CABG CABG CABG CABG 
CABG CABG CABG CABG 
CABG CABG CABG CABG 
Post-CABG onset Pre-CABG onset 
Terminology 
 
First-ever: From the onset of the depressive episode there was no period of feeling better 
and normal functioning lasting at least 2 months.  
Post-CABG onset: A depressive episode that has an onset after the CABG event (i.e. 
during the CABG the patient was not depressed).  
Incident: A depressive episode meeting both of the abovementioned criteria (i.e. first-
ever and post-CABG onset).  
Incident Non-incident 
First-ever Recurrent 
Comparison 1: First-ever versus recurrent depressive episodes  
Comparison 2: Post-CABG onset versus pre-CABG onset depressive episodes  
Comparison 3: Incident versus non-incident onset depressive episodes  
Depression ↑ 
Depression ↑ 
Depression ↑ 
45 
 
In a 10-year follow-up study of the original cohort (Connerney et al., 2001), these 
authors found post-CABG depression was significantly associated with elevated cardiac 
mortality. Importantly, these authors further explored the relevance of depression onset for 
prognosis. In models adjusted for sex, age, ejection fraction and diabetes, those patients with 
new onset depression (n = 39) (HR 2.12, 95% CI 1.09-4.15, p = 0.03) had twice the risk of 
cardiac mortality compared with those patients who had never been depressed (n = 198). 
Recurrent depression (n = 24) was not significantly different to the never depressed group (HR 
1.72, 95% CI 0.78-3.80, p = 0.18). These authors also compared depression symptoms, finding 
cognitive/affective but not somatic symptoms to be predictive of cardiac mortality in models 
adjusted for confounders. These results have been supported by another recent study of 
morbidity and mortality in CABG patients, which also found cognitive depressive symptoms to 
be particularly damaging (Tully, Winefield, Baker, Turnbull, & De Jonge, 2011). These findings 
are contradictory to findings from MI patients and need to be corroborated by future research. 
It is also important to note that not all studies have supported the association between 
depression and increased mortality following CABG (Borowicz et al., 2002; Peterson et al., 
2002). However, these studies may have been under powered to find a significant effect. The 
study by Borowicz and colleagues studied the association between depression one month 
following CABG surgery and cardiac morbidity and mortality up to five years following surgery; 
however there were only 41 cases of depression, which may explain the null findings. The 
study by Peterson and colleagues investigated the effect of new onset depression cases at six 
months post-CABG on mortality at three-year follow-up, producing results of borderline 
significance (p = 0.054); these results may similarly be explained by the small number of 
depression cases (n = 12). In addition, a recent study has also noted the high prevalence of 
complicated grief in depressed CABG patients (Ghesquiere et al., 2011). Complicated grief is 
classified in the DSM-IV as a bereavement-related adjustment disorder, characterised by an 
inability to accept the death of a loved one, extreme feelings of sorrow and emotional pain, 
and a lack of future planning in one’s own life. The conceptual overlap that complicated grief 
has with depression demands awareness so that patients are not misdiagnosed in research 
studies.  
Interventions designed to improve emotional wellbeing after CABG have shown mixed 
results. Positive results were found by Freedland and colleagues (Freedland et al., 2009) who 
conducted a 12-week randomised controlled trial to assess the efficacy of two different types 
of non-pharmacological treatment for depression after CABG, in comparison to usual care 
controls. Results showed significantly higher rates of remission in depressed patients who 
received cognitive behavioural therapy (n = 41) or supportive stress-management (n = 42) 
compared to usual care controls (n = 40), at three- and nine-month follow-up.  A more recent 
46 
 
intervention study, the Bypassing the Blues trial, investigated the impact of a telephone 
delivered collaborative care intervention in post-CABG depressed patients (n = 150), compared 
to usual care depressed controls (n = 150) and non-depressed controls (n = 150). The primary 
aim of this study was to improve health-related quality of life, with secondary aims to improve 
mood, cardiovascular morbidity, employment, health service use and treatment costs. The 
intervention group received a tailored nurse-led telephone delivered programme for up to 
eight months following CABG. Specifically, they provided both written and oral educational 
materials and offered a variety of treatment options including initiation and adjustment of 
antidepressant medications, referral to community mental health services and, where 
appropriate, watchful waiting. Results showed significant improvements in health-related 
quality of life and mood in the intervention group compared to usual care controls, however 
the effect was stronger for men than women (Rollman & Herbeck Belnap, 2011; Rollman et al., 
2009). Other studies have produced less convincing results. For example, the results of a 
home-based psychological and informational intervention programme by Lie and colleagues 
(Lie, Arnesen, Sandvik, Hamilton, & Bunch, 2007) reported mixed results, finding that while 
significant improvements in depression symptoms over the six-month follow-up period were 
observed, there were no significant differences between the intervention and control arms of 
the study. An intervention administered prior to surgery was able to reduce depression 
compared to usual care, but these effects were not maintained in the post-operative period 
(Furze et al., 2009). Another study reported damaging results of a behavioural risk modification 
programme, with usual care controls improving significantly more than the intervention group 
(Sebregts, Falger, Appels, Kester, & Bär, 2005). In conclusion, there is some evidence to 
suggest that depression may be amenable to change in these patients, but more work is 
needed to explore the best treatment methods. Research exploring the mechanisms 
underpinning the relationship between depression and poor cardiac outcomes would also 
likely aid these interventions, providing a theoretical framework for treatment strategy. 
1.5 Anxiety, negative affect and coronary heart disease 
The depression literature by far outweighs studies of other psychological disorders in relation 
to poor cardiac outcomes. However, recent attention has also highlighted the role of anxiety 
and its prevalence in CHD patients. Some authors propose that depression and anxiety should 
be conceptualised as a single state of negative affectivity. These arguments are outlined 
below.  
 
 
47 
 
1.5.1 Anxiety 
Anxiety disorders refer to a collection of different diagnoses, including generalised anxiety 
disorder (GAD), panic disorder, phobic disorder and post-traumatic stress disorder, among 
others. Common to all anxiety disorders are intense and excessive feelings of fear and worry 
that impact on an individual’s ability to function as usual in everyday life. According to the 
DSM-IV, GAD refers to chronic feelings of anxiety and worry that are not specific to a single 
object or situation, that are difficult to control, and that persist on more days than not for at 
least six months. At least three accompanying symptoms must also be present, to include: 
feelings of restlessness or being ‘on edge’, fatigue, difficulty in concentrating, irritability, 
muscle tension and sleep disturbance. In panic disorder, an individual suffers from a discrete 
period of intense fear or discomfort that arises quickly and peaks within about 10 minutes of 
onset. Such episodes or ‘panic attacks’ are accompanied by at least four somatic (e.g. 
palpitations, shortness of breath) or cognitive symptoms (e.g. derealisation or 
depersonalisation, fear of dying). 
There is growing evidence surrounding the role of anxiety in predicting poorer 
prognosis in those patients with CHD (Player & Peterson, 2011). For example, in patients with 
stable heart disease, anxiety was able to predict increased risk of cardiac events in two large-
scale prospective studies (Martens, de Jonge, et al., 2010; Moser et al., 2011). Moreover in ACS 
patients, a recent meta-analysis concluded that anxiety following MI is associated with a 36% 
increased risk of adverse cardiac outcomes (Roest, Martens, Denollet, & de Jonge, 2010).  
These observations in MI patients were recently confirmed in a 10-year follow-up study of 438 
MI patients showing that three months after MI, those patients with GAD (n = 24) were almost 
twice as likely to experience adverse events (mortality or cardiac-related hospital 
readmissions) than those without GAD, even after controlling for baseline disease severity, 
demographic and depression variables (Roest, Zuidersma, & de Jonge, 2012). Similar 
observations have also been reported in CABG patients. Tully and colleagues (Tully, Baker, & 
Knight, 2008) found that those patients with higher levels of pre-operative anxiety were at 
greater risk of mortality (HR 1.88, 95% CI 1.12–3.17, p = 0.02). Another study has also 
confirmed the effect of anxiety on mortality in patients who had previously undergone CABG 
surgery (Rosenbloom, Wellenius, Mukamal, & Mittleman, 2009). Oxlad and colleagues showed 
anxiety in the immediate post-operative period was associated with greater hospital 
readmissions six months after CABG (Oxlad, Stubberfield, Stuklis, Edwards, & Wade, 2006). It is 
not yet clear to what extent anxiety predicts cardiac morbidity and mortality over and above 
depression and to what extent they can be considered overlapping disorders.  
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1.5.2 Negative affectivity: unifying psychological constructs 
Depression and anxiety often present as co-morbid conditions, which may partly be explained 
by the common symptom criteria for both disorders. Theories have been proposed in which 
anxiety and depressive disorders should be viewed collectively as part of a higher-order 
diagnosis of negative affectivity, characterised by heightened levels of distress, negative 
emotionality and neuroticism (Andrews et al., 2009; Brown & Barlow, 2009; Prenoveau et al., 
2010; Watson, 2009). Symptom clusters within negative affectivity have been identified and 
have been described as ‘anxious-misery’, including DSM-IV diagnoses of major depression, 
dysthymia, GAD and post-traumatic stress disorder, and ‘visceral fear’ including panic and 
phobic anxiety disorders (Krueger, 1999). Another method of grouping disorders does not look 
for symptom clusters, but instead identifies unique phenotypic2 variance that best represents 
each disorder. For example, low positive affect has been shown to be characteristic of 
depression, whereas somatic hyperarousal is a key trait in panic disorder (Prenoveau et al., 
2010; Watson, 2009).   
These issues have recently been investigated in 158 CHD patients prior to undergoing 
CABG surgery (Tully & Penninx, in press). Findings showed that symptom scores for somatic 
anxiety and low positive affect scores were able to detect cases of panic disorder and 
depression respectively. These authors did not find trait negative affect, anxious-misery or 
visceral fear to be an optimal screen for any emotional disorder.  However, it is not clear to 
what extent such classifications can predict cardiac outcomes over and above the current 
depression and anxiety definitions.  As such, more work is needed to explore the differential 
effects of anxiety and depression in greater detail, as it is unclear whether negative affectivity 
is more important than either depression or anxiety alone. 
1.6 Chapter summary 
Depression and CHD are common co-morbidities which present a challenge to researchers to 
understand why depression in combination with CHD increases morbidity and mortality in 
both ACS and CABG patients. Methodological issues arise in terms of how best to 
operationalise depression and in understanding to what extent depression presents a unique 
predictor of cardiac prognosis over and above other psychological disorders, including 
depression, vital exhaustion, complicated grief and anxiety. These problems all need to be kept 
in mind when interpreting the literature in this area.  
To understand the interaction between depression and CHD not only requires 
understanding of the direction of any causal relationship, but also the underlying mechanisms 
                                                          
2
 Phenotype refers to observable characteristics or traits. 
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and pathways involved. Only by doing this are we able to devise targeted and efficient 
interventions to tackle morbidity and mortality in these patients. These issues will be explored 
in the next chapter.     
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Chapter 2. Literature review (II): Understanding causal 
mechanisms 
2.1 Introduction 
Both antecedent and consequence models have been investigated, such that depression has 
been shown to be both a precursor to and consequence of CHD; these models are depicted in 
Figure 2.1. The literature relevant to both these models will be described below discussing 
whether there is consistent and reliable evidence in favour of depression causing both clinical 
and subclinical manifestations of CHD, or whether it is instead better to view depression as a 
consequence of underlying CHD disease processes (for a review see Steptoe, 2007; Williams & 
Steptoe, 2007). Methodological considerations will also be highlighted, in particular the timing 
of depression assessment. In addition, depression will be described as a prognostic factor, 
explaining the association between CHD and poor cardiac outcomes in some patients. Finally, 
cardiac surgery will be described as a model in which we can better elucidate the causal and 
mechanistic pathways linking depression and poor cardiac outcomes. 
 
 
ANETECEDENT MODEL: 
 
 
 
 
 
CONSEQUENCE MODEL: 
 
 
 
 
 
FIGURE 2.1: ANTECEDENT AND CONSEQUENCE CAUSAL MODELS OF DEPRESSION AND CHD 
 
 
 
Depression 
Depression 
CHD 
CHD 
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2.2 Determining causality 
Depression as an aetiological factor in the development of CHD has been subject to much 
interest and debate. Causality can be investigated using different research methods to 
establish whether those who are depressed or who have elevated depression symptoms are at 
increased risk of cardiac events in the future. The studies discussed here all used a clinical 
measure of CHD, with objectively verifiable outcomes such as MI, in order to transcend issues 
surrounding self-report data and recall bias. The earliest studies to suggest a link between 
psychological attributes and cardiac health were cross-sectional, showing depression to be 
more common in CHD patients compared to healthy controls. For example, the Interheart 
study used a case-control design with data from across 52 countries and over 12 thousand 
first-time MI patients and matched controls. Results showed a 9% population attributable risk 
(PAR)3 of depression symptoms being associated with MI (Rosengren et al., 2004). However, 
studies of this type are limited since they are unable to determine the temporal relationship, 
that is whether depression precedes CHD onset or vice versa.  
Other studies have made use of longitudinal designs, following a cohort of participants 
over time to determine the onset of depression in relation to the onset of cardiac symptoms. 
One such study showing a prospective association between depression and risk of future 
cardiac events was by Anda and colleagues (Anda et al., 1993), who used USA data from 2832 
participants in the National Health and Nutrition Examination Survey cohort. They followed 
individuals free from cardiac and other chronic illnesses at baseline for an average of 12.4 
years, finding that depression symptoms were associated with a 50% increased risk of cardiac 
mortality compared to those who were not depressed (relative risk 1.5, 95% CI 1.0-2.3). UK 
data have also replicated these findings (Surtees et al., 2008), showing in individuals free from 
CHD at baseline, elevated depressive symptoms in the year preceding baseline assessment was 
associated with greater risk of cardiac mortality over a median follow-up period of 8.5 years. 
These results have also been supported more recently (Brown et al., 2011) and have been 
subjected to systematic review (Kuper et al., 2002; Wulsin & Singal, 2003) and meta-analysis 
(Nicholson, Kuper, & Hemingway, 2006; Rugulies, 2002; Van der Kooy et al., 2007), also finding 
in favour of this association, independent of possible confounders. Indeed, the systematic 
review of prospective cohort studies by Kuper and colleagues (Kuper et al., 2002) 
demonstrated that in individuals free from disease at baseline, the presence of depression 
symptoms was related to an increased risk of future cardiac events, both fatal and non-fatal, 
up to 40 years later (c.f. Ford et al., 1998). However, these authors have also cautioned that 
careful interpretation of the literature is required, and while results from their horizontal 
                                                          
3
 PAR can be defined as the proportion of all cases attributable to the given factor, if causality was proven.  
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systematic review show a relative risk of 1.9 for CHD in depressed patients, they discuss how 
the European guidelines for CHD prevention (De Backer et al., 2003) prioritise depression over 
and above other important risk markers such as the inflammatory marker, C-reactive protein 
(CRP) (Kuper et al., 2009). Inflammatory processes are discussed in this literature review in 
Section 2.6.4.   
Other authors have also argued that care must be taken when considering these 
results, as heterogeneity between studies exists. For example, some studies have found that 
major depression carries more risk than minor depression (Penninx et al., 2001), and clinical 
depression diagnosed by interview has been reported to be a better predictor than depressive 
symptoms as measured using standardised questionnaires (Rugulies, 2002). Moreover, the 
review by Kuper and colleagues (Kuper et al., 2009) pointed to problems with reverse causality 
and publication bias in the depression-CHD field. Other methodological issues also exist in this 
literature, as discussed in a review by Frasure-Smith and Lespérance (Frasure-Smith & 
Lespérance, 2005). These authors argue that despite the large number of empirical studies and 
reviews showing in favour of depression as a risk factor for future cardiac mortality, 
cardiologists have yet to seriously take note because of issues surrounding low sample sizes, 
the heterogeneity of depression measures, frequent repeat publications using the same data, 
as well as inconsistencies in the control of covariates. Consequently, researchers need to pay 
greater attention to standardising their approach to this issue. Regardless, the weight of 
evidence does conclude in favour of depression preceding the onset of cardiac events. 
However, the relationship becomes less clear-cut when the aetiology of CHD is considered as a 
process which begins in childhood.  
 Studies have sought to investigate whether depression is involved in the long term 
evolution of cardiac disease as well as being related to its clinical manifestations. These studies 
have become possible in recent years with the advent of non-invasive methods of measuring 
atherosclerosis, including measures of intima-media thickness using ultrasonography 
techniques and measures of coronary artery calcification using computed tomography. 
Research of this type has been able to add to our understanding of the temporal relationship 
between depression and CHD. Atherosclerosis is a progressive disease, and post-mortem 
evidence of young (aged 15-34 years) victims of accidental or violent death has shown the 
extent of stenosis to be associated with risk factors such as smoking and high serum 
cholesterol (Zieske, Malcom, & Strong, 2002). This means it is difficult to establish that 
depression precedes the development of atherosclerotic disease underlying CHD, even in a 
prospective study that involves participants who are apparently healthy at baseline. For 
example, it could be argued that subclinical CHD causes biological changes, which in some 
susceptible individuals can cause depression. In this scenario, depression would then act to 
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compound these biological changes, perhaps also causing unhealthier lifestyle choices and 
eventually leading to clinical manifestations of the disease in these vulnerable individuals. 
However, this debate is largely hypothetical and has not been supported in a recent 
large-scale cohort study which tracked the progression of subclinical atherosclerosis on 
incident (i.e. new onset) depression risk in 3564 community-dwelling older adults over a six-
year follow-up (Newson et al., 2010). This study found no evidence to suggest that underlying 
subclinical atherosclerosis increased the risk of incident depression onset, concluding that 
depression either contributes to vascular burden or that both are caused by a third, 
unmeasured, biological process. It is important to note that this study used measures of 
extracoronary atherosclerosis as a proxy measure of coronary atherosclerosis. Another 
prospective study has supported the association between higher baseline levels of depression 
with greater subclinical atherosclerosis at three-year follow-up, using a measure of carotid 
intima-media thickness in 324 healthy, community dwelling men and women (Stewart, Janicki, 
Muldoon, Sutton-Tyrrell, & Kamarck, 2007). Others studies have used cross-sectional designs, 
with mixed results. For example, one study found depressed patients to be at greater risk of 
subclinical heart disease, as measured by carotid intima-media thickness, compared to healthy 
controls (Seldenrijk et al., 2010), while others have not supported the association using 
measures of coronary calcification (Diez Roux et al., 2006; Matthews, Owens, Edmundowicz, 
Lee, & Kuller, 2006). It is not clear to what extent the different measurement techniques 
explain the disparate findings. Moreover, single assessments of depression may raise problems 
regarding reliability and validity, since mood is likely to be affected by environmental and 
situational factors, and previous research has shown multiple assessments of depression, but 
not single assessments, to be associated with the extent of coronary artery calcification 
(Hamer, Kivimaki, Lahiri, Marmot, & Steptoe, 2010). Future work is needed to address these 
methodological issues, however it seems plausible from these initial studies that depression 
contributes not only to the clinical manifestations of CHD, but also to the underlying disease 
pathology. 
Another methodological concern is with regards to the timing of depression in relation 
to the cardiac event (Steptoe, 2007). This is relevant since depression that is particularly 
cardiotoxic may have certain features that distinguish it from other, less cardiotoxic, forms. For 
example, it has been thought that depression may be causally related to acute coronary events 
only in those with advanced disease. However, the prospective cohort study by Anda and 
colleagues (Anda et al., 1993) accounted for this by excluding those who had died within two 
years of the psychological assessment, finding the relationship between depression and future 
cardiac mortality remained. As such it is thought that depression is an important predictor of 
cardiac endpoints even for those with less advanced disease. Moreover, the problem of 
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singular assessment points is also relevant here, since it is possible that depression that varies 
according to its transience and severity may have differential effects on CHD outcomes. 
Penninx and colleagues (Penninx et al., 1998) analysed CHD events in a sample of 3701 older 
adults with repeated measurements of depression symptoms over a six-year period. These 
authors were able to show that CHD risk was greatest for newly depressed participants as 
opposed to those with a more chronic course of depression symptoms. This supports the 
earlier discussion (Section 1.4.1) that depression with new onset may be particularly 
damaging. Indeed, another possibility is that the onset of a depressive episode could actually 
act as a trigger for an ACS; a trigger being an external stimuli, emotional state, or other activity 
that provokes an acute pathophysiological change directly causing the start of a coronary 
event (Strike & Steptoe, 2005). Steptoe’s group found that in 295 men and women admitted to 
hospital for ACS, who were interviewed regarding their emotional state in the two hour period 
prior to symptom onset, that 18.2% had experienced depressed mood in this hazard period 
(Steptoe, Strike, Perkins-Porras, McEwan, & Whitehead, 2006). This highlights the fact that 
depression may not only have accumulative effects but may also have an acute effect in 
vulnerable individuals. Taking all these issues into account, it seems that methodological issues 
surrounding the measurement of depression are key to understanding its causal relationship 
with CHD.  
The difficulty arises when one attempts to reconcile our understanding that depression 
leads to greater cardiac risk, with the literature previously described in Chapter 1, in which an 
ACS and CABG surgery have both been found to be capable of triggering a first-time depressive 
episode (see Section 1.4). In a systematic review, incident (i.e. new onset) depressive episode 
patients were shown to have a less severe course and were less likely to have a previous 
history of MI, than non-incident depressed ACS patients (Zuidersma et al., 2011). The reasons 
for this are not clear, but as alluded to earlier, it could be that new onset/incident depression 
is distinct from, or a unique subtype of, psychiatric depression in cardiac patients. These issues 
are part of an on-going debate within the literature (Bech, 2010; Ormel & de Jonge, 2011; 
Poole, Dickens, et al., 2011). The issue of causality has yet to be fully resolved, and research 
has meanwhile focussed on depression as a prognostic marker in CHD.  
2.3 Depression as a prognostic factor in CHD 
Depression has been described as a prognostic factor contributing to, or directly causing, poor 
cardiac outcomes in CHD patients. Opponents to this hypothesis would argue that a direct 
relationship between CHD and poor cardiac outcomes exists, such that the relationship 
between CHD and recurrent cardiac events is due to underlying coronary artery disease 
severity. Recurrent cardiac events and mortality are predicted by the extent of coronary 
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stenosis and by features of the ACS such as impaired left ventricular function. In a meta-
analysis of depression as a prognostic risk factor in CHD (all-cause mortality or fatal CHD), it 
was found that control of underlying heart disease is salient but inconsistently taken into 
account in studies of this type (Nicholson et al., 2006). These authors reported that, although 
the mortality risk is still present, it is reduced by 48% when LVEF is included in analyses. 
Surprisingly, only eight studies out of the 34 included in this meta-analysis actually reported 
LVEF adjusted analyses, highlighting the need for careful interpretation of the work in this 
area.  
A number of composite measures of risk have also been developed such as the Global 
Registry of Acute Events (GRACE) index that uses nine variables to predict survival, namely 
older age, history of MI, history of heart failure, increased pulse rate at presentation, lower 
systolic blood pressure at presentation, elevated initial serum creatinine level, elevated initial 
serum cardiac biomarker levels, ST-segment depression on presenting electrocardiogram, and 
not having a percutaneous coronary intervention performed in hospital (Eagle et al., 2004). 
The predictive value of the index for short- and longer-term morbidity has been confirmed in 
independent studies (Bradshaw, Ko, Newman, Donovan, & Tu, 2006; Tang, Wong, & Herbison, 
2007). Lett and colleagues (Lett, Ali, & Whooley, 2008) found no relationship between 
depression and disease severity in a sample of over 1000 outpatients with stable CHD. A more 
recent study of 457 patients with ACS showed that that even after adjusting for GRACE scores, 
the relationship between depression and future cardiac morbidity remained significant 
(Kronish, Rieckmann, Schwartz, Schwartz, & Davidson, 2009). Meurs and colleagues (Meurs, 
Zuidersma, Dickens, & de Jonge, in press) used data from 494 MI patients and studied 
associations of somatic/affective and cognitive/affective depression with recurrent cardiac 
events, before and after controlling for GRACE scores. Findings showed controlling for GRACE 
score did not affect the relationship of total depression score nor cognitive/affective 
depression on prognosis and only partly attenuated the risk of somatic/affective depression on 
prognosis. Consequently, depression can be considered a causal factor in cardiac prognosis, 
and a number of different mechanistic pathways have been proposed (see Sections 2.5 and 
2.6). We can gain a better understanding of these pathways by investigating these issues in 
different cardiac patient groups. In the following section, the case of cardiac surgery will be 
described.  
2.4 Depression and cardiac prognosis: The case of cardiac surgery 
The relative dearth of literature using CABG patients to explore the CHD-depression 
relationship is surprising considering the several advantages that a CABG population offers 
over MI patients. One difficulty in interpreting findings from ACS patients is that mental health 
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before the cardiac event is assessed retrospectively. Although this criticism could also be 
levelled at the Connerney studies (Connerney et al., 2001; Connerney et al., 2010), this 
problem has the potential to be overcome in studies of CABG patients, since measures of 
mood can be taken beforehand. Another problem is that the temporal relationship of 
depression and CHD is not clear and it is difficult to assess in ACS patients because of problems 
with defining the direction of the causal pathway: does depression cause CHD or vice versa? 
Since we can get true baseline measures of depression and disease severity (including 
measures of non-coronary disease) and because CABG actually physically manipulates the level 
of coronary stenosis, by studying CABG patients we are able to tease out the long-term effects 
of disease severity on depression and are more able to elucidate causal pathways. It is not 
clear why some patients who have CABG develop new onset depression: if it is due to 
underlying disease severity we would expect alleviation of the physical burden of the disease 
to lead all patients to show at least some improvements after surgery. Since this is not the 
case, other processes must be at play and potential mechanisms include demographic, clinical, 
behavioural, social, cognitive and biological factors. These factors have not been fully 
investigated in CABG patients, with pre-operative levels not adequately measured and 
perioperative factors rarely considered. The existing literature will be discussed in the 
following sections.  
However, throughout the subsequent discussion, several caveats need to be borne in 
mind. First, even though we can measure depression pre-operatively, this does not mean 
patients are being tested in a disease-free state. CABG surgery patients often have multivessel 
disease and many will have experienced an MI prior to revascularisation; therefore it is 
possible for pre-CABG depressed patients to also be classified as post-ACS depressed. 
Disentangling the relative risk associated with post-CABG depression over and above post-ACS 
depression thus becomes more complex in these patients. Moreover, even in those patients 
who have not experienced an MI, depression has been associated with greater subclinical 
disease (e.g. Stewart et al., 2007). Therefore, care needs to be taken to characterise depressed 
CABG patients as a heterogeneous group and the effects of depression need to be fully 
explored in relation to all these contributing factors.  
Second, although post-ACS depression provides a useful model on which we can base 
our research rationale and hypotheses, this does not amount to post-ACS and post-CABG 
depression being one in the same, even in new onset cases. While both ACS and CABG surgery 
provide a huge assault to the body’s resources, the psychological environment is likely to differ 
between the two scenarios. In particular, fear of dying in patients who have experienced an MI 
is thought to be an important factor in post-ACS depression (Steptoe et al., 2011; Whitehead, 
Strike, Perkins-Porras, & Steptoe, 2005) and ACS is now considered as a potential trigger for 
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the development of post-traumatic stress disorder (Wikman et al., 2011); however it is unclear 
whether CABG surgery provides the same stimulus. While there are likely to be similarities 
between the two patient groups, it is important to not interpret findings from CABG patients 
as being ‘true’ simply because they are in line with ACS patient findings, just as it is important 
not to discount incongruous findings.  
The final caution is that it is not yet clear whether CABG surgery patients tell us 
anything over and above patients undergoing other major surgery. For example, depression 
has been shown to increase the risk of mortality in patients undergoing orthopaedic surgery 
(Guerini, Morghen, Lucchi, Bellelli, & Trabucchi, 2010), organ transplant surgery including 
kidney, liver and heart (Corruble, Barry, Varescon, Durrbach, et al., 2011; Corruble, Barry, 
Varescon, Falissard, et al., 2011; Havik et al., 2007), as well as a myriad of other surgical 
procedures (Abrams, Vaughan-Sarrazin, & Rosenthal, 2010). Nor is it clear to what extent 
CABG surgery differs from other types of cardiac surgery. While the majority of work has 
focussed on depression in CABG surgery patients, recent evidence suggests similar effects of 
depression on mortality in percutaneous coronary intervention patients too (Damen et al., in 
press). Regardless of this, a CABG population presents a useful model in which we can unpick 
some of the mechanistic pathways linking depression with future morbidity and mortality in 
the physically ill, and is made more relevant since cardiac disease and revascularisation 
treatment is so common. Moreover, from a pragmatic perspective, since CABG surgery offers a 
population at high risk of depression, it presents a good opportunity to recruit enough cases to 
demonstrate an effect, which can contribute to the cardiac literature as well as the dialogue on 
the commonality of disease processes (Field, 2001; Southerland, Taylor, Moss, Beck, & 
Offenbacher, 2006).  
2.4.1 Demographic risk factors 
Gender and age have been recently reviewed as risk factors for post-operative depression in 
CABG patients, with results proving inconclusive (McKenzie, Simpson, & Stewart, 2010). 
Gender has been shown to be a risk factor in CABG patients, with women thought to be at 
greatest risk of experiencing depressive symptoms both pre-operatively (Dunkel et al., 2009) 
and post-operatively (Doering et al., 2006). However, not all studies have supported this post-
operative association; for example Mitchell and colleagues (Mitchell et al., 2005), found no 
gender effect, with women showing a significant improvement in depression symptoms from 
pre- to post-CABG time points compared to men. Moreover, negative sequelae of depression 
in CABG patients have been shown for both women (Phillips Bute et al., 2003) and men (Burg, 
Benedetto, Rosenberg, et al., 2003; Burg, Benedetto, & Soufer, 2003) and Connerney and 
colleagues (Connerney et al., 2010) found no effect of gender on either cardiac or all-cause 
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mortality in CABG surgery patients. Younger age has also been highlighted as a risk factor for 
depression in CABG patients (Mallik et al., 2005), although some authors have not reported 
this effect (Burg, Benedetto, Rosenberg, et al., 2003; Pirraglia et al., 1999) and still others have 
found the relationship to be inconsistent (Timberlake et al., 1997).  
Socioeconomic position has also been implicated in the link between depression and 
CHD. Data from the Whitehall II epidemiological study of UK civil servants, have shown that 
employment grade is prospectively associated with mental health in patients with known CHD, 
such that those with lower employment grade showed greater deterioration in mental health 
functioning during the 12-year follow-up than those in the highest grades (Sacker, Head, & 
Bartley, 2008). In a sample of 298 men and women admitted to hospital with ACS, it has been 
reported that low household income was associated with elevated depression symptoms on 
the BDI at three weeks, six months and one year following ACS and this effect was 
independent of other demographic and clinical risk factors as well as history of depression 
(Steptoe et al., 2011). The same effect on depression was not observed for another marker of 
socioeconomic position, education. Other studies have also found education to be 
inconsistently associated with depression in ACS patients. For example, Frasure-Smith and 
colleagues (Frasure-Smith et al., 1993) found no difference in in-hospital depression between 
those with low and high levels of education, and Martens and colleagues (Martens, Smith, 
Winter, Denollet, & Pedersen, 2008) found a similarly null effect of education on persistent 
depression over the 12 months following ACS. However, another study did find a difference by 
education levels, finding new onset and recurrent depressed patients to be more likely to have 
less than 12 years of education than their non-depressed counterparts (Carney et al., 2009).  
When socioeconomic status has been taken into account in relation to depression in 
CABG patients, results are mixed. For example, some have shown that low education is 
associated with greater risk of pre-operative depression (Dunkel et al., 2009; Pirraglia et al., 
1999), but not others (Burg, Benedetto, Rosenberg, et al., 2003). In terms of post-operative 
depression, Connerney and colleagues (Connerney et al., 2001) reported no difference in 
education levels between depressed and non-depressed CABG patients and this has been 
found by others (Pirraglia et al., 1999).  The mixed results may be a result of education being a 
weak marker of socioeconomic position in this patient group, since most will have completed 
formal education several decades prior to the onset of cardiac disease (Steptoe et al., 2011). 
More studies are needed to determine to what extent socioeconomic position mediates or 
moderates the effect of depression on cardiac prognosis.  
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2.4.2 Clinical risk factors 
Depression has been shown to be associated with traditional cardiac risk factors including 
smoking, diabetes mellitus and hypertension (Carney, Freedland, Miller, & Jaffe, 2002) and  
also cardiac medications such as statins and beta-blockers. Statins have actually been shown to 
have a protective effect for depression, with several longitudinal studies finding use of statins 
to confer a risk reduction for depression onset in CHD patients (Otte, Zhao, & Whooley, 2012; 
Stafford & Berk, 2011). In contrast, the literature on beta-blockers and depression is less clear, 
with some early evidence suggesting they may be capable of inducing mood disturbance 
(Greenblatt & Koch-Weser, 1974). More recently, evidence from systematic reviews has not 
substantiated this link, although the popular misconception persists in prescription practice 
(Ko et al., 2002). Nevertheless, these clinical risk factors need to be considered when 
investigating the association between depression and cardiac outcomes.  
In the CABG literature, pre-surgical clinical factors such as co-morbidities and pre-
existing cerebrovascular disease, aspects of the surgical procedure itself, and sequelae such as 
inflammatory responses and cardiac arrhythmia, may contribute to impairment after surgery 
(Karimi et al., 2008; Murphy, Ascione, Caputo, & Angelini, 2003; Newman et al., 2006; Sadeghi, 
Sadeghi, Mood, & Karimi, 2002). Despite the importance of these factors, their relationship 
with emotional adjustment has been variable. For example, Dunkel and colleagues (Dunkel et 
al., 2009) studied 1238 MI patients awaiting CABG surgery, finding clinical factors to be 
predictive of pre-operative depression status. These authors reported that dyspnoea 
(shortness of breath) on exertion and at rest, history of previous MI, co-morbidities and use of 
tranquilisers, were all significantly associated with pre-operative depression risk. Wellenius 
and colleagues (Wellenius et al., 2008) reported depression to be independently associated 
with graft disease progression after controlling for previous medical history, blood pressure 
and renal function. However, the effect was attenuated when aggressive lipid lowering 
medication was taken into account. Another study reported no quality of life differences after 
surgery when comparing on-pump and off-pump CABG patients (Motallebzadeh, Bland, 
Markus, Kaski, & Jahangiri, 2006). This suggests that surgical technique may not be predictive 
of emotional adaptation following surgery. Another clinical risk factor that may be relevant is 
metabolic syndrome, which refers to a combination of symptoms including diabetes or insulin 
resistance, hypertension, dyslipidaemia and obesity (for a review of different classification 
systems see Beilby, 2004). Metabolic syndrome has been shown to partly mediate the link 
between depression and subclinical atherosclerosis (Hamer, Malan, Harvey, & Malan, 2011) 
and depression and clinical disease (Vaccarino et al., 2008), but has yet to be studied in CABG 
patients. In summary, it is not clear to what extent clinical risk factors impact on patient quality 
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of life and emotional responses following CABG surgery and whether such factors are best 
conceptualised as confounders or mechanisms in this relationship.  
2.5 Depression and cardiac prognosis: Non-biological mechanisms  
The definition of mechanisms as mediators described by Skala and colleagues (Skala, 
Freedland, & Carney, 2006) will be used here. They describe a mechanism to be a variable on 
the causal pathway between depression and cardiac prognosis (illustrated in Figure 2.2, 
showing the direct and indirect pathways). Such mechanisms are usually identified since they 
are either predictive of cardiac outcomes or are aetiologically involved in them. However, to 
be a valid mechanism, mediation must also be upheld such that depression precedes the 
candidate mechanism, and in turn the mechanism precedes the cardiac outcome. In statistical 
analysis, partial mediation occurs when the addition of the mechanism to the model 
attenuates the association between depression and the cardiac outcome, whereas full 
mediation entirely removes this association. Since the majority of studies only report partial 
mediation, other mechanisms are usually also implicated in the causal pathway.  As such it is 
important to consider how individual mechanisms may be interrelated. The following section 
will describe potential mechanisms and their possible linkages. Principally under discussion is 
the literature in CABG patients, but where evidence is scarce, work on ACS patients will also be 
drawn upon to add to the discussion. 
 
 
 
 
 
 
 
FIGURE 2.2: MEDIATION MODEL OF DEPRESSION AND POOR CARDIAC PROGNOSIS 
 
2.5.1 Behavioural and social factors 
Candidate mechanisms linking depression to cardiac prognosis are likely to include behavioural 
and social factors. Physical activity has been shown to be an important component of cardiac 
rehabilitation, being associated with reduced total and cardiovascular mortality and hospital 
Mechanisms 
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Poor cardiac 
outcomes 
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readmission (Heran et al., 2011). A recent study showed that the relationship between 
depressive symptoms and future cardiac events in patients with CHD was largely accounted for 
by poor health behaviours, particularly physical inactivity (Whooley et al., 2008). Few studies 
have investigated these effects in CABG patients, although physical activity is thought to have 
important protective effects in these patients (Nery & Barbisan, 2010). The effect of other 
health behaviours, such as smoking, is less clear. For example, smokers were found to be at 
greater risk of pulmonary complication following CABG surgery, but not of in-hospital mortality 
(Al-Sarraf et al., 2008). In an eight-year follow-up study, smokers were found to be at lower 
risk of arrhythmia than non-smokers (Al-Sarraf et al., 2010). Smoking has long been associated 
with depression (Fergusson, Goodwin, & Horwood, 2003; Glassman et al., 1990), although the 
causal relationship is unclear (Kendler et al., 1993). The study by Whooley and colleagues 
(Whooley et al., 2008) did show current smoking to partially mediate the association between 
depression and future cardiac events in patients with stable CHD, but this has yet to be tested 
in CABG patients.  Obesity is another cardiac risk factor that has also been associated with 
depression (Luppino et al., 2010) and although many studies using CABG patients do not report 
body mass index (BMI) statistics, the few that have do not show BMI or obesity to be 
associated with depression (Blumenthal et al., 2003; Burg, Benedetto, Rosenberg, et al., 2003; 
Dunkel et al., 2009). Therefore, at present it is not clear whether obesity plays a role in the 
relationship between depression and cardiac prognosis.  
Poor adherence to medical and lifestyle advice has been documented in CABG patients 
(Kulik, Shrank, Levin, & Choudhry, 2011; Yam et al., 2006). Studies of patients following acute 
MI indicate that patients who become depressed are less adherent to medication (Rieckmann, 
Gerin, et al., 2006; Rieckmann, Kronish, et al., 2006) and secondary prevention advice such as 
quitting smoking and attending cardiac rehabilitation programmes (Kronish et al., 2006). 
Furthermore, non-adherence may partly explain the increased risk of a major adverse cardiac 
event in depressed patients, up to one-year following ACS (Rieckmann et al., 2011). The 
personal, social and economic costs of non-adherence are profound for many patients with 
CHD (Ho et al., 2004), therefore it is important to better understand the mediatory role of non-
adherence for long-term outcomes in CABG patients.  
Another behaviour which has recently emerged in the literature as an important factor 
is sleep. Sleep duration and quality have been associated with both cardiovascular disease and 
events (Leineweber, Kecklund, Janszky, Akerstedt, & Orth-Gomér, 2003; Sabanayagam & 
Shankar, 2010; Schwartz et al., 1998). A recent meta-analysis of prospective studies found that 
both short and long sleep duration was associated with increased risk of developing or dying 
from CHD and stroke (Cappuccio, Cooper, D’Elia, Strazzullo, & Miller, 2011). Poor sleep is also 
thought to have negative consequences for emotional wellbeing and research has shown an 
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association between poor sleep quality and depression (Almeida, Alfonso, Yeap, Hankey, & 
Flicker, 2011; Benca, Obermeyer, Thisted, & Gillin, 1992). While evidence for the direction of 
this relationship is limited, studies tend to suggest poor sleep contributes to depression onset 
(Baglioni et al., 2011; Cho et al., 2008; Ford & Kamerow, 1989; Roberts, Shema, Kaplan, & 
Strawbridge, 2000). Although sleep is recognised to be an important issue in post-CABG 
recovery (Jenkins, Jono, & Stanton, 1996; Redeker & Hedges, 2002), very few studies have 
investigated the impact of poor sleep on physical and emotional adaptation and recovery 
following cardiac surgery.  
Hunt and colleagues (Hunt, Hendrata, & Myles, 2000) assessed 108 CABG patients 12-
months after surgery and used cross-sectional analyses to test for associations between poor 
self-reported sleep quality and poor quality of life. They assessed sleep quality using a one- 
item measure devised by the authors to assess how often participants felt they slept well; 
quality of life was measured using the short form health survey (SF)-36. These authors found 
patients reporting poor sleep were 4.8 times more likely to also report poor quality of life (95% 
CI, 1.66-14.0, p = 0.002). Redeker and colleagues (Redeker, Ruggiero, & Hedges, 2004) studied 
72 cardiac surgery patients in a study which implemented both self-report (Pittsburgh Sleep 
Quality Index) and objective (wrist actigraphy) measures of sleep on quality of life after 
surgery. They reported cross-sectional associations between poor sleep and worsened physical 
and emotional health status at four and eight weeks after surgery, showing that in regression 
models entering both the self-report measure of sleep quality and the objective measure of 
sleep efficiency in the same step, poor sleep accounted for 16% of variance in physical 
functioning at four weeks post-CABG and 8% at eight weeks post-CABG, and 13% of variance in 
emotional functioning at four weeks post-CABG and 16% at eight weeks post-CABG. However, 
these authors only controlled for age and sex in their models. Lastly, a study which recruited 
38 males prior to CABG surgery used prospective analyses to show that the pre-surgery sleep 
symptom of feeling unrefreshed on awakening explained 44.5% of variance in quality of life 
scores, as measured using the Nottingham Health Profile questionnaire, six months after 
surgery (Edéll-Gustafsson & Hetta, 1999). These authors also reported that having a sad or 
depressed mood reaction to sleep loss was predictive of sleep problems, suggesting the 
problem may be self-perpetuating. The studies in this area highlight sleep as important factor 
in the prediction of mental and physical adaptation following CABG, but issues surrounding 
study quality, such as use of cross-sectional analyses and small sample sizes, limit the 
inferences that can be drawn. Moreover, it is not clear to what extent sleep is a cause or 
consequence of depressed mood in CABG patients and whether it affects cardiac prognosis 
following surgery; this is an important area for further work given that sleep disturbance is in 
itself a symptom of depression.   
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The role of social processes is less clear, although social support and social networks or 
connectivity are likely to be important (Lett et al., 2005). Steptoe’s group has shown that social 
networks, practical social support, marital status and stress within social relationships affect 
adherence to medication and lifestyle advice following acute MI (Molloy, Perkins-Porras, 
Bhattacharyya, Strike, & Steptoe, 2008; Molloy, Perkins-Porras, Strike, & Steptoe, 2008; 
Molloy, Stamatakis, Randall, & Hamer, 2009). There is a small research base examining the role 
of social support in recovery and quality of life after CABG, but these studies report mixed 
findings. For example, Okkonen and colleagues found that lower perceived family support 
prior to surgery was associated with greater depression symptoms, feelings of hopelessness 
and anxiety (Okkonen & Vanhanen, 2006). Another study found that instrumental social 
support was associated with positive improvements in mental health but not physical 
functioning at six months following CABG (Barry, Kasl, Lichtman, Vaccarino, & Krumholz, 2006). 
Husak and colleagues (Husak et al., 2004) found that low social support was not able to predict 
cardiac rehabilitation attendance in CABG patients after adjusting for confounders. There is a 
need, therefore, to clarify the role of social support in emotional adaptation and quality of life 
following CABG. In summary, low social support may mediate the relationship between 
depression and cardiac outcomes by affecting a patient’s ability to perform health behaviours; 
this hypothesis has yet to be empirically tested. 
Psychological factors are also relevant. Indeed, there is evidence that hostility is 
associated with poor outcomes (Chida & Steptoe, 2009a), while optimistic dispositions appear 
to be protective (Scheier et al., 1989) and may improve treatment response in depressed 
cardiac patients (Tindle et al., 2012). However, it is not yet clear whether these factors are 
mediators in the relationship between depression and cardiac outcomes.  
2.5.2 Cognitive factors 
Cognitions, including illness perceptions, may well be implicated in linking depression to poor 
cardiac prognosis. The illness perception perspective emphasises the importance of patients’ 
beliefs about their treatment and the course of their illness. The relevance of these cognitions 
will be influenced by the extent to which patients’ expectations are fulfilled, and unanticipated 
patterns of symptom recovery and healing may undermine belief structures. The majority of 
the work in this area has used MI patients, and negative illness perceptions (e.g. my illness will 
last a long time and my illness will not be cured) have been associated with an array of poorer 
outcomes for this population, including greater illness related disability at home and at work 
(Petrie, Weinman, Sharpe, & Buckley, 1996), reduced quality of life (French, Lewin, Watson, & 
Thompson, 2005; Stafford, Berk, & Jackson, 2009),  later return to work (Maeland & Havik, 
1987; Petrie et al., 1996), increased fatigue (Alsén, Brink, Persson, Brändström, & Karlson, 
64 
 
2010), and greater risk of in-hospital complications (Cherrington, Moser, Lennie, & Kennedy, 
2004). This work is made more relevant since research has shown that illness perceptions are 
amenable to change in several intervention studies, with results of one trial showing 
improvements in functional recovery, i.e. faster return to work, as a result of a brief in-hospital 
intervention to challenge and replace negative illness perceptions in MI patients (Broadbent, 
Ellis, Thomas, Gamble, & Petrie, 2009). In addition, more negative illness perceptions have 
been related to poorer emotional responses to ACS, such as greater depression symptoms 
(Grace, Krepostman, et al., 2005; Stafford et al., 2009). In a study which assessed illness 
perceptions in the days following hospital admission for MI, more negative beliefs were 
associated with the development of new onset depression in particular (Dickens et al., 2008b).  
 The notion that illness perceptions are causally related to depression in MI patients is 
consistent with the cognitive vulnerability theory of depression in which negative cognitive 
appraisals, or negative schemas4, are thought to be triggered during stressful situations and 
consequently are then capable of leading to depression onset, maintenance and 
relapse/recurrence (Scher, Ingram, & Segal, 2005). However, more recent evidence has 
proposed a mediation model in which negative illness perceptions mediate the relationship 
between depression and cardiac outcomes. Such a model suggests that depression leads to 
negative illness perceptions, which in turn are capable of affecting health outcomes. For 
example, in a study of 201 (25 depression cases) stable CHD outpatients who completed 
baseline and six-month follow-up assessments, the negative illness perceptions of 
consequences, identity, illness concern and emotional representation were shown to partly 
mediate the prospective, negative, relationship between baseline depression and follow-up 
health-related quality of life (Dickens, Cherrington, & McGowan, 2011). Only two studies to 
date have examined these effects in cardiac surgery patients, the first of these studies showed 
pre-surgical negative illness perceptions predicted depression three months after surgery 
(Juergens, Seekatz, Moosdorf, Petrie, & Rief, 2010). The second study reported associations 
between negative illness perceptions and greater psychological distress in patients before 
CABG (Hermele, Olivo, Namerow, & Oz, 2007). In summary, patients with a clinical 
manifestation of CHD (either ACS or CABG) may be more prone to depression if they have a 
more negative view of their illness. However, it is not clear to what extent negative illness 
perceptions may actually mediate the relationship between depression and poor cardiac 
prognosis; further work is needed to explore this in greater detail.  
                                                          
4
 Negative schemas refer to: “negatively toned representations of self-referent knowledge and information that guide appraisal 
and interact with information to influence selective attention, memory search, and cognitions” (Scher, Ingram, & Segal, 2005, 
p.489). 
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Other cognitive factors have also been implicated as mechanisms. For example, there 
has been marked interest and debate in the evidence suggesting a deterioration in various 
neurocognitive processes following CABG, such as memory loss and difficulties with 
concentration and problem-solving. Both short- and long-term deficits in neurocognition have 
been observed in CABG patients. In a systematic review of studies using CABG patients, van 
Dijk and colleagues (van Dijk et al., 2000) reported pooled estimates showing on average, 
22.5% of CABG patients had a cognitive deficit two months following surgery. Longer-term 
effects have also been observed, with a study of 261 (171 available at five years) CABG 
patients by Newman and colleagues (Newman et al., 2001) reporting cognitive decline in 42% 
of patients at five-year follow-up.  
Some research has suggested that the type of CABG surgical procedure used may 
affect neurocognitive risk, with on-pump patients thought to be particularly vulnerable 
(Stroobant, Van Nooten, Van Belleghem, & Vingerhoets, 2005; Zamvar et al., 2002). However, 
this has not been replicated in the majority of studies. The Octopus study is a large-scale 
prospective randomised controlled trial comparing cognitive decline in on-pump and off-pump 
CABG patients in the Netherlands (van Dijk et al., 2007; van Dijk et al., 2002). Two hundred and 
eighty one participants were randomised to receive either an on-pump or off-pump CABG 
procedure and were assessed one day prior to surgery and initially followed-up three and 12 
months after surgery. Findings showed that the off-pump patients had significantly better 
cognitive function at three months after CABG than on-pump patients, but this effect had 
disappeared by 12 months (van Dijk et al., 2002); nor was it evident in recently published data 
from the five-year follow-up (van Dijk et al., 2007). This has also been supported by others 
(Hernandez et al., 2007; Stroobant, van Nooten, De Bacquer, Van Belleghem, & Vingerhoets, 
2008) and confirmed in a recent systematic review which concluded that there is insufficient 
evidence that brain damage in cardiac surgery patients is attributable to the use of 
cardiopulmonary bypass (Alston, 2011).  
Other studies using control groups are beginning to question whether CABG surgery 
per se confers risk of cognitive deterioration or whether it is more general to CHD patients or 
surgical patients at large. One study which tried to address this recruited 140 CABG patients 
and 92 matched non-surgical CHD controls, finding that at 12-month follow-up there was no 
difference between the groups in an array of neurocognitive tests (Selnes et al., 2003); these 
results have been supported by others (McKhann et al., 2005; Sweet et al., 2008) and have 
been replicated at three-year follow-up (Selnes et al., 2007). The problem of using an adequate 
control group has also been highlighted by recent analyses performed on the Octopus dataset, 
which was reanalysed and compared to neuropsychological test scores of 112 healthy controls 
at baseline, three and 12-month follow-up (Keizer, Hijman, Kalkman, Kahn, & Van Dijk, 2005). 
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Interestingly, by their three month assessment, between 14% and 28% of controls were 
classified as having cognitive decline, which is similar to the CABG patient group, in which 25% 
were classed as having cognitive decline. This highlights the need for conservative cut-offs 
which taken into account the natural variability in test scores over repeated assessments. 
When the Octopus cohort was re-analysed according to the new cut-offs, only 7.7% were 
defined as suffering from cognitive decline. Such results reinforce the need for careful 
interpretation of the literature in this area. As mentioned,  it is also not clear to what extent 
CABG surgery patients are at greater risk than other surgical patients, who are also at risk of 
cognitive decline: a phenomenon termed post-operative cognitive dysfunction (for a review 
see Reichenberg, Dahlman, Mosovich, & Silverstein, 2007).  
Regardless of this on-going debate, cognitive function is a potential mediator between 
depression and cardiac outcomes. Low levels of cognitive function have long been associated 
with greater all-cause (Bosworth & Siegler, 2002) and cardiac mortality (Batterham, 
Mackinnon, & Christensen, 2012). This latter study followed-up 592 community-dwelling 
participants for up to 17 years, and showed that while initial cognitive function was the better 
predictor, deterioration in cognition function over time was also predictive of future mortality, 
after adjustment for demographic, physical functioning and depression and anxiety scores. 
Cognitive difficulties are also well-established in depression, among the geriatric depressed 
(Butters et al., 2004; Rapp et al., 2005) and also younger adults (Castaneda, Tuulio-Henriksson, 
Marttunen, Suvisaari, & Lönnqvist, 2008; Herrmann, Goodwin, & Ebmeier, 2007; Thomas et al., 
2009). However, McKhann and colleagues (McKhann et al., 1997) found no association 
between depression and cognitive decline in a one-year follow-up study of 124 CABG patients. 
A more recent study has shown cross-sectional associations between depression and cognitive 
function at six months and five years following CABG surgery, though the effects were only 
small and explained no more than 7.2% of variance in any of the cognitive domains (Tully, 
Baker, Knight, Turnbull, & Winefield, 2009). Other studies have also found mixed results 
(Andrew, Baker, Kneebone, & Knight, 2000; Tsushima, Johnson, Lee, Matsukawa, & Fast, 
2005), with further high-quality work needed. In summary, it is not yet clear to what extent 
CABG patients are at increased risk of cognitive deterioration following surgery, or whether 
any observed deterioration mediates the association between depression and cardiac 
outcomes. Further work is needed to test this hypothesis in greater detail.  
Another cognitive factor that may be important is the concept of health literacy. 
Health literacy describes the degree to which individuals have the capacity to obtain, process, 
and understand the basic health information and services needed to make appropriate health 
decisions (Von Wagner, Steptoe, Wolf, & Wardle, 2009). Poor health literacy has been 
associated with failure to follow medical advice in many clinical groups (Herndon, Chaney, & 
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Carden, 2010; Ngoh, 2009), and may be important in CABG patients (Conlin & Schumann, 
2002). Therefore, in people with depression, poor health literacy may act to compound non-
adaptive health behaviours, particularly adherence to medication, because of an inability to 
comprehend medical advice; this has yet to be tested empirically. 
2.6 Depression and cardiac prognosis: Biological mechanisms 
Emotional distress and depression are associated with a number of biological processes in 
patients with CHD, which may contribute to poor health outcomes, including autonomic 
dysfunction, platelet reactivity, heightened neuroendocrine responses and inflammation, 
among others (Carney et al., 2002; de Jonge et al., 2010; Nemeroff & Goldschmidt-
Clermont, 2012; Skala et al., 2006; Steptoe, 2007).  An overview of these processes will be 
provided in the following sections. As with the previous mechanisms described, the CABG 
literature is of primary importance here, but where studies are scarce work in ACS patients will 
be drawn upon. However, drawing direct comparisons between ACS and CABG patients must 
be conducted with care since there are obvious differences between the two groups in terms 
of the cause of the physiological trauma: ACS being the result of internal pathophysiology 
whereas CABG is an external assault.  
2.6.1 Autonomic dysfunction  
Autonomic balance is essential for health and on the contrary, imbalance, characterised 
typically by hyperactive sympathetic nervous system activity and hypoactive parasympathetic 
activity, is associated with several cardiac pathologies (Sztajzel, 2004). Heart rate variability 
(HRV) refers to beat to beat changes in heart rate in reaction to internal and external stimuli 
and it can be used as a marker of cardiac autonomic control and the sympathetic/ 
parasympathetic balance; for a thorough discussion of this methodology see Thayer, Hansen, 
& Johnson (2010). In essence, low HRV is associated with poorer health outcomes, including 
increased risk of mortality, than high HRV.  Indeed, low HRV has been shown to predict the 
occurrence of potentially fatal arrhythmias in MI patients (La Rovere et al., 2001) and mortality 
following MI (Bigger et al., 1992; Kleiger, Miller, Bigger, & Moss, 1987). Moreover, HRV has 
been shown to be lower in depressed patients than their non-depressed counterparts in stable 
CHD populations (Carney et al., 1995; Krittayaphong et al., 1997; Stein et al., 2000) and in MI 
patients (Carney et al., 2001). However, it should be noted that not all studies have reported 
this association (Gehi, Mangano, Pipkin, Browner, & Whooley, 2005) and HRV may be 
differentially associated with somatic and cognitive depression symptoms (De Jonge, 
Mangano, & Whooley, 2007). A review by Carney and Freedland (Carney & Freedland, 2009b) 
concluded that HRV may partly mediate the association between depression and poor cardiac 
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outcomes. Autonomic dysregulation has also been associated with depressed mood following 
CABG surgery (Hallas, Thornton, Fabri, Fox, & Jackson, 2003) and may partly explain why 
depressed patients have poorer outcomes following CABG (Dao et al., 2010). However, little is 
known about the impact of these autonomic changes on long-term recovery following CABG.  
2.6.2 Platelet reactivity 
Platelets are circulating cells that play a key role in haemostasis and in the repair and healing 
of vascular damage. Platelet aggregation plays an essential role in the pathophysiology of 
atherosclerosis and acute coronary events (Lefkovits, Plow, & Topol, 1995; Markovitz & 
Matthews, 1991). These latter authors were the first to describe that abnormal platelet 
function can be increased by psychological stress and circulating catecholamines. Moreover, a 
case-control study showed that mental stress in male CHD outpatients stimulated sustained 
platelet activation compared to healthy controls (Strike et al., 2004). Several authors have 
supported the association between depression and increased platelet activation 
(Musselman et al., 1996; Nemeroff & Musselman, 2000). However, only limited evidence exists 
for this effect in depressed CHD patients (Laghrissi-Thode, Wagner, Pollock, Johnson, & Finkel, 
1997; Serebruany et al., 2003). More recently, a critical review deemed the findings to be 
inconclusive, with most studies not reporting increased platelet aggregation in depressed 
patients. However, these authors did find evidence in favour of the platelet hypothesis being 
more evident in those with CHD than those without; they concluded that further large-scale 
studies are needed (Von Känel, 2004). These effects have yet to be tested in depressed CABG 
patients.  
2.6.3 Neuroendocrine dysfunction 
Another biological factor thought to play a mediatory role is the neuroendocrine hormone, 
cortisol. On perception of a stressor, the HPA axis is activated (see Figure 2.3 (Glaser & Kiecolt-
Glaser, 2005, p.245)) and, via release of corticotrophin releasing hormone (CRH), the 
corticosteroid cortisol is secreted. Cortisol is vital to life, being involved in glucose production 
and metabolism as well as regulating the immune system. However, chronic over-activity of 
the HPA axis can lead to dysregulation of cortisol output and since cortisol is essential for 
homeostasis, any deviation from the optimal range is thought to have deleterious effects. For 
example, in the cardiac literature, elevated cortisol has been linked to cardiac risk factors such 
as hypercholesterolemia, abdominal obesity and hypertension, by some (Brown, Varghese, & 
McEwen, 2004), but not all (Otte et al., 2004), authors. Cortisol dysregulation may contribute 
to cardiovascular risk not only through effects on metabolic processes (Chandola, Brunner, & 
Marmot, 2006) but also via atherosclerosis (Whitworth, Williamson, Mangos, & Kelly, 2005). In 
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addition, flatter cortisol rhythms across the day have been linked with the progression of 
coronary calcification (Matthews, Schwartz, Cohen, & Seeman, 2006). 
 
 
FIGURE 2.3: THE HYPOTHALAMIC PITUITARY ADRENAL AXIS  
(From: Glaser & Kiecolt-Glaser, 2005, p.245) 
 
Cortisol has also been implicated in the pathophysiology of depression (Zunszain et al., 
2011). HPA axis abnormalities have been observed in patients with major depression, including 
increased secretion and reactivity of cortisol (Cowen, 2010), elevated CRH 
(Nemeroff et al., 1984), and increased size and activity of the pituitary and adrenal glands 
(Nemeroff et al., 1992).  Moreover, Steptoe’s group recently showed that alterations in the 
diurnal profile of cortisol were associated with depressed mood in patients with CHD 
(Bhattacharyya, Molloy, & Steptoe, 2008), and with Type D personality (negative affectivity 
and social inhibition) in patients following ACS (Molloy, Perkins-Porras, Strike, & Steptoe, 
2008b; Whitehead, Perkins-Porras, Strike, Magid, & Steptoe, 2007). HPA axis dysregulation has 
also been associated with greater cardiac-related mortality in depressed patients (Jokinen & 
70 
 
Nordström, 2009). There are limited studies investigating cortisol in CABG surgery patients, 
although there is some evidence that there is heightened cortisol output in the post-operative 
period (Roth-Isigkeit & Schmucker, 1997; Tønnesen, Brinkløv, Christensen, Olesen, & Madsen, 
1987) and one study found this pattern to be associated with post-operative complications, in 
particular delirium (Mu et al., 2010). The relationship between cortisol output, depressed 
mood and long-term adaptation has not been investigated in CABG patients before. 
2.6.4 Inflammatory processes 
The immune system is closely linked to the HPA axis via bidirectional feedback (Maier & 
Watkins, 1998). The signalling molecules of the immune system are called cytokines, of which 
there are pro- and anti-inflammatory cell types. Systemic infection triggers macrophages to 
release pro-inflammatory cytokines such as interleukin (IL)-1, IL-6 and tumour necrosis factor-
alpha (TNF-α), which are responsible for coordinating an adaptive whole-body response known 
as sickness behaviour. Sickness behaviour refers to a cluster of symptoms affecting both 
behavioural and affective state such as fever, increased sleep, reduced social interaction, 
malaise, increased negative mood, fatigue and listlessness. Anti-inflammatory cytokines work 
to moderate the inflammatory response and are responsible for the intensity and duration of 
sickness behaviour due to their regulatory role in the production and signalling of pro-
inflammatory cytokines. Several comprehensive reviews have been published in this area 
(Dantzer, 2001a, 2001b; Dantzer, O’Connor, Freund, Johnson, & Kelley, 2008).  
The inflammatory literature is much more substantial than that of other biological 
mechanisms, so the main arguments will be described below. Much of the work linking 
cytokines to depression is reviewed in our paper (Poole, Dickens, et al., 2011). 
2.6.4.1 Depression and inflammation 
Depression is associated with an innate inflammatory response (Raison, Capuron, & Miller, 
2006), and a meta-analysis by Howren and colleagues has shown depressive symptoms to be 
positively associated with CRP, IL-1 and IL-6 in both clinical and community samples (Howren, 
Lamkin, & Suls, 2009). A more recent meta-analysis by Dowlati and colleagues (Dowlati et al., 
2010) has supported the role of pro-inflammatory markers in depression, in particular IL-6 and 
TNF-α. Interestingly, depression is associated with both immune up-regulation, characterised 
by increasing pro-inflammatory cytokines, as well as immune down-regulation such as reduced 
proliferative responses of immune cells (Blume, Douglas, & Evans, 2011). Epidemiological 
evidence for the directionality of the depression-inflammation relationship is mixed, with 
some studies suggesting that depression precedes inflammation (Stewart, Rand, Muldoon, & 
Kamarck, 2009), while others show that inflammation precedes depression (Gimeno et al., 
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2008). The relationship has also been studied experimentally or quasi-experimentally, testing 
the depressive responses to acute inflammatory stimuli. 
Vaccination studies  
Inflammatory responses can be stimulated by administration of endotoxin or by inoculation 
with attenuated vaccines. Reichenberg and colleagues (Reichenberg et al., 2001) used a cross-
over design to test the effects of Salmonella abortus equi endotoxin or saline on sickness 
symptoms and mood. Blood was collected at baseline and at hourly intervals for up to 10 
hours post-injection. Results showed that healthy participants showed a transient significant 
increase in their levels of depressive and anxiety symptoms in response to the endotoxin 
together with increases in IL-6, IL-1 receptor antagonist (IL-1Ra) and TNF-α. No differences in 
sickness were reported after the endotoxin as compared with placebo. These results were 
confirmed in a similar study using S. typhi vaccine or placebo, reporting negative changes in 
mood following injection with vaccine that were significantly correlated with increases in IL-6 
production (Wright, Strike, Brydon, & Steptoe, 2005). Notably, no significant symptoms of 
nausea were reported, so it cannot be argued that negative mood arose because the 
participants were feeling ill. Brain imaging studies indicate that the cytokine-induced mood 
response to typhoid vaccination is correlated with activity within the subgenual anterior 
cingulate gyrus (sACC) and with reduced connectivity between the sACC and amygdala, medial 
prefrontal cortex, nucleus accumbens and superior temporal sulcus (Harrison et al., 2009). 
Interestingly, the inflammation induced by typhoid vaccination impairs endothelial-dependent 
vascular dilatation, implicating transient endothelial dysfunction (Hingorani et al., 2000). This 
may be the mechanism underlying the transient increased risk of ACS in patients following 
acute infections such as influenza (Smeeth et al., 2004). In summary, vaccination studies have 
shown that experimentally induced inflammation is capable of triggering negative mood 
responses. 
Immunotherapy-induced depression  
A second set of relevant literature concerns clinical studies investigating the effects of 
treatment with cytokine-based therapy on mood. These studies were stimulated by the 
observation of depression in some patients with cancer, treated with immunotherapy 
(Capuron & Miller, 2004). Capuron and colleagues (Capuron et al., 2001) systematically 
investigated the association between different immunotherapies (IL-2, IL-2 plus interferon 
(IFN)-α, subcutaneous IFN-α or intravenous IFN-α) and the development of depressive 
symptoms in 33 patients with cancer. Patients treated with IL-2 or IL-2 plus IFN-α showed 
concomitant increases in depression symptoms and increased levels of the anti-inflammatory 
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cytokine IL-10 during treatment. Patients who were susceptible to inflammation-induced 
depression were more likely to show higher depression symptom scores prior to treatment 
(Capuron, Ravaud, Miller, & Dantzer, 2004) and a heightened pituitary–adrenal response 
following the first IFN-α injection (Capuron et al., 2003). Another study showed that around 
one-third of patients who were free of depression before therapy developed major depression 
during treatment with IFN-α (Beratis et al., 2005). Interestingly, Musselman and colleagues 
(Musselman et al., 2001) studied the effects of treatment with an antidepressant on 
depression induced by IFN-α treatment in a randomised placebo-controlled trial of 40 
malignant melanoma patients. The intervention (paroxetine or placebo) began two weeks 
before initiation of IFN-α therapy and continued for 12 weeks. Results showed that there was a 
fourfold reduction in risk of developing major depression by pre-treatment with paroxetine (an 
SSRI). To summarise, cytokine-based immunotherapy induces depressive symptomatology, and 
these effects can be attenuated by pre-treatment with antidepressant medication. 
Animal work  
Animal studies have also investigated the mechanisms linking inflammatory responses with 
depression-like syndromes. A comprehensive review is provided by Dantzer and colleagues 
(Dantzer et al., 2008), who present two lines of argument in support of the role of 
inflammation in the development of depression. 
First, inflammatory stimuli induce depression-like symptoms. Frenois and colleagues 
(Frenois et al., 2007) conducted an experiment using two measures considered to be indicative 
of depressive state in animal models: immobility and decreased preference for sweet 
solutions. They showed that mice treated with a pro-inflammatory cytokine stimulant 
(lipopolysaccharide) displayed increased immobility 24 hours after two stress tasks aimed to 
elicit a depressive response (tail suspension and forced swim), even though motor activity had 
returned to normal. In addition, preference for sweetened water was also reduced even after 
food intake and drinking had returned to baseline levels. These effects are more prominent in 
genetically vulnerable species. For example, fawn-hooded rats, which exhibit many of the 
symptoms thought to align with depression, are more sensitive to IL-1β-induced immobility in 
the forced-swim test compared with controls (Simmons & Broderick, 2005). 
Second, pharmacological corroboration for the role of inflammation has been provided 
by studies showing that depression-like symptoms induced by exogenously administered 
inflammatory stimuli can be attenuated with antidepressant drugs. For example, pre-
treatment with the antidepressant drugs imipramine or fluoxetine blocked the reduced intake 
of sweetened solution and reduced social exploration in rats treated with lipopolysaccharide 
(Yirmiya, 1996; Yirmiya et al., 2001). In another study, pre-treatment with fluoxetine abolished 
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the impaired performance of IL-1β-treated rats in a task designed to test reactivity to reward 
(anhedonia) (Merali, Brennan, Brau, & Anisman, 2003). 
These findings indicate that animal models corroborate the human literature with 
evidence that depression-like symptoms can be experimentally induced by inflammatory 
stimuli and are likewise responsive to pre-treatment with antidepressant drugs. 
2.6.4.2 Depression and low-grade inflammation in CHD patients 
Inflammatory processes are involved at several stages of the development of atherosclerosis 
and CHD, including endothelial dysfunction, smooth muscle cell migration and proliferation, 
and plaque rupture. Depression has been linked to inflammation in persons with CHD although 
the literature is somewhat inconsistent. Some evidence shows depressed cardiac patients to 
have heightened inflammation. For example, Bankier and colleagues (Bankier, Barajas, 
Martinez-Rumayor, & Januzzi, 2009) studied 72 CHD outpatients of whom 30 were classified as 
suffering from major depressive disorder. Stepwise multiple regression analyses revealed a 
significant positive relationship between depression and levels of CRP. Mixed findings were 
found in a much larger study by Lespérance and colleagues (Lespérance, Frasure-Smith, 
Théroux, & Irwin, 2004) who assessed 481 outpatients two months after hospitalisation for 
ACS with diagnostic psychiatric interviews. Depressed participants had higher levels of soluble 
intracellular adhesion molecule-1, but there was no association with IL-6. Frasure-Smith and 
colleagues (Frasure-Smith et al., 2007; Frasure-Smith, Lespérance, Irwin, Talajic, & Pollock, 
2009) found patients with elevated depression symptoms to have higher levels of CRP, but not 
IL-6, as compared with non-depressed cardiac patients.  
However, other studies have not supported this observation. Schins and colleagues 
(Schins et al., 2005) conducted a case-controlled study of depressed (n = 57) and non-
depressed (n = 46) MI patients, and found no differences between the groups in levels of IL-6, 
TNF-α or CRP. Frasure-Smith and colleagues (Frasure-Smith et al., 2007) followed up 741 
patients for two years after ACS for major adverse cardiac events and showed that elevated 
CRP and BDI scores two months after the cardiac event were both associated with increased 
risk to a similar extent. In other studies, Empana and colleagues (Empana et al., 2005) and 
more recently Davidson and colleagues (Davidson et al., 2009) did not find that inflammation 
mediated the association between depression and cardiac outcome.  
One difficulty in the interpretation of this literature is the impact of medications such 
as statins. In addition to their effects on cholesterol synthesis, statins have marked 
immunomodulatory and anti-inflammatory properties, and modulate vascular endothelial 
function (Greenwood & Mason, 2007). Other cardiovascular medications, such as aspirin, are 
also anti-inflammatory, and have not been consistently taken into account. There has also 
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been controversy concerning the relevance of inflammation to prognosis in patients with 
stable coronary artery disease due to methodological concerns. Contrary to guidelines issued 
by the American Heart Association (Pearson et al., 2003), some authors (Hemingway et al., 
2010; Kushner, Broder, & Karp, 1978) have demonstrated that the literature relating elevated 
CRP with poor prognosis is seriously flawed, with poor control for confounders, poor 
methodology and publication bias. The significance of any associations between inflammatory 
markers and future CHD risk in patients with established disease is therefore uncertain. 
2.6.4.3 Inflammation during ACS and depression 
The depression-inflammation relationship has also been studied by looking at the 
inflammatory response during the cardiac event. An ACS is associated with a massive acute 
inflammatory response (Kushner et al., 1978; Suleiman et al., 2003). The magnitude of the 
acute inflammatory response during ACS is predictive of poor cardiac outcome. For example, 
Biasucci and colleagues (Biasucci et al., 1999) showed in unstable angina patients that 
increases in IL1-Ra and IL-6 measured 48 hours after hospital admission were associated with 
greater risk of in-hospital cardiac events, while elevated CRP predicted 14 day mortality in 
unstable angina and non-Q wave MI independently of troponin responses (Morrow et al., 
1998). Further studies have confirmed this positive association in non ST-segment elevation 
ACS patients (Kosuge et al., 2008) and acute MI patients (Berton et al., 2010; Bursi et al., 2007; 
Kosuge et al., 2008; Suleiman et al., 2003, 2006; Yip et al., 2005). A recent meta-analysis of 20 
cohort and randomised controlled trials showed that CRP levels >10 mg/l measured within 72 
hours of ACS onset were associated with a relative risk of 2.18 (95% C.I. 1.77 – 2.68) for 
recurrent cardiovascular events or death compared with values ≤3 mg/l (He, Tang, Ling, Chen, 
& Chen, 2010). Most of these studies controlled for age, sex, cardiac enzyme levels, ejection 
fraction, heart failure and other markers of risk, suggesting that the impact of acute 
inflammation is independent of multiple risk indicators. The association between these large 
acute inflammatory responses and subsequent depression has not been tested. 
CABG surgery is also associated with an acute inflammatory response. The contact 
with the surfaces of the extracorporeal circuit inherent in cardiopulmonary bypass surgery (on-
pump) triggers a systemic inflammatory response which in severe cases can lead to systemic 
inflammatory response syndrome; this is a serious disorder capable of causing major organ 
dysfunction and death (Day & Taylor, 2005). Clinical management of the perioperative 
inflammatory response is therefore critical to patient outcomes. An observational study of 29 
cardiopulmonary bypass patients by Holmes and colleagues (Holmes et al., 2002) used a 
median split to compare outcomes between those patients who showed a heightened 
inflammatory response at four hours post-CABG, to those who did not. Findings showed that 
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hyper-responders in IL-8, IL-6 and CR3 (an anaphylatoxin) had greater risk of adverse clinical 
outcomes. However, the small sample size limits the generalisability of these findings. More 
recently, pre-operative CRP has been shown to predict adverse outcomes in CABG patients (De 
Lorenzo, Pittella, & Rocha, 2012). In this study, 76 patients had CRP assessed prior to surgery, 
with results showing that those with elevated CRP (≥3 mg/l) had significantly greater risk of 
post-operative mortality; other work has replicated this finding (Perry et al., 2010).  
Kaireviciute and colleagues (Kaireviciute et al., 2010) have shown that perioperative measures 
of high sensitivity (hs)-CRP and IL-6 are associated with greater risk of atrial fibrillation post-
operatively. Additionally, an acute inflammatory response is not only observed in on-pump but 
also off-pump surgery (Biglioli et al., 2003). The extent of the inflammatory response is thought 
largely to reflect the amount of trauma derived from the surgical procedure itself and is 
associated with a host of clinical outcomes, both cardiac and non-cardiac in scope (Biglioli et 
al., 2003; Levy & Tanaka, 2003). Only one study to date has assessed the association between 
depression and inflammation in CABG patients (Yang et al., 2012). These authors studied 232 
patients undergoing CABG surgery and found that higher pre-operative hs-CRP was predictive 
of depression symptoms up to six months following surgery, after controlling for covariates.  
However, there still remains a lack of studies in which perioperative variables have been 
adjusted for, limiting the conclusions to be drawn from this literature. In summary, both ACS 
and CABG surgery are associated with an acute inflammatory response. In ACS patients this 
inflammation is linked to prognosis. Although the literature points towards this being true in 
CABG populations as well, more high quality research is needed. 
2.6.4.4  A sickness behaviour model of depression 
Parallels can be drawn between sickness behaviour and the symptoms of depression, including 
lassitude, fatigue and dysphoric mood, and this similarity forms the basis for a sickness 
behaviour model of depression in patients experiencing ACS or CABG (Dantzer et al., 2008; 
Poole, Dickens, & Steptoe, 2011). Table 2.1 shows the characteristics of sickness behaviour and 
their parallel symptoms in depression; it is important to note that these two syndromes do not 
perfectly overlap, with some sickness symptoms not having a parallel in depression while 
others relate to an opposing symptom. Sickness behaviour is thought to be adaptive in 
organising bodily responses that fight infection, promoting cellular (T-helper 1) immunity  
which targets intracellular organisms through activation of macrophages, cytotoxic T 
lymphocytes and natural killer cells (Dantzer, Castanon, Lestage, Moreau, & Capuron, 2006). 
This hypothesised model posits that, in the case of ACS and CABG, the extent of tissue trauma 
invokes a large inflammatory response, capable of triggering a series of sickness behaviours. In 
these vulnerable individuals, where the immune response is exacerbated in duration and 
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intensity, decompensation (i.e., functional deterioration) occurs, causing a shift in balance 
between pro-inflammatory and anti-inflammatory cytokines towards one of inflammation. 
 
TABLE 2.1: CHARACTERISTICS OF SICKNESS BEHAVIOUR AND THEIR PARALLELS IN 
DEPRESSIVE SYMPTOMATOLOGY 
Sickness behaviour Depression 
Symptoms with a direct parallel: 
Anhedonia Dysphoric mood/sadness 
Behavioural withdrawal Inability to work/perform daily tasks 
Decreased social interaction Social withdrawal 
Reduced sexual behaviour Loss of libido 
Sleep Increased sleep/fatigue* 
Loss of appetite Loss of appetite/weight loss* 
Increased pain Increased pain** 
Symptoms without a direct parallel: 
Fever - 
Malaise - 
Symptoms with an incongruent parallel: 
Reduced aggression Increased irritability 
*N.B. in some depressed patients sleep is decreased and appetite increased. 
**e.g. Bair, Robinson, Katon, & Kroenke (2003) 
 
This sickness behaviour model suggests there may be a direct biological element to the 
development of depression, although there is still something lacking in this argument—
inflammation elicits a behavioural syndrome that resembles depression, yet it is not quite 
depression. One explanation could be that these sickness behaviours act as an additional 
burden among people who are already vulnerable. Alternatively, it might be that there are 
neurocognitive changes associated with inflammation that account for the behaviours and 
possibly result in mood changes. Underlying this could be the effects of inflammatory 
mediators on neurotransmitters such as serotonin (Wichers & Maes, 2002) or even minor 
damage to the central nervous system (Denes, Thornton, Rothwell, & Allan, 2010). More 
research is needed to delineate these mechanisms in greater detail. In addition, more 
understanding is needed regarding why some individuals show a hyper-inflammatory response 
to a cardiac event. One hypothesis that has attracted recent attention is the psychiatric version 
of the hygiene hypothesis, which states dysregulation of the inflammatory response arises due 
to decreased exposure to microorganisms (Raison & Miller, in press; Raison, Lowry, & Rook, 
2010). These authors suggest that increased sanitation in industrialised societies has led to our 
immune systems mounting inappropriate inflammatory responses to a wide range of stimulus, 
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including psychosocial stressors. This hyper-response could partly explain why some 
individuals who perceive cardiac surgery as particularly threatening or stressful have an 
increased inflammatory response, which in turn is capable of triggering depression; further 
work is needed to investigate this theory in CABG patients.  
Other pathways and processes are undoubtedly at work alongside the inflammatory 
pathway. If an inflammatory pathway is relevant, it would have several implications (Poole, 
Dickens, et al., 2011). Firstly, one would expect the magnitude of the acute inflammatory 
response to predict the development and duration of depression following acute cardiac 
events or CABG. Second, the size of acute inflammatory responses might be associated with 
the other biological mechanisms related to future cardiac morbidity that are associated with 
depression, including reduced HRV, HPA axis dysregulation and impaired platelet function. 
Third, the association between depression after ACS or CABG and adverse cardiac outcomes 
would be expected to be reduced if inflammation was included in the model. Finally, one 
would expect that interventions that reduce acute inflammation during cardiac events might 
reduce the magnitude of depressive responses. Current trials are evaluating techniques for 
limiting acute inflammatory responses, for example, the MRC-ILA-HEART study (Crossman et 
al., 2008). If these trials are successful, they would provide the opportunity to test links 
between inflammation and the development of depression in ACS patients.  
2.6.4.5 Other plausible biological mechanisms 
Other less investigated mechanisms may also play a role in the depression-cardiac prognosis 
relationship. For example, ventricular electrical instability, which refers to inducible ventricular 
tachycardia or ventricular fibrillation, is associated with greater risk of mortality following MI 
(Richards et al., 1983; Richards & Denniss, 2007). In addition, depression has been shown to 
better predict fatal cardiac arrhythmias and cardiac mortality than it is able to predict non-fatal 
MI (Carney & Freedland, 2003). It is not clear why depression may increase the risk of lethal 
arrhythmias, but it is possible that depression increases vulnerability to transient myocardial 
ischaemia due to its effect on pro-thrombotic factors (discussed in Section 2.6.2). Another 
possible mechanism that has received interest recently is endothelial dysfunction, which has 
been observed in depressed populations (Broadley, Korszun, Jones, & Frenneaux, 2002; 
Rajagopalan et al., 2001) and has been related to elevated depression symptoms (BDI ≥10) in 
those with established CHD (Sherwood, Hinderliter, Watkins, Waugh, & Blumenthal, 2005). 
Anaemia has also recently been posited to be a possible biological mechanism linking ACS with 
depression, and has been shown to be predictive of recurrent cardiac events up to one year 
post-MI (Steptoe, Wikman, Molloy, & Kaski, 2012).  
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The role of polyunsaturated fatty acids, particularly omega-3, has also been investigated 
since dietary intake of omega-3 is known to be implicated in endothelial function and 
inflammatory processes (Hjerkinn et al., 2005; Pischon et al., 2003; Ros et al., 2004). Moreover, 
low levels of omega-3 (including two forms largely found in oily fish, docosahexaenoic acid and 
eicosapentaenoic acid) have been associated with cardiac mortality and sudden cardiac death 
(Albert et al., 2002; Kris-Etherton, Harris, & Appel, 2002), as well as major depression and 
suicidal ideation (Hibbeln, 1998; Tanskanen et al., 2001). Moreover, there is some evidence 
that depressed post-ACS patients have lower plasma levels of omega-3 than their non-
depressed counterparts (Amin, Menon, Reid, Harris, & Spertus, 2008; Frasure-Smith, 
Lespérance, & Julien, 2004); the effect of this association on long-term cardiac outcomes has 
yet to be tested.  
Another possibility is that of the so-called vascular depression hypothesis (Alexopoulos 
et al., 1997), which posits that cerebrovascular disease can cause or perpetuate late-onset 
depression in elderly individuals. Since cerebrovascular disease is commonly observed in older-
aged patients with advanced CHD, this would again suggest cardiac prognosis is a function of 
disease severity, not depression per se.  However, this hypothesis has received mixed support, 
with some studies finding structural or functional brain abnormalities in late onset depression 
(Krishnan, Hays, & Blazer, 1997), while others have not (Greenwald et al., 1996). While there is 
some evidence in support of this view in ACS patients (Rapp et al., 2010), age is typically 
adjusted for in analyses, with the effect of depression on cardiac morbidity and mortality being 
upheld. What is more, recent analyses have not identified greater risk of vascular depression in 
new onset depression patients with CHD (Habra et al., 2010). Therefore, further work is 
needed to substantiate this hypothesis in cardiac patients.  
2.7 Chapter summary 
A summary of the literature described in both Chapter 1 and 2 of this thesis is displayed in 
Table 2.2. This chapter has discussed the direction of the causal relationship linking depression 
and CHD, highlighting the evidence in favour of an antecedent, rather than a consequence, 
model. It also raised the issue of new onset depression after ACS and CABG, which may 
present an exception to this argument.  Depression has also been described as mediator in the 
relationship between CHD and cardiac prognosis, irrespective of disease severity. Many 
mechanisms are likely to partly explain the relationship between depression and cardiac 
outcome, including behavioural and social factors, cognitive factors and biological processes. 
Key to understanding these causal pathways is to take a holistic, integrative view, looking for 
the interrelationship between these seemingly separate factors, in order to generate a unified 
model. Figure 2.4 provides a summary of factors affecting recovery after CABG surgery.  
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TABLE 2.2: SUMMARY OF LITERATURE REVIEW 
Main findings from previous literature What my PhD will add 
1. Depression is highly prevalent in ACS populations, 
but is less well studied in CABG populations. 
 My PhD will study depression in a CABG surgery 
population.  
2. The direction of the causal relationship between 
depression and CHD has been well-studied, but 
the reverse causality argument cannot be ruled 
out.  
 Depression will be assessed as a risk factor for poor 
recovery, independent of disease severity; 
depression-CHD causality will not be directly 
tested.  
3. Depression is thought to be an important 
prognostic marker in cardiac patients, but a wide 
range of recovery endpoints have yet to be 
investigated in CABG patients.  
 Multiple recovery endpoints will be studied, 
including clinical, physical, emotional and quality of 
life factors.  
4. The relevance of changes in depression over time 
is thought to be important, but is not easily 
studied in ACS patients due to problems with 
recall bias. 
 Depression will be studied prospectively, both pre- 
and post-operatively.  
5. Different symptom subtypes of depression have 
been studied in ACS patients and are thought to 
affect cardiac prognosis, but have not been well-
studied in CABG patients. 
 Depression symptom subtypes will be explored in 
relation to recovery, including both 
somatic/affective and cognitive/affection 
symptoms.  
6. Multiple mechanisms are thought to exist by 
which depression may affect recovery, but these 
are yet to be systematically studied.  
 Information on multiple possible mechanisms, 
including behavioural, social, cognitive and 
biological factors will be collected. 
 
80 
 
 
FIGURE 2.4: A MODEL REPRESENTING THE PATHWAYS FROM PRE-SURGERY TO POST-
SURGERY PHASES OF RECOVERY IN CABG PATIENTS 
LVEF: left ventricular ejection fraction; ICU: intensive care unit; PA: physical activity; QoL: quality of life 
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Chapter 3. Method: Pilot study 
3.1 Introduction and study aims 
Emotional adjustment, and in particular depression, has been described in the literature 
review as a significant risk factor for poor prognosis in CHD, both in ACS and CABG patients. By 
using CABG patients, as opposed to ACS patients, we can advance our understanding of the 
causal pathways by which CHD and depression are associated and how they interact to affect 
recovery. As previously discussed, research is beginning to explore these mechanisms, but a 
comprehensive study of all the different factors has yet to be undertaken and there is a need 
for longitudinal, prospective exploration to elucidate the independent contribution and 
interaction of these competing pathways.  
 To investigate the causes and consequences of poor emotional adaptation and 
adjustment in cardiac surgery patients requires the development of such a study. In particular 
the study must aim to extend the current literature in three ways. Firstly, using a prospective 
longitudinal design, rather than a cross-sectional study, will enable the temporal sequence of 
depression and the recovery process to be observed. Next, by using a multidisciplinary 
approach the study will simultaneously be able to assess behavioural, social, psychological, 
cognitive and biological factors, all of which are thought to operate along the causal pathway. 
Lastly, the use of pre-operative and post-operative time points will allow for the collection of 
baseline mood and disease severity measures, against which to compare follow-up 
assessments.  
The Adjustment and Recovery after Cardiac Surgery (ARCS) study was coined so as to 
investigate the causes and consequences of poor emotional wellbeing following CABG surgery, 
and their implications for patient quality of life and physical recovery. To establish the method 
for this study, a pilot study was first designed to test the feasibility of conducting the ARCS 
study and to establish the suitability of the measures for the sample. The development of the 
ARCS study and the undertaking of the pilot study form the first part of this PhD. The aims for 
the ARCS pilot study (P-ARCS) can be stated as:  
1. To design a prospective, longitudinal study for repeated assessment of psychosocial and 
cognitive factors relevant to recovery and quality of life in cardiac surgery patients.  
2. To establish a collaboration with a hospital and clinical team for the purpose of data 
collection.  
3. To conduct preliminary analyses on the collected data to assess the feasibility of the ARCS 
study and the suitability of questionnaire measures and to ascertain initial associations 
between variables.  
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3.2 Recruitment and data collection site 
In order to set-up P-ARCS, collaboration with Professor Marjan Jahangiri (MJ) from the 
cardiothoracic surgery team at St. George’s Hospital, University of London5, was established in 
order to identify and target the sample population. This hospital was selected for a number of 
reasons. St. George’s has one of the largest cardiology departments in the country and is part 
of the southwest London cardiac network; it was named, in 2006, as the heart attack centre in 
southwest London due to its 24-hour angioplasty service. The cardiothoracic surgery team 
consists of five consulting surgeons who perform CABG surgery, with data from 2008-2009 
showing an average survival rate of 98.7% (542 operations) and 6.2% of patients having in-
hospital stay of more than 14 days (Care Quality Commission, 2010). In addition, Steptoe’s (AS) 
group has previously worked with St. George’s cardiology department researching ACS 
patients (Steptoe, Molloy, et al., 2011a; Steptoe, Molloy, et al., 2011b; Steptoe, Wikman, 
Molloy, & Kaski, 2012).  
3.3 Participants  
We planned consecutive recruitment of up to 100 CABG surgery patients for P-ARCS, with 
minimal exclusions. We decided upon this sample size in order to give ourselves time to adapt 
the protocol where necessary, to establish the rate of refusal to participate and withdrawal 
and to have enough data on which to run preliminary analyses of associations between 
variables. The inclusion criteria were patients who were undergoing first-time, elective CABG 
surgery or CABG plus valve replacement, at St George's Hospital, London. We decided to 
exclude emergency cases for both logistical and methodological reasons. Emergency cases are 
usually admitted through accident and emergency wards and as such are usually stabilised 
overnight before surgery the following day. Therefore, there is little time to obtain informed 
consent of these patients and, for those in agreement, to complete the questionnaires. 
Moreover, baseline values of emotional distress are likely to differ from elective patients who 
have been to the pre-assessment clinic; this reasoning also applies for re-do cases, which is 
why we chose to use first-time CABG patients only. Other inclusion criteria were that patients 
must have been able to complete the research interviews and questionnaires in English, and 
have been 18 years or older. Participants with communication or cognitive impairments were 
excluded since this would have affected their ability to complete the questionnaires; this was 
assessed on the recommendation of the pre-assessment nursing staff. Participants who were 
too unwell or clinically unstable were also excluded for ethical reasons.   
 
                                                          
5
 http://www.stgeorges.nhs.uk/services_cardiology.asp 
83 
 
3.4 Study design and procedure 
P-ARCS used a prospective, longitudinal design incorporating three assessments spanning the 
pre-operative period until two months following cardiac surgery. The time one (T1) assessment 
was planned to occur approximately one to three weeks prior to surgery when patients 
attended their pre-assessment clinic appointment in the hospital outpatients department. The 
time two (T2) assessment took place three to five days after surgery while patients were in 
hospital on the cardiac care ward. The time three (T3) appointment took place approximately 
six to eight weeks after surgery via post. These time points were selected to maximise access 
to patients. By recruiting patients at the pre-assessment clinic ensured patients could be met 
in person by one of the research team and have the opportunity to ask any questions about 
the research study. The T2 assessment was chosen in order to assess patients in the acute 
phase of recovery while still in the hospital. Finally, patients are expected to be able to return 
to normal functioning within two months of surgery and are usually discharged from their 
surgeon’s care at the six-week post-surgery outpatient appointment; hence T3 was selected to 
coincide with this point.   
  As stated in the aims, P-ARCS was designed to assess psychosocial and cognitive 
factors; biological factors were not included at this stage.  The study obtained ethical approval 
(South West London REC1, 09/H0708/38). The procedure for assessing participants at each of 
the three time points is described below. Full details of measures included at each time point 
are provided in Section 3.5.  
Time 1 (1-3 weeks before surgery): Prior to being approached in person, a letter introducing 
the study and a participant information sheet was sent to all patients scheduled for elective 
CABG surgery. This first point of contact was made by the clinical team to avoid breach of 
confidentiality. A member of the research team (Dr Tara Kidd (TK) and Ms Lydia Poole (LP)) 
then approached patients in the waiting area of the pre-assessment surgery clinic and asked if 
they would be willing to participate in the study. The procedure was explained, before 
obtaining signed consent. The researcher discreetly conducted a brief interview with the 
patient in the waiting area to collect demographic information and to assess health literacy. 
The participant was also issued with a postal questionnaire to self-complete and return in a 
freepost envelope. The measures assessed included demographic information, emotional 
distress, health behaviour, health status, social support, marital functioning and illness 
perceptions.  
Time 2 (3-5 days after surgery): Participants were approached in the cardiac care ward 
during their post-surgery recovery and asked if they would be willing to participate in the 
second assessment. Having gained verbal consent, the researcher discreetly conducted a brief 
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structured interview. The interview included questionnaire measures of emotional distress, 
pain, and physical symptoms.  
Time 3 (6-8 weeks after surgery): Participants were telephoned and asked if they 
would be willing to participate in the final assessment. If in agreement, a postal questionnaire 
was sent for self-completion. This incorporated measures used at T1 and T2 as well as an 
additional measure of surgery satisfaction. A freepost envelope was provided for return of the 
completed questionnaire. 
3.5 Measures 
3.5.1 Identifying measures 
P-ARCS used questionnaire measures for the assessment of psychosocial and cognitive factors. 
This has particular implications for the measurement of depression, where clinical diagnosis 
can be given only through administration of a clinical interview. As such, questionnaire 
measures are said to capture depression symptoms and not depression per se. This decision 
was taken for a number of reasons. Principally, it was a decision of cost and time, with 
questionnaire measures being cheaper and quicker to administer than clinical interviews. 
Furthermore, it was also a logistical decision regarding access to patients and ease of follow-
up: questionnaires can be self-completed and returned via post. Questionnaire measures of 
depression symptoms have been widely used in cardiac populations, however there is some 
discrepancy in their sensitivity (the proportion of depression cases correctly identified as such) 
and specificity (the proportion of non-depression cases correctly identified as such) (Thombs et 
al., 2008). As such we were aware of the need for careful choice of cut-offs and planned to use 
continuous variables where possible.  
All questionnaire measures were researched and selected based on several criteria. 
First, measures that have been used previously in cardiac populations were given preference. 
Second, those measures that have been shown to be valid over repeated time points and thus 
suited to the longitudinal study design were deemed most appropriate. Third, validated brief 
or shortened versions were chosen over and above full versions to reduce the questionnaire 
burden on participants. Where this was not possible, some subscales were used, rather than 
the full measure. Although from a methodological perspective this latter approach is not ideal, 
this decision was taken in order to reduce conceptual overlap across items and also to 
minimise the questionnaire length. The T2 measures were administered as an interview to aid 
completion. Table 3.1 presents the questionnaire measures used at each assessment. Full 
details of individual measures are given below and are included in Appendices 2 and 3.  
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TABLE 3.1: MEASURES IN THE ARCS PILOT STUDY 
BDI: Beck Depression Inventory; BIPQ: Brief Illness Perception Questionnaire; CROQ-CABG: Coronary 
Revascularisation Outcomes Questionnaire; ESSI: ENRICHD Social Support Instrument; HADS: Hospital 
Anxiety and Depression Scale; IPAQ: International Physical Activity Questionnaire; MARS: Medication 
Adherence Report Scale; MPQ-SF: McGill Pain Questionnaire – Short Form; SAQ: Seattle Angina Questionnaire; 
SF-12: Short Form health survey – 12 item; STOFHLA: Short Test of Functional Health Literacy in Adults; 
YCBQ: York Cardiac Beliefs Questionnaire. 
 
 T1 T2 T3 
Mode of assessment 
Interview/ 
Postal 
Interview Postal 
Time 
1-3 weeks pre-
CABG 
3-5 days post-
CABG 
6-8 weeks post-
CABG 
Measures    
Socio-demographics – general  - - 
Socio-economic status - income  - - 
Cardiac rehabilitation attendance - - - 
Clinical information - -  
Emotional distress    
Depression (BDI)    
Anxiety (HADS subscale)    
Health status    
Health status (SF-12)  -  
Health behaviour    
Adherence (MARS)  -  
Physical activity (IPAQ – walking)  -  
Diet  -  
Sleep (Jenkins Scale)  -  
Smoking  -  
Alcohol  -  
Cognitive function    
Health literacy (STOFHLA – prose subscale)  - - 
Illness beliefs    
Illness perceptions (BIPQ)  -  
Cardiac beliefs (YCBQ)  -  
Social support    
Social network  - _ 
Social support (ESSI)  -  
Marital quality  -  
Physical symptoms    
Angina (SAQ adapted)  -  
Pain (MPQ-SF) -   
Symptoms (CROQ-CABG) -   
Satisfaction    
Satisfaction (CROQ-CABG) - -  
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3.5.2 Demographic information 
Personal details were collected from all participants to include age, marital status, ethnicity 
and religious affiliation. In addition, three markers of socio-economic status were obtained: 
level of education, household income and occupational status. All educational qualifications 
were self-reported and categorised as: no educational qualifications, school certificate, GCE O-
levels/GCSEs/O-levels/CSEs, GCE A-levels, undergraduate degree, postgraduate degree and 
other. For statistical purposes, these groupings were categorised as none, secondary education 
(school certificate/ CSEs/ RSA/ City & Guilds/ GCE O-levels/ GCSEs/ ONC/ OND), higher 
secondary (GCE A-levels/ HND/ HNC) and degree (undergraduate/ postgraduate). Annual 
household income was categorised as under £10,000, £10,000 to £20,000, £20,000 to £30,000 
and more than £40,000. Occupational status was assessed by asking participants to specify 
their job title. If retired, participants were asked to record their last major occupation. 
Occupations were classified according to the UK Office for National Statistics 2010 guidelines 
(Office for National Statistics, 2010). According to these guidelines, nine occupational 
classifications were assigned: managers, directors and senior officials, professional 
occupations, associate professional and technical occupations, administrative and secretarial 
occupations, skilled trade occupations, caring, leisure and other service occupations, sales and 
customer service occupations, process, plant and machine operatives, elementary 
occupations.  
3.5.3 Clinical information 
Clinical information was gathered from patients’ medical notes. Information gathered 
included, pre-operative details such as medical history and co-morbidities, cardiac history, 
height, weight, medications, perioperative details including graft sites, cardiopulmonary time, 
intra-operative blood products, and post-operative details including medications, 
complications and length of intensive care unit (ICU) stay.   
We employed two markers of disease severity: LVEF and the European System for 
Cardiac Operative Risk Evaluation (euroSCORE). LVEF was measured by echocardiogram and 
refers to the percentage of blood pumped through the heart’s left ventricle with each 
contraction; it is commonly used as a proxy measure of heart function. We dichotomised LVEF 
into high (≥ 50%) and low (≤ 49%), with higher scores indicative of normal functioning. The 
euroSCORE (Roques et al., 1999) is a composite measure of risk based on 17 factors comprising 
patient-related factors (e.g. age, gender), cardiac-related factors (e.g. unstable angina, recent 
MI) and surgery-related factors (e.g. surgery on thoracic aorta). Appendix 4 provides a copy of 
the scoring sheet for the euroSCORE using the additive method; full details are available on the 
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euroSCORE website6. Scores for the 17 factors were summed to produce a total score, ranging 
from 1 to 39, with higher scores indicating greater risk. 
3.5.4 Emotional distress 
3.5.4.1 Beck Depression Inventory 
The BDI (Beck, Steer, & Carbin, 1988) can be used to determine the intensity of depression in 
psychiatrically diagnosed populations and also to diagnose depression in healthy, non-
psychiatric individuals. Moreover, the National Heart, Lung and Blood Institute Working Group 
recommend its use in epidemiological studies and to gain a depression severity rating during a 
trial (Davidson et al., 2006). A systematic review suggested the BDI to be preferable to the 
HADS for measuring depression symptoms in cardiac patients (Thombs et al., 2006). It is a 21-
item questionnaire which provides groups of four statements per question and asks the 
respondent to choose the one statement which best reflects how they have been feeling over 
the past two weeks.  
The BDI was scored by summing each chosen answer (on a scale of 0 to 3), higher 
scores indicating greater emotional disturbance, with a range of 0 to 63. A score of 0 to 10 
indicates a person is not depressed, 11 to 20 suggests a person is mildly to borderline clinically 
depressed, 21 to 30 signifies moderate depression and a score of 31 to 63 indicates severe to 
extreme depression. The BDI is thought to be suitable for use in repeated measure designs, 
showing high sensitivity to change across time (Richter, Werner, Heerlein, Kraus, & Sauer, 
1998).   
A systematic review (Thombs et al., 2008) of screening instruments used to detect 
depression in cardiac patients cites three studies using a BDI cut-off score of ≥10 with a mean 
sensitivity range between 82% and 88%  and a mean specificity score range between 58% and 
79% (Frasure-Smith, Lespérance, & Talajic, 1995; Freedland et al., 2003; Strik, Honig, Lousberg, 
& Denollet, 2001). One study used a BDI cut-off ≥13 finding a mean sensitivity value of 83% 
and a mean specificity value of 94% (Gutierrez & Davis, 1999). Therefore, where necessary we 
applied a conservative cut-off of ≥13. The Cronbach’s alpha for this questionnaire in P-ARCS 
was 0.78, 0.78 and 0.75, at T1, T2 and T3 respectively. 
3.5.4.2 Hospital Anxiety and Depression Scale 
The HADS was designed as a self-report, 14-item measure of anxiety and depression for use in 
an outpatient clinical setting (Zigmond & Snaith, 1983) and as such does not include any 
somatic symptom questions. The HADS has been found to be sensitive to change across time in 
                                                          
6
 http://www.euroscore.org/index.htm 
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medical patients and in response to therapeutic intervention, making it suitable for use in 
longitudinal studies (Herrmann, 1997). The HADS has been used in cardiac patients, with a 
systematic review of its use in MI patients finding it to under-report depression prevalence as 
compared to the BDI and clinical interviews, probably due to its omission of somatic symptoms 
which may overlap with the physical symptoms of heart disease (Thombs et al., 2006). 
Therefore, in the ARCS study we used the seven-item anxiety subscale only. This subscale was 
favoured over other anxiety questionnaires, such as the 21-item Beck Anxiety Inventory (Beck, 
Epstein, Brown, & Steer, 1988), because of its brevity. The validity of the HADS has recently 
been scrutinised, with concerns regarding its latent structure and its ability to differentiate 
between cases of depression and anxiety (Cosco, Doyle, Ward, & McGee, 2012; Coyne & van 
Sonderen, 2012). These latter authors also point out issues surrounding use of colloquialisms 
in the HADS such as “butterflies in the stomach” and the subtlety of the reverse phrasing of 
some items such as “I can sit at ease and feel relaxed”, which they argue leads to response 
errors by participants. The limitations of this measure will therefore be borne in mind 
throughout this thesis. 
Questions are answered on a Likert scale ranging from 0 to 3, to indicate the extent to 
which the symptom has been experienced over the past two weeks. Items were summed to 
generate an overall score, with reverse coding on item 4 (I can sit at ease and feel relaxed) and 
item 5 (I get a sort of frightened feeling like ‘butterflies’ in the stomach). Scores range from 0 
to 21 and the recognised cut-off for moderate anxiety is ≥8, with higher scores indicating 
greater anxiety. The Cronbach’s alpha for this questionnaire in P-ARCS was 0.91, 0.76 and 0.76, 
at T1, T2 and T3 respectively. 
3.5.5 Health status 
3.5.5.1 Short form health survey – 12 item 
The Short Form health survey–12-item (SF-12) (Ware, Kosinski, & Keller, 1996) has been 
developed as a brief version of the SF-36 and is a measure of health related quality of life, or 
‘health status’, along two dimensions – mental and physical. Findings suggest that the SF-12 is 
comparable to the SF-36 in detecting change across time in longitudinal studies, for both the 
mental and physical component scores (Jenkinson et al., 1997). The SF-36 has been used 
widely in cardiac patients and has recently been used in CABG patients to evaluate the effects 
of a telephone-delivered collaborative care programme for the treatment of post-CABG 
depression (Rollman et al., 2009). The shorter SF-12 was selected over the SF-36 for P-ARCS to 
reduce the questionnaire burden on participants. Different items on the SF-12 have different 
response categories, some questions having a binary response (yes/no), while others have a 
Likert scale (3- or 5-point). Questions were coded, summarised and calibrated into a scale 
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ranging from 0 (worst possible health) to 100 (best possible health) to give a mental and 
physical score, both with a normative value of 50.  The Cronbach’s alpha for this questionnaire 
in P-ARCS was 0.62 and 0.51 at T1 and T3 respectively for the physical component score and 
0.61 and 0.65 at T1 and T3 respectively for the mental component score. 
3.5.6 Health behavior 
3.5.6.1 Physical activity 
Physical activity was assessed using the walking item from the International Physical Activity 
Questionnaire (IPAQ) (Booth, 2000), which asks the number of days a participant walked for at 
least 10 minutes at a time in the past week, and the average length of time spent walking on 
one of those days. This was used to calculate average time spent walking per week, in hours. 
Given the target population in P-ARCS we chose not to use other items from this measure, 
which capture moderate and vigorous physical activities, since these are rare in a population of 
older people with advanced CHD.  
3.5.6.2 Diet 
Dietary choices were assessed using a two-item fruit and vegetable scale (Cappuccio et al., 
2003) which asks the participant to estimate the average number of portions of fruit and 
vegetables (excluding potatoes) they consume per day and how often they eat less than this 
per week. Results were used to calculate average daily fruit and vegetable intake 
(pieces/week). Dietary fat intake was assessed using a nine-item scale relating to the 
frequency certain fatty foods are consumed, such as butter, cheese and processed meats. 
Scores range from 0 to 27, with higher scores reflecting a higher fat diet.  
3.5.6.3 Smoking 
Smoking of tobacco, including cigarettes, cigars and pipes, was assessed using standard survey 
questions to allow participants to be classified as a current smoker, an ex-smoker, or someone 
who had never smoked. Smokers were also asked to estimate the number of cigarettes 
smoked in a day. Current use of nicotine replacement therapy was also measured. 
3.5.6.4 Alcohol consumption  
Estimated weekly alcohol consumption in units was self-reported (one unit = half a pint of 
beer, one small glass of wine, or one measure of spirit). These responses were used to produce 
an estimate of weekly intake of alcohol units.  
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3.5.6.5 Medication Adherence Report Scale 
The Medication Adherence Report Scale (MARS) was developed by Horne and Weinman 
(Horne & Weinman, 1999) as a brief five-item measure of medication adherent behaviours. 
The MARS has been used previously in cardiac populations (Molloy et al., 2012; Williams, 
O’Connor, Grubb, & O’Carroll, 2011) and has been validated against electronic monitoring 
devices (Cohen et al., 2008). The items of the MARS are: 1) I forget to take my medicines, 2) I 
alter the dose of my medicines, 3) I stop taking my medicines for a while, 4) I decide to miss 
out a dose, 5) I take less than instructed. Responses are given on a five-point Likert scale 
ranging from 0 (Never) to 4 (Always). Items were summed, with a range of 0 to 20; higher 
scores indicating greater medication non-adherence. The Cronbach’s alpha for this 
questionnaire in P-ARCS was 0.80 and 0.72, at T1 and T3 respectively. 
3.5.6.6 Jenkins Sleep Problems Scale 
Sleep problems were assessed using an adapted version of the Jenkins Sleep Problems Scale 
(Jenkins, Stanton, Niemcryk, & Rose, 1988), a widely used brief self-report instrument which 
was specifically developed for use in clinical populations. In addition to the original four-item 
scale, a fifth item was included: “how often in the past month did you have disturbed or 
restless sleep?” (Kumari et al., 2009). The Jenkins scale has been used to assess sleep problems 
in cardiac surgery patients in a prospective study which was designed to investigate predictors 
of cardiac symptoms up to six months following surgery (Jenkins et al., 1996). Participants are 
asked to respond to the questions by estimating the number of days each sleep complaint was 
experienced during the previous month. A total score was derived by summing responses from 
0 (Not at all) to 5 (21 to 31 days of the month). Scores could range from 0 to 25, with higher 
scores indicating greater sleep disturbance. The Cronbach’s alpha for this questionnaire in P-
ARCS was 0.88 and 0.90, at T1 and T3 respectively. 
3.5.7 Physical symptoms 
3.5.7.1 Seattle Angina Questionnaire 
The Seattle Angina Questionnaire (SAQ) (Spertus et al., 1995) was developed as a disease-
specific measure of health-related quality of life. SAQ is a 19-item self-administered 
questionnaire which measures five dimensions of CHD: physical limitation, angina stability, 
angina frequency, treatment satisfaction and disease perception. The scale has been found to 
be a valid and reliable measure of quality of life in cardiac populations and was found to be 
sensitive to clinical change. It has been previously used in CABG populations as an outcome 
measure to assess CABG recovery (Folkmann et al., 2010; Huber, Goeber, Berdat, Carrel, & 
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Eckstein, 2007) and to evaluate the effectiveness of a post-CABG home-based psycho-
educational programme (Lie, Arnesen, Sandvik, Hamilton, & Bunch, 2009). In order to avoid 
overlap with the SF-12, in P-ARCS we employed an adapted six-item version, assessing the 
dimensions of angina frequency and treatment satisfaction only. Questions require responses 
using either a five- or six-point Likert scale. Two scores were derived: an angina frequency 
score ranging from 0 to 15 and a treatment satisfaction score ranging from 0 to 12; higher 
scores on the former indicate poorer functioning and on the latter indicate greater treatment 
satisfaction. The Cronbach’s alpha for angina frequency in P-ARCS was 0.58 and 0.59, at T1 and 
T3 respectively, and for treatment satisfaction it was 0.87 and 0.91, at T1 and T3 respectively. 
3.5.7.2 McGill Pain Questionnaire – Short Form 
The McGill Pain Questionnaire – Short Form (MPQ-SF) (Melzack, 1987) was developed as a 
brief version of the standard MPQ and is suitable for use in post-surgical patients. The MPQ 
has been used in CABG surgery patients to assess recovery (Bruce et al., 2003; Eisenberg, 
Pultorak, Pud, & Bar-El, 2001; Parry et al., 2010). There are three components to the MPQ-SF: 
the first is a list of 15 affective (e.g. fearful) and sensory (e.g. throbbing) descriptor words for 
which respondents are asked to rate their current experience of that particular type of pain 
from 0 (none) to 3 (severe), the second is a rating scale of total pain and the final component is 
a present pain intensity scale from 0 (no pain) to 5 (excruciating). The MPQ-SF has been shown 
to be sensitive to change according to analgesic use and can be used for repeated measure 
assessments (Melzack, 1987). After piloting the scale on several participants (n = 4) at T2, we 
decided to employ an adapted version, changing the rating scale from a visual analogue scale 
to a numerical rating scale to aid completion for our patient group. We derived four separate 
scores. The affective pain score is the sum of the intensity values for the affective descriptor 
words (range: 0 to 12) and, similarly, the sensory pain score is the sum of the intensity values 
for the sensory descriptor words (range: 0 to 33). The Likert scale response for the numerical 
rating scale (range: 0 to 10) and the pain intensity scale (range: 0 to 5) comprise the scores for 
these items. The Cronbach’s alpha for the sensory pain subscale in P-ARCS was 0.61 and 0.73, 
at T2 and T3 respectively, and for the affective pain subscale it was 0.45 and 0.56, at T2 and T3 
respectively.  
3.5.7.3 Coronary Revascularisation Outcomes Questionnaire  
The Coronary Revascularisation Outcomes Questionnaire (CROQ) (Schroter & Lamping, 2004) 
was designed to assess quality of life and health outcomes following cardiac surgery. The 
CROQ is comprised of several subscales relevant to the pre-operative period, such as angina 
symptoms, physical functioning and psychosocial functioning, and the post-operative period 
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such as physical symptoms for CABG patients and angioplasty patients. The pre-operative 
scales greatly overlap with the SF-12 and SAQ which are included in P-ARCS. Therefore, this 
study only used the 11-item post-surgery physical symptom subscale from the version 
designed for CABG surgery patients.  This scale asks patients to rate the extent to which they 
have experienced certain physical symptoms related to their surgery such as bruising, 
numbness and tingling and swelling, using a five-point Likert scale ranging from 0 (Not at all) to 
4 (A lot). Responses were summed, ranging from 0 to 44, with higher scores indicating greater 
negative symptoms. The Cronbach’s alpha for this questionnaire in P-ARCS was 0.48 and 0.78, 
at T2 and T3 respectively. 
We also used the CROQ six-item satisfaction scale, which asks patients to rate the 
extent to which they are satisfied with their care and their recovery. Participants responded to 
the first three of these items on a four-point Likert scale ranging from 0 (very dissatisfied) to 3 
(very satisfied).  The fourth item used a five-point Likert scale ranging from 0 (much worse) to 4 
(much better); the fifth item used a three-point Likert scale ranging from 0 (slower than 
expected) to 2 (faster than expected) and the sixth item also used a three-point Likert scale 
ranging from 0 (worse than expected) to 2 (better than expected). Responses were summed, 
ranging from 0 to 17, with higher scores indicating better satisfaction. The Cronbach’s alpha 
for the satisfaction subscale at T3 was 0.73.  
3.5.8 Cognitive function 
3.5.8.1  The Short Test of Functional Health Literacy in Adults 
The Short Test of Functional Health Literacy in Adults (STOFHLA) is a validated abbreviated 
version of the original 20-item test (Baker, Williams, Parker, Gazmararian, & Nurss, 1999).  The 
STOFHLA consists of four numeracy items and two prose passages and is designed to offer a 
brief assessment of functional health literacy, which refers to a person’s ability to read and 
understand information in a health care environment. This assessment has been used in 
cardiac populations, including hypertension (Levinthal, Morrow, Tu, Wu, & Murray, 2008) and 
heart failure (Morrow et al., 2006) patients.  We utilised the 11-item comprehension task 
(prose passage A) of the STOFHLA, which describes the imaginary medical scenario of 
undergoing a stomach x-ray. Participants were required to complete the sentences using one 
of four given words.  
The full STOFHLA requires scores to be summed and weighted in order to derive a total 
score. Since we were utilising just a sub-section of the full measure, we planned to simply sum 
responses for use as a continuous measure; higher scores would indicate better health literacy. 
However, after piloting the STOFHLA on several participants (n = 6) it became apparent that for 
those who had difficulty in completing the measure, the waiting room was an unsuitable 
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environment for its administration. Due to limited research room availability at the time of the 
pilot study, we were forced to remove the STOFHLA from P-ARCS. 
3.5.9 Social support 
3.5.9.1 Social networks 
Social networks refer to the size of a person’s social support structure. We employed a 
questionnaire developed by Cohen and colleagues (Cohen, Doyle, Skoner, Rabin, & Gwaltney, 
1997) which asks participants to think back over a typical two-week period and rate the 
frequency of social interaction with 11 sets of possible contacts, such as children, friends, 
neighbours and work colleagues. In line with work published previously by Steptoe’s group in 
cardiac patients (Molloy, Perkins-Porras, Strike, et al., 2008), we scored responses according to 
the number of social contacts a participant spoke with (either in person or by telephone), with 
each type of relationship being assigned a score of 1. Scores range from 0 to 13, with greater 
values indicating more diverse social networks.  
3.5.9.2 The ENRICHD Social Support Instrument 
The ENRCIHD Social Support Instrument (ESSI) is a validated seven-item scale to assess the 
quality of social support. This measure was developed specifically for use in the ENRCIHD study 
of cardiac patients (Mitchell et al., 2003). The items relate to structural (i.e. partner) support, 
instrumental (i.e. tangible) support and emotional (i.e. caring) support. Example items include: 
“is there someone available to whom you can count on to listen to you when you need to 
talk?” and “is there someone there to help you with daily chores?” The response categories 
are on a five-point Likert scale ranging from 1 (None of the time) to 5 (All of the time). 
Responses to item 7 (“Are you currently married or living with a partner?”) were scored 4 (Yes) 
and 2 (No) in accordance with the scoring guidelines from the original scale. Responses were 
summed to produce a total score, ranging from 8 to 34; higher scores indicate greater social 
support. The Cronbach’s alpha for this questionnaire in P-ARCS was 0.93 at both T1 and T3.   
3.5.9.3 Marital quality 
The marital quality scale was developed by Troxel and colleagues (Troxel, Matthews, Gallo, & 
Kuller, 2005) as a brief, seven-item, measure of marital satisfaction in the Pittsburgh Healthy 
Women Study. This measure asks participants to rate the amount of satisfaction they 
perceived with their cohabiting partner or spouse, across seven different domains: time spent 
together, communication, sexual activity, agreement on financial matters, and similarity of 
interests, lifestyle and temperament. This questionnaire was only completed by participants to 
whom it was applicable. Possible scores range from 0 to 21, with scores awarded on a four-
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point Likert scale from 0 (Not at all satisfied) to 3 (Very satisfied); greater scores indicating 
higher marital quality. The Cronbach’s alpha for this questionnaire in P-ARCS was 0.85 and 
0.82, at T1 and T3 respectively. 
3.5.10 Illness beliefs 
3.5.10.1 Brief Illness Perceptions Questionnaire 
The Brief Illness Perceptions Questionnaire (BIPQ) (Broadbent, Petrie, Main, & Weinman, 
2006) was designed as a short nine-item version of the IPQ to provide rapid assessment of 
emotional and cognitive representations of illness. The IPQ has been used in cardiac surgery 
populations previously to assess emotional adaptation following surgery (Dunkel, Kendel, 
Lehmkuhl, Hetzer, & Regitz-Zagrosek, 2011; Juergens et al., 2010). The brief version was 
utilised in P-ARCS to minimise the questionnaire load. The first eight items ask respondents to 
rate the extent to which a statement corresponds to their views on a scale from 0 to 10. The 
last item asks respondents to list the three most important factors that they believe caused 
their illness. A total score of the first eight items was derived by summing the responses, with 
items 3, 4 and 7 reverse coded. The range for this questionnaire is 0 to 80. Individual items can 
also be used to reflect the different illness perception dimensions: consequences, timeline, 
personal control, treatment control, identity, concern, emotional representation, and illness 
comprehensibility. The responses to item 9 were scored by grouping the proffered causes into 
categories such as hereditary, stress, lifestyle etc., and then performing categorical analysis. 
The Cronbach’s alpha for this questionnaire (items 1-8) in P-ARCS was 0.67 and 0.82, at T1 and 
T3 respectively. 
3.5.10.2 The York Cardiac Beliefs Questionnaire 
The York Cardiac Beliefs Questionnaire (YCBQ) (Furze et al., 2009) was designed as a measure 
of common misconceptions that patients often have about living with heart disease, such as 
“people who have heart disease should never get excited or upset” and “heart problems are a 
sign that you have a worn out heart”. There are three subscales to this questionnaire, one 
which covers common misconceptions relating to heart disease, one relating to angina and 
another relating to MI; this study utilised the 12-item heart disease subscale only. There are 
also two versions, one for use in clinical practice and another for use in research; the latter was 
used in P-ARCS. Respondents are asked to rate the extent to which they agree or disagree with 
12 statements on a scale from 0 (strongly disagree) to 4 (strongly agree). A total score was 
derived by summing the responses (scores ranging from 0 to 48), with items 6 and 7 reverse 
coded. Higher scores reflect more misconceptions. The Cronbach’s alpha for this questionnaire 
in P-ARCS was 0.85 at both T1 and T3. 
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3.6 Data storage 
Data were collated and stored in line with ethical guidelines and University College London 
(UCL) policy. All data were treated as strictly confidential. The project was registered with the 
UCL Data Protection Office. Consent forms and patient personal details were stored separately 
from the questionnaire data; all data were stored in locked filing cabinets, in locked offices at 
UCL. Anonymised raw data were entered into a computer database for statistical analysis; 
personal identification information was kept in a separate file to the questionnaire responses. 
Data were kept on password protected computers, in files accessible only to the study 
researchers. Data may be kept in this secure manner for up to 20 years prior to being 
destroyed.  
3.7 My involvement and contribution 
The research question regarding depression symptoms and cardiac recovery was mutually 
established between myself and AS. AS has worked extensively in the depression and ACS field 
and under his tutelage I first authored a review paper of the ACS and depression literature 
(Poole, Dickens, et al., 2011). In researching the literature for this review paper I became 
interested in the cardiac surgery population and through discussion with AS, the ARCS study 
began to take shape. AS established the collaboration with St. George’s hospital and 
introduced me to MJ. Together, AS and I applied for National Health Service (NHS) ethical 
approval and host site approval. I began to liaise with the nursing team to set-up the study and 
to establish a protocol for recruitment. TK and I began recruiting for the pilot study in 
December 2009 and data collection for T2 and T3 assessments continued through to October 
2010. Clinical data was collected by a clinical research associate (Dr Kate Evans). I was 
responsible for creating all the P-ARCS questionnaires and resources. In addition, I was in 
charge of maintaining participant records and T3 assessments and prompts. Along with help 
from another PhD student (Ms Elizabeth Leigh [EL]), I completed all the data entry for the pilot 
study. I conducted all the statistical analyses myself, with guidance from my supervisor, AS.  
3.8 Statistical analysis 
All statistical analyses were performed using SPSS version 20.0 software (SPSS, Inc., Chicago, 
Illinois, USA). The significance level was set to p < 0.05 for all analyses, with precise p values 
reported for all test results. Specific details on the analyses conducted are presented in the 
results section of Chapter 4.   
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Chapter 4. Results: Pilot study 
4.1 Introduction 
P-ARCS was carried out between December 2009 and October 2010. To reiterate, the aims of 
the pilot study were threefold:  
1. To design a prospective, longitudinal study for repeated assessment of psychosocial and 
cognitive factors relevant to recovery and quality of life in cardiac surgery patients.  
2. To establish a collaboration with a hospital and clinical team for the purpose of data 
collection.  
3. To conduct preliminary analyses on the collected data to assess the feasibility of the ARCS 
study and the suitability of questionnaire measures, and to ascertain initial associations 
between variables.  
Having described the first of these two aims in Chapter 3, this chapter will present the results 
pertaining to the third aim. First the recruitment statistics will be described, followed by 
descriptive analyses of the questionnaire measures. Lastly, preliminary analyses of associations 
between data will be presented, specifically the associations between pre-operative illness 
perceptions and recovery and pre-operative sleep disturbance and recovery.  
4.2 Uptake, attrition and missing data 
 
TABLE 4.1: ATTRITION NUMBERS AND REASONS 
Reason for non-completion Time point missing n 
Clinical events  5 
Death T3 3 
Stroke T3 2 
Non-return of questionnaires  25 
T1 questionnaires never returned T1 9 
T2 questionnaires – participant refused to 
complete at this time point 
T2 8 
T2 questionnaires – patient discharged at 
weekend 
T2 1 
T3 questionnaires never returned T3 7 
Clinical data  5 
Unable to track medical notes T3 5 
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FIGURE 4.1: FLOW DIAGRAM OF PARTICIPANTS’ PROGRESSION THROUGH THE PILOT STUDY 
 
   
ENROLLMENT 
FOLLOW-UP 
ANALYSIS 
Assessed for eligibility 
(n = 115) 
Excluded 
 Declined to participate (n = 11) 
Consented 
(n = 104) 
BASELINE 
Completed baseline 
assessments 
(n = 95) 
Lost to T2 follow-up 
(n = 15) 
 Study withdrawal (n = 10) 
 Clinical event (n = 1) 
 Surgery cancelled (n = 4) 
Analysed 
 T1-T3 (n= 70) 
Lost to T3 follow-up 
(n = 10) 
 Study withdrawal (n = 6) 
 Clinical event (n = 4) 
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TABLE 4.2: TYPES OF MISSING QUESTIONNAIRE DATA IN ANALYTIC SAMPLE (N = 70) 
Measures T1 T2 T3 
Socio-demographics    
Education 2 - - 
Income 13 - - 
Cardiac rehabilitation attendance - - 5 
Emotional distress    
Depression (BDI) 8 4 16 
Anxiety (HADS subscale) 2 0 5 
Health status    
Health status (SF-12) – Physical 0 - 5 
Health status (SF-12) – Mental 0 - 5 
Health behaviour    
Adherence (MARS) 0 - 5 
Physical activity (IPAQ – walking) 2 - 8 
Diet – fruit 1 - 5 
Diet – vegetables 1 - 4 
Diet – fat intake 1 - 7 
Sleep (Jenkins Scale) 4 - 5 
Illness beliefs    
Illness perceptions (BIPQ) 12 - 10 
Cardiac beliefs (YCBQ) 5 - 8 
Social support    
Social network 18 - - 
Social support (ESSI) 12 - 13 
Marital quality 34 - 27 
Physical symptoms    
Angina symptoms (SAQ) 9 - 10 
Angina treatment satisfaction (SAQ) 11 - 9 
Pain (MPQ-SF) - Sensory - 5 10 
Pain (MPQ-SF) - Affective - 3 6 
Symptoms (CROQ-CABG) - 11 7 
Satisfaction    
Satisfaction (CROQ-CABG) - - 9 
 
One hundred and four participants were recruited to take part in the pilot study, of whom four 
participants did not eventually undergo CABG and so were withdrawn from the study. Nine 
participants consented to participate but did not return the T1 questionnaire, leaving a total 
sample of 91. A flow diagram of uptake and attrition is presented in Figure 4.1. Five 
participants suffered from clinical events following surgery and 16 participants failed to 
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complete T2 and T3 questionnaires. Further details of missing data are provided in Table 4.1, 
showing loss of participants across time points was roughly equal. Due to attrition, the final 
total of participants who completed the questionnaires at all three time points was 70. 
Reasons for missing data are not entirely clear, though are likely to involve both 
accidental and deliberate non-completion of items. For example, the high rates of missing data 
on the SAQ can be attributed to some participants stating they do not suffer from angina; 
therefore these questions were not applicable. Similarly, those participants who were not 
married or cohabiting (n = 22) were not required to complete the marital functioning 
questionnaire. Some participants had difficulty completing the BIPQ which is presented as a 
numerical rating scale; specific examples will be added to the main ARCS study to aid 
completion. Questions that were sensitive in nature, such as household income and libido on 
the BDI, may partly account for high levels of missing data on these scales. Missing data 
regarding clinical information is documented in Section 4.3 (Table 4.5). 
4.3 Sample characteristics 
Table 4.3 and Table 4.4 describe the characteristics of the entire sample and analytic sample, 
respectively, at baseline. Clinical data of the analytic sample is displayed in Table 4.5. The 
analytic sample had an age range between 22 to 83 years, was predominantly male (75.7%) 
and overweight (BMI >25 = 63.6%). The majority of participants were retired (76.5%), one 
participant was registered disabled and four participants were unemployed, one of which was 
a university student. The majority of the analytic sample had either no or only secondary 
educational qualifications (67.6%). Fifty-six per cent of participants had a family history of CHD. 
Co-morbidities were prevalent in the analytic sample. The majority of participants had on-
pump (cardiopulmonary bypass) surgery (71.7%) in isolation. Post-operative complications 
occurred in 29 participants, some of whom had more than one. Serious complications occurred 
particularly in one patient who suffered from atrial fibrillation, cardiac arrest, MI and renal 
impairment.  
Cross-tabulations were performed on age, total yearly household income, education and 
sex, to compare the characteristics of those who completed all three time points (n = 70) to 
those who did not (n = 21). Age was converted to a categorical variable for chi-squared analysis 
(<50 years, 50-60 years, 60-70 years, 70-80 years, >80 years).  There was no statistical 
difference between groups in terms of age groups (2 = 2.646, df = 4, N = 91, p = 0.619). The 
mean age, in years, was slightly lower in the non-completers (Mean: 66.90 ± SD: 11.02) 
compared with the completers (Mean: 68.01 ± SD: 9.53), but this did not reach statistical 
significance (t = -0.451, p = 0.653). Nor was there a significant difference between completers 
and non-completers in terms of income group (2 = 2.866, df = 4, N = 76, p = 0.580), education 
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group (2 = 1.773, df = 3, N = 89, p = 0.621), and sex (2 = 0.157, df = 1, N = 91, p = 0.692). 
Markers of disease severity did also not significantly differ between completers and non-
completers in terms of both euroSCORE (2 = 13.165, df = 11, N = 88, p = 0.283) and LVEF (2 = 
1.129, df = 1, N = 89, p = 0.288) groups.   
 Kolmogorov-Smirnov tests were performed revealing scores on all continuous measures 
apart from the SF-12 physical score, the BIPQ and the YCBQ to be non-normally distributed (p 
> 0.05). Both non-parametric and parametric tests were performed on the data, but since 
results were similar, the parametric results are presented here.   
 
TABLE 4.3: CHARACTERISTICS OF THE ENTIRE SAMPLE AT BASELINE 
Characteristic N Mean ± SD or n (%) 
Age (years)  91 67.76±9.84 
Female  91 23 (25.3) 
BMI (kg/m
2
) 63 27.52±4.67 
Married/cohabiting  91 62 (68.1) 
Ethnicity – White British/other White  91 84 (92.3) 
Currently employed 91 16 (17.6) 
Employment grade of current/last major occupation 
Unemployed 
Managers, directors and senior officials 
Professional  
Associate professional and technical  
Administrative and secretarial  
Skilled trades  
Caring, leisure and other service  
Sales and customer service  
Process, plant and machine operatives 
Elementary  
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8 (9.2) 
6 (6.9) 
26 (29.9) 
9 (10.3) 
8 (9.2) 
16 (18.4) 
5 (5.7) 
2 (2.3) 
3 (3.4) 
4 (4.6) 
Yearly household income  
≤ 10,000 GBP 
10,000 – 20,000 GBP 
20,000 – 30,000 GBP  
30,000 – 40,000 GBP 
≥40,000 
76 
 
21 (27.6) 
22 (28.9) 
12 (15.8) 
16 (21.1) 
5 (6.6) 
Education 
None 
Secondary 
Higher secondary 
Degree 
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37 (41.6) 
22 (24.7) 
13 (14.6) 
17 (19.1) 
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TABLE 4.4: CHARACTERISTICS OF THE ANALYTIC SAMPLE AT BASELINE 
Characteristic N Mean ± SD or n (%) 
Age (years)  70 68.01±9.53 
Female  70 17 (24.3) 
BMI (kg/m
2
) 55 27.18±4.54 
Married/cohabiting  70 48 (68.6) 
Ethnicity – White British/other White  70 67 (95.7) 
Currently employed 70 11 (15.7) 
Employment grade of current/last major occupation 
Unemployed 
Managers, directors and senior officials 
Professional  
Associate professional and technical  
Administrative and secretarial  
Skilled trades  
Caring, leisure and other service  
Sales and customer service  
Process, plant and machine operatives 
Elementary  
68 
 
4 (5.9) 
6 (8.8) 
20 (29.4) 
7 (10.3) 
8 (11.8) 
15 (22.1) 
3 (4.4) 
1 (1.5) 
2 (2.9) 
2 (2.9) 
Yearly household income  
≤ 10,000 GBP 
10,000 – 20,000 GBP 
20,000 – 30,000 GBP  
30,000 – 40,000 GBP 
≥40,000 
57 
 
13 (22.8) 
18 (31.6) 
9 (15.8) 
13 (22.8) 
4 (7.0) 
Education 
None 
Secondary 
Higher secondary 
Degree 
68 
 
27 (39.7) 
19 (27.9) 
10 (14.7) 
12 (17.6) 
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TABLE 4.5: CLINICAL CHARACTERISTICS OF THE ANALYTIC SAMPLE AT BASELINE 
*Absolute number of cases in sample. 
 
4.4 Descriptive analyses of predictor and outcome measures 
In order to evaluate the pilot study it was important to establish whether the questionnaire 
measures utilised were sensitive, that is that they were able to produce a range of scores in 
Characteristic Missing N n (%) 
Co-morbidities* 
 
 
 
Diabetes 9 61 13 (21.3) 
Renal failure (requiring dialysis) 10 60 1 (1.7) 
Chronic respiratory disease 9 61 10 (16.4) 
Hypothyroidism 9 61 3 (4.9) 
Other chronic illness 
Rheumatoid arthritis 
Arthritis 
9 
 
61 
 
39 (63.9) 
1 (1.6) 
17 (27.9) 
Disease severity 
 
 
 
Ejection fraction < 50 1 69 16 (23.2) 
euroSCORE 
0 
1-4 
5-7 
8-10 
1 69 
 
5 (7.2) 
37 (53.6) 
24 (34.8) 
3 (4.3) 
Surgical details 
 
 
 
Off-pump 10 60 17 (28.3) 
CABG in isolation 10 60 43 (71.7) 
Graft sites 
1 
2 
3 
4 
5 
11 59 
 
5 (8.5) 
13 (22.0) 
27 (45.8) 
12 (20.3) 
2 (3.4) 
Post-operative recovery 
 
 
 
Intensive care stay > 2 days 12 58 3 (5.2) 
Post-operative infection 10 60 15 (25.0) 
Reoperation necessary 10 60 4 (6.7) 
At least 1 complication 
Atrial fibrillation/arrhythmia/tachycardia 
Ventricular fibrillation 
Atrial flutter 
Pleural effusion/heart failure 
Pneumothorax 
Cardiac arrest 
Myocardial Infarction 
9 
 
61 
 
29 (47.5) 
17 (27.9)* 
1 (1.6)* 
2 (3.3)* 
3 (4.9)* 
2 (3.3)* 
1 (1.6)* 
1 (1.6)* 
Cardiac rehabilitation attendance 5 65 31(47.7) 
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the population targeted in this sample. As such, frequency analyses were performed to identify 
potential ceiling effects.  
4.4.1 Emotional distress 
4.4.1.1 Depression symptoms 
The timeframe for answering questions on the BDI at T1 and T3 was the previous two weeks, 
while at T2 it was the past few days since the surgery. Figure 4.2 represents the frequency of 
scores on the BDI across all three time points, showing scores to be clustered towards the 
lower end and middle of the scale, but with a wide range (0-46). The widest distribution of 
scores occurred at T1. To analyse the distribution further, scores were grouped into categories 
in accordance with the BDI handbook cut-offs. Results from the frequency analysis of these 
categories are displayed in Table 4.6 showing that the majority of participants had normal 
levels of depression symptoms at each time point (T1 >10 = 24.2%; T2 >10 = 39.4%; T3 >10 = 
20.4%). These data also show a higher proportion of participants with mild depression at T2 
than at other assessments. Individual items on the BDI were examined using paired samples t-
tests to compare scores at T1 and T2 (Table 4.7). These analyses show that before surgery, 
participants were more likely to report significantly higher symptoms of irritability and lack of 
interest in others (social withdrawal), than after surgery at T2. However, following surgery at 
T2, participants were more likely to report significantly higher symptoms of difficulty in 
working, sleep problems, fatigue and loss of appetite than at T1. Therefore, the higher 
proportion of participants with mild depression at T2 is likely due to the higher reporting of 
somatic symptoms and symptoms associated with the in-hospital environment. Similar 
numbers of participants had moderate-severe-extreme scores (≥21) at each time point (Table 
4.6).  
Paired samples t-tests were performed on the BDI mean scores showing BDI scores 
were lower before surgery (Mean: 8.40, SD: 7.94) compared with the days following surgery 
(Mean: 9.95, SD: 6.83), but this was not significant (t(57) = -1.629, p = 0.109). However, from 
T2 (Mean: 10.02, SD: 6.86) to T3 (Mean: 7.08 ± SD: 4.86) there was a significant decrease in 
depression symptom scores, with levels falling to just below baseline scores (t(49) = 2.970, p = 
0.005). There was no significant difference between scores at T1 (Mean: 8.45 ± SD: 8.12) 
compared with T3 (Mean: 7.27 ± SD: 4.68) (t(48) = 1.255, p = 0.216). 
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FIGURE 4.2: FREQUENCY OF SCORES ON THE BDI ACROSS TIME 
 
TABLE 4.6: FREQUENCY OF SCORES ACCRODING TO BDI SUBGROUP 
BDI score BDI Classification 
n (%) 
T1 (N=62) T2 (N=66) T3 (N=54) 
0-10 Normal 47 (75.8) 40 (60.6) 43 (79.6) 
11-16 Mild 9 (14.5) 20 (30.3) 9 (16.7) 
17-20 Borderline clinical 3 (4.8) 2 (3.0) 1 (1.9) 
21-30 Moderate 2 (3.2) 3 (4.5) 1 (1.9) 
31-40 Severe - 1 (1.5) - 
41-63 Extreme 1 (1.6) - - 
 
 
To examine caseness on the BDI, a binary cut-off was implemented in accordance with 
previous literature at a conservative ≥13 (Gutierrez & Davis, 1999). According to this cut-off, 
21.4% of participants were depressed at baseline, 26.1% were depressed at T2 and 9.2% were 
depressed at T3. Eight groups were created in order to examine the pattern of depression 
symptoms across time. Results from these analyses are shown in Table 4.8 revealing that six 
participants can be classified as having persistent depression after surgery and one participant 
can be classified as developing post-CABG onset depression. A further 14 participants had 
depression that had resolved by T3. 
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TABLE 4.7: PAIRED SAMPLES T-TESTS OF BDI ITEMS AT T1 AND T2 
Symptom N Mean ± SD t p 
1. Sadness  
T1 
69 
0.36± 0.57 
2.190 0.032 
T2 0.22± 0.45 
2. Pessimism   
T1 
69 
0.29± 0.60 
1.839 0.070 
T2 0.13± 0.45 
3. Sense of failure  
T1 
69 
0.22± 0.64 
0.962 0.340 
T2 0.14± 0.58 
4. Dissatisfaction  
T1 
68 
0.47± 0.63 
0.727 0.470 
T2 0.40± 0.65 
5. Guilt  
T1 
68 
0.07± 0.32 
0.000 1.000 
T2 0.07± 0.26 
6. Punishment  
T1 
69 
0.12± 0.44 
0.469 0.641 
T2 0.09± 0.41 
7. Self-dislike  
T1 
69 
0.25± 0.53 
0.575 0.567 
T2 0.20± 0.44 
8. Self-accusations  
T1 
69 
0.25± 0.53 
1.472 0.146 
T2 0.14± 0.52 
9. Suicidal ideas  
T1 
69 
0.07± 0.31 
1.000 0.321 
T2 0.04± 0.21 
10. Crying  
T1 
69 
0.26± 0.63 
1.927 0.058 
T2 0.12± 0.37 
11. Irritability  
T1 
68 
0.59± 0.74 
2.921 0.005 
T2 0.31± 0.53 
12. Social withdrawal  
T1 
69 
0.22± 0.51 
2.802 0.007 
T2 0.07± 0.40 
13. Indecisiveness  
T1 
69 
0.33± 0.61 
1.636 0.106 
T2 0.20± 0.63 
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14. Body image change  
T1 
69 
0.20± 0.56 
-0.207 0.837 
T2 0.22± 0.48 
15. Work difficulty  
T1 
69 
0.91± 0.78 
-2.082 0.007 
T2 1.35± 1.10 
16. Insomnia  
T1 
68 
0.93± 0.97 
-2.995 0.004 
T2 1.43± 1.24 
17. Fatigue  
T1 
68 
1.00± 0.57 
-4.042 <0.001 
T2 1.59± 1.01 
18. Loss of appetite  
T1 
69 
0.35± 0.61 
-6.981 <0.001 
T2 1.41± 1.06 
19. Weight loss  
T1 
68 
0.35± 0.77 
0.287 0.775 
T2 0.32± 0.58 
20. Somatic preoccupation  
T1 
68 
0.68± 0.80 
1.539 0.128 
T2 0.50± 0.66 
21. Loss of libido  
T1 
64 
0.91± 1.15 
0.424 0.673 
T2 0.83± 1.16 
 
 
TABLE 4.8: DEPRESSION CASENESS ACCORDING TO TIME POINT  
Depression type 
BDI ≥ 13 
n (%) 
T1 T2 T3 
Persistent    1 (2.2) 
Post-CABG onset X X  1 (2.2) 
Transient X  X 10 (22.2) 
Delayed onset X   - 
Never depressed X X X 26 (57.8) 
Resolved   X 2 (4.4) 
Persistent  X  3 (6.7) 
Resolved  X X 2 (4.4) 
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4.4.1.2 Anxiety 
Figure 4.3 represents the frequency of scores on the HADS anxiety subscale across all three 
time points, showing scores to be clustered towards the lower end of the scale, but with a 
wide range (0-21). The widest distribution of scores occurred at T1. To analyse the distribution 
further, scores were grouped into categories in accordance with the HADS severity cut-offs.  
Results from the frequency analysis of these categories are displayed in Table 4.9 showing a 
higher proportion of participants with borderline and case anxiety at T1 than at other 
assessments. Paired samples t-tests were performed on the HADS anxiety mean scores 
showing there to be a significant decrease from before surgery (Mean: 6.04 ± SD: 4.50) to the 
days following surgery (Mean: 3.84 ± SD: 3.56) (t(67) = 4.048, p <0.001) and from before 
surgery (Mean: 5.62 ± SD: 4.07) to T3 (Mean: 3.48 ± SD: 2.82) (t(62) = 5.295, p <0.001). From 
T2 (Mean: 3.65 ± SD: 3.52) to T3 (Mean: 3.60 ± SD: 2.86) there was no significant change in 
anxiety scores (t(64) = 0.104, p = 0.917).  
To examine participants with borderline to case anxiety on the HADS, a binary cut-off 
was implemented in accordance with previous literature at ≥8. Eight groups were created in 
order to examine the pattern of anxiety across time. Results from these analyses are shown in 
Table 4.10 revealing that three participants can be classified as having persistent anxiety after 
surgery. A further 12 participants had anxiety that had resolved by T3. Overall, there were very 
few cases of anxiety. 
 
 
FIGURE 4.3: FREQUENCY OF SCORES ON THE HADS ACROSS TIME 
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TABLE 4.9: FREQUENCY OF HADS ANXIETY SCORES  
HADS anxiety 
score 
HADS classification 
n (%) 
T1 (N=68) T2 (N=70) T3 (N=65) 
≤7 Normal 47 (69.1) 60 (85.7) 58 (89.2) 
8-10 Borderline 10 (14.7) 7 (10.0) 6 (9.2) 
≥11 Caseness 11 (16.2) 3 (4.3) 1 (1.5) 
 
TABLE 4.10: ANXIETY TYPE ACCORDING TO TIME POINT 
Anxiety type 
HADS ≥ 8 
n (%) 
T1 T2 T3 
Persistent    3 (4.8) 
Post-CABG onset X X  1 (1.6) 
Transient X  X 3 (4.8) 
Delayed onset X   - 
Never anxious X X X 42 (66.7) 
Resolved   X 2 (3.2) 
Persistent  X  2 (3.2) 
Resolved  X X 10 (15.9) 
 
4.4.2 Health status 
4.4.2.1 Physical and mental health status 
Figure 4.4 and Figure 4.5 show the distribution of scores on the SF-12 for the mental and 
physical components, respectively. Scores show a wide range across both time points 
indicating no ceiling effects. The scores on the mental component were clustered around the 
normative value of 50, in line with findings from the BDI. In comparison, the physical 
component had a much higher percentage of scores below 50, with the majority of 
participants reporting reduced physical health status at T1 (85.7%) and T3 (95.4%) (see Table 
4.11). Paired samples t-tests showed no change in mental health status from T1 (Mean: 56.12 
± SD: 6.27) to the T3 post-operative assessment (Mean: 56.79 ± SD: 6.92) (t(64) = -0.816, p = 
0.417). However, paired samples t-tests showed there was a significant decrease in physical 
health status from T1 (Mean: 39.22 ± SD: 10.12) to T3 (Mean: 35.09 ± SD: 8.28) (t(64) = 2.813, 
p = 0.007). 
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FIGURE 4.4: FREQUENCY OF SF-12 MENTAL COMPONENT SCORE AT T1 AND T3 
 
 
FIGURE 4.5: FREQUENCY OF SF-12 PHYSICAL COMPONENT SCORE AT T1 AND T3 
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TABLE 4.11: FREQUENCY OF SCORES ON SF-12  
SF-12 Score 
Range 
SF-12 Mental n (%) SF-12 Physical n (%) 
T1 (N = 70) T3 (N = 65) T1 (N = 70) T3 (N = 65) 
10-20 - - 1 (1.4) 1 (1.5) 
21-30 - - 17 (24.3) 19 (29.2) 
31-40 - - 21 (30.0) 29 (44.6) 
41-50 17 (24.3) 16 (24.6) 21 (30.0) 13 (20.0) 
51-60 35 (50.0) 24 (36.9) 10 (14.3) 3 (4.6) 
61-70 18 (25.7) 25 (38.5) - - 
 
4.4.3 Health behaviour 
4.4.3.1 Adherence 
Figure 4.6 shows the distribution of scores on the MARS at T1 and T3. Scores were skewed, 
with most participants reporting no to minimal non-adherence at both time points (T1 mean: 
1.17 ± SD: 1.77; T3 mean: 0.83 ± SD: 1.50). Paired samples t-tests showed no significant change 
in non-adherence levels from pre- to post-operative assessments (t(64) = 1.925, p = 0.059). 
Since scores were skewed, categorical analyses was also performed, computing binary scores 
for adherence at both T1 and T3. Adherers were classed as all those people who had a total 
score of 0, and non-adherers were those who scored ≥1. Cross-tabulation results are displayed 
in Table 4.12, showing that only 44.6% of the sample was medication adherent and 36.9% of 
the sample was non-adherent at both T1 and T3. Few people changed from being adherent at 
T1 to non-adherent at T3 (6.5%), though 29.4% of non-adherers at T1 went on to become 
adherent following surgery. A Chi-square analysis was performed showing there was a 
significant difference between adherent and non-adherent groups over time (2 = 27.793, df = 
1, N = 65, p <0.001). 
 
TABLE 4.12: CROSS-TABULATION OF ADHERERS AND NON-ADHERERS AT T1 AND T3 
 T3 
Total 
Adherer Non-adherer 
T1 
Adherer 
n 29 2 31 
% within T1 93.5 6.5 100.0 
Non-adherer 
n 10 24 34 
% within T1 29.4 70.6 100.0 
 Total 
39 26 65 
60.0 40.0 100.0 
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FIGURE 4.6: FREQUENCY OF MARS SCORES AT T1 AND T3 
 
4.4.3.2 Physical activity 
Average weekly walking time in hours varied considerably across the sample, ranging from 0-
35 hours per week at T1 (Mean: 5.19 ± SD: 7.39) to 0-10.5 hours per week at T3 (Mean: 2.88 ± 
SD: 1.89). Moreover, a paired samples t-test showed a significant decrease in physical activity 
levels from pre- to post-operative assessments (t(59) = 2.368, p = 0.021). 
4.4.3.3 Diet 
 
TABLE 4.13: PAIRED SAMPLES T-TESTS OF DIET AT T1 AND T3 
Measure N Mean ± SD t p 
Fat  
T1 
62 
15.76±3.10 
3.580 0.001 
T3 14.68±2.69 
Fruit (pieces/week)  
T1 
64 
14.22±11.10 
-1.332 0.188 
T3 15.94±8.74 
Vegetables (pieces/week)  
T1 
65 
15.92±8.60 
-0.549 0.585 
T3 16.62±10.30 
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Paired samples t-tests results (Table 4.13) showed participants tended to make dietary 
improvements after surgery, compared to their baseline values. Fat intake significantly 
decreased after surgery; fruit and vegetable intake slightly increased following CABG but these 
changes were not significant.  
4.4.3.4 Sleep 
Figure 4.7 shows the distribution of scores on the Jenkins sleep problems questionnaire at T1 
and T3. The amount of self-reported sleep problems varied considerably across the sample, 
ranging from 0-25 at both time points, with a wide spread of scores. A paired samples t-test 
showed a significant increase in self-reported sleep problems from T1 (Mean: 9.60 ± SD: 7.13) 
to T3 (Mean: 11.98 ± SD: 7.56) (t(61) =-2.970, p = 0.004). 
 
 
FIGURE 4.7: FREQUENCY OF JENKINS TOTAL SCORE AT T1 AND T3 
 
Analyses were also performed on the individual items of the Jenkins questionnaire to 
look at the particular characteristics of sleep that changed across time. Table 4.14 displays the 
paired samples t-test results comparing each item at T1 and T3. Results show that problems 
falling asleep significantly increased in frequency following surgery, as did symptoms of waking 
during the night and troubles staying asleep.  
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TABLE 4.14: PAIRED SAMPLES T-TESTS OF JENKINS ITEMS AT T1 AND T3 
Sleep problem N Mean ± SD t p 
1. Trouble falling asleep  
T1 
65 
1.02±1.47 
-3.713 <0.001 
T3 1.75±1.78 
2. Waking during night  
T1 
64 
2.53±1.80 
-2.124 0.038 
T3 2.94±1.76 
3. Trouble staying asleep  
T1 
64 
2.30±1.80 
-2.588 0.012 
T3 2.83±1.76 
4. Waking feeling tired/ worn out  
T1 
63 
1.57±1.79 
-1.382 0.172 
T3 1.86±1.86 
5. Disturbed/restless sleep  
T1 
63 
2.11±1.91 
-1.683 0.097 
T3 2.51±1.98 
 
4.4.3.5 Smoking  
 
TABLE 4.15: CURRENT AND PAST SMOKING HISTORY 
 n (%) 
 T1 (N = 70) T3 (N = 66) 
Current smoker  5 (7.1) 2 (3.0) 
Type 
Cigarettes 
Self-rolled cigarettes 
 
4 (5.7) 
1 (1.4) 
 
- 
- 
Frequency (cigarettes/day) 
≤ 5 
6-15 
>15 
 
1 (1.4) 
2 (2.9) 
2 (2.9) 
 
- 
2 (3.0) 
- 
Duration (years) 
30-40  
>40  
 
3 (4.3) 
2 (2.9) 
 
- 
- 
Past smoker * 41 (64.1) - 
Time since quitting (months) 
<6  
6–12  
>12  
 
6 (9.4) 
1 (1.6) 
34 (53.1) 
 
- 
- 
- 
Currently using nicotine replacement 3 (4.7) 2 (3.0) 
*N = 64 
114 
 
Smokers were classified as current and past, with frequency rates displayed in Table 4.15. Only 
a small minority of participants were current smokers at T1, but many had smoked in the past 
(64.1%). At T3, only two participants continued to smoke and two of the non-smokers were 
using nicotine replacement therapy.  
4.4.3.6 Alcohol 
Forty-nine participants were alcohol drinkers at baseline, with 21 abstainers. At T3 the number 
of drinkers had reduced to 31, with 35 abstainers. Table 4.16 shows participants’ average 
alcohol unit consumption per week, before and after surgery. A paired samples t-test showed 
there was a significant decrease in mean alcohol consumption from T1 (Mean: 9.63 ± SD: 
11.75) to T3 (Mean: 6.46 ± SD: 10.37) (t(62) = 3.421, p = 0.001) assessments. 
 
TABLE 4.16: CURRENT WEEKLY ALCOHOL CONSUMPTION 
 n (%) 
Alcohol consumption (units/week) T1 (N = 68) T3 (N = 65) 
<1 30 (46.9) 36 (55.4) 
1-10 13 (19.1) 16 (24.6) 
11-20 10 (14.7) 6 (9.2) 
21-30 10 (14.7) 4 (6.2) 
31-40 5 (7.4) 3 (4.6) 
>40 - 1 (1.5) 
 
4.4.4 Illness beliefs 
4.4.4.1 Illness perceptions 
Figure 4.8 shows the distribution of scores on the BIPQ at T1 and T3. Scores were evenly 
distributed across the scale, with a greater spread of scores at T3 (range: 0-61) compared to T1 
(range: 14-62). Mean illness perception scores were lower at follow-up compared to pre-
surgery scores, with a paired samples t-test confirming a significant decrease from T1 (Mean: 
35.92 ± SD: 11.26) to T3 (Mean: 28.26 ± SD: 14.40) (t(53) = 4.538, p = 0.001). These findings 
indicate participants viewed their illness as less threatening after surgery than before.  
The causal beliefs data were grouped into nine categories, with absolute frequencies 
for each causal belief cited displayed in Table 4.17. Multiple citations of the same category by a 
participant were not included. Participants were able to cite up to three causal beliefs at each 
time point; N represents the number of participants who cited at least one. Lifestyle was the 
most commonly cited reason participants gave for the cause of their heart disease, at both 
time points. 
115 
 
 
FIGURE 4.8: FREQUENCY OF ILLNESS PERCEPTION SCORES AT T1 AND T3 
 
TABLE 4.17: ABSOLUTE FREQUENCIES OF CAUSAL BELIEFS AT T1 AND T3 
Causal belief Example/explanation 
n(%) 
T1 (N=60) T3 (N=62) 
Lifestyle Diet, exercise, smoking, work 45 (75.0) 47 (75.8) 
Stress Stress, worries, other emotions 13 (21.7) 21 (33.9) 
Genetics Family history, genetics, inherited 19 (31.7) 19 (30.6) 
Biology Faulty valve, blood pressure, diabetes 16 (26.7) 18 (29.0) 
Congenital From birth 2 (3.3) 1 (1.6) 
Age Old age 8 (13.3) 6 (9.7) 
Medical care Poor medical care, GP delay 1 (1.7) - 
Fate Fate, bad luck 1 (1.7) 2 (3.2) 
Social support Lack of social support - 2 (3.2) 
 
4.4.4.2 Cardiac beliefs 
Figure 4.9 shows the distribution of scores on the YCBQ at T1 and T3. Scores were evenly 
distributed across the scale at both time points. Mean cardiac misconception scores were 
relatively stable across time, with a paired samples t-test confirming there was no significant 
change from T1 (Mean: 21.41 ± SD: 7.04) to T3 (Mean: 20.62 ± SD: 7.42) (t(57) = 1.261, p = 
0.212). This lack of observed change is interesting given 47.7% of the sample attended cardiac 
rehabilitation classes (Table 4.5).  
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FIGURE 4.9: FREQUENCY OF CARDIAC MISCONCEPTIONS SCORE AT T1 AND T3 
 
4.4.5 Social support 
4.4.5.1 Social networks 
Social networks showed a normal distribution, with a range of 1-9 social contacts (see Figure 
4.10). The mean network size in the sample was 4.67 (SD: 1.84) contacts.  
 
 
FIGURE 4.10: FREQUENCY OF SOCIAL NETWORK SIZE AT T1  
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4.4.5.2 Social support 
Figure 4.11 shows the distribution of scores on the ESSI questionnaire at T1 and T3. Scores 
were skewed towards the higher end of the scale and had an identical range (T1: 10-34, T3: 10-
34) at both time points. The maximum score on this questionnaire is 34, therefore ceiling 
effects have been observed. Paired samples t-tests showed no significant change in self-
reported social support from T1 (Mean: 29.62 ± SD: 6.11) to T3 (Mean: 29.63 ± SD: 6.18) (t(64) 
= -0.044, p = 0.965). 
 
 
FIGURE 4.11: FREQUENCY OF ESSI SOCIAL SUPPORT SCORE AT T1 AND T3 
 
4.4.5.3 Marital quality 
Figure 4.12 shows the distribution of scores on the marital quality questionnaire at T1 and T3. 
Scores were skewed towards higher scores and had an identical range (7-21) at both time 
points. These results suggest a ceiling effect as the maximum score on this questionnaire was 
21. Paired samples t-tests showed no significant change in self-reported marital quality from 
T1 (Mean: 18.00 ± SD: 3.25) to T3 (Mean: 17.74 ± SD: 3.32) (t(33) = 0.902, p = 0.374). 
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FIGURE 4.12: FREQUENCY OF MARITAL QUALITY SCORE AT T1 AND T3 
 
4.4.6 Physical symptoms 
4.4.6.1 Angina 
Figure 4.13 and Figure 4.14 show the distribution of scores on the SAQ subscales, angina 
symptoms and treatment satisfaction, at T1 and T3. Angina symptoms were evenly distributed 
across the scale, whereas treatment satisfaction scores clustered towards the higher end of 
the scale. Mean angina symptom scores were lower at follow-up compared to pre-surgery 
scores, with a paired samples t-test confirming a significant decrease from T1 (Mean: 4.04 ± 
SD: 2.82) to T3 (Mean: 2.56 ± SD: 2.63) (t(53) = 2.915, p = 0.005). There was no significant 
change in treatment satisfaction across time from T1 (Mean: 10.35 ± SD: 2.22) to T3 (Mean: 
9.57 ± SD: 3.27) (t(53) = 1.750, p = 0.086). 
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FIGURE 4.13: FREQUENCY OF ANGINA SYMPTOMS AT T1 AND T3 
 
 
FIGURE 4.14: FREQUENCY OF TREATMENT SATISFACTION SCORES AT T1 AND T3 
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4.4.6.2 Pain 
 
 
FIGURE 4.15: FREQUENCY OF SENSORY PAIN SCORES AT T2 AND T3 
 
 
FIGURE 4.16: FREQUENCY OF AFFECTIVE PAIN SCORES AT T2 AND T3 
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Figure 4.15 and Figure 4.16 show the distribution of scores on the MPQ-SF for the affective 
and sensory pain scores, respectively. A wider range of scores were reported for sensory pain 
at T3 (0-18) than at T2 (0-15); affective pain scores showed a similar range at T2 (0-8) and T3 
(0-7). Paired samples t-test results (Table 4.18) showed pain decreased significantly following 
surgery from T2 to T3, as measured using the numerical rating scale and the current pain 
descriptor. Sensory and affective pain scores did not significantly differ over time, indicating 
that the cognitive and emotional experience of pain did not resolve by T3. 
 
TABLE 4.18: PAIRED SAMPLES T-TEST RESULTS OF PAIN AT T1 AND T3 
Pain measure N Mean ± SD t p 
Sensory pain  
T2 
56 
4.11±3.27 
-0.039 0.969 
T3 4.13±3.88 
Affective pain  
T2 
61 
1.39±1.72 
1.618 0.111 
T3 1.05±1.54 
Numerical rating scale  
T2 
63 
3.87±2.16 
3.449 0.001 
T3 2.87±2.43 
Current pain descriptor  
T2 
66 
1.56±1.08 
2.889 0.005 
T3 1.17±0.87 
 
4.4.6.3 Symptoms 
Higher scores on the CROQ indicate greater negative symptoms. The distribution of negative 
symptom scores on the CROQ is represented in Figure 4.17 showing participants reported 
fewer negative symptoms at T2 (Mean: 10.94 ± SD: 4.60) than at T3 (Mean: 15.17 ± SD: 7.75); 
this was confirmed to be significant using a paired samples t-test (t(55) = -3.870, p <0.001). 
This could be due to symptoms such as numbness and tingling not being fully apparent to the 
participant while in hospital, perhaps being masked by the use of medications. Other problems 
such as wound infections are likely to only develop after discharge, since all patients are 
routinely prescribed prophylactic antibiotics in the hospital. A wider range of scores were 
observed at T3. Ceiling effects were not apparent at either assessment.  The frequencies of the 
different types of symptoms reported are displayed in Table 4.19. Pain, tenderness, bruising 
and swelling of the feet and ankles were all commonly reported at both time points after 
surgery, this suggests that negative symptoms continue up to two months after CABG.  
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FIGURE 4.17: FREQUENCY OF PHYSICAL SYMPTOM SCORES AT T2 AND T3 
 
TABLE 4.19: TYPE OF PHYSICAL SYMPTOM SCORES REPORTED AT T2 AND T3 
Symptom severity (Moderate to A lot) 
T2  T3 
N n (%) N n (%) 
Pain in chest wound 70 51 (72.9) 66 29 (43.9) 
Infection in chest wound 68 1 (1.5) 66 5 (7.6) 
Tenderness around chest wound 70 41 (58.6) 66 37 (56.1) 
Numbness/tingling around chest wound 70 5 (7.1) 66 25 (37.9) 
Bruising around chest wound 64 6 (9.4) 66 16 (24.2) 
Pain in arm/leg wound 70 28 (40.0) 63 34 (54.0) 
Other pain in arm/leg due to operation 70 7 (10.0) 63 23 (36.5) 
Infection in arm/leg wound 69 - 63 18 (28.6) 
Numbness/tingling in arm/leg due to 
operation 
70 16 (22.9) 63 31 (49.2) 
Bruising arm/leg where vein was removed 65 26 (40.0) 63 30 (47.6) 
Swollen feet/ankles 69 36 (52.2) 63 39 (61.9) 
 
4.4.7 Satisfaction 
Satisfaction with the results of surgery scores were skewed towards the higher end of the scale 
(see Figure 4.18), with a mean score of 12.98 (SD: 3.17). This indicates the majority of 
participants were satisfied with their CABG surgery.  
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FIGURE 4.18: FREQUENCY OF SURGERY SATISFACTION SCORES AT T3 
 
4.5 Inferential statistical analyses 
4.5.1 T1 depression symptoms and impaired adaptation following CABG 
The association between depression symptoms and poor recovery was examined using 
Pearson’s correlations to analyse the prospective relationship between baseline depression 
symptoms and post-operative pain, physical symptoms and health status. Specifically, it was 
hypothesised that greater depression symptoms before and after surgery would be associated 
with greater reports of pain and physical symptoms and poorer physical and mental health 
status following surgery. To clarify, lower scores on the SF-12 indicate poorer health status. To 
deal with missing data, on questionnaires where respondents had provided valid responses on 
at least half the questionnaire items, responses were scaled up. For example, if an individual 
who completed 16 items on the 21-item BDI had a total score of 6, this would be scaled to the 
full scale by computing (6/16)*21 = 7.9. This procedure maintained the full range of possible 
scores while maximising the number of participants for analysis. 
Correlation results shown in Table 4.20 revealed that baseline depression symptoms 
were correlated with pain in the days shortly following surgery. In addition, T1 BDI scores were 
significantly negatively associated with T3 SF-12 mental component scores. Scores on the BDI 
were not associated with T3 scores of affective and sensory pain and physical health status, or 
with physical symptom scores on the CROQ at T2 or T3.  
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TABLE 4.20: PEARSON’S CORRELATIONS OF T1 TOTAL BDI SCORE AND T3 RECOVERY 
Measure N T1 BDI total score 
T2 Recovery   
T2 Sensory pain 
r 
p 
63 
 
0.346 
0.005 
T2 Affective pain 
r 
p 
60 
 
0.365 
0.002 
T2 Physical symptoms 
r 
p 
59 
 
0.088 
0.507 
T3 Recovery   
T3 Sensory pain 
r 
p 
60 
 
0.240 
0.065 
T3 Affective pain 
r 
p 
64 
 
0.193 
0.126 
T3 Physical symptoms 
r 
p 
63 
 
0.127 
0.320 
T3 Mental health status 
r 
p 
65 
 
-0.358 
0.003 
T3 Physical health status 
r 
p 
65 
 
-0.049 
0.699 
 
 
Cross-sectional analyses were also performed to study the associations between T3 
depression symptoms and indices of T3 recovery. Pearson’s correlations showed T3 BDI scores 
to be significantly associated with T3 sensory (r = 0.419, p = 0.003) and affective (r = 0.464, p 
<0.001) pain, as well as T3 mental (r = -0.382, p = 0.004) and physical (r = -0.321, p = 0.018) 
health status.   
Clinical indices of disease severity and recovery, including LVEF, euroSCORE, 
reoperation, length of intensive care stay, post-operative infection and other complications 
were not significantly associated with baseline or T3 depression symptoms; this suggests 
depression symptoms occurred independently of clinical risk factors. However, due to the 
small sample size this needs to be corroborated in the main ACS study.  
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4.5.2 T1 illness perceptions and recovery 
In order to assess the prospective relationship between illness perceptions and emotional 
adaptation following surgery, regression analyses were performed using pre-surgical data to 
predict post-surgical recovery endpoints. Specifically, it was hypothesised that patients who 
reported a more negative view of their illness before surgery would be more likely to have 
greater physical symptoms, poorer mental and physical health status and poorer emotional 
adaptation in the days and months after surgery, and that the associations would be 
independent of baseline mood, demographic and disease severity factors.  
Multiple regression analyses were used to examine the relationship between pre-
operative illness perceptions (total BIPQ score) and post-operative physical and emotional 
recovery, adjusting for age, sex, and disease severity (LVEF and euroSCORE). To control for the 
possible confounding effects of emotional distress, baseline scores of anxiety (HADS) and 
depression symptoms (BDI) were also added to the models as covariates. Models predicting T3 
health status also adjusted for baseline scores on the SF-12.  
4.5.2.1 T1 illness perceptions and post-operative physical recovery 
Regression analyses were carried out to assess whether baseline illness perceptions predicted 
physical symptom reporting at T2 and T3. The T2 results displayed in Table 4.21 show baseline 
illness perception score (t = 2.213, p = 0.031) was a significant predictor in the model after 
controlling for covariates. The complete model accounted for 17.9% of the variance. The T3 
results displayed in Table 4.22 show baseline illness perception score (t = 2.081, p = 0.042) was 
a significant predictor in the model after controlling for covariates. The complete model 
accounted for 24.2% of the variance. 
 
TABLE 4.21: MULTIPLE REGRESSION ON PHYSICAL SYMPTOMS AT T2 
Model B SE ß p 
Age -0.165 0.096 -0.316 0.090 
Sex -0.507 1.564 -0.041 0.747 
euroSCORE 0.201 0.398 0.097 0.615 
LVEF -0.356 1.816 -0.029 0.845 
T1 Anxiety -0.407 0.195 -0.368 0.041 
T1 BDI total score 0.024 0.109 0.038 0.825 
T1 Illness perceptions 0.172 0.078 0.397 0.031 
Note R2 = 0.179. 
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TABLE 4.22: MULTIPLE REGRESSION ON PHYSICAL SYMPTOMS AT T3 
Model B SE ß p 
Age 0.259 0.149 0.324 0.088 
Sex 5.962 2.422 0.317 0.017 
euroSCORE -0.357 0.640 -0.107 0.579 
LVEF -0.326 2.848 -0.017 0.909 
T1 Anxiety -0.430 0.307 -0.249 0.167 
T1 BDI total score 0.034 0.164 0.035 0.835 
T1 Illness perceptions 0.248 0.119 0.370 0.042 
Note R2 = 0.242. 
 
TABLE 4.23: MULTIPLE REGRESSION ON PHYSICAL HEALTH STATUS AT T3 
Model B SE ß p 
Age 0.052 0.166 0.063 0.756 
Sex -2.001 2.697 -0.103 0.461 
euroSCORE 0.324 0.713 0.094 0.651 
LVEF 1.021 3.171 0.052 0.749 
T1 Anxiety 0.597 0.342 0.334 0.087 
T1 BDI total score -0.013 0.182 -0.013 0.942 
T1 Illness perceptions -0.280 0.133 -0.403 0.040 
Note R2 = 0.122. 
 
Regression analyses were next carried out to assess whether baseline illness 
perceptions predicted physical health status (SF-12) at T3. The results displayed in Table 4.23 
show baseline illness perception score (t = -2.106, p = 0.040) was a significant predictor in the 
model after controlling for covariates. This was a negative association such that higher pre-
operative illness perceptions scores, indicative of a more negative view of one’s illness, were 
associated with lower T3 SF-12 scores, which reflect poorer health status. The complete model 
accounted for 12.2% of the variance.  
4.5.2.2 T1 illness perceptions and post-operative emotional recovery 
Table 4.24 displays the regression coefficients for the model using baseline illness perceptions 
to predict T3 BDI depression symptoms scores.  Baseline illness perceptions were a significant 
predictor of greater depression symptoms following surgery (t = 2.140, p = 0.037), 
independently of covariates. The complete model accounted for 37.5% of the variance. These 
findings suggest that more negative illness perceptions before surgery were associated with 
greater depression symptoms up to two months following surgery. However, baseline illness 
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perceptions were not a significant predictor of T3 mental health status (t = -0.830, p = 0.410); 
in fact there were no significant predictors in this model.  
 
TABLE 4.24: MULTIPLE REGRESSION ON DEPRESSION SYMPTOMS AT T3 
Model B SE ß p 
Age -0.008 0.112 -0.012 0.944 
Sex 3.030 1.831 0.197 0.104 
euroSCORE -0.365 0.478 -0.134 0.449 
LVEF -0.911 2.127 -0.059 0.670 
T1 Anxiety -0.411 0.249 -0.264 0.105 
T1 BDI total score 0.353 0.122 0.431 0.006 
T1 Illness perceptions 0.191 0.089 0.339 0.037 
Note R2 = 0.375. 
 
4.5.3 T1 sleep and recovery 
The aim of the subsequent analyses was to examine the relationship between pre-operative 
sleep disturbance and post-operative physical and emotional recovery, both in the days and 
months following CABG surgery. Specifically, it was hypothesised that patients who reported 
poorer sleep before surgery would be more likely to have worse physical recovery and 
emotional adaptation in the days and months after surgery, including greater self-reported 
physical symptoms, greater depression symptoms and impaired physical and mental health 
status, and that the associations would be independent of baseline mood, demographic and 
disease severity factors. In addition, it was hypothesised that the specific sleep symptoms 
would be differentially predictive of recovery outcomes.  
Multiple regression analyses were used to examine the relationship between pre-
operative sleep (total Jenkins sleep score) and post-operative recovery, adjusting for age, sex, 
and disease severity (LVEF and euroSCORE). To control for the possible confounding effects of 
anxiety, baseline scores on the anxiety subscale of the HADS were also added to the models as 
a covariate. Models predicting T3 health status also adjusted for baseline scores on the SF-12.  
Regression models with the same covariates, but with the individual items of the Jenkins sleep 
scale entered as predictor variables of recovery, were also used. Please note all analyses were 
run with item 16 of the BDI (sleep problems) removed. 
4.5.3.1 T1 sleep and post-operative physical recovery 
Table 4.25 displays the regression coefficients for the model using baseline sleep to predict T2 
CROQ physical symptoms scores.  Baseline sleep disturbance was a significant predictor of 
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greater T2 physical symptoms (t = 2.015, p = 0.048) independently of covariates. The complete 
model accounted for 16.5% of the variance. However, at T3, baseline sleep disturbance no 
longer predicted CROQ physical symptoms (t = 1.344, p = 0.184).  Models using individual 
Jenkins items as the predictor variable found only item 5 (disturbed or restless sleep) (t = 
2.090, p = 0.041) to be significant predictor of T2 CROQ physical symptoms; other items were 
not significant predictors in the models. 
 
TABLE 4.25: MULTIPLE REGRESSION ON PHYSICAL SYMPTOMS AT T2 
Model B SE ß p 
Age -0.217 0.097 -0.413 0.028 
Sex -1.561 1.533 -0.134 0.313 
euroSCORE 0.483 0.412 0.234 0.246 
LVEF -0.749 1.820 -0.064 0.682 
T1 Anxiety -0.243 0.184 -0.218 0.194 
T1 BDI total score* 0.037 0.117 0.054 0.755 
T1 Sleep 0.190 0.094 0.283 0.048 
Note R2 = 0.165. *Item 16 removed. 
 
TABLE 4.26: MULTIPLE REGRESSION ON PHYSICAL HEALTH STATUS AT T3 
Model B SE ß p 
Age 0.153 0.164 0.179 0.355 
Sex -0.273 2.662 -0.014 0.919 
euroSCORE -0.057 0.713 -0.016 0.936 
LVEF 2.446 3.122 0.128 0.437 
T1 Anxiety 0.118 0.110 0.147 0.285 
T1 BDI total score* 0.192 0.322 0.104 0.554 
T1 SF-12 physical 0.156 0.203 0.141 0.446 
T1 Sleep -0.394 0.162 -0.361 0.018 
Note R2 = 0.174. *Item 16 removed. 
 
Regression analyses were next carried out to assess whether baseline sleep predicted 
physical health status (SF-12) at T3. The results displayed in Table 4.26 show baseline sleep 
was a significant predictor in the model (t = -2.434, p = 0.018) after controlling for covariates. 
This is a negative association such that higher pre-operative sleep scores, indicative of poor 
sleep, were associated with lower T3 SF-12 scores, which reflect poorer health status. The 
complete model accounted for 17.4% of the variance in SF-12 scores at T3. Models using 
individual Jenkins items as the predictor variable found item 2 (wake up several times per 
night) (t = -2.514, p = 0.015), item 3 (trouble staying asleep, including waking far too early) (t = 
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-2.543, p = 0.014) and item 4 (wake up after usual amount of sleep feeling tired and worn out) 
(t = -2.246, p = 0.029) to all significantly predict SF-12 physical health at T3. Item 5 (disturbed 
or restless sleep) (t = -2.003, p = 0.050) was of borderline significance.  
4.5.3.2 T1 sleep and post-operative emotional recovery 
Table 4.27 summarises the regression model on T3 BDI scores.  Baseline sleep was a significant 
predictor of greater post-operative depression symptoms (t = 2.787, p = 0.007), independently 
of covariates. The complete model accounted for 35.6% of the variance in T3 depression 
symptoms. Models using individual Jenkins items as the predictor variable found item 4 (wake 
up after usual amount of sleep feeling tired and worn out) (t = 2.390, p = 0.020) and item 5 
(disturbed or restless sleep) (t = 2.813, p = 0.007) significantly predicted T3 BDI scores. 
 
TABLE 4.27: MULTIPLE REGRESSION ON DEPRESSION SYMPTOMS AT T3 
Model B SE ß p 
Age -0.068 0.079 -0.141 0.398 
Sex -0.162 1.332 -0.015 0.904 
euroSCORE 0.202 0.349 0.103 0.564 
LVEF -0.571 1.494 -0.054 0.704 
T1 Anxiety 0.082 0.166 0.072 0.625 
T1 BDI total score* 0.175 0.096 0.277 0.073 
T1 Sleep 0.223 0.080 0.345 0.007 
Note R2 = 0.356. *Item 16 removed. 
 
Baseline sleep was not a significant predictor of T3 mental health status (t = -1.165, p = 
0.249; the only significant predictor in this model was baseline SF-12 mental health status (t = 
3.248, p = 0.002). 
4.6 Discussion  
4.6.1 Descriptive analyses  
In this chapter, data from P-ARCS was explored and described in order to inform the 
development of the main ARCS study. Descriptive analyses were performed on the data in 
order to assess the feasibility of the study and to check the suitability of the chosen measures.  
4.6.1.1 Feasibility 
Descriptive statistics from P-ARCS data were presented to ascertain the feasibility of the ARCS 
study. Feasibility was defined as the willingness of participants to take part in the study and 
the completeness of data. Results suggest that uptake to the study was good, with only 17.9% 
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of participants refusing to take part or failing to complete the first questionnaire. Overall 
attrition was quite high, with approximately one-third of participants withdrawing by the T3 
follow-up. Importantly, cross-tabulations showed there to be no statistical significance 
between participants who withdrew and remained in the study on demographic and disease 
severity indices. Therefore, it is unclear why some participants withdrew from the study while 
others were happy to continue. However, it is possible that a sampling bias has occurred and 
those who failed to emotionally adjust, or who had a poor physical recovery, were at greatest 
risk of withdrawal following surgery. If this is the case, it is important to take attrition into 
account when calculating the sample size for the main ARCS study as a greater number of 
participants will be needed to demonstrate an effect. It also means there is a risk the study 
may underestimate the negative emotional outcomes of participants. Attrition will be 
particularly important in the main ARCS study which will include an additional time point at 12 
months after surgery. Telephone calls will be introduced to prompt the return of 
questionnaires in addition to the reminder letters used during P-ARCS.  
Missing data is also an issue to be addressed in the main ARCS study. Reasons for 
missing data are not entirely clear, though as discussed earlier, for some questionnaires we 
can attempt to ascertain a cause. For example, the high rates of missing data on the SAQ can 
be attributed to some participants stating they do not suffer from angina, therefore these 
questions were not applicable. Similarly, those participants who were not married or 
cohabiting (n = 22) were not required to complete the marital functioning questionnaire. These 
non-responses due to questions not being applicable are in large part unavoidable. However, 
results from P-ARCS suggest that missing data also occurs frequently for the socioeconomic 
status question, asking participants about yearly household income, and for the BDI. Such 
questions are sensitive in nature and, therefore, may lead to deliberate non-response on these 
items. Other questionnaires involved a numerical rating scale which is likely to be an unfamiliar 
response format for some participants, which may explain missing data on these measures. 
Specific examples will be added to the main ARCS questionnaire packs to aid completion on 
measures with numerical rating scales. Additional explanations of why participants are asked 
to provide details of income and why questions are repeated at each of the time points will 
also be added to the main ARCS study questionnaire packs. In addition, the need to answer all 
questions will be discussed with participants during recruitment.  
4.6.1.2 Suitability of measures 
Descriptive analyses were performed to assess whether the questionnaires used were 
sensitive, that is that they were able to produce a range of scores in the population targeted in 
this sample. Ceiling effects were only observed for ESSI and the marital quality questionnaire. 
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An alternative questionnaire, the Close Person Questionnaire (CPQ) (Stansfeld & Marmot, 
1992) has been identified for inclusion in the main ARCS study to replace the marital 
functioning questionnaire. This replacement was not only made due to the ceiling effect, but 
also to capture a wider array of marital functioning issues. The CPQ is a short, 15-item 
questionnaire which assesses the amount to which the participant’s partner/spouse has 
provided practical and emotional support over the past 12-months. The CPQ has been shown 
to be a valid and reliable measure over repeated assessments. The ESSI questionnaire was 
retained in the main ARCS study, but the issue of potential ceiling effects will be borne in mind 
since this will limit the ability to differentiate between people reporting high levels of social 
support.  
Notably, the only measure removed from the questionnaire pack as a result of P-ARCS 
was the BDI from T2. It was concluded that the length of the BDI and the nature of the 
questions, which often overlap with the physical symptoms experienced as a result of the 
surgery and the hospital environment, made it an inappropriate choice. Instead the positive 
emotional style and negative emotional style scale (Cohen, Alper, Doyle, Treanor, & Turner, 
2006; Cohen, Doyle, Turner, Alper, & Skoner, 2003) has been included in the main study as a 
brief measure of both positive and negative mood. This measure has been previously used in 
Steptoe’s group (Poole, Steptoe, et al., 2011).  
4.6.2 Inferential statistical analyses  
Preliminary analyses were performed on the P-ARCS data to ascertain initial associations 
between variables. Due the small sample size in P-ARCS further work is needed to corroborate 
these findings in the main ARCS study. 
4.6.2.1 Depression symptoms and impaired adaptation  
Correlation analyses confirmed that baseline depression symptoms were associated with 
increased pain and poorer mental health status following surgery, but not physical health 
status nor any of the clinical indices of recovery. These null findings are possibly due to the 
small sample size reducing the power to detect an effect. Other authors have found 
depression to be predictive of poorer quality of life and worse health outcomes in CABG 
patients (Doering et al., 2008, 2005; Kendel et al., 2010). The findings from P-ARCS are largely 
in line with a study by Burg and colleagues (Burg, Benedetto, Rosenberg, & Soufer, 2003) who 
found that patients who were depressed prior to CABG surgery were more likely to report 
poor quality of life and worse recovery following their operation. Moreover, another study 
found depressed CABG patients to report greater pain symptoms up to 12-months following 
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surgery (Morone et al., 2010), suggesting these patients are in greatest need for targeted 
interventions.  
Analysis plans for the full dataset from the main ARCS study include examining the 
types of symptoms patients report on the BDI, such as cognitive/affective or somatic/affective, 
and assessing how they differentially predict recovery outcomes both in the early- and short-
term. In addition, if cases allow, participants will be grouped according to the timing and 
recurrence of a depressive episode to allow comparisons to be made regarding differences in 
recovery according to depression onset.  
4.6.2.2 Illness perceptions and recovery 
Regression analyses were performed to assess the association between negative illness 
perceptions prior to surgery and poorer recovery in the days and months following surgery. 
The main findings of these analyses were that a more negative perception of one’s illness at 
baseline was predictive of poorer physical and emotional recovery, independently of baseline 
mood, disease severity and demographic factors. Specifically, baseline illness perceptions were 
able to predict increased physical symptoms and poorer physical health status and increased 
depression symptoms and poorer mental health status following surgery. Moreover, these 
results were consistent across time points, both in the days and months following CABG.  
Previous research has also shown that negative illness perceptions are related to 
greater depression symptoms in cardiac surgery patients. For example, cross-sectional 
associations between negative illness perceptions and greater psychological distress have been 
reported in patients before CABG (Hermele et al., 2007). Moreover, the prospective 
association, which is in line with my findings, has been reported by Juergens and colleagues 
(Juergens et al., 2010) who showed pre-surgical negative illness perceptions predicted 
depression, disability and quality of life three months after surgery. Another study has shown 
that more negative illness perceptions in the days following hospital admission for MI, were 
associated with the development of new onset depression in particular (Dickens et al., 2008b). 
This hypothesis was unable to be tested using the P-ARCS data due to the small sample size; as 
such future work is needed to test this association in CABG patients.  
Work using ACS patients has also shown negative illness perceptions mediate the 
relationship between depression and health-related quality of life in stable CHD outpatients 
(Dickens, Cherrington, & McGowan, 2011). However, the results shown here using CABG 
patients were unable to corroborate this finding, since no association was found between 
baseline depression and physical SF-12 scores at T3. Instead pre-surgical illness perceptions 
were shown to independently predict physical health status following surgery. Further work on 
a larger sample is needed to explore these mediation hypotheses in greater detail.  
133 
 
Confounders of the relationship between illness perceptions and later recovery were 
considered in the analyses. For example, baseline anxiety was included in models as a 
covariate and subsequently this is not likely to account for the relationship observed between 
illness perceptions and recovery. Nor did the analyses find a relationship between illness 
perceptions and co-morbid conditions which could otherwise have accounted for the 
relationship. However, other potential covariates such as socio-economic position were not 
considered. All these factors will be explored in greater detail using data from the main ARCS 
study. In particular, the mediatory role of illness perceptions to the depression symptoms-
recovery relationship will be tested.  
4.6.2.3 Sleep and recovery 
In the sleep and recovery analyses the associations between self-rated sleep prior to CABG 
surgery and physical and emotional recovery in the days and months following surgery were 
examined. The main findings of these analyses were that sleep disturbance before surgery was 
associated with greater physical symptoms, poorer physical health status and greater 
depressive symptoms after CABG surgery, independent of baseline mood, disease severity and 
demographic factors. Time since surgery was an important factor, with baseline sleep a 
significant predictor of CROQ physical symptoms in the immediate post-operative period but 
not at T3; the reason for this is not clear. As hypothesised, different characteristics of sleep 
problems were associated with different recovery outcomes, independent of covariates. For 
example, disturbed and restless sleep was a predictor of CROQ physical symptoms and the BDI, 
and was of borderline statistical significance in predicting SF-12 physical health status. Overall, 
it appeared that the symptoms of sleep that were most predictive of poor recovery were 
problems maintaining sleep throughout the night as opposed to trouble initiating sleep. 
Baseline sleep was not associated with emotional health status following surgery after 
controlling for covariates.  
It is important to note that all analyses were run with item 16 of the BDI (sleep 
problems) removed, with significant findings still being demonstrated. Therefore, the 
association between poor baseline sleep and recovery outcomes cannot be attributed to poor 
sleep also being assessed in the BDI. However, it is difficult to unpick the association between 
poor sleep and greater depression symptoms entirely, since sleep problems are in themselves 
a symptom of depression. Further work is needed in order to assess the contribution of sleep 
to depression, however there is some evidence to suggest poor sleep does contribute to 
depression onset (Baglioni et al., 2011; Cho et al., 2008; Ford & Kamerow, 1989; Roberts et al., 
2000). 
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The findings are in line with the results from Hunt and colleagues (Hunt et al., 2000) 
and Redeker and colleagues (Redeker et al., 2004) who reported cross-sectional associations 
between poor sleep and worsened quality of life after CABG. In addition, the results from P-
ARCS have demonstrated a prospective relationship, such that poor sleep prior to surgery was 
associated with poorer recovery following surgery. Edéll-Gustafsson and Hetta (1999) found 
that those patients reporting greater anxiety were more prone to sleep disturbance. Since 
baseline anxiety was controlled for in the analyses used in this PhD, this is not likely to account 
for the relationship observed between sleep and recovery. Nor did the analyses find a 
relationship between sleep and co-morbid conditions which could otherwise have accounted 
for the relationship. Other biological pathways may be relevant, but were not tested in these 
analyses. In their review, Meerlo, Sgoifo and Sucheecki (2008) suggest that changes to 
autonomic function and neuroendocrine systems may be important in linking poor sleep to 
health outcomes. For example, sleep deprivation or disruption may act as a stressor, leading to 
increased sympathetic nervous system activation. If sleep recovery is insufficient these effects 
continue, with studies showing persistent elevated heart rate and blood pressure (Lusardi et 
al., 1996; Tochikubo et al., 1996). Changes to the neuroendocrine system have also been 
observed after sleep loss, although the findings are somewhat inconsistent with some studies 
reporting a slight elevation in cortisol in response to sleep deprivation (Chapotot et al., 2001; 
Spiegel, Leproult, & Van Cauter, 1999), while others have reported no changes or even small 
decrements in cortisol levels (Akerstedt et al., 1980; Follenius et al., 1992). Modulation of 
cortisol responses may have particular importance as greater cortisol output has been 
associated with slower wound healing (Ebrecht et al., 2004; Vedhara et al., 2010) and 
depression in coronary artery disease patients (Bhattacharyya et al., 2008). These biological 
pathways warrant future investigation in CABG patients.  
The findings reported here suggest that the type of sleep complaint is likely to be 
important in predicting recovery after surgery. For example, the characteristic of disturbed and 
restless sleep was shown to be significant. Data from large epidemiological studies have also 
demonstrated that disturbed and restless sleep carries greater cardiac risk 
(Chandola, Ferrie, Perski, Akbaraly, & Marmot, 2010), but this has been little investigated in 
studies using CABG surgery patients. The distinction between sleep symptoms is an important 
line of enquiry for establishing targeted interventions. 
The timing of assessment is likely to affect how well the results can predict long-term 
prognosis. For example, Hedner and colleagues (2002) assessed sleep in just over 1200 
individuals prior to CABG surgery and one year following surgery and reported that baseline 
sleep disturbance was not generally associated with survival at five-year follow-up. The 
analyses in this PhD have shown baseline sleep to be associated with short-term differences in 
135 
 
recovery; however, it is not clear to what extent these effects would be maintained in the 
longer term or the impact of sleep disturbance on mortality risk. Future work is needed to 
address these issues.   
Sleep measurement is also likely to be important in studies of this type. Marked 
discrepancies have been observed between subjective and objective measures of sleep 
(Fernandez-Mendoza et al., 2011; Lauderdale et al., 2008; Silva et al., 2007; Van Den Berg et 
al., 2008), with self-rated sleep being modulated by psychosocial characteristics and affect 
(Jackowska et al., 2011). There is a lack of sleep studies in cardiac patients using objective 
measures. One exception is a study using polysomnographic recordings to map the pattern of 
sleep activity before and after CABG surgery; these authors found changes in sleep 
architecture and decreased night-time sleep and increased daytime sleep after surgery (Edéll-
Gustafsson & Hetta, 1999). Another study used objective (actigraphy) and subjective sleep 
measures in cardiac patients to track improvements in sleep after surgery (Yilmaz & Iskesen, 
2007). Only one study to date has combined data from self-report and objective methods in 
association with post-CABG outcomes. Redeker and colleagues (2004) showed that objective 
and self-reported measures of sleep quality were related to health status at four and eight 
weeks following surgery. More studies are needed to investigate the different measurement 
methods in greater detail.  
4.6.2.4 Limitations of P-ARCS 
These analyses have a number of strengths and limitations. One of the main strengths of P-
ARCS is the longitudinal design. However, the direction of the relationship between illness 
perceptions/poor sleep and recovery is uncertain: whether illness perceptions/poor sleep 
causes worse recovery or vice versa, or whether both are related to an unmeasured third 
factor, such as lifestyle (e.g. alcohol consumption, physical activity, smoking). The sample was 
restricted to elective surgery participants and, therefore, does not capture the full range of 
disease severity and co-morbidities that may be apparent in patients undergoing cardiac 
surgery.  
In addition, P-ARCS used self-report measures of sleep and illness perceptions and it is 
possible these responses may be influenced by negative affectivity (Jackowska et al., 2011). 
These analyses tried to address this issue by controlling for anxiety and depressive symptoms 
in the regression models, and indeed the associations remained significant even after these 
adjustments. Additionally, in the sleep and recovery analyses, sleep medication and history of 
sleep disorders was not taken into account; although very few patients reported use of sleep 
medications, records were incomplete so could not be included in the statistical models. 
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Finally, the small sample size in P-ARCS means further work is needed to corroborate these 
findings. 
4.7 Chapter summary 
Descriptive results will be used to inform the development of the main ARCS study, including 
strategies to decrease attrition and missing data and the choice of questionnaires to be used. 
Results from the inferential statistical analyses must be interpreted carefully due to the small 
sample size, but are a useful guide to inform future analyses on the main ARCS dataset. The 
correlation analyses performed suggest that depression symptoms were associated with poor 
mental health status and pain, two months after surgery. Moreover, illness perceptions and 
sleep prior to surgery were related to emotional and physical recovery after surgery. These 
latter results suggest that both a cognitive and behavioural model may be useful to our 
understanding of the depression symptoms-impaired adaptation relationship. Future analyses 
on the main ARCS study will explore these issues in greater detail and will make use of 
biological data to assess the role of inflammatory and neuroendocrine factors in the 
depression-recovery relationship.  
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Chapter 5. Method: The ARCS study 
5.1 Introduction 
Following completion of the pilot study, the modifications and adjustments were made to the 
protocol in order to establish the main ARCS study. As in P-ARCS, the ARCS study was 
developed and designed to investigate the causes and consequences of poor emotional 
wellbeing following CABG surgery, and their implications for patient quality of life and physical 
recovery. The ARCS study was developed in order to address the limitations and problems 
observed in the pilot, and to extend the scope in order to address the biological mechanisms, 
discussed in Chapter 2 of the literature review, relating depression to poor outcomes following 
CABG surgery. As such, ARCS builds on the pilot study by focussing on five sets of factors that 
are potentially relevant to mood and quality of life following CABG: (1) clinical factors, (2) 
cognitive factors, (3) social factors, (4) psychological factors, (5) biological factors. The 
biological measures included are saliva samples for the measurement of the neuroendocrine 
hormone cortisol and blood samples for the measurement of inflammatory markers.    
Other distinctions can be made between P-ARCS and the main ARCS study. First, P-
ARCS used a maximum follow-up of two months following surgery. Participants were found to 
still be experiencing negative physical symptoms of surgery at T3, greater than those in the 
acute period (T2). Therefore, a 12-month assessment was included at time four (T4) as a long-
term follow-up of participants following surgery, to enable us to better understand the 
recovery process. Second, the P-ARCS study was limited in the conclusions which could be 
drawn relating to patient quality of life due to the inclusion of only a small number of 
measures. In ARCS we extended the psychosocial measures to include more diverse, global, 
measures of quality of life, not just those measures specific to health problems. Third, we 
needed to address the problems of missing data in clinical information experienced in P-ARCS. 
Therefore we included questions of self-reported physical and mental health questions in 
ARCS. Lastly, the partners of CABG patients are also at risk of adverse psychological outcomes, 
and the burden of caregiving has been found to have a negative impact on partners’ physical 
health (Randall, Molloy, & Steptoe, 2009).  The ARCS study therefore assesses changes to 
partners’ psychological and physical health following patients’ surgery.  
The ARCS study aims to address several research questions. What are the causes and 
consequences of poor emotional adjustment in patients undergoing CABG surgery, and what 
are their implications for quality of life and patient wellbeing?  What is the impact of CABG 
surgery on the psychological and physical health of partners, and what role does the partner 
play in the recovery and adaptation of the patient? By successfully answering these questions, 
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the ARCS study has the potential to guide risk stratification and to help develop targeted and 
effective interventions to improve patient prognosis following CABG surgery.  
5.2 Differentiating my PhD from the ARCS study 
The development and completion of P-ARCS formed the first part of this PhD. However, the 
main ARCS study is a multidisciplinary study involving several researchers and accordingly, 
other issues will be investigated that are outside the scope of my PhD. For example, the ARCS 
study will assess changes to partners’ psychological and physical health following the patients’ 
surgery; these data will not be included in my PhD. In addition, T4 data collection is on-going, 
and is due to be completed in the summer of 2013; therefore, these data are not available for 
use in this thesis. In the following sections I will describe both the methods for the ARCS study 
as a whole, but will also differentiate those which are applicable to my PhD. The measures 
included in the partner study and at T4 are outlined in Table 5.1; however, the methods 
relating to the partner study and 12-month follow-up are not relevant to this thesis and, 
therefore, are not described.  
5.3 PhD aims and hypotheses 
Having developed the ARCS study, this PhD aims to characterise the progression of patients 
from the pre-operative to post-operative phases of recovery following cardiac surgery, and in 
particular to study the impact of experiences in the weeks prior to surgery on early- and short-
term physical and mental adaptation. This PhD will focus on the relationship between 
depression symptoms and recovery over time and the underlying mechanistic pathways. Three 
main mechanisms will be explored in detail: social-behavioural, cognitive and biological.  To 
address these aims, this PhD will make use of data from the ARCS study.  
 It is important to note that, as in the literature review, throughout the subsequent 
chapters, the terms adaptation and recovery will be used interchangeably to describe the post-
surgery outcomes of the ARCS participants. Adaptation and recovery both imply a return to 
normal functioning, but obviously this is difficult to characterise in CABG patients with 
advanced disease, since pre-operative levels of functioning may already be lower than 
population norms. Indeed, one may expect an improvement in functioning after surgery 
compared to before, in line with a reduction in the cardiac symptoms which the surgery aims 
to alleviate. Therefore, recovery and adaptation will be operationalised in this PhD as the 
endpoints after surgery which capture functional status and suffering. Such factors include 
measures of clinical recovery such as length of post-operative hospital stay, physical recovery 
such as pain and surgical healing, emotional recovery such as anxiety and mental and physical 
quality of life. Some authors would argue that these endpoints actually describe prognosis 
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(Hemingway, Riley, & Altman, 2009), however for the purpose of this PhD adaptation and 
recovery will be conceptualised as distinct from prognosis. Instead, prognosis will be used to 
refer to cardiac endpoints such as recurrent events and mortality.  
The hypotheses of this PhD can be stated as:   
(1) Depression symptoms are associated with impaired adaptation following CABG surgery 
i. Somatic/affective depression symptoms will carry greater risk than no depression 
symptoms and cognitive/affective depression symptoms for poor adaptation in the days 
following surgery and up to two months following surgery, including: 
a) Early- and short-term emotional recovery such as anxiety,   
b) Early- and short-term surgical recovery such as length of hospital stay, pain, physical 
symptom reporting, 
c) Short-term physical and mental adaptation,  
and these associations will be independent of demographic and clinical factors.  
ii. Persistent depression and post-CABG onset depression will carry greater risk than no 
depression and resolved depression for poor adaptation up to two months following 
surgery, including: 
a) Short-term emotional recovery such as anxiety,   
b) Short-term surgical recovery such as pain and physical symptom reporting, 
c) Short-term physical and mental adaptation, 
and these associations will be independent of demographic and clinical factors.  
(2) Social-behavioural factors affect the depression symptoms-poor adaptation relationship 
i. Patients who show more negative health behaviours before surgery will be more likely to 
have poorer emotional adaptation and recovery up to two months following surgery, 
including: 
a) Early- and short-term emotional recovery, 
b) Early- and short-term surgical recovery, 
c) Short-term physical and mental adaptation, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
ii. Patients who show lower social support before surgery will be more likely to have poorer 
emotional adaptation and recovery up to two months following surgery, including: 
a) Early- and short-term emotional recovery, 
b) Early- and short-term surgical recovery, 
c) Short-term physical and mental adaptation, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
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(3) Cognitive factors affect the depression symptoms-poor adaptation relationship 
i. Patients who show more neurocognitive impairment before surgery will be more likely to 
have poorer emotional adaptation and recovery up to two months following surgery, 
including: 
a) Early- and short-term emotional recovery, 
b) Early- and short-term surgical recovery, 
c) Short-term physical and mental adaptation, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
ii. Patients who show more negative illness perceptions before surgery will be more likely to 
have poorer emotional adaptation and recovery up to two months following surgery, 
including: 
a) Early- and short-term emotional recovery, 
b) Early- and short-term surgical recovery, 
c) Short-term  physical and mental adaptation, 
and these will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
(4) Biological factors affect the depression symptoms-poor adaptation relationship 
i. Patients who show a flatter diurnal cortisol profile before surgery will be more likely to 
show poorer emotional and physical recovery up to two months following surgery, 
including: 
a) Early- and short-term emotional recovery, 
b) Early- and short-term surgical recovery, 
c) Short-term physical and mental adaptation, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
ii. Patients who show greater inflammatory responses in the days after surgery will be more 
likely to show poorer emotional and physical recovery up to two months following surgery, 
including: 
a) Early- and short-term emotional recovery, 
b) Early- and short-term surgical recovery, 
c) Short-term physical and mental adaptation, 
and these factors will partly mediate the association between baseline depression 
symptoms and adaptation following cardiac surgery.  
iii. Patients who show greater inflammatory responses in the days after surgery will be more 
likely to display greater depression symptoms up to two months following surgery. 
141 
 
5.4 Sample size 
A power calculation was performed using nQuery Advisor version 4.0 (Statistical Solutions, 
Cork, Ireland) to determine a sample size for the ARCS study. Power was determined using 
results from a recently published paper by Beresnevaitė et al. (2010), which investigated the 
effect of pre-operative depression on post-operative complications in CABG patients.  This 
paper was identified as appropriate because the research question clearly defined a CABG 
population, used a longitudinal cohort design, and employed a measure of recovery (length of 
hospital stay) as the dependent variable. These authors found, in their regression model to 
predict length of hospital stay, that covariates accounted for 0.195 of variance. The addition of 
depression to the model increased the variance explained by 0.105. Using a significance 
criterion of α = 0.01, power at a level of 0.90, for a multiple regression model using up to eight 
covariate variables and one predictor variable, 103 participants are required to detect an 
effect. We inflated this to 200 participants in order to allow for missing data, variability in 
biological data and the testing of various sub-hypotheses within the dataset. 
5.5 Participants 
We planned consecutive recruitment of up to 300 CABG surgery patients to allow for attrition.  
As in P-ARCS, the inclusion criteria for ARCS were patients who were undergoing first-time, 
elective CABG surgery or CABG plus valve replacement, at St George's Hospital, London. 
Patients must have been able to complete the research interviews and questionnaires in 
English, and have been 18 years or older. Participants with communication or cognitive 
impairments were excluded since this would have affected their ability to complete the 
questionnaires; this was assessed on the recommendation of the pre-assessment nursing staff. 
Participants who were too unwell or clinically unstable were also excluded. Recruitment began 
in February 2011 and completed in August 2012. 
The sample for this PhD is restricted to those participants who had completed T1 
through to T2 for the early-term outcomes and T1 through to T3 for the short-term outcomes, 
at the time of analysing the results (June 2012). This provides a sample of 216 and 154 
participants respectively. Data collection will continue for the remaining participants in this 
study beyond the timeframe of this PhD. 
5.6 Design and procedure  
The ARCS study used a prospective longitudinal design incorporating four assessments 
spanning the pre-operative period for up to 12 months following CABG surgery. However, only 
the first three assessments are available for this PhD; these time points were the same as in P-
ARCS. The T1 assessment occurred approximately one to three weeks before surgery when 
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patients come to the hospital for their pre-assessment clinic appointment. The T2 assessment 
took place approximately three to five days after surgery while patients were still in hospital 
on the cardiac care ward. The T3 follow-up took place six to eight weeks after surgery via post. 
The study was submitted as a substantial amendment to the original P-ARCS protocol (AM1 
25/11/2010) and obtained ethical approval (South West London REC1, 09/H0708/38). Details 
of the procedures used at each of these time points are described below.  
Time 1 (1-3 weeks before surgery): Prior to being approached in person, a letter 
introducing the study and a participant information sheet was sent to all patients scheduled 
for elective CABG surgery (see Appendix 5). This first point of contact was made by the clinical 
team to avoid breach of confidentiality. A member of the research team (TK, LP or EL) then 
approached patients in the waiting area of the pre-assessment surgery clinic and asked if they 
would be willing to participate in the study. The procedure was explained, before obtaining 
signed consent (see Appendix 6). The researcher discreetly conducted a brief interview with 
the patient in the waiting area to collect demographic information. After attending the clinic 
appointment with the pre-assessment nurse, participants were taken to a private research 
office for administration of a health literacy and cognitive assessment. At this time the 
sampling procedure for the saliva samples was explained and saliva collection tubes were 
given to participants for the measurement of cortisol over the course of one day; participants 
were also given a sampling diary to record their samples (see Appendix 7). The participant was 
also issued with a postal questionnaire to self-complete and return in a freepost envelope. 
Participants were taken back to the outpatient clinic for blood collection by one of the pre-
assessment nurses. Participants were instructed to complete the saliva samples, saliva diary 
and questionnaire booklet at home at their earliest convenience before surgery.  
Time 2 (3-5 days after surgery): Participants were approached in the cardiac care ward 
during their post-surgery recovery and asked if they would be willing to participate in the 
second assessment. Having gained verbal consent, the researcher discreetly conducted a brief 
structured interview. Blood request forms were issued to coincide with patients’ post-surgery 
day 1 and day 4; some variation in these timings were made to avoid bloods being requested 
on weekend days when the phlebotomy rounds were often operated by bank staff. 
Time 3 (6-8 weeks after surgery): Participants were telephoned and asked if they 
would be willing to participate in the next assessment. If in agreement, a postal questionnaire 
was sent for self-completion. They were also posted saliva collection tubes to measure cortisol 
over the course of one day. A freepost envelope was provided for the return of the completed 
questionnaire and samples. 
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5.7 Psychosocial measures 
Many psychosocial measures were included as part of the ARCS study, these are displayed in 
Table 5.1. However, only a selection of these measures has been used for the purpose of this 
thesis, and these are displayed in Table 5.2. Many of the measures have previously been 
described in Chapter 3 and can be found in Appendices 2 and 3; details of the Appendix cross-
reference for these measures are provided in Table 5.2. Only the measures directly applicable 
to this PhD, and which have not been previously described, will be discussed in detail here. The 
Cronbach’s alphas for questionnaires used in this thesis are presented in Chapters 6 and 7, 
since different sample sizes were used in the early- and short-term analyses.  
5.7.1 Clinical information 
The clinical information data collection remained the same as in P-ARCS, with the addition of 
some self-report items of health and medication use. Specifically, participants were asked to 
document the number of visits they had made to their GP and the number of emergency and 
routine hospital visits they had made relating to their heart disease or other conditions. In 
addition, they were asked to report any co-morbidity and list their use of prescribed and non-
prescribed medications. T1 questions were worded to reflect the past 12 months and T3 
questions were worded to reflect the period since the patient’s surgery. Cardiac-related 
prescription medicines were classified according to drug type, for example statin and beta-
blocker, whereas non-cardiac and non-prescription medications were classified according to 
their usage, for example analgesic, asthma, and nutritional supplement. In addition, 
participants were also asked to answer six questions relating to their pre-surgery psychiatric 
status, including details of any current or past psychiatric diagnosis and any treatment they 
were receiving in the four weeks prior to their surgery. Treatment categories included 
antidepressant or anxiolytic medication, counselling or psychotherapy, or other. 
  P-ARCS implemented the additive method for scoring of the euroSCORE, however in 
the main ARCS study the logistic scoring method (Roques, Michel, Goldstone, & Nashef, 2003) 
was implemented. This method uses the same 17 risk factors as in the additive calculation, but 
enters them into a logistic regression equation to predict mortality. This approach is better 
able to estimate risk for patients at the higher end of the scale who are at greatest risk from 
surgery. Details of this calculation can be found in Appendix 8. Scores are presented as a 
percentage.  
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TABLE 5.1: MEASURES IN THE ARCS STUDY FOR USE AT PATIENT (T1, T2, T3 & T4) AND 
PARTNER (P1, P2 & P3) ASSESSMENTS.  
AAS-R: Adult Attachment Scale – Revised; BDI: Beck Depression Inventory; BFQ: Benefit Finding 
Questionnaire; BIPQ: Brief Illness Perception Questionnaire; CASP-19: Control, Autonomy, Self-realisation and 
Pleasure questionnaire – 19 item; CPQ: Close Persons Questionnaire; CROQ-CABG: Coronary Revascularisation 
Outcomes Questionnaire; ECQ: Efficacy/Confidence Questionnaire; ESSI: ENRICHD Social Support Instrument; 
HADS: Hospital Anxiety and Depression Scale; IPAQ: International Physical Activity Questionnaire; LOT: Life 
Orientation Test; MARS: Medication Adherence Rating Scale; MoCA: Montreal Cognitive Assessment; MPQ-SF: 
McGill Pain Questionnaire – Short Form; OCBS: Oberst Caregiving Burden Scale; PES/NES: Positive Emotional 
Style/Negative Emotional Style; SAQ: Seattle Angina Questionnaire; SF-12: Short Form health survey – 12 item; 
YCBQ: York Cardiac Beliefs Questionnaire.  
 
 T1 P1 T2 T3 P2 T4 P3 
Mode of assessment 
Interview
/ Post 
Post Interview Post Post  Post Post 
Time 
2-3 weeks pre-
CABG 
3-5 days 
post-
CABG 
6-8 weeks post-
CABG 
12 months 
post-CABG 
Measures  
Socio-demographics – general   - - - - - 
Socio-economic status - 
income 
 - - - - - - 
Clinical information & 
euroSCORE 
- - -  - - - 
Rehabilitation attendance - - -  -  - 
Self-report health status   -  -   
Self-report psychiatric history - - -  - - - 
Emotional distress  
Anxiety (HADS subscale)        
Depression (BDI)   -     
Positive/Negative affect 
(PES/NES)
7
 
       
Optimism (LOT
8
)   - - - - - 
Chronic stress (from MESA)
9
   - - -   
Health behaviour  
Adherence (MARS)  - -  -  - 
Physical activity (IPAQ – 
walking) 
  -  -   
Diet   -  -   
Sleep (Jenkins Scale)   -     
Smoking   -  -   
Alcohol   -  -   
Quality of life  
Health status (SF-12)   -     
                                                          
7
 Cohen, S., Alper, C. M., Doyle, W. J., Treanor, J. J., & Turner, R. B. (2006). Positive emotional style predicts resistance to illness 
after experimental exposure to rhinovirus or influenza A virus. Psychosomatic Medicine, 68, 809. 
Cohen, S., Doyle, W. J., Turner, R. B., Alper, C. M., & Skoner, D. P. (2003). Emotional style and susceptibility to the common cold. 
Psychosomatic Medicine, 65, 652. 
8
 Scheier, M. F., & Carver, C. S. (1985). Optimism, coping, and health: Assessment and implications of generalized outcome 
expectancies. Health Psychology, 4, 219-247. 
9
 Diez Roux, A. V., Ranjit, N., Powell, L., Jackson, S., Lewis, T. T., Shea, S., & Wu, C. (2006). Psychosocial factors and coronary 
calcium in adults without clinical cardiovascular disease. Annals of internal medicine, 144(11), 822–831 
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Quality of life (CASP-19)
10
   -     
Benefit finding (BFQ
11
) - - -     
Efficacy/Confidence (ECQ
12
) - - -  -  - 
Illness beliefs  
Illness perceptions (BIPQ)   -  -   
Cardiac beliefs (YCBQ)   -  -   
Partner illness perceptions
13
 -  - - - -  
Social support  
Social network    - -  -  
Social support (ESSI)   -     
Hospital partner support - -  - - - - 
Attachment (AAS-R
14
)   - - - - - 
Attachment
15
 - - - - -  - 
Marital functioning (CPQ
16
)   -     
Loneliness (UCLA Scale
17
)   -     
Physical symptoms  
Angina (SAQ, adapted)  - -  -  - 
Symptoms (CROQ-CABG) - -   -  - 
Pain (MPQ-SF) - -   -  - 
Satisfaction  
Satisfaction (CROQ-CABG 
scale) 
- - -  -  - 
Cognitive function  
Health literacy
18
  - - - - - - 
Cognitive screen (MoCA)  - - - - - - 
Caregiver burden  
Caregiving duties (Heart 
Scan
19
) 
  - -    
Caregiving burden (OCBS
20
) -  - -  -  
 
                                                          
10
 Hyde, M., Wiggins, R. D., Higgs, P., & Blane, D. B. (2003). A measure of quality of life in early old age: the theory, development 
and properties of a needs satisfaction model (CASP-19). Aging & Mental Health, 7, 186–194. 
11
 Carver, C. S., & Antoni, M. H. (2004).  Finding benefit in breast cancer during the year after diagnosis predicts better adjustment 
5 to 8 years after diagnosis. Health Psychology, 26, 595-598.  
12
 Rohrbaugh, M. J., Shoham, V., Coyne, J. C., Cranford, J. A., Sonnega, J. S. & Nicklas, J. M. (2004). Beyond the "self" in self-
efficacy: Spouse confidence predicts patient survival following heart failure. Journal of Family Psychology, 18, 184-93. 
13
 Broadbent, E. Et al, (2009), Can an illness perception intervention reduce illness anxiety in spouses of myocardial infarction 
patients? A randomized controlled trial. Journal of Psychosomatic Research, 67, 11-15. 
14
 Collins, N. L., & Read, S. J. (1990). Adult Attachment, Working Models and Relationship Quality in Dating Couples. Journal of 
Personality and Social Psychology, 58, 644-663. 
15
 Fraley, RC, Heffernan ME, Vicary AM, Brumbaugh CC. The Experiences in Close Relationships—Relationship Structures 
Questionnaire: A Method for Assessing Attachment Orientations Across Relationships. (2011) Psychological Assessment, 23, 615–
625. 
16
 Stansfeld, S., and Marmot, M. (1992). Deriving a survey measure of social support: the reliability and validity of the close 
persons questionnaire. Social Science & Medicine, 35, 1027-1035. 
17
 Hughes, M. E., Waite, L. J., Hawkley, L. C. & Cacioppo, J. T. (2004). A Short Scale for Measuring Loneliness in Large Surveys: 
Results from Two Population-Based Studies. Research on Aging, 26, 655. 
18
 Organisation for Economic Co-operation and Development: Statistics Canada. (2000). Literacy in the Information Age: Final 
Report of the International Adult Literacy Survey. Paris: OECD Publications Service. 
19
 Seldenrijk, A., Hamer, M., Lahiri, A., Penninx, B. W. J. H., & Steptoe, A. (2012). Psychological distress, cortisol stress response 
and subclinical coronary calcification. Psychoneuroendocrinology, 37, 48–55. 
20
 Stolarik, A., Lindsay, P., Sherrard, H. and Woodend, K. (2000). Determination of the burden of care in families of cardiac surgery 
patients. Progress in Cardiovascular Nursing, 15, 4-10. 
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TABLE 5.2: MEASURES APPLICABLE TO MY PHD 
BDI: Beck Depression Inventory; BIPQ: Brief Illness Perception Questionnaire; CROQ-CABG: Coronary 
Revascularisation Outcomes Questionnaire; ESSI: ENRICHD Social Support Instrument; HADS: Hospital 
Anxiety and Depression Scale; IPAQ: International Physical Activity Questionnaire; MoCA: Montreal Cognitive 
Assessment; MPQ-SF: McGill Pain Questionnaire – Short Form; SF-12: Short Form health survey – 12 item. 
 T1 T2 T3 
Appendix 
Reference 
Mode of assessment 
Interview/ 
Postal 
Hospital Ward Postal 
Time 
1-3 week pre-
CABG 
3-5 days post-
CABG 
6-8 weeks 
post-CABG 
Measures     
Socio-demographics – general  _ _ 2.A 
Socio-economic status - 
income 
 
_ _ 
2.L 
Clinical information  _ _  - 
Rehabilitation attendance _ _  3.C 
Self-report health status  _  2.J 
Self-report psychiatric history _ _  3.D 
Emotional distress   
Anxiety (HADS subscale)    2.F 
Depression (BDI)  _  2.G 
Health behaviour   
Physical activity (IPAQ – 
walking) 
 
_ 
 2.C 
Sleep (Jenkins Scale)  _  2.I 
Smoking  _  2.B 
Alcohol  _  2.D 
Health status   
Health status (SF-12)  _  2.E 
Illness beliefs   
Illness perceptions (BIPQ)  _  2.K 
Social support   
Social support (ESSI)  _  2.H 
Physical symptoms   
Symptoms (CROQ-CABG) _   3.A 
Pain (MPQ-SF) _   3.B 
Cognitive function   
Cognitive screen (MoCA)  _ _ 9 
 
5.7.2 Health behaviour: Alcohol 
We introduced a different series of questions in ARCS compared to those used in P-ARCS to aid 
participant completion. Participants were asked to think back over the previous week and 
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record on how many days they drank an alcoholic drink. They were then asked to specify the 
type of alcohol and to approximate the number of measures consumed in this period. Each 
glass of wine and pint of beer consumed was estimated to be equivalent to two units of 
alcohol, while a single measure of a spirit was estimated to be equivalent to one unit of 
alcohol. These responses were used to produce an estimate of weekly intake of alcohol units. 
5.7.3 Emotional distress 
5.7.3.1 Beck Depression Inventory 
 
TABLE 5.3: ITEMS CORRESPONDING TO BDI SYMPTOM SUBYTPES 
BDI Item  Somatic/affective score Cognitive/affective score 
1. Sadness   
2. Pessimism   
3. Sense of failure -  
4. Dissatisfaction   
5. Guilt -  
6. Punishment -  
7. Self-dislike -  
8. Self-accusations -  
9. Suicidal ideas -  
10. Crying  - 
11. Irritability  - 
12. Social withdrawal   
13. Indecisiveness   
14. Body image change -  
15. Work difficulty  - 
16. Insomnia  - 
17. Fatigue  - 
18. Appetite  - 
19. Weight loss  - - 
20. Somatic preoccupation  - 
21. Loss of libido  - 
 
As in P-ARCS, the ARCS study scored the BDI by summing each chosen answer (on a scale of 0 
to 3), with higher scores indicating greater emotional disturbance. A score of 0 to 10 indicates 
a person is not depressed, 11 to 20 suggests a person is mildly to borderline clinically 
depressed, 21 to 30 signifies moderate depression and a score of 31 to 63 indicates severe to 
extreme depression. In addition to this total score, a cognitive/affective and a 
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somatic/affective score were calculated in accordance with de Jonge’s work in this field (De 
Jonge, Ormel, et al., 2006). Although various different combinations of items have been 
proposed using the BDI (Beck & Steer, 1987; Morley, Williams, & Black, 2002), the item loading 
devised by de Jonge and colleagues (De Jonge, Ormel, et al., 2006) was deemed appropriate 
due to the use of a cardiac population and since this has been used by Steptoe’s group in the 
past (Steptoe et al., 2012).  
The items which comprise these subscales are displayed in Table 5.3. As displayed in 
this table, these subtypes cannot be deemed mutually exclusive, with some of the affective 
symptoms being included in both the somatic and cognitive scores. One of the main limitations 
of this particular scoring method is that this conceptual overlap raises issues of 
multicollinearity (r = 0.801, p <0.001) and therefore it will not be possible to examine the 
independent effect of one subtype over and above the effect of the other subtype. Instead, 
separate models will need to be used to examine each subtype separately. The range of 
possible scores for the cognitive/affective dimension was 0 to 36 and for the somatic/affective 
dimension was 0 to 39, with higher scores indicating greater symptoms.  
5.7.4 Cognitive function 
5.7.4.1 Montreal Cognitive Assessment 
The Montreal Cognitive Assessment (MoCA) (Nasreddine et al., 2005)21 was developed as a 
brief measure of mild cognitive impairment covering eight cognitive domains (see Appendix 9). 
Visuospatial awareness is assessed using a clock drawing task and a cube copy task. Several 
aspects of executive functioning are assessed including an alternation task adapted from the 
Trail Making B, a phonemic fluency task (using the letter ‘F’) and a two-item verbal abstraction 
task. A test of short-term memory recall involves two learning trials in which participants are 
asked to remember five nouns, with a delayed recall after approximately five minutes. 
Attention, concentration and working memory are assessed through administration of a serial 
subtraction task, a sustained attention ask (target detection using tapping), and digits forward 
and backwards. Several tests of language also take place, including a three-item confrontation 
naming task with low-familiar animals, repetition of two syntactically complex sentences, and 
the abovementioned fluency task. Lastly, participants’ orientation to time and place is 
appraised with six questions relating to the date and place of assessment. A maximum of 30 
points was awarded, with a cut-off of <26. An extra point is awarded to participants with ≤12 
years of education. More recent work suggests using a more conservative cut-off of ≤20 for 
older adult populations (Waldron-Perrine & Axelrod, 2012) and <24 for cardiovascular samples 
                                                          
21
 www.mocatest.org 
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(McLennan, Mathias, Brennan, & Stewart, 2011). To side-step this issue, we used results on a 
continuous scale, rather than splitting participants into groups of impaired or not impaired.  
5.8 Biological measures 
5.8.1.1 Cortisol sampling 
Cortisol can be assessed in saliva and salivary cortisol has been shown to accurately reflect 
plasma cortisol. Moreover, saliva sampling has the advantage of being a non-invasive and 
convenient method of assessing diurnal variation of cortisol in a naturalistic setting 
(Kirschbaum & Hellhammer, 1989, 1994). Saliva sampling relies on participants taking the 
samples themselves and accurately reporting the time of assessment. This reflects a trade-off, 
since the control over the measurement is surrendered in order to gain ecological validity.  
 The saliva samples were collected using Salivettes (Sarstedt, Leicester, UK). Cortisol 
sampling was described and the salivette method explained at T1. Participants were instructed 
to choose one day prior to surgery on which to give seven samples at set time points: on 
awakening, 30 minutes after awakening, 10am, midday, 4pm, 8pm and bedtime. Participants 
were told not to eat, drink caffeinated beverages, smoke cigarettes, take any medications, or 
brush their teeth, for the 30-minutes prior to giving the sample. Participants were also 
required to complete a diary as a record of their sampling schedule (Appendix 7). Each sample 
had a corresponding set of questions, including time of collection and a brief record of pre-
sampling activities and emotions. Saliva samples were obtained at T1 and T3; they were 
returned using a freepost envelope and stored at -20 degrees Celsius for analysis at a later 
date.  Cortisol levels were assessed using a time resolved immunoassay with fluorescence 
detection, at the University of Dresden. The intra- and inter-assay coefficients of variation 
were less than 4%.  
Cortisol data were analysed by computing four different measures. The cortisol 
awakening response (CAR) represents the difference between the sample taken on awakening 
and 30 minutes later. To generate a valid CAR relies on the waking sample being obtained 
without a delay, since otherwise the magnitude of the response will be masked (Chida & 
Steptoe, 2009b). In line with other work in Steptoe’s group, participants who reported giving 
their first sample more than 15 minutes after awakening were excluded from analyses 
(Dockray, Bhattacharyya, Molloy, & Steptoe, 2008). The estimated area under the curve (AUC) 
with respect to ground was generated as an approximation of total cortisol output over the 
day (Pruessner, Kirschbaum, Meinlschmid, & Hellhammer, 2003). The slope of cortisol decline 
over the day was calculated as the reduction in cortisol per hour, using regression methods. 
Importantly, the slope excluded the 30-minute post-awakening sample, as is usual with this 
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data (Messerli-Bürgy et al., 2012). Finally, the difference between waking and bedtime values 
was calculated, which is closely related to the slope.  
5.8.1.2 Immunoassays 
To assess inflammatory activity, a 20ml blood sample was drawn into plain serum tubes by 
venepuncture from the forearm at T1. At T2, two blood samples were drawn on approximately 
day 1 and day 4 after surgery. For those patients still in ICU this was usually taken from a 
cannula in the external jugular vein in the neck, otherwise for patients on the ward this was by 
venepuncture from the forearm. Blood was allowed to clot and centrifuged for 10 minutes at 
3000 rpm. The resulting serum was frozen at -80°C until batch analysis at a later date. Assays 
were performed by Dr David Gaze at St George’s Healthcare NHS Trust, using commercial 
automated immunoassay on the Immulite 1 (Siemens Healthcare Diagnostics, Frimley, Surrey) 
for IL-6, hs-CRP and TNF-Quality control statistics are reported in Table 5.4.   
 
TABLE 5.4: QUALITY CONTROL STATISTICS FOR IMMUNOASSAYS 
Assay 
Inter-assay CV 
(%) 
Intra-assay CV 
(%) 
Total-assay CV 
(%) 
Minimal 
detectable 
dose 
Upper limit of 
the calibration 
range 
IL-6 - 3.5-6.2 5.1-7.5 2.0 pg/mL 1000 pg/mL 
TNF-α 4.0-6.5 2.6-3.6 - 1.7 pg/mL 1000 pg/mL 
hs-CRP - 4.2-6.4 4.8-10.0 0.01 mg/dL 15mg/dL 
 
5.9 Data storage 
As in P-ARCS, all ARCS data were collated and stored in line with ethical guidelines and UCL 
policy. All data were treated as strictly confidential. The project was registered with the UCL 
Data Protection Office. Consent forms and patient personal details were stored separately 
from the questionnaire data; all data were stored in locked filing cabinets, in locked offices at 
UCL. Anonymised raw data were entered into a computer database for statistical analysis; 
personal identification information was kept in separate files to the questionnaire responses. 
Data were kept on password protected computers, in files accessible only to the study 
researchers. Data may be kept in this secure manner for up to 20 years prior to being 
destroyed.  
5.10 My involvement and contribution 
Along with the other researchers involved in ARCS (TK and EL), I was directly involved in the 
development of the main ARCS study, under guidance from AS. I helped compile and select the 
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questionnaires for inclusion in the study and drafted the substantial amendment submitted to 
gain ethical approval. I was responsible for creating all the patient ARCS questionnaires and 
resources. Along with EL, I was in charge of the preparation of all T1 to T4 resources and 
databases. I was actively involved in participant recruitment and follow-up assessments from 
February 2011 until April 2012. I was also partly responsible, along with EL, for the day to day 
management of a research assistant who worked on the administrative aspects of the project 
from November 2011 to March 2012. I undertook a large proportion of the patient data entry. 
I conducted all the statistical analyses myself, with guidance from my supervisor, AS. 
5.11 Statistical analysis 
All statistical analyses were performed using SPSS version 20.0 software (SPSS, Inc., Chicago, 
Illinois, USA). The significance level was set to p < 0.05 for all analyses, with precise p values 
reported for all test results. In regression analyses, R2 is presented as an indicator of variance 
explained by the models relevant to the current sample; adjusted R2 values which take into 
account variation across the whole population are not reported here though were generally 
smaller. It is important to note that these analyses were exploratory in nature, hence multiple 
hypotheses were tested. The issue of multiple testing remains an important issue, rendering 
the results subject to careful interpretation. Given the fact all analyses were based on a priori 
hypotheses, no formal statistical adjustments were made. Specific details on the analyses 
conducted are presented in the results sections of Chapter 6 and 7.   
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Chapter 6. Results: Early-term outcomes 
6.1 Introduction 
The ARCS study began in February 2011 and data collection is on-going. The data presented in 
the succeeding results chapters, Chapter 6 and Chapter 7, comprise all participants who 
partook up to June 2012. To reiterate, the aim of the ARCS study was to characterise the 
progression of patients from the pre-operative to post-operative phases of recovery following 
cardiac surgery, and in particular to study the impact of experiences in the weeks prior to 
surgery on longer-term adaptation. Using data from the main ARCS study, this PhD focuses on 
the relationship between depression symptoms and impaired adaptation over time, and the 
underlying mechanistic pathways. Two main pathways are explored here in detail: 
psychosocial and biological. This chapter presents results pertaining to early-term outcomes, 
as measured at baseline and T2. Chapter 7 focuses on recovery outcomes at T3. In this 
chapter, the recruitment statistics are described, followed by descriptive statistics of predictor 
and outcome variables, covariates, and candidate mechanisms. Lastly, mediation analyses of 
associations between depression symptoms and recovery are presented. In particular, this 
chapter assesses the role of three possible mechanistic pathways: social-behavioural factors, 
cognitive factors, and biology.    
 The specific hypotheses to be tested in this chapter are: 
(1) Depression symptoms are associated with impaired adaptation following CABG surgery 
i. Pre-operative somatic/affective depression symptoms will carry greater risk than no 
depression symptoms or cognitive/affective depression symptoms for poor adaptation 
during the in-hospital recovery period, including:  
a) Early-term emotional recovery such as anxiety,   
b) Early-term surgical recovery such as pain and physical symptom reporting, 
c) Early-term clinical recovery such as post-operative complications, length of ICU stay, 
length of post-operative hospital stay, 
and these associations will be independent of demographic and clinical factors.  
(2) Social-behavioural factors affect the depression symptoms-poor adaptation relationship 
i. Patients who show more negative health behaviours before surgery will be more likely to 
have poorer emotional adaptation and recovery during the in-hospital recovery period, 
including: 
a) Early-term emotional recovery, 
b) Early-term surgical recovery, 
c) Early-term clinical recovery, 
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and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
ii. Patients who show lower social support before surgery will be more likely to have poorer 
emotional adaptation and recovery during the in-hospital recovery period, including: 
a) Early-term emotional recovery, 
b) Early-term surgical recovery, 
c) Early-term clinical recovery, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
(3) Cognitive factors affect the depression symptoms-poor adaptation relationship 
i. Patients who show more neurocognitive impairment before surgery will be more likely to 
have poorer emotional adaptation and recovery up to two months following surgery, 
including: 
a) Early-term emotional recovery, 
b) Early-term surgical recovery, 
c) Early-term clinical recovery, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
ii. Patients who show more negative illness perceptions before surgery will be more likely to 
have poorer emotional adaptation and recovery during the in-hospital recovery period, 
including: 
a) Early-term emotional recovery, 
b) Early-term surgical recovery, 
c) Early-term clinical recovery, 
and these factors will partly mediate the association between baseline depression 
symptoms and adaptation following cardiac surgery.  
(4) Biological factors affect the depression symptoms-poor adaptation relationship 
i. Patients who show a flatter diurnal cortisol profile before surgery will be more likely to 
show poorer emotional and physical recovery during the in-hospital period, including: 
a) Early-term emotional recovery, 
b) Early-term surgical recovery, 
c) Early-term clinical recovery, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
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ii. Patients who show greater inflammatory responses in the days after surgery will be more 
likely to show poorer emotional and physical recovery during the in-hospital period, 
including: 
a) Early-term emotional recovery, 
b) Early-term surgical recovery, 
c) Early-term clinical recovery, 
and these factors will partly mediate the association between baseline depression 
symptoms and adaptation following cardiac surgery.  
6.2 Uptake, attrition and missing data 
At time of analysis, 406 participants had been invited to participate in the ARCS study. Of 
these, 104 declined to participate; the reasons for decline are displayed in Table 6.1. A flow 
diagram of uptake and attrition is presented in Figure 6.1. In total, 302 participants were 
recruited to take part in the ARCS study, of whom 13 participants were withdrawn from the 
study since they did not undergo CABG surgery. A further 46 participants consented to 
participate but did not return the T1 questionnaire, leaving a total sample of 216 participants. 
Two participants died prior to surgery, one withdrew and 24 participants failed to complete T2 
questionnaires. Of the 24 participants who failed to complete T2, 14 of these participants had 
not had surgery at time of analysis and ten participants were discharged over the weekend and 
so it was not possible to conduct their interview. At T3, 62 participants failed to complete their 
follow-up, 10 of whom had withdrawn from the study and 27 of whom had not reached two 
months post-surgery. Of the 25 who had not withdrawn but failed to complete T3, seven 
participants stated they were too unwell, three participants’ questionnaires were lost in the 
post and one patient had a post-operative stroke; a reason was not attained for all other 
participants.  
Due to attrition, the final total of participants who completed the questionnaires at all 
three time points was 154. This chapter presents data on T1 and T2, therefore describes the 
216 participants that completed both these time points. On average participants completed 
their T1 questionnaire 29.12 days (SD = 30.41) prior to surgery and had their T2 assessment 
4.61 days (SD = 4.81) after surgery. The time delay variables were associated with neither 
depression symptoms nor recovery outcomes in regression analyses.   
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FIGURE 6.1: FLOW DIAGRAM OF PARTICIPANTS’ PROGRESSION THROUGH THE ARCS STUDY 
 
 
ENROLLMENT 
FOLLOW-UP 
ANALYSIS 
Assessed for eligibility 
(n = 406) 
Excluded 
 Declined to participate (n = 104) 
Consented 
(n = 302) 
BASELINE 
Completed baseline 
assessments 
(n = 243) 
Lost to T2 follow-up 
(n = 27) 
 Study withdrawal (n = 1) 
 Mortality (n = 2) 
 Not yet reached T2 (n = 14) 
 Failure to complete T2 (n = 10) 
Analysed 
 T1 –T2 (n = 216) 
 T1-T3 (n= 154) 
Lost to T2 follow-up 
(n = 62) 
 Study withdrawal (n = 10) 
 Not yet reached T3 (n = 27) 
 Failure to complete T3 (n = 25) 
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TABLE 6.1: REASONS FOR REFUSAL TO PARTICPATE 
Reason for non-participation n 
Cognitive decline 4 
English not adequate 22 
Hearing impaired 1 
Learning disability 2 
Non-UK resident 1 
Not enough time prior to surgery 6 
Not interested 59 
Prisoner 1 
Too anxious/stressed 6 
Too unwell 1 
Visually impaired 1 
 
Missing data on questionnaires meant analyses were performed on a reduced number 
of participants for some measures. Details of the types of missing questionnaire data are 
provided in Table 6.2. This table (Table 6.2) also displays the Cronbach’s alphas for each 
questionnaire measure, as applicable. Different methods to deal with missing data exist, with 
one of the newest approaches being multiple imputations. While this method is a statistically 
robust procedure, since there was only minimal missing data in ARCS, a simpler ‘scaling-up’ 
approach was taken.  On questionnaires where respondents had provided valid responses on 
at least half the questionnaire items, data were scaled up (see Table 6.2). For example, if an 
individual who completed 16 items on the 21-item BDI had a total score of 6, this would be 
scaled to the full scale by computing (6/16)*21 = 7.9. This procedure maintained the full range 
of possible scores while maximising the number of participants for analysis. As such, all 
analyses in this chapter were performed using the scaled-up data, to increase power. Reasons 
for missing data are not entirely clear; though it is likely some responses were intentionally not 
completed, while others were accidentally missed. Questions that were sensitive in nature, 
such as household income and libido on the BDI, may partly account for high levels of missing 
data on these scales. In addition, the MoCA was not always administered due to participants’ 
refusal to complete them, or being unable to complete it due to a lack of reading glasses.  
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TABLE 6.2: TYPES OF MISSING QUESTIONNAIRE DATA IN T1-T2 ANALYTIC SAMPLE  
Measure 
T1 T2 
n α 
Scaled-
up 
n α 
Scaled-
up 
Socio-demographics       
Education 11 - - - - - 
Income 12 - - - - - 
Emotional distress       
Depression symptoms (BDI) 20 0.85 3 - - - 
Anxiety (HADS subscale) 9 0.87 3 1 0.78 0 
Quality of life       
Health status (SF-12) – 
Physical 
0 0.66 - - - - 
Health status (SF-12) – 
Mental 
1 0.59 1 - - - 
Health behaviour       
Physical activity (IPAQ – 
walking) 
15 - - - - - 
Sleep (Jenkins Scale) 2 0.83 2 - - - 
Cognitive factors    - - - 
Illness perceptions (BIPQ) 11 0.63 1 - - - 
Cognitive screen (MoCA) 16 0.53 15 - - - 
Social support       
Social support (ESSI) 5 0.89 3 - - - 
Physical symptoms       
Pain (MPQ-SF) - Sensory - - - 7 0.76 1 
Pain (MPQ-SF) - Affective - - - 2 0.57 1 
Symptoms (CROQ-CABG) - - - 11 0.67 0 
 
6.3 Sample characteristics 
Table 6.3 and Table 6.4 describe the characteristics of the entire sample (n = 243) and analytic 
sample (n = 216), respectively, at baseline. The analytic sample had an age range of 44 to 88 
years, was predominantly male (87.0%) and overweight (BMI >25.0 = 80.1%). The majority of 
participants were retired (61.7%), three participants were registered disabled and nine 
participants were unemployed. The majority of the analytic sample had either no or only 
secondary educational qualifications (71.7%). Over 50% of the sample was a past-smoker, but 
only a minority were current smokers (7.5%). The majority of participants (91.4% of men and 
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96.4% of women) adhered to UK government guidelines22 concerning alcohol consumption, 
which equate to a maximum of 28 units per week for men and 21 units per week for women.  
 
TABLE 6.3: CHARACTERISTICS OF THE T1-T2 ENTIRE SAMPLE AT BASELINE  
Characteristic N Mean ± SD or n (%) 
Age (years) 243 67.97±8.84 
Female 243 33 (13.6) 
BMI (kg/m
2
) 223 28.55±4.23 
Married/cohabiting 243 184 (75.7) 
Ethnicity – White British/other White 243 214 (87.7) 
Tobacco smoking 
Never 
Past 
Current 
223 
 
82 (36.8) 
126 (56.5) 
15 (6.7) 
Alcohol consumption (units/week) 242 8.75±12.77 
Currently employed 241 74 (30.7) 
Employment grade of current/last major occupation 
Unemployed 
Managers, directors and senior officials 
Professional 
Associate professional and technical 
Administrative and secretarial 
Skilled trades 
Caring, leisure and other service 
Sales and customer service 
Process, plant and machine operatives 
Elementary 
232 
 
12 (5.2) 
48 (20.7) 
47 (20.3) 
26 (11.2) 
17 (7.3) 
25 (10.8) 
12 (5.2) 
12 (5.2) 
19 (8.2) 
14 (6.0) 
Yearly household income 
≤ 10,000 GBP 
10,000 – 20,000 GBP 
20,000 – 30,000 GBP 
30,000 – 40,000 GBP 
≥40,000 
228 
 
36 (15.8) 
73 (32.0) 
47 (20.6) 
33 (14.5) 
39 (17.1) 
Education 
None 
Secondary 
Higher secondary 
Degree 
228 
 
72 (31.6) 
92 (40.4) 
28 (12.3) 
36 (15.8) 
 
 
 
                                                          
22
 http://www.drinkaware.co.uk 
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TABLE 6.4: CHARACTERISTICS OF THE T1-T2 ANALYTIC SAMPLE AT BASELINE  
Characteristic N Mean ± SD or n (%) 
Age (years) 216 67.55±8.87 
Female 216 28 (13.0) 
BMI (kg/m
2
) 211 28.55±4.21 
Married/cohabiting 216 165 (76.4) 
Ethnicity – White British/other White 216 190 (88.0) 
Tobacco smoking 
Never 
Past 
Current 
213 
 
83 (39.0) 
115 (54.0) 
16 (7.5) 
Alcohol consumption (units/week) 215 9.01±12.99 
Currently employed 214 70 (32.7) 
Employment grade of current/last major occupation 
Unemployed/disabled 
Managers, directors and senior officials 
Professional 
Associate professional and technical 
Administrative and secretarial 
Skilled trades 
Caring, leisure and other service 
Sales and customer service 
Process, plant and machine operatives 
Elementary 
205 
 
12 (5.9) 
44 (21.5) 
41 (20.0) 
24 (11.7) 
16 (7.8) 
20 (9.8) 
11 (5.4) 
10 (4.9) 
18 (8.8) 
9 (4.4) 
Yearly household income 
≤ 10,000 GBP 
10,000 – 20,000 GBP 
20,000 – 30,000 GBP 
30,000 – 40,000 GBP 
≥40,000 
204 
 
29 (14.2) 
66 (32.4) 
45 (22.1) 
28 (13.7) 
36 (17.6) 
Education 
None 
Secondary 
Higher secondary 
Degree 
205 
 
63 (30.7) 
84 (41.0) 
27 (13.2) 
31 (15.1) 
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TABLE 6.5: CLINICAL CHARACTERISTICS OF THE T1-T2 ANALYTIC SAMPLE AT BASELINE  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Absolute number of cases in sample. 
Characteristic N n (%) 
Co-morbidities*   
Diabetes 211 50 (23.7) 
Renal failure (requiring dialysis) 211 3 (1.4) 
Chronic respiratory disease 211 13 (6.2) 
Cancer (self-reported) 
Colon 
Prostate 
Breast 
Bladder 
208 
 
1 (0.5) 
4 (1.9) 
1 (0.5) 
1 (0.5) 
Psychiatric history*   
History of depression 146 23 (15.8) 
History of anxiety disorder 147 19 (12.9) 
Current depression diagnosis 146 5 (3.4) 
Current anxiety diagnosis 147 1 (0.7) 
Cardiac morbidity   
Hypertension 211 163 (77.3) 
Angina 
None 
No limitation 
Slight limitation 
Marked limitation 
Symptoms at rest 
211 
 
7 (3.3) 
46 (21.8) 
124 (58.8) 
33 (15.6) 
1 (0.5) 
Dyspnoea 
None 
Slight 
Moderate 
211 
 
50 (23.7) 
129 (61.1) 
32 (15.2) 
Previous MI 
None 
1 
2 or more 
211 
 
145 (68.7) 
61 (28.9) 
5 (2.4) 
Disease severity   
Ejection fraction < 50 211 24 (11.4) 
Logistic euroSCORE (%) 
<3.0 
3.0-6.0 
6.1-9.0 
9.1-12.0 
>12.0 
211 
 
92 (43.6) 
74 (35.1) 
28 (13.3) 
6 (2.8) 
11 (5.2) 
Surgical details   
Off-pump 211 44 (20.9) 
CABG in isolation 211 164 (77.7) 
Graft sites 
1-2 
3-4 
5+ 
211 
 
64 (30.3) 
130 (61.6) 
17 (8.1) 
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Clinical data for the analytic sample are displayed in Table 6.5. Clinical data collected 
from medical notes were only available for 223 participants of the entire sample and 211 
participants of the analytic sample. Missing clinical data for the 20 participants was due to 14 
of the participants who completed T1 not having had surgery at time of analysis and four 
participants having had surgery too recently for the notes to be released from the cardiac 
surgeon. In addition, clinical data were not available for the two participants who died during 
the study. It is important to note that this clinical information was missing at random, and does 
not reflect a selection bias; it therefore does not represent a confounder for analyses. 
Psychiatric history information was collected at T3, hence the reduced number of participants 
with information available for these items. Co-morbidities were prevalent in the analytic 
sample, with almost a quarter (23.7%) of participants having diabetes. In terms of psychiatric 
morbidity, 15.8% of participants reported a history of depression, but only 3.4% were being 
treated for depression symptoms within the four weeks prior to CABG. The association 
between baseline depression symptoms and current use of antidepressant medication was 
assessed in Pearson’s correlations, but there were no significant associations between total 
BDI scores, somatic/affective depression symptom scores, cognitive affective depression 
symptom scores and use of antidepressant medications. Therefore, these participants were 
retained in analyses. The majority of participants had on-pump (cardiopulmonary bypass) 
surgery (79.1%) in isolation. All participants were alive on discharge.  
Cross-tabulations were performed on age, total yearly household income, education 
and sex, to compare the characteristics of those who completed the first two time points (n = 
216) to those who did not (n = 27). Age was converted to a categorical variable for chi-squared 
analysis (<50 years, 50-60 years, 60-70 years, 70-80 years, >80 years). There was no statistical 
difference between completers and non-completers in terms of age groups (2 = 3.842, df = 4, 
n = 243, p = 0.428). However, the mean age, in years, was higher in the non-completers (Mean: 
71.37 ± SD: 7.95) compared with the completers (Mean: 67.55 ± SD: 8.87) and this reached 
statistical significance (t = -2.135, p = 0.034). There was no significant difference between 
completers and non-completers in terms of income groups (2 = 6.153, df = 4, n = 228, p = 
0.188), or education groups (2 = 2.543, df = 3, n = 228, p = 0.468), and sex (2 = 0.631, df = 1, n 
= 243, p = 0.427). Markers of disease severity did also not significantly differ between 
completers and non-completers in terms of both euroSCORE groups (2 = 6.211, df = 4, n = 
223, p = 0.184) and LVEF (2 = 0.105, df = 1, n = 223, p = 0.745); cut-offs for these variables are 
displayed in Table 4.5. In addition, an independent samples t-test for mean euroSCORE values 
confirmed this lack of difference between completers (Mean: 4.39, SD: 3.14) and non-
completers (Mean: 5.96, SD: 3.73) (t = -1.679, p = 0.094).   
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Kolmogorov-Smirnov tests were performed revealing scores on all continuous 
questionnaire measures apart from the BIPQ to be non-normally distributed (p >0.05). Both 
non-parametric and parametric tests were performed on the data, but since results were 
similar the parametric results are presented here. Distribution of the biological data was also 
tested using Kolmogorov-Smirnov tests and raw data were assessed for log transformation, 
however in order to keep the full range of responses on the biological measures, and to retain 
those participants who had extreme responses, the raw data was used for both cortisol and 
inflammatory marker measures. In addition, this ensures the unit of measurement is 
preserved, maintaining the clinical relevance of the results. Again, both non-parametric and 
parametric tests were performed on the biological data, but since results were similar the 
parametric results are presented here. Correlation analyses were used throughout to assess 
the assumption of multicollinearity, prior to using regression analyses. Multicollinearity 
assumptions were not violated since correlation coefficients were <0.80 throughout.   
6.4 Descriptive analyses of depression symptom and recovery measures 
6.4.1 Depression symptoms at T1 
 
TABLE 6.6: T1 DEPRESSION SYMPTOM SCORES 
Depression symptom score N 
T1 
Mean ± SD or n (%) 
Total BDI 213 8.38±6.31 
Total cognitive/affective BDI 215 2.91±3.83 
Total somatic/affective BDI 213 6.84±5.53 
Normal (0-10) 212 150 (70.8) 
Mild (11-16) 212 43 (20.3) 
Borderline clinical (17-20) 212 11 (5.2) 
Moderate (21-30) 212 6 (2.8) 
Severe (31-40) 212 2 (0.9) 
Extreme (41-63) 212 - 
 
A summary of the depression symptom scores are displayed in Table 6.6. Total, 
somatic/affective and cognitive/affective scores on the BDI were used as predictor variables in 
analyses of the relationship between depression symptoms and early-term recovery over time. 
Please note that this table displays the values on the BDI in accordance with the BDI handbook 
severity cut-offs. Baseline values of the BDI, according to these guidelines, reveal the majority 
of participants were within the normal range for depression symptom scores (BDI >10 = 
29.2%). However, as described in the method chapter (Chapter 3) a systematic review (Thombs 
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et al., 2008) of screening instruments used to detect depression symptoms in cardiac patients 
cites three studies using a BDI cut-off score of ≥10 with a mean sensitivity range between 82% 
and 88%  and a mean specificity score range between 58% and 79% (Frasure-Smith et al., 
1995; Freedland et al., 2003; Strik et al., 2001). One study used a BDI cut-off ≥13 finding a 
mean sensitivity value of 83% and a mean specificity value of 94% (Gutierrez & Davis, 1999). 
Therefore, to examine caseness on the BDI, a binary cut-off was implemented at a 
conservative ≥13, to maximise the specificity of this measure. Using this cut-off, 18.4% of 
participants were classified as depressed at baseline. Somatic/affective (range: 0-24) and 
cognitive/affective (range: 0-23) depression symptom scores are also displayed in this table 
(Table 6.6).   
6.4.2 Early-term recovery outcome variables 
Three different recovery outcomes at T2 were considered: emotional distress, physical 
symptoms and duration of participants’ post-operative hospital stay. Anxiety was used as the 
measure of emotional distress at T2; descriptive analyses are displayed in Table 6.7. A paired 
samples t-test was performed on means scores for anxiety (see p in Table 6.7), revealing a 
significant decrease from before to after surgery. The majority of participants were free from 
anxiety at both time points, with only 10.6% of participants being clinically anxious (≥11) at T2. 
To examine borderline to caseness anxiety on the HADS, a binary cut-off was implemented in 
accordance with previous literature at ≥8. Four groups were created in order to examine the 
pattern of anxiety across time. Results from these analyses are shown in Table 6.8, revealing 
that 26 participants (12.2%) can be classified as having anxiety that persists to T2. A further 39 
participants (18.3%) had anxiety that had resolved by T2. 
Physical symptoms were measured using the MPQ-SF and the CROQ. The majority of 
participants experienced physical pain and discomfort at T2, with only 11.2% of participants 
reporting no sensory pain at T2 (Mean: 5.36, SD: 5.14). Affective pain (Mean: 1.37, SD: 1.98) 
was reported in just under half (47.4%) of participants. Scores on the numerical rating scale 
(Mean: 3.43, SD: 2.50) and the current pain descriptor (Mean: 1.53, SD: 1.03) items, reinforce 
the fact that pain was prevalent at T2. Physical symptoms, as measured by the CROQ, were 
also frequently reported following surgery (Table 6.9). In particular, feelings of pain around the 
surgical wound sites, bruising and swollen feet and ankles were commonly experienced by 
participants.   
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TABLE 6.7: ANXIETY AT T1 AND T2 
Anxiety 
 T1 T2 
p 
N 
Mean ± SD or   
n (%) 
Mean ± SD or   
n (%) 
Anxiety total 213 5.83±4.27 4.69±4.14 <0.001 
Anxiety normal (≤7) 213 148 (69.5) 168 (77.8)* - 
Anxiety borderline (8-10) 213 33 (15.5) 25 (11.6)* - 
Anxiety caseness (≥11) 213 32 (15.0) 23 (10.6)* - 
*N = 216 
 
TABLE 6.8: ANXIETY TYPE ACCORDING TO TIME POINT 
Anxiety type 
HADS ≥ 8 
n (%) 
T1 T2 
Never anxious x x 127 (59.6) 
Post-CABG onset x  21 (9.9) 
Persistent   26 (12.2) 
Resolved  x 39 (18.3) 
 
TABLE 6.9: FREQUENCY OF CROQ PHYSICAL SYMPTOMS AT T2 
Symptom severity (Moderate to A lot) 
T2  
N n (%) 
Pain in chest wound 216 133 (61.6) 
Infection in chest wound 216 6 (2.8) 
Tenderness around chest wound 216 115 (53.2) 
Numbness/tingling around chest wound 214 16 (7.5) 
Bruising around chest wound 216 23 (10.6) 
Pain in arm/leg wound 208 81 (38.9) 
Other pain in arm/leg due to operation 209 18 (8.6) 
Infection in arm/leg wound 208 9 (4.3) 
Numbness/tingling in arm/leg due to operation 208 25 (12.0) 
Bruising arm/leg where vein was removed 208 49 (23.6) 
Swollen feet/ankles 216 95 (44.0) 
Mean ± SD 9.06±5.28 
 
Clinical outcome variables at T2 included length of ICU stay, ICU re-admission, 
reoperation, post-operative dialysis, new cerebrovascular accident, and length of post-
operative hospital stay. However, since many of these outcomes occurred in just a handful of 
patients, only length of in-hospital stay was included in subsequent analyses. Descriptive 
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statistics of these outcomes are displayed in Table 6.10. One of the most policy relevant 
outcomes displayed in this table is length of post-operative hospital stay. This variable is a 
marker of clinical recovery, with those participants experiencing the poorest recovery and the 
greatest in-hospital complications, expected to have the longest hospital stays after CABG. 
Since data on length of post-operative hospital stay were skewed, this variable is presented 
here as a categorical variable, with participants coded as ≤7 days or >7 days. While other 
approaches were considered such as log-transformation of the data, this approach was 
deemed appropriate given it is a clinically pertinent indicator of recovery, with hospital 
guidelines aiming for all patients to be discharged within seven days of CABG surgery. A 
limitation of this approach is the fact that it reduces power, making it more difficult to 
demonstrate an effect.  However, this binary variable was used in all further analyses.  
 
TABLE 6.10: CLINICAL OUTCOMES 
 
 
 
 
 
 
 
6.4.3 Covariates of the depression symptoms-recovery relationship 
Covariates are factors associated with the predictor or outcome variable, which may spuriously 
account for the relationship the predictor variable has with the outcome of interest. Potential 
covariates of the depression symptoms-recovery relationship have been identified in the 
literature review. Thorough identification of covariates is necessary in order to identify the 
extent to which relationships are upheld after taking into account confounders; in other words 
the extent to which the relationship can be deemed causal. A limitation of ARCS is that some 
confounders have not been captured, whereas others may have been inadequately measured. 
An example is disease severity, where ARCS adequately captures coronary disease, but lacks 
data on cardiovascular disease severity more generally, including peripheral arterial and 
cerebrovascular disease. A full discussion of this is provided in Chapter 8 (Section 8.3.7).  
Nevertheless, various potential demographic covariates have previously been 
described, but for ease of reference are presented again here in Table 6.11; they include age, 
Post-operative recovery N n (%) 
Intensive care stay > 2 days 211 25 (11.8) 
Intensive care re-admission 211 5 (2.4) 
Length of post-operative stay  
≤7 days 
>7 days 
211 
 
153 (72.5) 
58 (27.5) 
Reoperation necessary 211 7 (3.3) 
Post-operative complications 
Transient stroke 
Post-operative dialysis 
211 
 
1 (0.5) 
5 (2.4) 
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sex, and socioeconomic status as measured by education, occupation level and household 
income. Disease severity, including LVEF and euroSCORE, also need consideration as 
covariates, and are again presented in Table 6.11. To clarify, LVEF was used as a binary variable 
(<50 or ≥50) and logistic euroSCORE was used a continuous variable. Other clinical factors such 
as medication use and co-morbidities may also play a role in recovery and were also 
considered as potential covariates. Pre-operative medication usage is displayed in Table 6.12, 
demonstrating ACE inhibitors, aspirin, statins and beta-blockers were frequently prescribed. 
 
TABLE 6.11: DEMOGRAPHIC AND DISEASE SEVERITY COVARIATES 
Characteristic N Mean ± SD or n (%) 
Age (years) 216 67.55±8.87 
Female 216 28 (13.0) 
Employment grade of current/last major occupation 
Unemployed/disabled 
Managers, directors and senior officials 
Professional 
Associate professional and technical 
Administrative and secretarial 
Skilled trades 
Caring, leisure and other service 
Sales and customer service 
Process, plant and machine operatives 
Elementary 
205 
 
12 (5.9) 
44 (21.5) 
41 (20.0) 
24 (11.7) 
16 (7.8) 
20 (9.8) 
11 (5.4) 
10 (4.9) 
18 (8.8) 
9 (4.4) 
Yearly household income 
≤ 10,000 GBP 
10,000 – 20,000 GBP 
20,000 – 30,000 GBP 
30,000 – 40,000 GBP 
≥40,000 
204 
 
29 (14.2) 
66 (32.4) 
45 (22.1) 
28 (13.7) 
36 (17.6) 
Education 
None 
Secondary 
Higher secondary 
Degree 
205 
 
63 (30.7) 
84 (41.0) 
27 (13.2) 
31 (15.1) 
Ejection fraction < 50 211 24 (11.4) 
Logistic euroSCORE (%) 211 4.40±3.15 
 
Although primary identification of covariates was theory driven, in order to create a 
parsimonious model of the depression symptoms-recovery relationship, some tailoring was 
required to identify those covariates applicable to recovery in my sample. This was necessary 
since the ARCS study was powered to include nine predictor variables, and some analyses were 
performed on a reduced sample size due to missing data. The potential covariates were 
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entered into correlation analyses in order to identify those variables which were strongly 
related to the predictor and outcome variables.  
 
TABLE 6.12: PRE-OPERATIVE PRESCRIBED MEDICATION USE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results of the correlation analyses offer some insight into the covariates applicable to 
the depression symptoms-recovery relationship in this sample. In correlation analyses, age (p = 
0.049) and sex (p = 0.023) showed positive significant associations with length of hospital stay, 
such that older and female participants had a longer post-operative stay. Out of the three 
markers of socioeconomic position considered as potential covariates (education, occupation 
level and household income), total household income (p = 0.002) and occupation (p = 0.026) 
were significantly related to recovery, with those participants reporting lower socioeconomic 
position having a longer hospital stay. Similarly, euroSCORE (p = 0.001) was significantly 
associated with length of hospital stay, so that those with greater disease severity had a longer 
in-hospital recovery. This is an important finding given that euroSCORE was not originally 
designed as a specific measure of in-hospital recovery, but rather as mortality risk model. 
However, given that a significant association was found between euroSCORE and length of 
post-operative stay suggests that it is an appropriate marker of disease severity to include in 
analyses. Associations between use of medications and co-morbidities and recovery outcome 
Medication N n (%) 
Symptom reduction drugs   
Anti-arrhythmia 195 4 (2.1) 
Antibiotic 195 4 (2.1) 
Calcium channel blocker 195 61 (31.3) 
Nitrate 195 60 (30.8) 
NSAID 195 24 (12.3) 
Sleeping tablet 195 5 (2.6) 
Risk reduction drugs   
ACE inhibitors 195 105 (53.8) 
Angiotensin II receptor antagonist 195 26 (13.3) 
Anticoagulant 195 15 (7.7) 
Antiplatelet 195 62 (31.8) 
Aspirin 200 162 (81.0) 
Beta-blockers 195 128 (65.6) 
Statins 195 173  (88.7) 
Mood-enhancing drugs   
Antidepressants 146 5 (3.4) 
Anxiolytics 147 1 (0.7) 
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variables were also performed, with no significant associations found. Correlation analyses 
were also performed between the baseline depression scores (total, somatic/affective and 
cognitive/affective) and the potential covariates. The only significant associations observed 
were between depression symptoms and age, with a negative association such that younger 
participants had greater depression symptoms. The results of these analyses are shown in 
Table 6.13.   
As a result of these analyses, household income was used as a proxy measure of 
socioeconomic status in analyses, rather than education or occupation level, since this 
produced the strongest association with length of hospital stay. Due to the fact that 
euroSCORE and LVEF were correlated (r = 0.181, p = 0.008) and euroSCORE actually takes into 
account LVEF, only euroSCORE was included in mediation models as a marker of disease 
severity.  
TABLE 6.13: PEARSON’S CORRELATIONS TO IDENTIFY COVARIATES 
Measure 
T1 BDI 
Total 
T1BDI 
Somatic/
Affective 
T1BDI 
Cognitive/ 
Affective 
T2 
Anxiety 
(HADS) 
T2 
Sensory 
pain 
T2 
Affective 
pain 
T2 
Physical 
symptoms 
(CROQ) 
T2 
Length of 
post-
CABG 
stay 
(binary) 
Age 
r 
p 
-0.221 
0.001 
-0.149 
0.029 
-0.293 
<0.001 
-0.066 
0.335 
-0.103 
0.132 
0.028 
0.688 
0.126 
0.065 
0.136
 
0.049 
Sex 
r 
p 
0.097 
0.159 
 
0.120 
0.079 
 
0.037 
0.585 
-0.073 
0.287 
-0.100 
0.143 
-0.016 
0.812 
0.072 
0.292 
0.157
 
0.023 
Level of 
education 
r 
p 
 
0.017 
0.810 
 
0.008 
0.911 
0.076 
0.282 
-0.039 
0.576 
0.058 
0.408 
-0.026 
0.715 
-0.029 
0.682 
0.021 
0.768 
Occupation 
level 
r 
p 
-0.004 
0.951 
-0.001 
0.992 
-0.079 
0.279 
-0.085 
0.240 
-0.061 
0.397 
-0.091 
0.210 
-0.084 
0.246 
0.162
 
0.026 
Household 
income 
r 
p 
-0.071 
0.317 
-0.083 
0.240 
0.008 
0.908 
-0.013 
0.854 
0.004 
0.959 
0.028 
0.692 
-0.077 
0.274 
-0.214
 
0.002 
Logistic 
euroSCORE 
r 
p 
-0.029 
0.680 
0.041 
0.561 
-0.106 
0.125 
0.025 
0.722 
-0.096 
0.166 
0.079 
0.251 
0.039 
0.575 
0.236
 
0.001 
LVEF 
r 
p 
0.068 
0.331 
0.062 
0.374 
0.062 
0.371 
0.024 
0.725 
0.031 
0.660 
-0.005 
0.947 
-0.054 
0.433 
0.114 
0.099 
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6.5 T1 depression symptoms predicting early-term recovery 
Regression models were built to assess depression symptoms as a predictor of anxiety, 
physical symptoms (CROQ and MPQ-SF) and length of post-operative hospital stay at T2. 
Multiple regression analyses were used for continuous outcomes (anxiety, CROQ symptoms, 
MPQ-SF pain) and a logistic regression model was used for the binary outcome, length of 
hospital stay. All models were adjusted for the covariates age, sex, household income and 
euroSCORE, and anxiety models controlled for baseline anxiety.  
6.5.1 Emotional distress outcomes 
Multiple regression analyses were performed using T2 anxiety, as measured on the HADS, as 
the outcome variable. Results showed that total and somatic/affective depression symptom 
scores on the BDI were both significant predictors of anxiety scores after controlling for 
covariates. The results of total BDI scores are displayed in Table 6.14 showing BDI total score (t 
= 2.249, p = 0.026) was a significant predictor of T2 anxiety after controlling for covariates. The 
only other significant predictor in the model was T1 anxiety (t = 3.855, p <0.001). The results of 
somatic/affective scores are displayed in Table 6.15 showing BDI somatic/affective depression 
symptom score (t = 3.075, p = 0.002) was a significant predictor of T2 anxiety after controlling 
for covariates. The only other significant predictors in the model were T1 anxiety (t = 3.596, p 
<0.001) and sex (t = -0.144, p = 0.044), with male sex being more strongly associated with T2 
anxiety than female sex.  
 
TABLE 6.14: MULTIPLE REGRESSION OF T2 ANXIETY ON T1 TOTAL BDI SCORE  
Model B SE ß p 
Age 0.017 0.043 0.037 0.701 
Sex -1.725 0.930 -0.133 0.065 
Household income 0.038 0.207 0.012 0.855 
euroSCORE 0.050 0.134 0.037 0.709 
T1 Anxiety 0.308 0.080 0.312 <0.001 
T1 BDI total score 0.125 0.056 0.186 0.026 
R
2
 = 0.202, N = 194 
 
Cognitive/affective depression symptom score (t = 1.860, p = 0.065) was not a 
significant predictor or T2 anxiety in adjusted regression models, with the only significant 
predictor in this model being T1 anxiety (t = 4.115, p <0.001).  Overall, these regression models 
suggest that greater pre-operative depression symptoms were associated with greater 
emotional distress in the days following surgery, and that somatic/affective depression 
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symptom scores were particularly important for predicting anxiety outcomes. A moderate 
amount of variance in anxiety was explained in these models: 20.2% in the total BDI score 
model and 22.0% in the somatic/affective BDI score model. 
 
TABLE 6.15: MULTIPLE REGRESSION OF T2 ANXIETY ON T1 SOMATIC/AFFECTIVE BDI SCORE 
Model B SE ß p 
Age 0.015 0.042 0.033 0.726 
Sex -1.875 0.923 -0.144 0.044 
Household income 0.041 0.205 0.014 0.841 
euroSCORE 0.041 0.133 0.030 0.759 
T1 Anxiety 0.280 0.078 0.283 <0.001 
T1 BDI somatic 0.224 0.073 0.245 0.002 
R
2
 = 0.220, N = 194 
 
6.5.2 Physical symptom outcomes 
Pain 
Multiple regression analyses were next performed using T2 pain symptoms, as measured on 
the MPQ-SF, as the outcome variables. Results showed that total and somatic/affective 
depression symptom scores on the BDI were both significant predictors of affective pain scores 
after controlling for demographic and disease severity covariates. The results of total BDI 
scores are displayed in Table 6.16 showing BDI total score (t = 1.995, p = 0.047) was a 
significant predictor of T2 affective pain score after controlling for covariates. None of the 
covariates were significant predictors in the final model. The results of somatic/affective 
scores are displayed in Table 6.17 showing BDI somatic/affective depression symptom score (t 
= 2.115, p = 0.036) was a significant predictor of T2 affective pain score after controlling for 
covariates. Again, none of the covariates were significant predictors in the final model. 
Cognitive/affective depression symptom score (t = 1.931, p = 0.055) approached statistical 
significance as a predictor or T2 affective pain scores in adjusted regression models. None of 
the depression symptom scores were significant predictors of sensory pain, pain numerical 
rating scale score or current pain descriptor in regression models adjusted for covariates.  
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TABLE 6.16: MULTIPLE REGRESSION OF T2 AFFECTIVE PAIN ON T1 TOTAL BDI SCORE  
Model B SE ß p 
Age 0.002 0.024 0.009 0.932 
Sex -0.574 0.506 -0.088 0.257 
Household income 0.077 0.113 0.051 0.495 
euroSCORE 0.055 0.072 0.083 0.445 
T1 BDI total score 0.050 0.025 0.148 0.047 
R
2
 = 0.029, N = 196 
 
TABLE 6.17: MULTIPLE REGRESSION OF T2 AFFECTIVE PAIN ON T1 SOMATIC/AFFECTIVE 
BDI SCORE 
Model B SE ß p 
Age <0.001 0.023 0.001 0.990 
Sex -0.604 0.506 -0.093 0.234 
Household income 0.077 0.112 0.051 0.497 
euroSCORE 0.053 0.072 0.080 0.461 
T1 BDI somatic 0.071 0.034 0.156 0.036 
R
2
 = 0.031, N = 196 
 
Overall, these regression models suggest that pre-operative depression symptoms 
were positively associated with the distress component of physical pain in the days following 
surgery, and that somatic/affective depression symptom scores were particularly important 
for predicting affective pain outcomes. However, it should be noted that only a small amount 
of variance in affective pain was explained in these models: just 2.9% in the total BDI score 
model and 3.1% in the somatic/affective BDI score model.  
 
Physical symptoms 
Multiple regression analyses were also performed using T2 physical symptoms, as measured 
on the CROQ, as the outcome variable. Results showed that total, somatic/affective and 
cognitive/affective depression symptom scores on the BDI were all significant predictors of 
physical symptoms after controlling for demographic and disease severity covariates. The 
results of total BDI scores are displayed in Table 6.18 showing BDI total score (t = 2.279, p = 
0.024) was a significant predictor of T2 physical symptom score after controlling for covariates. 
Age was the only other significant predictor in the model (t = 2.464, p = 0.015). The results of 
somatic/affective scores are displayed in Table 6.19 showing BDI somatic/affective depression 
symptom score (t = 2.661, p = 0.008) was a significant predictor of T2 physical symptom score 
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after controlling for demographic and disease severity variables. Age was the only other 
significant predictor in the model (t = 2.455, p = 0.015). The results of cognitive/affective 
scores are displayed in Table 6.20 showing BDI cognitive/affective depression symptom score 
(t = 2.476, p = 0.014) was a significant predictor of T2 physical symptoms after controlling for 
covariates. Age was the only other significant predictor in the model (t = 2.532, p = 0.012).  
 
TABLE 6.18:  MULTIPLE REGRESSION OF T2 PHYSICAL SYMPTOMS ON T1 TOTAL BDI SCORE  
Model B SE ß p 
Age 0.147 0.060 0.257 0.015 
Sex 0.340 1.279 0.020 0.791 
Household income -0.143 0.285 -0.037 0.616 
euroSCORE -0.264 0.181 -0.156 0.148 
T1 BDI total score 0.144 0.063 0.167 0.024 
R
2
 = 0.051, N = 197 
 
TABLE 6.19: MULTIPLE REGRESSION OF T2 PHYSICAL SYMPTOMS ON T1 
SOMATIC/AFFECTIVE BDI SCORE 
Model B SE ß p 
Age 0.145 0.059 0.253 0.015 
Sex 0.219 1.276 0.013 0.864 
Household income -0.139 0.283 -0.036 0.624 
euroSCORE -0.273 0.181 -0.162 0.132 
T1 BDI somatic 0.225 0.085 0.192 0.008 
R
2
 = 0.060, N = 197 
 
TABLE 6.20: MULTIPLE REGRESSION OF T2 PHYSICAL SYMPTOMS ON T1 
COGNITIVE/AFFECTIVE BDI SCORE 
Model B SE ß p 
Age 0.151 0.060 0.264 0.012 
Sex 0.386 1.236 0.024 0.755 
Household income -0.190 0.282 -0.049 0.501 
euroSCORE -0.249 0.179 -0.147 0.167 
T1 BDI cognitive 0.266 0.107 0.182 0.014 
R
2
 = 0.054, N = 199 
 
As with the models predicting affective pain, these models accounted for a relatively 
small amount of variance in physical symptom scores on the CROQ, ranging from 5.1% using 
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the total depression symptom score to 6.0% using the somatic/affective depression symptom 
score. Overall, these regression models suggest baseline somatic/affective and 
cognitive/affective depression symptom scores were similarly predictive of T2 CROQ physical 
symptoms.  
6.5.3 Length of hospital stay outcome 
Logistic regression analyses were performed using T2 length of post-operative stay as the 
outcome variable. As previously described, this outcome is a binary variable, with participants 
split into two groups: ≤7 days and >7 days. Household income was also entered into models as 
a binary variable using a median split: ≤£20,000 days and >£20,000 per year. Results showed 
that total, somatic/affective and cognitive/affective depression symptom scores on the BDI 
were all significant predictors of length of hospital stay after controlling for demographic and 
disease severity covariates.  
 
TABLE 6.21: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON T1 TOTAL BDI 
SCORE  
Model OR 95% CI p 
Age 1.030 0.974-1.090 0.298 
Sex
a
 2.048 0.717-5.850 0.181 
Household income
b
 0.405 0.202-0.811 0.011 
euroSCORE 1.056 0.901-1.238 0.499 
T1 BDI total 1.073 1.013-1.136 0.016 
Reference groups are: 
a
male; 
b
 <£20,000/year. N = 197. OR: Odds ratio; CI: Confidence interval. 
 
The results of total BDI scores are displayed in Table 6.21 showing BDI total score (p = 
0.016) was a significant predictor of length of hospital stay after controlling for covariates. 
These results show that for every unit increase in BDI score, there was a 7.3% greater odds of 
having a post-operative hospital stay of greater than one week. Household income was the 
only other significant predictor in the model (p = 0.011). The results of somatic/affective scores 
are displayed in Table 6.22 showing BDI somatic/affective depression symptom score (p = 
0.030) was a significant predictor of T2 physical symptom score after controlling for 
demographic and disease severity variables. These results show that for every unit increase in 
BDI somatic/affective score, there was a 9.1% greater odds of having a post-operative hospital 
stay of greater than one week. Household income was again the only other significant 
predictor in the model (p = 0.009).  The results of cognitive/affective scores are displayed in 
Table 6.23 showing BDI cognitive/affective depression symptom score (p = 0.008) was a 
significant predictor of T2 physical symptom score after controlling for covariates. These 
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results show that for every unit increase in BDI cognitive/affective score, there was a 13.9% 
greater odds of having a post-operative hospital stay of greater than one week. Household 
income was also a significant predictor in the model (p = 0.005). Overall, these regression 
models show that pre-operative cognitive/affective depression symptoms carry slightly greater 
risk of an extended post-operative hospital stay, compared with total BDI and 
somatic/affective depression symptom score.  
 
TABLE 6.22: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON T1 
SOMATIC/AFFECTIVE BDI SCORE  
Model OR 95% CI p 
Age 1.025 0.970-1.083 0.381 
Sex
a
 1.992 0.695-5.707 0.200 
Household income
b
 0.398 0.199-0.795 0.009 
euroSCORE 1.056 0.901-1.238 0.502 
T1 BDI somatic 1.091 1.008-1.180 0.030 
Reference groups are: 
a
male; 
b
 <£20,000/year. N = 197. OR: Odds ratio; CI: Confidence interval.  
 
TABLE 6.23: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON T1 
COGNITIVE/AFFECTIVE BDI SCORE  
Model OR 95% CI p 
Age 1.034 0.977-1.095 0.250 
Sex
a
 2.104 0.758-5.844 0.153 
Household income
b
 0.372 0.185-0.745 0.005 
euroSCORE 1.064 0.909-1.246 0.442 
T1 BDI cognitive 1.139 1.034-1.255 0.008 
Reference groups are: 
a
male; 
b
 <£20,000/year. N = 199. OR: Odds ratio; CI: Confidence interval.  
 
6.6 Mechanisms  
Candidate mechanisms were identified in the literature review and the pilot results (Chapter 4) 
to involve several biopsychosocial pathways. This PhD tests the role of three possible 
mechanistic pathways, namely social-behavioural factors, cognitive factors and biological 
factors. These candidate mechanisms were based on measures taken at T1, with the exception 
of the inflammatory markers, where blood was also drawn at T2. Each of these mechanisms 
are described in turn below, followed by analyses of their association with depression 
symptoms and the outcome variables, before finally including them in multivariate regression 
models.   
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To restate the earlier discussion in Chapter 2 (see Section 2.5), the definition of 
mechanisms as mediators described by Skala and colleagues (Skala et al., 2006) was used in 
this PhD. They describe a mechanism to be a variable on the causal pathway between 
depression symptoms and cardiac prognosis. To be a valid mechanism, mediation must be 
upheld such that depression symptoms are associated with the candidate mechanism, and in 
turn the mechanism is associated with the cardiac outcome. In statistical analysis, partial 
mediation occurs when the addition of the mechanism to the model attenuates the 
association between depression symptoms and the cardiac outcome, whereas full mediation 
entirely removes this association.  
 
 
TOTAL EFFECT: 
 
 
 
MEDIATION MODEL: 
 
 
 
 
 
 
In order to directly test mediation, the Sobel test method was implemented for the 
outcomes with continuous scores, using the method set out by Preacher and Hayes (Preacher 
& Hayes, 2004, 2008). This method examines the mediation of the predictor and outcome 
variables, and tests the significance of the indirect effect in the model. The bootstrapping 
technique advocated in this method was also employed as a non-parametric approach to 
handle the non-normally distributed data. The model included T1 depression symptom score 
as the independent variable and the T2 recovery outcome as the dependent variable, with 
candidate mechanisms entered as the mediator. Covariates included age, sex, household 
T1 Total BDI T2 Anxiety 
c 
 
 
T1 Total BDI T2 Anxiety 
T1 Illness 
perceptions 
 
 
 
 
 
 
c' 
b a 
FIGURE 6.1: EXAMPLE SOBEL TEST MEDIATION MODEL 
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income, euroSCORE, and for models predicting T2 anxiety, T1 anxiety was also included. The 
resulting model is perhaps best illustrated, and an example is provided in Figure 6.2. Pathway c 
represents the total effect of the predictor on the outcome, pathway c’ represents the direct 
effect after controlling for the mediator, and pathway ab represents the total indirect pathway 
of the mediator; the latter which can be expressed as c – c’. Since this method cannot be 
applied to the binary outcome data, a second approach was also taken to estimate the 
significance of the indirect effect. The change in the amount of variance explained by 
depression symptoms before and after the addition of the candidate mechanism in the models 
was estimated by calculating the percentage change: 1-(T2 β/ T1 β), or in the case of logistic 
regression models: 1-(T2 odds ratio/ T1 odds ratio). 
One caution with regard to the interpretation of these models concerns the issue of 
causality. The direction of causality between depression symptoms and the candidate 
mechanisms is difficult to establish empirically in this study since depression symptoms and 
the candidate mechanisms were all measured at the same time point. For example, we cannot 
know whether depression symptoms cause negative illness perceptions or vice versa using this 
data. Nevertheless, these models provide an insight into the complex relationships occurring 
between depression symptoms and recovery after CABG surgery. Since depression symptoms 
were significant predictors of affective pain, CROQ physical symptoms and length of hospital 
stay, these outcomes were assessed for inclusion in analyses of mediation.  
6.6.1 Behavioural and social mechanisms 
6.6.1.1 Descriptive analyses 
Social-behavioural factors such as physical activity, smoking, alcohol intake, sleep and social 
support were all discussed as important to both depression symptoms and cardiac outcomes 
in the literature review. Inclusion of these factors into mediation models would suggest that 
those participants with greater depression symptoms would also be more likely to have an 
unhealthy lifestyle, and this in turn would act to impede the recovery process. Importantly, 
sleep must be remembered as a symptom of depression, and therefore there are conceptual 
difficulties in describing sleep as a candidate mediator of the depression symptoms-recovery 
relationship. Given the interesting results from the pilot study, sleep was included in these 
analyses to assess its association with the recovery outcomes and for consideration in 
mediation analyses of cognitive/affective depression symptoms and recovery. 
The descriptive statistics for the social-behavioural candidate mechanisms are 
displayed in Table 6.24. The majority of the sample was overweight with a mean BMI of 28.55 
kg/m2. The majority of the sample drank alcohol moderately, within the UK government 
recommended guidelines, and only 7.5% of participants were current smokers. On average, 
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participants walked for 3.5 hours per week. However, only 39.2% of participants walked for at 
least 10 minutes at a time, on every day of the previous week, and 15.9% of participants did 
not walk for 10 minutes at all during the week. Data from the Jenkins sleep questionnaire 
show that participants frequently experienced sleep disturbances prior to surgery, with the 
symptoms of waking several times during the night, trouble staying asleep and disturbed or 
restless sleep being most commonly reported. Social support scores ranged from the lowest 
(8) to highest (34) possible scores on the ESSI questionnaire, with a mean score of 28.94 
indicating participants generally report high levels of support. 
 
TABLE 6.24: T1 SOCIAL-BEHAVIOURAL MECHANISMS 
Measure N 
T1 
Mean ± SD or n (%) 
Health Behaviour   
BMI (kg/m
2
) 211 28.55±4.21 
Alcohol consumption (units/week) 215 9.01±12.99 
Physical activity (hours/week) 201 3.58±4.92 
Current smoker 213 16 (7.5) 
Sleep total 214 9.22±6.85 
Sleep  items   
1. Trouble falling asleep 214 1.05±2.54 
2. Waking during night 214 2.54±1.88 
3. Trouble staying asleep 214 2.04±1.95 
4. Waking feeling tired/ worn out 214 1.56±1.65 
5. Disturbed/restless sleep 214 2.02±1.86 
Social support   
Social support (ESSI) 213 28.94±5.56 
 
6.6.1.2 Associations with depression symptom and recovery variables 
Pearson’s correlation analyses were performed to assess whether the candidate mechanisms 
were associated with depression symptoms (Table 6.25). To clarify, smoking was entered as a 
binary value (yes/no) to reflect current smoking status in these analyses. Results of these 
correlation analyses show smoking status, sleep problems and social support were all 
associated with depression symptoms. Independent t-tests confirmed the difference between 
depressed/non-depressed participants (BDI ≥13) on sleep scores (t(209) = -5.090, p <0.001) 
and social support scores (t(208)= 2.802, p = 0.006). Chi-square tests found no difference in 
smoking status (2 = 0.47, df = 1, p = 0.495) between depressed and non-depressed groups. In 
addition, independent t-tests confirmed the lack of difference between depressed/non-
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depressed participants in terms of BMI (t(205) = 0.614, p = 0.540), alcohol consumption (t(209) 
= 1.399, p = 0.163) and physical activity (t(196) = 0.578, p = 0.564).  
Pearson’s correlation analyses were also performed to assess the association of these 
social-behavioural factors with the recovery outcomes. These correlations found that smoking 
status was significantly associated with length of post-operative hospital stay (r = -0.152, p = 
0.029), indicating that smoking was significantly associated with a post-operative stay of more 
than one week. Results also found sleep was significantly positively associated with T2 anxiety 
(r = 0.225, p = 0.001) and T2 CROQ physical symptoms (r = 0.138, p = 0.043), such that greater 
pre-operative sleep problems were related to greater anxiety and greater physical symptoms 
at T2.  
 
TABLE 6.25: PEARSON’S CORRELATIONS OF T1 SOCIAL-BEHAVIOURAL FACTORS AND T1 
DEPRESSION SYMPTOMS 
Measure 
T1 BDI 
total 
T1 BDI 
somatic 
T1 BDI 
cognitive 
Health behaviour    
T1 BMI  
r 
p 
0.036 
0.610 
0.023 
0.738 
0.030 
0.668 
T1 Smoking 
r 
p 
-0.137
 
0.048 
-0.158
 
0.022 
-0.115 
0.094 
T1 Alcohol consumption 
r 
p 
-0.109 
0.115 
-0.113 
0.101 
-0.060 
0.385 
T1 Physical activity – walking 
r 
p 
0.075 
0.294 
0.021 
0.770 
0.094 
0.186 
T1 Sleep  
r 
p 
0.413
 
<0.001 
0.431
 
<0.001 
0.324
 
<0.001 
Social support    
T1 Social support  
r 
p 
-0.317
 
<0.001 
-0.316
 
<0.001 
-0.310
 
<0.001 
 
Regression analyses were also performed to assess whether the social-behavioural 
factors predicted any of the recovery outcomes after controlling for demographic and disease 
severity covariates. Anxiety models also controlled for baseline anxiety score. Statistically, the 
correlation coefficient represents the linear dependence between the predictor and outcome 
variable, but it does not control for the fact that other factors may also account for the 
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relationship, potentially producing a biased estimate. Interestingly, sleep was not a significant 
predictor of T2 anxiety (t = 1.047, p = 0.296), however sleep was a significant predictor of T2 
CROQ physical symptoms (t = 2.211, p = 0.028) after controlling for covariates in these 
regression models. This association was positive such that those participants who reported 
greater sleep complaints prior to surgery also reported more physical symptoms post-CABG. In 
addition, physical activity (t = -2.182, p = 0.030) was significantly associated with T2 anxiety. 
This association was negative such that those participants who walked fewer hours per week 
had greater anxiety after CABG. Finally, smoking status at T1 (odds ratio = 0.177, 95% CI = 
0.054-0.577, p = 0.004) was a significant predictor of length of post-operative hospital stay 
after controlling for covariates. This result suggests that compared with smokers, non-smokers 
had an 82.3% reduced odds of an extended post-operative stay. These significant predictors 
were examined as potential mediators of the depression symptoms-recovery relationship. 
6.6.1.3 Mediation models of T2 emotional distress 
 
TABLE 6.26: HIERARCHICAL REGRESSION OF T2 ANXIETY ON T1 PHYSICAL ACTIVITY AND T1 
TOTAL BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.008 0.044 0.017 0.858 
Sex -1.952 0.926 -0.154 0.036 
Household income 0.031 0.215 0.010 0.884 
euroSCORE 0.052 0.135 0.039 0.701 
T1 anxiety 0.275 0.082 0.273 0.001 
T1 BDI total score 0.194 0.060 0.269 0.001 
Step 2     
Age 0.007 0.044 0.016 0.869 
Sex -2.173 0.924 -0.171 0.020 
Household income 0.050 0.213 0.016 0.816 
euroSCORE 0.046 0.134 0.035 0.729 
T1 anxiety 0.285 0.081 0.282 0.001 
T1 BDI total score 0.188 0.059 0.261 0.002 
T1 Physical activity - walking -0.118 0.058 -0.137 0.041 
Step 1 R
2
 = 0.235; Step 2 R
2
 = 0.253; N = 181 
 
A regression model was built using the hierarchical method in which predictor variables were 
entered in steps, to assess the relative contribution of physical activity to the depression 
symptoms-T2 anxiety relationship (Table 6.26). The model shows that male sex (t = -2.109, p = 
0.036), T1 anxiety (t = 3.353, p = 0.001) and total BDI score (t = 3.241, p = 0.001) were the only 
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significant predictors of T2 anxiety in step 1 adjusted for covariates. After adding T1 hours 
spent walking per week into the model, male sex (t = -2.352, p = 0.020), T1 anxiety (t = 3.497, p 
= 0.001) and depression symptoms (t = 3.162, p = 0.002) remained significant predictors. In 
addition T1 physical activity was also a significant predictor (t = -2.058, p = 0.041), with a 
negative association such that the least active participants at baseline, had greater anxiety 
following surgery. The final model accounted for 25.2% (R2 = 0.252) of variance in T2 anxiety 
scores. Looking at the standardised regression coefficient (β) for depression symptoms shows 
that with the inclusion of T1 physical activity in the model, the β for depression symptoms 
changed from 0.269 to 0.261. This indicates that when physical activity was included in the 
model, there was only a 3.0% reduction in the size of β. However, in a separate regression 
model using physical activity as the dependent variable to assess the association with T1 total 
BDI depression symptoms, after adjusting for disease severity and demographic covariates, 
total BDI depression symptoms (t = -0.247, p = 0.805) was not significant. Therefore, a Sobel 
test of mediation was not performed. 
 
TABLE 6.27: HIERARCHICAL REGRESSION OF T2 ANXIETY ON T1 PHYSICAL ACTIVITY AND T1 
SOMATIC/AFFECTIVE BDI SCORE 
Model B SE ß p 
Step 1     
Age 0.001 0.044 0.003 0.976 
Sex -2.082 0.919 -0.164 0.025 
Household income 0.036 0.213 0.012 0.867 
euroSCORE 0.046 0.133 0.034 0.730 
T1 anxiety 0.267 0.079 0.265 0.001 
T1 BDI somatic 0.289 0.076 0.302 <0.001 
Step 2     
Age 0.001 0.043 0.002 0.986 
Sex -2.284 0.917 -0.180 0.014 
Household income 0.052 0.211 0.017 0.804 
euroSCORE 0.041 0.132 0.031 0.755 
T1 anxiety 0.278 0.078 0.275 0.001 
T1 BDI somatic 0.278 0.076 0.291 <0.001 
T1 Physical activity - walking -0.112 0.057 -0.130 0.050 
Step 1 R
2
 = 0.251; Step 2 R
2
 = 0.268; N = 181 
 
Hierarchical regression analyses were also performed for somatic/affective and 
cognitive/affective depression symptom scores, using the same covariates. The model for 
somatic/affective depression symptoms is displayed in Table 6.27 and shows that male sex (t = 
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-2.267, p = 0.025), T1 anxiety (t = 3.390, p = 0.001) and somatic/affective BDI score (t = 3.800, p 
<0.001) were the only significant predictors of T2 anxiety in step 1 adjusted for covariates. 
After adding T1 hours spent walking per week into the model, male sex (t = -2.492, p = 0.014), 
T1 anxiety (t = 3.543, p = 0.001) and somatic/affective depression symptoms (t = 3.679, p 
<0.001) remained significant predictors. In addition, T1 physical activity was a borderline 
significant predictor (t = -1.971, p = 0.050), with a negative association such that the least 
active participants at baseline, had greater anxiety following surgery. The final model 
accounted for 26.8% (R2 = 0.268) of variance in T2 anxiety scores. Looking at the standardised 
regression coefficient (β) for depression symptoms shows that with the inclusion of T1 physical 
activity in the model, the β for depression symptoms changed from 0.302 to 0.291. This 
indicates that when physical activity was included in the model, there was only a 3.6% 
reduction in the size of β. However, in a separate regression model using physical activity as 
the dependent variable to assess the association with T1 somatic/affective depression 
symptoms, after adjusting for disease severity and demographic covariates, somatic/affective 
depression symptom score (t = -0.540, p = 0.590)  was not significant. Therefore, a Sobel test of 
mediation was not performed.  
 
TABLE 6.28: HIERARCHICAL REGRESSION OF T2 ANXIETY ON T1 PHYSICAL ACTIVITY AND T1 
COGNITIVE/AFFECTIVE BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.015 0.045 0.032 0.745 
Sex -1.610 0.897 -0.129 0.074 
Household income -0.035 0.214 -0.011 0.871 
euroSCORE 0.055 0.134 0.041 0.681 
T1 anxiety 0.281 0.083 0.279 0.001 
T1 BDI cognitive 0.321 0.105 0.259 0.002 
Step 2     
Age 0.013 0.044 0.028 0.772 
Sex -1.841 0.897 -0.148 0.042 
Household income -0.016 0.212 -0.005 0.941 
euroSCORE 0.051 0.133 0.038 0.702 
T1 anxiety 0.293 0.083 0.291 0.000 
T1 BDI cognitive 0.304 0.104 0.245 0.004 
T1 Physical activity - walking -0.114 0.058 -0.132 0.049 
Step 1 R
2
 = 0.234; Step 2 R
2
 = 0.250; N = 183 
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The model for cognitive/affective depression symptoms is displayed in Table 6.28 and 
shows that T1 anxiety (t = 3.387, p = 0.001) and cognitive/affective BDI score (t = 3.070, p = 
0.002) were the only significant predictors of T2 anxiety in step 1 adjusted for covariates. After 
adding T1 hours spent walking per week into the model T1 anxiety (t = 3.555, p <0.001) and 
cognitive/affective depression symptoms (t = 2.922, p = 0.004) remained significant predictors. 
In addition, T1 physical activity was a significant predictor (t = -1.979, p = 0.049), with a 
negative association such that the least active participants at baseline, had greater anxiety 
following surgery. The final model accounted for 25.0% (R2 = 0.250) of variance in T2 anxiety 
scores. Looking at the standardised regression coefficient (β) for depression symptoms shows 
that with the inclusion of T1 physical activity in the model, the β for depression symptoms 
changed from 0.259 to 0.245. This indicates that when physical activity was included in the 
model, there was a 5.4% reduction in the size of β. However, in a separate regression model 
using physical activity as the dependent variable to assess the association with T1 
cognitive/affective depression symptoms, after adjusting for disease severity and demographic 
covariates, cognitive/affective depression symptom score (t = -0.633, p = 0.528)  was not 
significant. Therefore, a Sobel test of mediation was not performed.  
In summary, these results suggest that even though physical activity is an independent 
predictor of T2 anxiety, it does not account for the association between pre-operative 
depression symptoms and later anxiety.   
6.6.1.4 Mediation models of T2 physical symptoms 
Since sleep is a symptom of depression, the Jenkins score was included in these analyses to 
assess its association with the recovery outcomes. Due to the fact that somatic/affective 
depression symptom scores include item 16 of the BDI, which relates to sleep disturbance, pre-
operative Jenkins scores were only assessed as a potential mediator of the cognitive/affective 
depression symptoms and recovery relationship.  
A regression model was built to assess the contribution of sleep in explaining T2 CROQ 
physical symptoms (Table 6.29). This model shows that T1 sleep was not a significant predictor 
(t = 1.433, p = 0.154) in the model after controlling for baseline depression symptoms and 
demographic and disease severity covariates. The only significant predictor in the final model 
was age (t = 2.048, p = 0.042) with a positive association, such that older participants had 
greater physical symptoms following surgery. The final model accounted for 5.1% (R2 = 0.051) 
of variance in physical symptom scores. 
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TABLE 6.29: MULTIPLE REGRESSION OF T2 PHYSICAL SYMPTOMS ON T1 SLEEP 
Model B SE ß p 
Age 0.120 0.058 0.215 0.042 
Sex 0.605 1.242 0.038 0.627 
Household income -0.041 0.278 -0.011 0.883 
euroSCORE -0.234 0.176 -0.144 0.185 
T1 BDI total score 0.100 0.069 0.121 0.150 
T1 Sleep 0.073 0.059 0.099 0.222 
R
2
 = 0.051; N = 196 
 
Interestingly, using the cognitive/affective depression symptom score in the models 
did not change the results, with sleep still failing to predict T2 CROQ physical symptoms, with 
older age (t = 2.104, p = 0.037) being the only significant predictor in the final model. 
Therefore, contrary to the initial results from the pilot study, sleep was not associated with 
early-term recovery following CABG surgery nor was it a candidate mechanism of the 
cognitive/affective depression symptoms-recovery relationship.  
6.6.1.5 Mediation models of T2 length of post-operative hospital stay 
 
TABLE 6.30: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON T1 SMOKING 
STATUS AND T1 TOTAL BDI SCORE 
Model OR 95% CI p 
Step 1    
Age 1.029 0.973-1.089 0.318 
Sex
a
 2.014 0.705-5.753 0.191 
Household income
b
 0.393 0.196-0.788 0.009 
euroSCORE 1.057 0.902-1.239 0.494 
T1 BDI total 1.071 1.011-1.134 0.020 
Step 2    
Age 1.048 0.987-1.113 0.127 
Sex
a
 1.869 0.634-5.508 0.257 
Household income
b
 0.394 0.193-0.804 0.010 
euroSCORE 1.053 0.895-1.238 0.532 
T1 BDI total 1.067 1.005-1.134 0.034 
T1 Smoking
c
 0.195 0.059-0.645 0.007 
Reference groups are: 
a
male; 
b
 <£20,000/year; 
c
smoker. N = 195. OR: Odds ratio; CI: Confidence interval. 
 
Logistic regression models were built using the hierarchical method in which predictor 
variables were entered in steps, to assess the relative contribution of smoking status to the 
184 
 
depression symptoms-length of post-operative stay relationship. The model using T1 total BDI 
score is displayed in Table 6.30 and shows that depression symptoms (p = 0.020) and 
household income (p = 0.009) were the only significant predictors of length of hospital stay in 
step 1. After adding T1 smoking status into the model, depression symptoms (p = 0.034) and 
household income (p = 0.010) remained significant predictors. In addition, smoking (p = 0.007) 
was also a significant predictor of length of hospital stay after controlling for covariates. The 
final model showed that for every unit increase in total BDI score, there was a 6.7% greater 
odds of having a post-operative hospital stay of greater than one week. In addition, compared 
to smokers, non-smokers had 80.5% reduced odds of an extended post-operative stay. Looking 
at the odds ratio for depression symptoms shows that with the inclusion of T1 smoking status 
in the model, the odds changed from 1.071 to 1.067. This indicates that when smoking was 
included in the model, there was a 5.6% reduction in the size of the odds.  As such, the 
addition of smoking to the model only had a limited effect on the association between 
depression symptoms and longer hospital stays.  
 
TABLE 6.31: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON T1 SMOKING 
STATUS AND T1 SOMATIC/AFFECTIVE BDI SCORE 
Model OR 95% CI p 
Step 1    
Age 1.024 0.969-1.082 0.404 
Sex
a
 1.962 0.685-5.621 0.210 
Household income
b
 0.387 0.193-0.774 0.007 
euroSCORE 1.057 0.901-1.239 0.496 
T1 BDI somatic 1.087 1.005-1.176 0.038 
Step 2    
Age 1.041 0.982-1.104 0.179 
Sex
a
 1.839 0.626-5.407 0.268 
Household income
b
 0.388 0.191-0.789 0.009 
euroSCORE 1.054 0.897-1.239 0.524 
T1 BDI somatic 1.075 0.990-1.167 0.087 
T1 Smoking
c
 0.205 0.062-0.679 0.009 
Reference groups are: 
a
male; 
b
 <£20,000/year; 
c
smoker. N = 195. OR: Odds ratio; CI: Confidence interval. 
 
The models using somatic/affective and cognitive/affective depression symptom 
scores are shown in Table 6.31 and Table 6.32 respectively. Findings are in line with those 
using total BDI scores, whereby smoking status showed a significant relationship with length of 
post-operative stay in the final models. Interestingly, somatic/affective depression symptoms 
(p = 0.087) failed to be significant in the final model, while cognitive/affective depression 
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symptoms (p = 0.012) remained significant. Looking at the odds ratio for somatic/affective 
depression symptoms shows that with the inclusion of T1 smoking status in the model, the 
odds changed from 1.087 to 1.075. This indicates that when smoking was included in the 
model, there was a 13.8% reduction in the size of the odds.  In the cognitive/affective model 
the odds changed from 1.135 to 1.138 suggesting a 2.2% increase with the addition of smoking 
to the model. As such, the addition of smoking status to the model accounted for a moderate 
amount of the association between somatic/affective depression symptoms and longer 
hospital stays, but not the association between cognitive/affective depression symptoms and 
longer hospital stays.  
 
TABLE 6.32: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON T1 SMOKING 
STATUS AND T1 COGNITIVE/AFFECTIVE BDI SCORE 
Model OR 95% CI p 
Step 1    
Age 1.033 0.975-1.093 0.271 
Sex
a
 2.064 0.743-5.736 0.165 
Household income
b
 0.362 0.180-0.725 0.004 
euroSCORE 1.064 0.909-1.246 0.438 
T1 BDI cognitive 1.135 1.031-1.251 0.010 
Step 2    
Age 1.054 0.991-1.121 0.094 
Sex
a
 1.915 0.661-5.549 0.231 
Household income
b
 0.360 0.176-0.736 0.005 
euroSCORE 1.060 0.902-1.245 0.482 
T1 BDI cognitive 1.138 1.029-1.258 0.012 
T1 Smoking
c
 0.178 0.991-1.121 0.005 
Reference groups are: 
a
male; 
b
 <£20,000/year; 
c
smoker. N = 197. OR: Odds ratio; CI: Confidence interval. 
 
6.6.2 Cognitive mechanisms 
6.6.2.1 Descriptive analyses 
Cognitive factors such as neurocognitive function and illness beliefs were discussed in the 
literature review as important to both depression symptoms and cardiac outcomes. Inclusion 
of these factors in mediation models was based on the premise that those participants with 
greater depression symptoms would also be more likely to have poor cognitive function and 
more negative illness perceptions, and this in turn would act to impede the recovery process. 
Cognitive function, as measured by the MoCA, and illness perceptions, as measured by 
the BIPQ, were both considered as cognitive mechanisms of the depression symptoms-
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recovery relationship. Descriptive analyses for these candidate mechanisms are displayed in 
Table 6.33. This table shows the mean score on the MoCA was below the cut-off of 26, with a 
lowest score of 8, ranging to 30, and 42.3% of the sample scoring ≤25. Scores on the individual 
items of the BIPQ are also displayed in Table 6.33. Please note that items 3, 4 and 7 have been 
reverse coded, so higher means reflect a more negative illness perception for all items. 
Individual item scores show that participants held most negative perceptions for the 
consequences of their illness, personal control over their illness and concern for their illness.  
 
TABLE 6.33: T1 COGNITIVE MECHANISMS 
Measure N 
T1 
Mean ± SD 
Cognitive screen (MoCA) 201 25.45±3.36 
Illness perceptions (BIPQ) total 215 35.97±11.24 
Illness perceptions items   
1. Consequences 214 5.76±2.92 
2. Timeline 212 4.45±2.99 
3. Personal control 214 5.96±2.93 
4. Treatment control 214 1.16±1.59 
5. Identity 215 4.92±2.71 
6. Concern 215 7.24±2.72 
7. Understanding 212 1.61±1.96 
8. Emotional response 212 4.80±3.11 
 
6.6.2.2 Associations with depression symptom and recovery variables 
Pearson’s correlation analyses were performed to analyse the association between depression 
symptoms at T1 and the candidate cognitive mechanisms. Results are displayed in Table 6.34 
and show illness perceptions were associated with all subtypes of depression symptoms, while 
MoCA scores were not significantly associated with any of the BDI scores. Independent t-tests 
confirmed the difference between depressed/non-depressed participants (BDI ≥13) on illness 
perceptions (t(210) = -6.868, p <0.001), and confirmed the lack of difference in cognitive 
function scores on the MoCA (t(195) = 0.111, p = 0.912).  
Next, Pearson’s correlation analyses were performed to assess the association of the 
cognitive measures with the T2 recovery outcomes. These correlations are displayed in Table 
6.35 and show that illness perceptions, but not cognitive function, were significantly 
associated with the recovery outcomes: anxiety, affective pain and physical symptoms. The 
relationship between illness perceptions and length of hospital stay approached statistical 
significance (p = 0.056). The null findings for the MoCA were also confirmed in regression 
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models controlling for covariates.  As such, illness perception score was the only cognitive 
mechanism that was tested for mediation of the depression symptoms-early-term recovery 
relationship.  
 
TABLE 6.34: PEARSON’S CORRELATIONS BETWEEN T1 COGNITIVE MECHANISMS AND T1 
DEPRESSION 
Cognition  T1 BDI 
T1 BDI 
somatic 
T1 BDI 
cognitive 
T1 Cognitive function (MoCA) 
r 
p 
 
-0.002 
0.974 
 
-0.002 
0.982 
 
0049 
0.489 
T1 Illness perceptions (BIPQ) 
r 
p 
 
0.484 
<0.001 
 
0.515 
<0.001 
 
0.414 
<0.001 
 
 
TABLE 6.35: PEARSON’S CORRELATIONS BETWEEN T1 COGNITIVE MECHANISMS AND T2 
RECOVERY OUTCOMES 
Cognition  
T2 Anxiety 
(HADS) 
T2 Affective 
pain 
T2 Physical 
symptoms 
(CROQ) 
T2 Length of 
post-CABG 
stay (binary) 
T1 Cognitive function  
r 
p 
 
-0.030 
0.673 
 
-0.085 
0.234 
 
-0.067 
0.346 
 
-0.103 
0.149 
T1 Illness perceptions 
r 
p 
 
0.339 
<0.001 
 
0.149 
0.029 
 
0.228 
0.001 
 
0.132 
0.056 
 
6.6.2.3 Mediation models of T2 emotional distress 
A regression model was built using the hierarchical method in which predictor variables were 
entered in steps, to assess the relative contribution of illness perceptions to the depression 
symptoms-T2 anxiety relationship (Table 6.36). The model shows that T1 anxiety (t = 3.855, p 
<0.001) and total BDI score (t = 2.249, p = 0.026) were the only significant predictors of T2 
anxiety in step 1 adjusted for covariates. After adding T1 illness perceptions to the model, 
depression symptoms no longer remained a significant predictor (t = 1.709, p = 0.089). The 
only significant predictors in the final model were male sex (t = -1.990, p = 0.048), T1 anxiety (t 
= 2.754, p = 0.006) and T1 illness perceptions (t = 2.478, p = 0.014), both with a positive 
association such that more anxious participants at baseline who also held a more negative 
view of their illness, had greater anxiety following surgery. The final model accounted for 
22.7% (R2 = 0.227) of variance in T2 anxiety scores. Looking at the standardised regression 
188 
 
coefficient (β) for depression symptoms shows that with the inclusion of T1 illness perceptions 
in the model, the β for depression symptoms changed from 0.186 to 0.143. This indicates that 
when illness perceptions were included in the model, there was a 23.1% reduction in the size 
of β.  
    
TABLE 6.36: HIERARCHICAL REGRESSION OF T2 ANXIETY ON T1 ILLNESS PERCEPTIONS AND 
T1 TOTAL BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.017 0.043 0.037 0.701 
Sex -1.725 0.930 -0.133 0.065 
Household income 0.038 0.207 0.012 0.855 
euroSCORE 0.050 0.134 0.037 0.709 
T1 anxiety 0.308 0.080 0.312 <0.001 
T1 BDI total score 0.125 0.056 0.186 0.026 
Step 2     
Age 0.016 0.043 0.036 0.706 
Sex -1.828 0.919 -0.141 0.048 
Household income 0.107 0.206 0.035 0.606 
euroSCORE 0.074 0.133 0.054 0.579 
T1 anxiety 0.233 0.085 0.235 0.006 
T1 BDI total score 0.096 0.056 0.143 0.089 
T1 Illness perceptions 0.070 0.028 0.196 0.014 
Step 1 R
2
 = 0.202; Step 2 R
2
 = 0.227; N = 194 
 
Next, a Sobel test was used on the data. Results are presented in Figure 6.3 with the 
total effect and mediation model confirming the multiple regression models already 
presented. The indirect pathway (pathway ab) was also significant in this model (B = 0.029, SE 
= 0.018, 95% CI = 0.005-0.080), confirming illness perceptions to be a significant mediator in 
this model. Full mediation was shown such that the direct effect, pathway c’, was no longer 
significant after illness perceptions were taken into account.  
Regression analyses were also built for somatic/affective and cognitive/affective 
depression symptoms. The results for somatic/affective depression symptoms are illustrated in 
Figure 6.4 using the Sobel test results, showing a significant total effect (pathway c) for the T1 
somatic/affective depression symptoms and T2 anxiety relationship (B = 0.224, SE = 0.073, p = 
0.002) and a significant direct pathway (pathway c’) (B = 0.180, SE = 0.075, p = 0.018). The 
indirect pathway (pathway ab) was also significant in this model (B = 0.044, SE = 0.024, 95% CI 
= 0.009-0.107), confirming illness perceptions to be a significant mediator in this model. Partial 
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mediation was shown since the direct effect, pathway c’, was still significant after illness 
perceptions were taken into account. 
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MEDIATION MODEL: 
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T1 Total BDI T2 Anxiety 
c 
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FIGURE 6.2: MEDIATION MODEL OF T1 TOTAL BDI SCORE AND T2 ANXIETY THROUGH T1 
ILLNESS PERCEPTIONS 
FIGURE 6.3: MEDIATION MODEL OF T1 SOMATIC/AFFECTIVE BDI SCORE AND T2 ANXIETY 
THROUGH T1 ILLNESS PERCEPTIONS 
T1 Somatic 
BDI 
T2 Anxiety 
c 
B = 0.224 
p = 0.002 
 
T1 Somatic 
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B = 0.718 
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B = 0.180 
p = 0.018 
 
B = 0.062 
p = 0.033 
 a b 
c' 
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TABLE 6.37: HIERARCHICAL REGRESSION OF T2 ANXIETY AND T1 ILLNESS PERCEPTIONS 
AND T1 COGNITIVE/AFFECTIVE DEPRESSION BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.017 0.043 0.038 0.693 
Sex -1.478 0.904 -0.116 0.104 
Household income -0.000 0.206 0.000 1.000 
euroSCORE 0.056 0.133 0.041 0.676 
T1 anxiety 0.330 0.080 0.334 <0.001 
T1 BDI cognitive 0.178 0.096 0.156 0.065 
Step 2     
Age 0.017 0.043 0.038 0.687 
Sex -1.657 0.892 -0.130 0.065 
Household income 0.076 0.205 0.025 0.710 
euroSCORE 0.081 0.132 0.060 0.540 
T1 anxiety 0.239 0.086 0.242 0.006 
T1 BDI cognitive 0.152 0.095 0.133 0.111 
T1 Illness perceptions 0.074 0.028 0.206 0.008 
Step 1 R
2
 = 0.198; Step 2 R
2
 = 0.227; N = 196 
 
The cognitive/affective depression symptoms regression model is displayed in Table 
6.37 and shows that T1 anxiety (t = 4.115, p <0.001) was the only significant predictor of T2 
anxiety in step 1 adjusted for covariates. After adding T1 illness perceptions into the model, 
the only significant predictors in the final model were T1 anxiety (t = 2.783, p = 0.006) and T1 
illness perceptions (t = 2.669, p = 0.008), both with a positive association such that more 
anxious participants at baseline who held a more negative view of their illness, had greater 
anxiety following surgery. The final model accounted for 22.7% (R2 = 0.227) of variance in T2 
anxiety scores. However, since cognitive/affective depression symptoms were not a significant 
predictor in this model, a Sobel test of mediation was not performed.  
In addition, in order to see whether any one illness perception was best associated 
with T2 anxiety, individual items on the BIPQ were entered into regression models to predict 
T2 anxiety, controlling for the demographic and disease severity covariates, baseline anxiety 
and T1 depression symptoms symptom score. In models using total BDI depression symptom 
score, the illness perceptions of consequences (t = 2.378, p = 0.018), concern (t = 3.744, p 
<0.001) and emotional response (t = 4.541, p <0.001) were the only significant illness 
perception predictors in the models. In models using somatic/affective depression symptom 
scores, again concern (t = 3.606, p <0.001) and emotional response (t = 4.363, p <0.001) were 
the only significant illness perception predictors in the models. In models using 
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cognitive/affective depression symptom scores, consequences (t = 2.217, p = 0.028), concern (t 
= 4.012, p <0.001) and emotional response (t = 4.755, p <0.001) were the only significant 
illness perception predictors. In summary, consequences, concern and emotional response 
were the only significant illness perception predictors of T2 anxiety. This suggests that those 
participants who felt their illness would have more severe consequences and were most 
emotionally distressed about their illness prior to surgery were more likely to have greater 
anxiety in the days following CABG.  
6.6.2.4 Mediation models of T2 physical symptoms 
Affective pain 
A regression model was built using the hierarchical method in which predictor variables were 
entered in steps, to assess the relative contribution of illness perceptions to the depression 
symptoms-affective pain relationship (Table 6.38). The model shows that T1 total BDI score 
was the only significant predictor of T2 physical symptoms in step 1 after controlling for 
demographic and disease severity (t = 1.995, p = 0.047). However, after adding T1 illness 
perceptions to the model, depression symptoms were no longer a significant predictor (t = 
1.008, p = 0.315). In addition, illness perception score (t = 1.786, p = 0.076), was also non-
significant in the model. The final model accounted for 4.5% (R2 = 0.045) of variance in T2 
affective pain scores. Looking at the standardised regression coefficient (β) for depression 
symptoms shows that with the inclusion of T1 illness perceptions in the model, the β for 
depression symptoms changed from 0.148 to 0.083. This indicates that when illness 
perceptions were included in the model, there was a 43.9% reduction in the size of β.  
However, since illness perceptions were not a significant predictor in this model, a Sobel test 
was not performed.  
The same regression analyses were also run using somatic/affective and cognitive 
affective depression symptom scores, finding the same pattern of results, such that neither 
depression symptom score (somatic/affective model: t = 1.054, p = 0.293; cognitive/affective 
model: t = 1.101, p = 0.272) nor illness perceptions (somatic/affective model: t = 1.673, p = 
0.096; cognitive/affective model: t = 1.887, p = 0.061) were significant predictors of T2 
affective pain in the final models. Since illness perceptions were not a significant predictor in 
these models, Sobel tests of mediation were not performed.  
Despite total illness perceptions not mediating the depression symptoms-affective 
pain relationship, in order to see whether individual baseline illness perceptions were 
associated with pain, individual items on the BIPQ were entered into regression models to 
predict T2 affective pain, controlling for the demographic and disease severity covariates and 
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T1 depression symptoms symptom score. In models using total BDI depression symptom score, 
the illness perceptions of consequences (t = 2.001, p = 0.047) and emotional response (t = 
2.131, p = 0.034) were the only significant illness perceptions predictors in the models. In 
models using somatic/affective depression symptom scores, only emotional response (t = 
2.086, p = 0.038) was a significant illness perception predictor. In models using 
cognitive/affective depression symptom scores, both consequences (t = 2.146, p = 0.033) and 
emotional response (t = 2.217, p = 0.028) were significant illness perception predictors. In 
summary, consequences and emotional response were the only significant individual illness 
perception predictors of T2 affective pain. This suggests that those participants who viewed 
their illness as having more severe consequences and were most emotionally distressed about 
their illness prior to surgery, were more likely to have greater affective pain in the days 
following CABG. 
 
TABLE 6.38: HIERARCHICAL REGRESSION OF T2 AFFECTIVE PAIN ON T1 ILLNESS 
PERCEPTIONS AND T1 TOTAL BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.002 0.024 0.009 0.932 
Sex -0.574 0.506 -0.088 0.257 
Household income 0.077 0.113 0.051 0.495 
euroSCORE 0.055 0.072 0.083 0.445 
T1 BDI total score 0.050 0.025 0.148 0.047 
Step 2     
Age 0.002 0.023 0.010 0.923 
Sex -0.597 0.503 -0.092 0.236 
Household income 0.106 0.113 0.070 0.350 
euroSCORE 0.063 0.071 0.095 0.382 
T1 BDI total score 0.028 0.028 0.083 0.315 
T1 Illness perceptions 0.026 0.015 0.145 0.076 
Step 1 R
2
 = 0.029; Step 2 R
2
 = 0.045; N = 196 
 
CROQ physical symptoms 
A regression model was built using the hierarchical method in which predictor variables were 
entered in steps, to assess the relative contribution of illness perceptions to the depression 
symptoms-physical symptom relationship (Table 6.39). The model shows that T1 total BDI 
score (t = 2.279, p = 0.024) and age (t = 2.464, p = 0.015) were the only significant predictors of 
T2 physical symptoms in step 1. However, after adding T1 illness perceptions to the model, 
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depression symptoms were no longer significant (t = 0.888, p = 0.376). The only significant 
predictors in the final model were age (t = 2.520, p = 0.013) and illness perceptions (t = 2.668, 
p = 0.008), both with a positive association such that older participants with a more negative 
view of their illness had greater physical symptoms following surgery. The final model 
accounted for 8.5% (R2 = 0.085) of variance in physical symptom scores. Looking at the 
standardised regression coefficient (β) for depression symptoms shows that with the inclusion 
of T1 illness perceptions in the model, the β for depression symptoms changed from 0.167 to 
0.071. This indicates that when illness perceptions were included in the model, there was a 
57.5% reduction in the size of β.   
 
TABLE 6.39: HIERARCHICAL REGRESSION OF T2 PHYSICAL SYMPTOMS ON T1 ILLNESS 
PERCEPTIONS AND T1 TOTAL BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.147 0.060 0.257 0.015 
Sex 0.340 1.279 0.020 0.791 
Household income -0.143 0.285 -0.037 0.616 
euroSCORE -0.264 0.181 -0.156 0.148 
T1 BDI total score 0.144 0.063 0.167 0.024 
Step 2     
Age 0.148 0.059 0.259 0.013 
Sex 0.254 1.259 0.015 0.841 
Household income -0.035 0.283 -0.009 0.901 
euroSCORE -0.235 0.179 -0.139 0.191 
T1 BDI total score 0.061 0.069 0.071 0.376 
T1 Illness perceptions 0.097 0.036 0.212 0.008 
Step 1 R
2
 = 0.051; Step 2 R
2
 = 0.085; N = 197 
 
Next, a Sobel test was used on the data. The model included T1 total BDI score as the 
independent variable and T2 CROQ physical symptoms as the dependent variable, with illness 
perceptions entered as the mediator. Covariates included age, sex, household income and 
euroSCORE. The results are illustrated in Figure 6.5, showing a significant total effect (pathway 
c) for the T1 total BDI depression symptoms and T2 CROQ physical symptoms relationship (B = 
0.144, SE = 0.063, p = 0.024). However, the direct pathway (pathway c’) (B = 0.062, SE = 0.069, 
p = 0.376) was not significant after taking the mediator into account. The indirect pathway 
(pathway ab) was significant in this model (B = 0.082, SE = 0.032, 95% CI = 0.019-0.169), 
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confirming illness perceptions to be a significant mediator. Full mediation was shown since the 
direct effect, pathway c’, was not significant after illness perceptions were taken into account. 
 
TOTAL EFFECT: 
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FIGURE 6.5: MEDIATION MODEL OF T1 SOMATIC/AFFECTIVE BDI SCORE AND T2 
PHYSICAL SYMPTOMS THROUGH T1 ILLNESS PERCEPTIONS 
FIGURE 6.4: MEDIATION MODEL OF T1 TOTAL BDI SCORE AND T2 PHYSICAL SYMPTOMS 
THROUGH T1 ILLNESS PERCEPTIONS 
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Sobel tests of mediation were also performed for somatic/affective and 
cognitive/affective depression symptom scores, using the same covariates. The results for 
somatic/affective depression symptoms are illustrated in Figure 6.6, showing a significant total 
effect (pathway c) for the T1 somatic/affective depression symptoms and T2 CROQ physical 
symptom relationship (B = 0.226, SE = 0.085, p = 0.008). However, the direct pathway 
(pathway c’) (B = 0.113, SE = 0.096, p = 0.237) was not significant after taking the mediator into 
account. The indirect pathway (pathway ab) was significant in this model (B = 0.112, SE = 
0.052, 95% CI = 0.023-0.226), confirming illness perceptions to be a significant mediator. Full 
mediation was shown since the direct effect, pathway c’, was not significant after illness 
perceptions were taken into account. 
The results for cognitive/affective depression symptoms are illustrated in Figure 6.7, 
showing a significant total effect (pathway c) for the T1 cognitive/affective depression 
symptoms and T2 CROQ physical symptom relationship (B = 0.266, SE = 0.107, p = 0.014). 
However, the direct pathway (pathway c’) (B = 0.153, SE = 0.114, p = 0.180) was not significant 
after taking the mediator into account. The indirect pathway (pathway ab) was significant in 
this model (B = 0.112, SE = 0.055, 95% CI = 0.029-0.250), confirming illness perceptions to be a 
significant mediator. Full mediation was shown since the direct effect, pathway c’, was not 
significant after illness perceptions were taken into account. 
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FIGURE 6.6: MEDIATION MODEL OF T1 COGNITIVE/AFFECTIVE BDI SCORE AND T2 
PHYSICAL SYMPTOMS THROUGH T1 ILLNESS PERCEPTIONS 
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In addition, in order to see whether any one illness perception was best associated 
with T2 CROQ physical symptoms, individual items on the BIPQ were entered into regression 
models to predict T2 physical symptoms, controlling for the demographic and disease severity 
covariates and depression symptoms symptom scores. In models using total BDI depression 
symptom score, the illness perceptions of concern (t = 2.799, p = 0.006) and emotional 
response (t = 3.064, p = 0.003) were the only significant illness perceptions predictors in the 
models. In models using somatic/affective depression symptom scores, again concern (t = 
2.698, p = 0.008) and emotional response (t = 2.902, p = 0.004) were the only significant illness 
perception predictors in the models. In models using cognitive/affective depression symptom 
scores, the same findings were found such that concern (t = 2.816, p = 0.005) and emotional 
response (t = 2.976, p = 0.003) were the only significant illness perception predictors. In 
summary, concern and emotional response were the only significant illness perception 
predictors of T2 physical symptoms. This suggests that those participants who were most 
emotionally distressed about their illness prior to surgery were more likely to have greater 
physical symptoms in the days following CABG surgery. 
6.6.2.5 Mediation models of T2 length of post-operative hospital stay 
Logistic regression models were built using the hierarchical method in which predictor 
variables were entered in steps, to assess the relative contribution of illness perceptions to the 
depression symptoms-length of post-operative stay relationship. The model using T1 total BDI 
score is displayed in Table 6.40 and shows that depression symptoms (p = 0.016) and 
household income (p = 0.011) were the only significant predictors of length of hospital stay in 
step 1. Moreover, after adding T1 illness perceptions into the model, depression symptoms (p 
= 0.048) and household income (p = 0.012) remained significant predictors. Illness perceptions 
(p = 0.667) were not a significant predictor of length of hospital stay after controlling for 
covariates. The final model showed that for every unit increase in total BDI score, there was a 
6.6% greater odds of having a post-operative hospital stay of greater than one week. Looking 
at the odds ratio for depression symptoms shows that with the inclusion of T1 illness 
perceptions in the model, the odds changed from 1.073 to 1.066. This indicates that when 
illness perceptions were included in the model, there was a 9.6% reduction in the size of the 
odds.  As such, the addition of illness perceptions to the model accounted for a moderate 
amount of the association between depression symptoms and longer hospital stays. 
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TABLE 6.40: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON T1 ILLNESS 
PERCEPTIONS AND T1 TOTAL BDI SCORE  
Model OR 95% CI p 
Step 1    
Age 1.030 0.974-1.090 0.298 
Sex
a
 2.048 0.717-5.850 0.181 
Household income
b
 0.405 0.202-0.811 0.011 
euroSCORE 1.056 0.901-1.238 0.499 
T1 BDI total 1.073 1.013-1.136 0.016 
Step 2    
Age 1.030 0.974-1.089 0.301 
Sex
a
 2.029 0.711-5.788 0.186 
Household income
b
 0.409 0.204-0.819 0.012 
euroSCORE 1.059 0.903-1.242 0.477 
T1 BDI total 1.066 1.001-1.137 0.048 
T1 Illness perceptions 1.007 0.974-1.042 0.667 
Reference groups are: 
a
male; 
b
 <£20,000/year. N = 197. 
 
TABLE 6.41: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON T1 ILLNESS 
PERCEPTIONS AND T1 SOMATIC/AFFECTIVE BDI SCORE  
Model OR 95% CI p 
Step 1    
Age 1.025 0.970-1.083 0.381 
Sex
a
 1.992 0.695-5.707 0.200 
Household income
b
 0.398 0.199-0.795 0.009 
euroSCORE 1.056 0.901-1.238 0.502 
T1 BDI somatic 1.091 1.008-1.180 0.030 
Step 2    
Age 1.025 0.970-1.083 0.380 
Sex
a
 1.984 0.694-5.669 0.201 
Household income
b
 0.403 0.201-0.806 0.010 
euroSCORE 1.060 0.903-1.243 0.477 
T1 BDI somatic 1.080 0.987-1.182 0.095 
T1 Illness perceptions 1.008 0.973-1.044 0.658 
Reference groups are: 
a
male; 
b
 <£20,000/year. N = 197. 
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TABLE 6.42: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON T1 ILLNESS 
PERCEPTIONS AND T1 COGNITIVE/AFFECTIVE BDI SCORE 
Model OR 95% CI p 
Step 1    
Age 1.034 0.977-1.095 0.250 
Sex
a
 2.104 0.758-5.844 0.153 
Household income
b
 0.372 0.185-0.745 0.005 
euroSCORE 1.064 0.909-1.246 0.442 
T1 BDI cognitive 1.139 1.034-1.255 0.008 
Step 2    
Age 1.034 0.976-1.094 0.256 
Sex
a
 2.061 0.740-5.740 0.166 
Household income
b
 0.377 0.187-0.756 0.006 
euroSCORE 1.067 0.911-1.250 0.422 
T1 BDI cognitive 1.129 1.018-1.253 0.022 
T1 Illness perceptions 1.007 0.975-1.041 0.659 
Reference groups are: 
a
male; 
b
 <£20,000/year. N = 199. 
 
The models using somatic/affective and cognitive/affective depression symptom 
scores are shown in Table 6.41 and Table 6.42 respectively. Findings are in line with those 
using total BDI scores, with illness perceptions failing to show a significant relationship with 
length of post-operative stay in the final models. Interestingly, somatic/affective depression 
symptoms (p = 0.095) failed to be significant in the final model, while cognitive/affective 
depression symptoms (p = 0.022) remained significant. Looking at the odds ratio for 
somatic/affective depression symptoms shows that with the inclusion of T1 illness perceptions 
in the model, the odds changed from 1.091 to 1.080. This indicates that when illness 
perceptions were included in the model, there was a 12.1% reduction in the size of the odds. 
In the cognitive/affective model the odds changed from 1.139 to 1.129 suggesting a 7.2% 
reduction in odds with the addition of illness perceptions to the model. As such, the addition 
of illness perceptions to the accounted for a moderate amount of the association between 
depression symptoms and longer hospital stays.  
Despite the lack of association between total illness perception scores and length of 
hospital stay, the individual illness perceptions were entered into regression models 
controlling for demographic, disease severity and depression symptom score variables. 
Interestingly, none of the individual illness perceptions were able to predict length of hospital 
stay. 
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6.6.3 Biological mechanisms - Cortisol 
6.6.3.1 Descriptive statistics 
Biological mechanisms that were tested in this PhD include the neuroendocrine hormone, 
cortisol. Descriptive statistics for the non-transformed data for cortisol are displayed in Table 
6.43. Missing cortisol data was due to some participants declining to provide samples and 
some outliers being removed. Figure 6.8 represents the mean cortisol data at the seven 
measurement points for participants across the course of the day, showing a peak in cortisol at 
30 minutes after waking and a gradual decline throughout the rest of the day.   
Use of pre-operative cardiac medication, including aspirin, beta-blockers, statins and 
antiplatelets, was not associated with T1 cortisol responses; multiple regression models 
supported these findings. Therefore, the regression models shown in the following sections 
adjust for the demographic and disease severity covariates only.  
 
TABLE 6.43: T1 CORTISOL NON-TRANSFORMED DATA 
Cortisol (nmol/l) N Minimum Maximum Mean ± SD 
Waking 202 1.36 60.95 20.11±10.08 
Waking + 30 minutes 204 1.67 71.32 24.67±11.95 
10:00am 203 0.54 55.76 13.18±7.34 
12:00noon 204 0.33 37.02 9.59±5.24 
4:00 pm 206 0.55 22.38 6.49±3.22 
8:00 pm 206 0.38 35.56 4.65±4.22 
Bedtime 202 0.58 24.09 3.75±3.25 
Slope 207 -0.06 0.07 0.02±0.01 
CAR  208 -22.57 43.87 5.18±11.37 
AUC 189 3644.24 20436.73 8988.54±2917.62 
Waking-bedtime difference 196 -2.68 53.26 16.58±9.83 
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FIGURE 6.8: T1 MEAN SALIVARY CORTISOL ACROSS THE DAY  
N.B. Bars represent standard error of the means. 
 
6.6.3.2 Associations with depression symptoms and recovery variables 
 
TABLE 6.44: T1 CORTISOL BY T1 DEPRESSION CASENESS  
Cortisol (nmol/l) 
T1 
Depression 
symptom 
score 
N Mean ± SD t p 
T1 AUC  
<13 
≥13 
153 
33 
8773.83±2823.22 
10055.34±3261.80 
-2.299 0.023 
T1 Waking-bedtime 
difference  
<13 
≥13 
159 
34 
16.81±10.08 
15.24±8.96 
0.840 0.402 
T1 CAR  
<13 
≥13 
118 
18 
4.23±11.65 
7.45±14.01 
-1.064 0.289 
T1 Cortisol slope 
<13 
≥13 
168 
36 
0.02±0.01 
0.02±0.01 
0.516 0.607 
 
 
Pearson’s correlation analyses were performed to assess the relationship between the 
different cortisol scores (CAR, AUC, slope, waking-bedtime difference) and depression 
symptom scores and T2 recovery outcomes. Results showed AUC (r = 0.172, p = 0.019) was 
significantly correlated with depression symptoms caseness (BDI ≥13). The positive correlation 
coefficient for AUC suggests the presence of depression symptoms is associated with a higher 
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cortisol output across the day. No other significant correlations were found between cortisol 
and the predictor and outcome measures. These null findings were also confirmed in 
regression models controlling for covariates.    
 
 
FIGURE 6.9: T1 CORTISOL ACROSS THE DAY BY T1 DEPRESSION CASENESS 
Bars represent standard error of the means. 
 
To investigate this significant finding further, independent t-tests were also performed 
to examine the difference in cortisol measures between non-depressed and depressed 
participants (BDI≥13). Results from these analyses are displayed in Table 6.44, confirming the 
significant difference between depression symptoms groups in terms of the AUC (p = 0.023). 
The cortisol output over the day is represented in Figure 6.9, illustrating the fact that 
depressed participants had a larger total cortisol output (AUC) over the day then non-
depressed participants prior to surgery. This graph shows the 10am (t(198)= -2.025, p = 0.044) 
cortisol sample was higher in the depressed participants, suggesting a slower decline through 
the day. 
A multiple regression (Table 6.45) was also performed to examine the association 
between caseness on the BDI (t = 2.832, p = 0.005) and T1 cortisol AUC, showing a significant 
result after controlling for covariates. These results suggest that the difference in total cortisol 
output across the day between depressed and non-depressed participants was not accounted 
for by differences in demographic or disease severity covariates. In total, this model accounted 
for 8.3% (R2 = 0.083) of variance in cortisol AUC scores.  
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TABLE 6.45: MULTIPLE REGRESSION OF T1 CORTISOL AUC ON T1 DEPRESSION CASENESS 
Model B SE ß p 
Age 26.089 34.216 0.081 0.447 
Sex -1040.670 805.212 -0.103 0.198 
Household income 306.356 172.254 0.139 0.077 
euroSCORE 131.365 106.293 0.136 0.218 
T1 BDI caseness 1694.841 598.488 0.214 0.005 
R
2
 = 0.083, N = 172 
 
TABLE 6.46: PEARSON’S CORRELATIONS BETWEEN T1 CORTISOL AND T2 RECOVERY 
OUTCOMES 
Cortisol (nmol/l) 
T2 Anxiety 
(HADS) 
T2 Affective 
pain 
T2 Physical 
symptoms 
(CROQ) 
T2 Length of 
post-CABG 
stay (binary) 
T1 AUC  
r 
p 
0.099 
0.175 
0.018 
0.805 
-0.135 
0.064 
-0.023 
0.754 
T1 Waking-bedtime difference 
 r 
p 
0.005 
0.940 
0.025 
0.730 
-0.038 
0.596 
-0.077 
0.286 
T1 CAR  
r 
p 
-0.097 
0.256 
-0.125 
0.141 
0.100 
0.241 
0.023 
0.790 
T1 Cortisol slope 
 r 
p 
0.045 
0.518 
0.043 
0.537 
-0.020 
0.775 
-0.049 
0.483 
 
Pearson’s correlations were also performed to assess the association between baseline 
cortisol responses and the T2 recovery outcomes. Results for the Pearson’s correlations of 
cortisol with the outcome variables are displayed in Table 6.46. The results show that no 
significant associations were found between any of the cortisol responses and the recovery 
outcomes. These null findings were confirmed in regression models controlling for covariates. 
Since cortisol was not related to any of the recovery outcomes, mediation analyses were not 
performed. 
6.6.4 Biological mechanisms – Inflammatory markers 
6.6.4.1 Descriptive statistics 
The second biological pathway tested in the PhD was the role of inflammation, including the 
inflammatory markers IL-6, hs-CRP and TNF-α. Inflammatory markers were measured both 
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pre-CABG and during the post-surgery hospital stay. Due to the variability in collection day for 
the post-operative bloods, two summary scores were created. The first summary score used 
the mean for the inflammatory marker values on day’s one, two and three post-surgery and 
the second used the mean for the inflammatory marker values on day’s four, five, six, seven 
and eight post-surgery. These scores were termed ‘early’ and ‘late’ T2 bloods.  Change scores 
were also computed by deducting baseline from follow-up values; larger change scores 
indicate a greater response from T1 to T2.  
Use of pre-operative cardiac medication, including aspirin, beta-blockers, statins and 
antiplatelets, was not associated with T1 or T2 early and late inflammatory responses; multiple 
regression models supported these findings. Therefore, the regression models shown in the 
following sections adjust for the demographic and disease severity covariates only.  
 
TABLE 6.47: T1 INFLAMMATORY MARKER NON-TRANSFORMED DATA 
Inflammatory 
marker 
Pair N Mean ± SD t p 
IL-6 (pg/mL) 
T1  
148 
5.37±1.80 
-39.528 <0.001 
T2 Early 207.68±62.49 
T1  
138 
5.16±1.73 
-37.896 <0.001 
T2 Late 97.56±29.01 
T2 Early  
104 
206.26±68.39 
15.750 <0.001 
T2 Late 98.24±26.77 
hs-CRP 
(mg/mL) 
T1  
151 
7.78±7.36 
-16.098 <0.001 
T2 Early 80.65±55.35 
T1  
137 
8.68±9.75 
-11.336 <0.001 
T2 Late 64.69±60.06 
T2 Early  
103 
81.60±59.10 
3.596 0.001 
T2 Late 60.97±54.23 
TNF-α (pg/mL) 
T1  
151 
5.81±2.73 
-1.100 0.273 
T2 Early 6.14±2.65 
T1 
139 
5.74±2.77 
-0.840 0.402 
T2 Early  6.03±2.63 
T2 Early 
104 
6.26±2.70 
-0.167 0.868 
T2 Late 6.33±2.76 
 
 
Paired samples t-tests to assess change in the inflammatory markers over time are 
shown in Table 6.47. Data show that for IL-6 and hs-CRP there was a significant increase from 
T1 to T2, for both early and late samples. In addition, there was a significant decrease from T2 
early to T2 late samples for these inflammatory markers. The TNF-α data reveals that no 
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significant changes occurred over time. The change in each of the inflammatory markers across 
time is also represented in Figure 6.10 illustrating the fact that IL-6 displayed the greatest 
increase from baseline to T2 early, compared to both CRP and TNF-α. At four to eight days 
following surgery, both IL-6 and CRP had not returned to baseline levels, suggesting a 
persistent heightened inflammatory response for these markers following surgery. In addition, 
the graph also shows how TNF-α was comparatively stable over time, with no change from 
pre- to post-surgery.  
 
 
 
FIGURE 6.10: INFLAMMATORY MARKERS FROM PRE- TO POST-SURGERY  
Bars represent standard error of the means. N.B. Standard errors of the mean for TNF-α are not 
perceptible on this graph but are: 0.19, 0.20, and 0.22 at T1, T2 early and T2 late respectively.  
 
6.6.4.2 Associations with depression symptom variables 
Pearson’s correlation analyses were first performed to assess the relationship between the 
different inflammatory markers (IL-6, hs-CRP, TNF-α) and depression symptom scores. Results 
showed that baseline IL-6 was significantly associated with cognitive/affective depression 
symptoms (r = 0.152, p = 0.030); however after being entered into a regression model 
controlling for covariates, baseline IL-6 (t = 0.513, p = 0.609) was no longer significant.  The 
results from the correlation analyses found all the other inflammatory marker variables were 
not related to T1 depression symptoms.  
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TABLE 6.48: MULTIPLE REGRESSION OF IL-6 T2 EARLY ON T1 TOTAL BDI SCORE 
Model B SE ß p 
Age 1.913 0.943 0.257 0.045 
Sex 36.227 19.174 0.167 0.061 
Household income 0.004 4.173 <0.001 0.999 
euroSCORE -6.377 2.751 -0.305 0.022 
T1 BDI total 2.479 0.940 0.223 0.009 
R
2
 = 0.094, N = 141 
 
TABLE 6.49: MULTIPLE REGRESSION OF IL-6 T2 EARLY ON T1 SOMATIC/AFFECTIVE BDI 
SCORE  
Model B SE ß p 
Age 1.749 0.943 0.235 0.066 
Sex 34.938 19.376 0.161 0.074 
Household income -0.482 4.189 -0.010 0.908 
euroSCORE -6.369 2.771 -0.304 0.023 
T1 BDI somatic 2.859 1.280 0.188 0.027 
R
2
 = 0.081, N = 141 
 
 
TABLE 6.50: MULTIPLE REGRESSION OF IL-6 T2 EARLY ON T1 COGNITIVE/AFFECTIVE BDI 
SCORE  
Model B SE ß p 
Age 1.891 0.932 0.254 0.045 
Sex 41.223 18.351 0.195 0.026 
Household income -0.585 4.121 -0.012 0.887 
euroSCORE -6.135 2.715 -0.292 0.025 
T1 BDI cognitive 4.159 1.567 0.224 0.009 
R
2
 = 0.096, N = 143 
 
Next, regression analyses were performed to assess whether depression symptoms 
predicted the inflammatory markers after controlling for covariates. The results of the multiple 
regression model using total BDI depression symptom score are displayed in Table 6.48 
showing pre-operative depression symptoms (t = 2.637, p = 0.009) were a significant predictor 
of having a higher mean T2 early IL-6 response. The only other significant predictors in this 
model were age (t = 2.027, p = 0.045) and euroSCORE (t = -2.318, p = 0.022), such that older 
age and a lower euroSCORE value, or in other words a lower mortality risk, predicted greater 
IL-6 responses. This latter finding is counterintuitive and difficult to interpret, but is a result 
that was replicated for both the somatic/affective and cognitive/affective depression 
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symptoms models (see Table 6.49 and Table 6.50). These models also confirmed depression 
symptoms (somatic/affective: t = 2.233, p = 0.027; cognitive/affective: t = 2.654, p = 0.009) 
were a significant predictor of T2 early IL-6 response.  
Figure 6.11 illustrates the change in IL-6 over time according to depression status (BDI 
≥13). This graph shows there was no difference between depressed and non-depressed 
participants at baseline or four to eight days following CABG surgery. However, in the early 
term following surgery (T2 early) the depressed participants showed a greater IL-6 response 
compared to their non-depressed counterparts. This did not reach statistical significance in an 
independent t-test (t(154) = -1.431, p = 0.154), but illustrates the trend demonstrated using 
the continuous scores on the BDI in the covariate adjusted regression models.  
 
 
 
FIGURE 6.11: CHANGE IN IL-6 OVER TIME BY T1 DEPRESSION CASENESS 
Bars represent standard error of the means. 
 
Multiple regression analyses also showed that total BDI depression symptom score (t = 
2.478, p = 0.015) was a significant predictor of having a higher change in IL-6 from T1 to T2 
early (Table 6.51). There were no other significant predictors in this model. This finding was 
replicated for both the somatic/affective and cognitive/affective depression symptom models, 
such that depression symptoms (somatic/affective: t = 2.083, p = 0.039; cognitive/affective: t = 
2.475, p = 0.015) were the only significant predictor of change in IL-6 response. 
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TABLE 6.51: MULTIPLE REGRESSION OF CHANGE IN IL-6 (T1 TO T2 EARLY) ON T1 TOTAL BDI 
SCORE 
Model B SE ß p 
Age 1.716 0.969 0.238 0.079 
Sex 34.642 20.267 0.158 0.090 
Household income 1.077 4.191 0.023 0.798 
euroSCORE -4.671 2.827 -0.231 0.101 
T1 BDI total 2.378 0.959 0.219 0.015 
R
2
 = 0.077, N = 132 
 
6.6.4.3 Associations with recovery variables 
Next, Pearson’s correlations were performed to assess the association between inflammatory 
markers and the T2 recovery outcomes. Results for the Pearson’s correlations of inflammatory 
markers with the outcome variables are displayed in Table 6.52. Please note that since no 
significant findings were observed between TNF-α and the recovery outcomes, the results are 
not displayed. This table shows that the mean T2 late IL-6 response was significantly 
associated with length of hospital stay (p = 0.005); this result was negative such that a lower 
response was associated with a stay of more than a week. This negative association was 
confirmed in change in IL-6 from T1 to T2 late samples (p = 0.011), again suggesting a smaller 
response was related to a longer hospital stay. In terms of the CRP response, hs-CRP at 
baseline was positively associated with anxiety at T2 (p = 0.018) and affective pain at T2 (p = 
0.020), indicating a greater CRP level prior to surgery was related to poorer recovery after 
surgery. In addition, a higher T2 late hs-CRP level was associated with a longer hospital stay (p 
<0.001), and a greater change in hs-CRP was associated with a longer hospital stay (p <0.001).   
Since none of the inflammatory markers correlating with the outcomes also correlated 
with depression, mediation analyses were not performed. However, each of these associations 
was further examined using regression models, controlling for demographic, disease severity 
and depression symptom covariates. These results are described in turn below. Regression 
analyses were also built for TNF-α, but no significant findings were found.  
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TABLE 6.52: PEARSON’S CORRELATIONS BETWEEN INFLAMMATORY MARKERS AND T2 
RECOVERY OUTCOMES 
Inflammatory marker 
T2 Anxiety 
(HADS) 
T2 Affective 
pain 
T2 Physical 
symptoms 
(CROQ) 
T2 Length of 
post-CABG 
stay (binary) 
IL-6 (pg/mL)     
T1 IL-6  
r 
p 
-0.046 
0.512 
-0.073 
0.299 
-0.047 
0.503 
-0.118 
0.096 
T2 IL-6 Early 
r 
p 
0.121 
0.130 
0.098 
0.222 
0.073 
0.361 
0.026 
0.752 
T2 IL-6 Late 
r 
p 
0.084 
0.313 
0.114 
0.171 
0.084 
0.313 
-0.235
 
0.005 
IL-6 Change T1 – T2 early  
r 
p 
0.102 
0.216 
0.088 
0.286 
0.072 
0.387 
0.014 
0.869 
IL-6 Change T1 – T2 late  
r 
p 
0.077 
0.368 
0.110 
0.201 
0.063 
0.463 
-0.219
 
0.011 
hs-CRP (mg/mL)     
T1 hs-CRP 
r 
p 
0.165
 
0.018 
0.162
 
0.020 
-0.003 
0.967 
0.076 
0.287 
T2 hs-CRP Early 
r 
p 
-0.029 
0.713 
0.094 
0.236 
-0.027 
0.735 
0.105 
0.190 
T2 hs-CRP Late 
r 
p 
0.073 
0.383 
0.119 
0.156 
0.053 
0.530 
0.316
 
<0.001 
hs-CRP Change T1 – T2 early  
r 
p 
-0.079 
0.337 
0.058 
0.484 
-0.039 
0.633 
0.121 
0.144 
hs-CRP Change T1 – T2 late  
r 
p 
0.039 
0.654 
0.118 
0.170 
0.090 
0.296 
0.308
 
<0.001 
 
 
T2 emotional distress outcomes 
A multiple regression model was built to assess the relative contribution of inflammation to T2 
anxiety (Table 6.53). The model shows that T1 anxiety (t = 4.010, p <0.001), T1 total BDI score 
(t = 2.085, p = 0.039) and T1 hs-CRP (t = 2.746, p = 0.007) were significant predictors of T2 
anxiety after adjusting for covariates. All these associations were positive such that more 
anxious and depressed participants at baseline, who had a higher level of CRP, had greater 
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anxiety following surgery. The model accounted for 24.0% (R2 = 0.240) of variance in T2 
anxiety scores. T1 hs-CRP was also a significant predictor of T2 anxiety in models using 
somatic/affective (t = 2.716, p = 0.007) and cognitive/affective (t = 2.695, p = 0.008) depression 
symptoms.  
  
TABLE 6.53: MULTIPLE REGRESSION OF T2 ANXIETY ON T1 HS-CRP AND T1 TOTAL BDI 
SCORE  
Model B SE ß p 
Age 0.002 0.043 0.004 0.964 
Sex -1.723 0.927 -0.134 0.065 
Household income 0.039 0.206 0.013 0.848 
euroSCORE 0.122 0.134 0.091 0.365 
T1 Anxiety 0.318 0.079 0.329 <0.001 
T1 BDI total 0.117 0.056 0.175 0.039 
T1 hs-CRP (mg/mL) 0.078 0.028 0.181 0.007 
R
2
 = 0.240, N = 185 
 
T2 physical symptom outcomes 
 
TABLE 6.54: MULTIPLE REGRESSION OF T2 AFFECTIVE PAIN ON T1 HS-CRP AND T1 TOTAL 
BDI SCORE  
Model B SE ß p 
Age -0.012 0.022 -0.058 0.592 
Sex -0.556 0.484 -0.091 0.252 
Household income 0.041 0.107 0.029 0.704 
euroSCORE 0.091 0.069 0.148 0.186 
T1 BDI total 0.040 0.024 0.127 0.095 
T1 hs-CRP (mg/mL) 0.035 0.015 0.172 0.019 
R
2
 = 0.053, N = 187 
 
A multiple regression model was built to assess the relative contribution of inflammation to T2 
affective pain (Table 6.54). The model shows that T1 hs-CRP (t = 2.357, p = 0.019) was the only 
significant predictor of T2 affective pain after adjusting for covariates. T1 total BDI score (t = 
1.677, p = 0.095) was not a significant predictor in this model. CRP was positively associated 
with pain such that those participants who had a higher level of CRP at baseline also had 
greater affective pain following surgery. The model accounted for 5.3% (R2 = 0.053) of variance 
in T2 affective pain scores. T1 hs-CRP was also a significant predictor of T2 affective pain in 
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models using somatic/affective (t = 2.290, p = 0.023) and cognitive/affective (t = 2.359, p = 
0.019) depression symptoms.   
 
T2 length of post-operative hospital stay outcome 
IL-6 and CRP were both shown in the correlation analyses to relate to length of post-operative 
stay. Logistic regression models were built controlling for demographic and disease severity 
covariates as well as baseline total BDI score. The results using mean T2 late IL-6 scores are 
displayed in Table 6.55 showing that the IL-6 T2 late response was significantly associated with 
length of post-operative hospital stay (p = 0.003) after controlling for covariates. These results 
show that for every unit increase in IL-6, there was a 2.3% reduced odds of having a post-
operative hospital stay of greater than one week. Household income (p = 0.018) and 
depression symptoms (p = 0.003) were the only other significant variables in the model. T2 late 
IL-6 was also significantly associated with of T2 length of hospital stay in models using 
somatic/affective (p = 0.004) and cognitive/affective (p = 0.003) depression. A similar pattern 
of results were also found for change in IL-6 from T1 to T2 late (see Table 6.56), with the 
change being significantly associated with length of post-operative stay after controlling for 
covariates (p = 0.008). These results suggest that for every unit increase in IL-6 change over 
time, there was a 2.1% reduction in the odds of having an extended hospital stay. Change in IL-
6 was also significantly associated with T2 length of hospital stay in models using 
somatic/affective (p = 0.010) and cognitive/affective (p = 0.007) depression symptoms. 
 
TABLE 6.55: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON T2 LATE IL-6 AND 
T1 TOTAL BDI SCORE  
Model OR 95% CI p 
Age 0.987 0.924-1.054 0.689 
Sex
a
 1.568 0.415-5.927 0.508 
Household income
b
 0.355 0.151-0.835 0.018 
euroSCORE 1.190 0.978-1.447 0.082 
T1 BDI total 1.071 1.000-1.148 0.050 
T2 Late IL-6 (pg/mL) 0.977 0.962-0.992 0.003 
Reference groups are: 
a
male; 
b
 <£20,000/year. N = 130. OR: Odds ratio; CI: Confidence interval. 
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TABLE 6.56: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON CHANGE IN IL-6 
(T1 TO T2 LATE) AND T1 TOTAL BDI SCORE 
Model OR 95% CI p 
Age 0.989 0.926-1.056 0.744 
Sex
a
 1.480 0.394-5.560 0.562 
Household income
b
 0.387 0.164-0.913 0.030 
euroSCORE 1.184 0.971-1.445 0.096 
T1 BDI total 1.069 0.998-1.146 0.058 
IL-6 Change T1 - T2 late 
(pg/mL) 
0.979 0.964-0.994 0.008 
Reference groups are: 
a
male; 
b
 <£20,000/year. N = 123. OR: Odds ratio; CI: Confidence interval. 
 
The results of the logistic regression models using mean T2 late hs-CRP scores are 
displayed in Table 6.57 showing that the CRP T2 late response was significantly associated with 
length of post-operative hospital stay (p = 0.002) after controlling for covariates. These results 
show that for every unit increase in CRP, there was a 1.1% greater odds of having a post-
operative hospital stay of greater than one week. No other significant variables were found in 
this model. T2 late hs-CRP was also significantly associated with T2 length of hospital stay in 
models using somatic/affective (p = 0.002) and cognitive/affective (p = 0.001) depression 
symptoms. A similar pattern of results was also found for change in CRP from T1 to T2 late (see 
Table 6.58), with the change being significantly associated with length of post-operative stay 
after controlling for covariates (p = 0.003). Again, these results suggest that for every unit 
decrease in IL-6 change over time, there was a 1.1% increase in the odds of having an 
extended hospital stay. Change in hs-CRP was also significantly associated with T2 length of 
hospital stay in models using somatic/affective (p = 0.003) and cognitive/affective (p = 0.003) 
depression symptoms. 
Due to the inconsistency of the direction of the IL-6 and CRP findings, Pearson’s 
correlations were performed finding that IL-6 and CRP T2 late responses were not significantly 
associated, however IL-6 T2 early was significantly associated with CRP T2 late (r = 0.266, p = 
0.007). This indicates differences with the association between inflammatory markers over 
time. In summary, the late post-operative markers of inflammation were the best 
inflammatory variables to show associations with length of hospital stay, with lower IL-6 values 
and higher CRP being related to the greatest odds of having a post-operative stay of more than 
one week. These associations were cross-sectional, showing inflammatory responses and 
recovery outcomes measured in the days following surgery were closely related.   
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TABLE 6.57: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON T2 LATE HS-CRP 
AND T1 TOTAL BDI  SCORE  
Model OR 95% CI p 
Age 0.997 0.932-1.065 0.924 
Sex
a
 0.988 0.230-4.249 0.987 
Household income
b
 0.420 0.180-0.977 0.044 
euroSCORE 1.157 0.948-1.412 0.153 
T1 BDI total 1.051 0.982-1.125 0.148 
T2 Late hs-CRP 
(mg/mL) 
1.011 1.004-1.018 0.002 
Reference groups are: 
a
male; 
b
 <£20,000/year. N = 129. OR: Odds ratio; CI: Confidence interval. 
 
TABLE 6.58: LOGISTIC REGRESSION OF T2 LENGTH OF HOSPITAL STAY ON CHANGE IN HS-
CRP (T1 TO T2 LATE) AND T1 TOTAL BDI SCORE  
Model OR 95% CI p 
Age 0.998 0.934-1.068 0.965 
Sex
a
 0.933 0.218-3.991 0.926 
Household income
b
 0.479 0.205-1.120 0.089 
euroSCORE 1.155 0.942-1.417 0.165 
T1 BDI total 1.052 0.982-1.127 0.149 
hs-CRP Change T1 - T2 
late (pg/mL) 
1.011 1.004-1.018 0.003 
Reference groups are: 
a
male; 
b
 <£20,000/year. N = 122. OR: Odds ratio; CI: Confidence interval. 
 
6.7 Discussion 
6.7.1 Summary of results 
The table (Table 6.59) displays a summary of the main findings presented in this chapter. Total 
and somatic/affective depression symptoms were related to all the recovery outcomes after 
controlling for covariates. However, cognitive/affective depression symptoms were only 
significantly associated with physical symptoms and length of post-operative hospital stay in 
covariate adjusted models.  
 Health behaviours were of limited importance in predicting recovery outcomes. 
Physical activity was an important predictor of T2 emotional distress, such that participants 
who walked for fewer hours per week prior to CABG were most anxious after surgery. Notably, 
depression symptoms were not related to physical activity and so physical activity had an 
independent effect on anxiety. The other health behaviour that was able to predict recovery 
was smoking status at baseline, which predicted length of post-operative stay. Participants 
who smoked were more likely to have a hospital stay of greater than one week. This effect was 
213 
 
also shown to be independent of depression symptom score, such that depression symptoms 
were not significantly related to smoking status.  
 
TABLE 6.59: SUMMARY OF EARLY-TERM OUTCOME RESULTS 
Main findings using total BDI score Supported using depression symptom models? 
1. Pre-operative total BDI score was able to predict: 
greater anxiety, greater affective pain, greater 
physical symptoms and longer hospital stays at 
T2.  
 Somatic/affective depression symptoms showed 
the same relationship with recovery outcomes. 
 Cognitive/affective depression symptoms were 
only predictive of greater physical symptoms and 
a longer hospital stay.  
2. Baseline physical activity was associated with 
greater anxiety at T2, after adjusting for total BDI 
score. 
 The same finding was found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms.  
3. Baseline smoking was associated with longer 
hospital stays, after adjusting for total BDI score.  
 The same finding was found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
4. Baseline illness perceptions mediated the 
relationship between total BDI score and greater 
anxiety and greater physical symptoms at T2.  
 The same findings were found using 
somatic/affective depression.  
 Using cognitive/affective depression, baseline 
illness perceptions only mediated the relationship 
with greater physical symptoms.  
5. Baseline CRP was associated with greater anxiety 
and greater affective pain at T2, after adjusting 
for total BDI score.  
 The same findings were found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
6. Lower IL-6 responses 4-8 days after surgery and 
a lower change in IL-6 from baseline to 4-8 days 
post-surgery were associated with longer 
hospital stays, after adjusting for total BDI score. 
 The same findings were found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
7. Greater CRP responses 4-8 days after surgery 
were associated with longer hospital stays, after 
adjusting for total BDI score. 
 The same finding was found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
 
Illness perceptions were broadly predictive of the self-reported recovery outcomes, 
but not length of hospital stay. In particular, the specific illness perceptions of consequence, 
concern and emotional representation were the most relevant. These perceptions capture the 
emotional distress element of illness cognitions and so suggest that illness-specific distress 
prior to surgery led to greater anxiety, greater affective pain and greater physical symptoms, 
but not a longer post-operative hospital stay. The relationship between depression symptoms 
and the recovery outcomes was in large part explained by these greater distress perceptions. 
However, the depression symptoms-length of hospital stay relationship was not explained by 
illness perceptions, suggesting that depression symptoms acted independently from illness 
perceptions.  
Baseline levels of cortisol were not significantly related to the recovery outcomes. 
Depressed participants did however have a higher cortisol output over the course of the day, 
but this higher cortisol AUC did not mediate the relationship depression symptoms had with 
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the recovery outcomes. The inflammatory markers also produced interesting results, with 
baseline depression symptoms being significantly related to IL-6 in the days after surgery, such 
that those participants with greater depression symptoms had higher levels of IL-6 shortly 
after surgery. However, in terms of recovery it was the IL-6 and CRP responses that happened 
in the latter part of the post-operative hospital stay that were associated with poorer recovery 
outcomes. These results indicated that those participants who had the lowest IL-6 responses 
and the highest CRP responses four to eight days after surgery had the longest hospital stays 
after surgery. Prospective associations were also shown for baseline CRP and recovery, such 
that higher CRP levels prior to surgery predicted greater anxiety, affective pain and physical 
symptoms scores at T2.  
6.7.2 Analysis of results 
6.7.2.1 Hypothesis 1: Depression symptoms and recovery 
Hypothesis 1 stated that depression symptoms would be associated with impaired adaptation 
following CABG surgery and in particular that pre-operative somatic/affective depression 
symptoms would carry greater risk than no depression symptoms or cognitive/affective 
depression symptoms for poor adaptation during the in-hospital recovery period. This 
hypothesis was supported for the emotional distress outcome, such that pre-operative 
somatic/affective depression symptoms were a significant predictor of T2 anxiety, after 
controlling for covariates, while cognitive/affective depression symptoms were not. In terms of 
surgical recovery there was only limited evidence to suggest that somatic/affective depression 
symptoms were a better predictor of recovery than cognitive/affective depression. Indeed, 
somatic/affective, but not cognitive/affective depression symptoms were predictive of 
affective pain following surgery, but neither predicted sensory pain and both predicted 
physical symptoms. In addition, with regards to the clinical outcomes, both somatic/affective 
and cognitive/affective depression symptoms were predictive of a post-operative hospital stay 
of greater than one week. No significant findings were found for any of the other clinical 
recovery indices, probably due to a lack of cases on these endpoints.  
The rationale for this hypothesis was based on evidence from MI patients where 
studies have found some types of symptoms to be more “cardiotoxic” than others, with 
somatic symptoms being particularly damaging (de Jonge, Ormel, et al., 2006; Doyle et al., 
2010; Hoen et al., 2010; Linke et al., 2009; Martens et al., 2010; McGowan et al., 2004). 
However, the work using CABG patients has not been congruent with these findings in MI 
patients. One of the few studies to date which has begun to address these issues in CABG 
patients has been published recently (Connerney, Sloan, Shapiro, Bagiella, & Seckman, 2010). 
In a 10-year follow-up study of the original cohort (Connerney et al., 2001), cognitive/affective 
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but not somatic symptoms were predictive of cardiac mortality in models adjusted for 
confounders. These results have been supported by another recent study of morbidity and 
mortality in CABG patients, which also found cognitive depressive symptoms to be particularly 
damaging (Tully et al., 2011).  
The results from this PhD were not able to add to the discussion of the effect of 
symptom subtypes of depression symptoms having differential effects on mortality, however 
the results do add to the discussion on impaired adaptation outcomes. Pre-CABG 
somatic/affective depression symptoms were shown to be a better predictor of distress 
outcomes, including anxiety and the distress component of physical pain, but there was no or 
little difference between somatic/affective and cognitive/affective depression symptoms in 
predicting the more physical outcomes, such as physical symptom reporting and length of 
hospital stay. Therefore, in the short term, it seems there was little difference between the 
depression symptom subtypes on predicting the hard clinical outcome, length of post-
operative hospital stay.  
It is important to note that length of post-operative hospital stay, while arguably the 
most policy relevant outcome, is only a proxy measure of recovery. Longer hospital stay is 
taken as a marker of poorer recovery in these analyses, but it is not clear to what extent this 
was always the case. For example, some participants may have been given bed-space for an 
extended period due to social reasons preventing their discharge. Moreover, re-admittance is 
also not captured; for example some participants may have been discharged early only to be 
readmitted for complications shortly again afterwards.  
6.7.2.2 Hypothesis 2: Social-behavioural mechanisms 
Hypothesis 2 stated that social-behavioural factors would affect the depression symptoms-
poor adaptation relationship, in particular that patients who showed more negative health 
behaviours and lower social support before surgery would be more likely to have poorer 
emotional adaptation and recovery during the in-hospital recovery period. This hypothesis was 
partially upheld, such that lower physical activity prior to surgery was a significant predictor of 
greater anxiety after surgery in models controlling for covariates and all depression symptoms 
subtypes. Moreover, smoking was shown to be predictive of longer hospital stays, again after 
controlling for covariates and depression symptoms subtypes. Physical activity and smoking 
did not significantly predict the physical symptom recovery outcomes including pain and 
physical symptom reporting on the CROQ. In addition, no other social-behavioural factors were 
found to be significant predictors of poor recovery at T2 after adjusting for covariates, 
including BMI, alcohol intake, sleep and social support.  
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Health behaviours were hypothesised to be important to recovery outcomes since 
they have been shown to be related to both depression symptoms and cardiac outcomes. 
Physical activity has been shown to be an important component of cardiac rehabilitation after 
surgery, being associated with reduced total and cardiovascular mortality and hospital 
readmission (Heran et al., 2011). A recent study showed that the relationship between 
depressive symptoms and future cardiac events in patients with CHD was largely accounted for 
by poor health behaviours, particularly physical inactivity (Whooley et al., 2008). This PhD has 
shown that levels of pre-surgical physical activity, as measured by hours spent walking per 
week, were important for the distress outcomes after surgery.  However, the results did not 
support the findings by Whooley and colleagues (Whooley et al., 2008) that physical activity 
acted as a mediator, since pre-operative depression symptoms were not associated with time 
spent walking.  
The effect of other health behaviours, such as smoking, is less clear in the literature. 
For example, smokers were found to be at greater risk of pulmonary complication following 
CABG surgery, but not of in-hospital mortality (Al-Sarraf et al., 2008). In an eight-year follow-
up study, smokers were found to be at lower risk of arrhythmia than non-smokers (Al-Sarraf et 
al., 2010). The study by Whooley and colleagues (Whooley et al., 2008) did show current 
smoking to partially mediate the association between depression symptoms and future cardiac 
events in patients with stable CHD.  This PhD has shown smokers to have a longer in-hospital 
recovery period after CABG surgery, but mediation was not found since depression symptoms 
prior to surgery were not related to smoking.  
6.7.2.3 Hypothesis 3: Cognitive mechanisms 
Hypothesis 3 stated that cognitive factors would affect the depression symptoms-poor 
adaptation relationship, with patients who showed lower cognitive function and more 
negative illness perceptions before surgery being more likely to have poorer emotional 
adaptation and recovery during the in-hospital recovery period. In fact, lower cognitive 
function was not found to produce any significant results in these analyses, neither with 
depression symptoms nor the recovery outcomes. Therefore, there was no evidence to 
suggest that those participants with depression symptoms had lower cognitive function, or 
those participants with lower cognitive function had poorer recovery.  
Previous literature has shown low levels of cognitive function to be associated with 
greater all-cause (Bosworth & Siegler, 2002) and cardiac mortality (Batterham et al., 2012). The 
relationship between neurocognitive function and mortality was not assessed in this PhD. 
Nevertheless, low cognitive function was predominant in the ARCS sample, with the majority 
of participants scoring below the threshold for normal performance. Previous literature has 
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pointed to deterioration in various neurocognitive processes following CABG, such as memory 
loss and difficulties with concentration and problem-solving. Both short- and long-term deficits 
in neurocognition have been observed in CABG patients. In a systematic review of studies 
using CABG patients, van Dijk and colleagues (van Dijk et al., 2000) reported pooled estimates 
showing on average, 22.5% of CABG patients had a cognitive deficit two months following 
surgery. Longer-term effects have also been observed, with a study of 261 (171 available at 
five years) CABG patients by Newman and colleagues (Newman et al., 2001) reporting 
cognitive decline in 42% of patients at five-year follow-up. However, in the ARCS study it is not 
clear to what extent deterioration in cognitive function from before to after surgery would 
have affected outcomes, since the MoCA was only administered at baseline.  
 Negative illness perceptions were shown to be relevant to both depression symptoms 
and the recovery outcomes. Both somatic/affective and cognitive/affective depression 
symptoms were related to greater negative illness perceptions and in turn greater negative 
illness perceptions were predictive of greater anxiety following surgery and greater physical 
symptoms after controlling for covariates. Total illness perceptions were not a significant 
predictor of T2 affective pain or length of post-operative hospital stay; however, the individual 
perceptions of consequences and emotional response were significant predictors of affective 
pain.  Overall, the individual illness perceptions that were predictive of anxiety, affective pain 
and physical symptoms were related to illness-specific distress, suggesting that those 
participants who were most emotionally affected by their illness had poorer recovery.  
These findings support previous literature which has shown negative illness 
perceptions to be associated with an array of poorer outcomes in the cardiac population, 
including greater illness related disability at home and at work (Petrie et al., 1996), reduced 
quality of life (French et al., 2005; Stafford et al., 2009),  later return to work (Maeland & 
Havik, 1987; Petrie et al., 1996), increased fatigue (Alsén et al., 2010), and greater risk of in-
hospital complications (Cherrington et al., 2004). Only two studies to date have examined 
these effects in cardiac surgery patients, the first of these studies showed pre-surgical negative 
illness perceptions predicted depression symptoms three months after surgery (Juergens et al., 
2010). The second study reported associations between negative illness perceptions and 
greater psychological distress in patients before CABG (Hermele et al., 2007). 
More recent evidence has proposed a mediation model in which negative illness 
perceptions mediate the relationship between depression symptoms and cardiac outcomes. 
Such a model suggests that depression symptoms lead to negative illness perceptions, which in 
turn are capable of affecting health outcomes. For example, in a study of 201 (25 depression 
symptoms cases) stable CHD outpatients who completed baseline and six-month follow-up 
assessments, the negative illness perceptions of consequences, identity, illness concern and 
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emotional representation were shown to partly mediate the prospective, negative, 
relationship between baseline depression symptoms and follow-up health related quality of 
life (Dickens, Cherrington, & McGowan, 2011).  
Notably, the ARCS study is the first study to test the mediation model in CABG surgery 
patients. While this study did find evidence to support a mediation model of illness 
perceptions for depression symptoms and the self-reported recovery outcomes, this effect did 
not extend to length of hospital stay, suggesting that while depressed mood prior to surgery 
was capturing elements of illness-specific distress, it was not limited to this. Depression 
symptoms were more important than illness perceptions for predicting the length of the in-
hospital recovery period.  
6.7.2.4 Hypothesis 4: Biological mechanisms 
Hypothesis 4 stated that biological factors affect the depression symptoms-poor adaptation 
relationship, with patients who show flatter cortisol before surgery and greater inflammatory 
responses in the days after surgery being more likely to show poorer emotional and physical 
recovery during the in-hospital period. The results produced limited support for this 
hypothesis, since cortisol slope was not associated with depression or the T2 recovery 
outcomes. Results did support previous research which has shown alterations in the diurnal 
profile of cortisol to be associated with depressed mood in patients with CHD (Bhattacharyya 
et al., 2008), since this study found depression symptoms were associated with a greater 
cortisol AUC. Previous literature has also shown that HPA axis dysregulation is associated with 
greater cardiac-related mortality in depressed patients (Jokinen & Nordström, 2009). There are 
limited studies investigating cortisol in CABG surgery patients, although there is some evidence 
that there is heightened cortisol output in the post-operative period (Roth-Isigkeit & 
Schmucker, 1997; Tønnesen et al., 1987) and one study found this pattern to be associated 
with post-operative complications, in particular delirium (Mu et al., 2010). However, none of 
the cortisol responses were related to any of the early-term recovery outcomes in this study, 
including the AUC, the awakening response and slope of cortisol across the day.  
In relation to the inflammatory markers, more promising results were found, but they 
were in an inconsistent direction, such that lower post-surgery IL-6, but higher post-surgery 
CRP was associated with poorer recovery. In particular, lower IL-6 responses four to eight days 
following CABG were associated with a longer post-operative stay, while higher CRP responses 
at the same time were also predictive of a longer hospital stay. Interestingly, IL-6 and CRP T2 
late responses were not correlated, while IL-6 T2 early and CRP T2 late responses were 
significantly associated. This suggests that timing of assessment is an important indicator of 
the interrelationship between inflammatory markers. However, the reason for this discrepancy 
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in inflammatory responses on recovery outcomes is not clear and has not been supported in 
previous literature. For example, an observational study of 29 cardiopulmonary bypass 
patients by Holmes and colleagues (Holmes et al., 2002) used a median split to compare 
outcomes between those patients who showed a heightened inflammatory response at four 
hours post-CABG, to those who did not. Findings showed that hyper-responders in IL-8, IL-6 
and CR3 (an anaphylatoxin) had greater risk of adverse clinical outcomes. In addition, 
Kaireviciute and colleagues (Kaireviciute et al., 2010) have shown that perioperative measures 
of hs-CRP and IL-6 are associated with greater risk of atrial fibrillation post-operatively. It will 
be necessary to corroborate the IL-6 findings reported in this chapter with results from the 
short-term follow-up data in Chapter 7.  
More recently, pre-operative CRP has been shown to predict adverse outcomes in CABG 
patients (De Lorenzo et al., 2012). These authors studied 76 patients who had CRP assessed 
prior to surgery, with results showing that those with elevated CRP (≥3 mg/l) had significantly 
greater risk of post-operative mortality; other work has replicated this finding (Perry et al., 
2010).  In this study, findings were in line with these results such that baseline CRP was 
predictive of greater anxiety, greater affective pain and greater physical symptoms after 
surgery, independent of covariates.  Therefore, those participants with greater inflammation 
prior to surgery were more likely to report poorer self-reported outcomes after surgery. This 
effect did not mediate the relationship between depression symptoms and the recovery 
outcomes, since depression symptoms were not associated with baseline CRP after controlling 
for covariates.  
6.8 Chapter summary 
This chapter has assessed the relationship between pre-operative depression, including 
somatic/affective and cognitive/affective symptom subtypes, and emotional distress, physical 
symptoms and length of post-operative hospital stay recovery outcomes. In addition, 
mechanisms accounting for this relationship were explored, finding little evidence of social-
behavioural or biological mediation. Illness perceptions were found to mediate the 
relationship between pre-operative depression symptoms and greater anxiety, physical 
symptoms and affective pain after surgery, but not length of post-operative hospital stay. 
Therefore, it appears depression symptoms exert a unique influence on early-term recovery 
not entirely explained by the mechanisms explored in this PhD.   
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Chapter 7. Results: Short-term outcomes 
7.1 Introduction 
The ARCS study began in February 2011 and data collection is on-going. The data presented in 
this chapter comprise the 154 participants (Figure 6.1) who had completed all three time 
points by June 2012. To reiterate, the aim of the ARCS study was to characterise the 
progression of patients from the pre-operative to post-operative phases of recovery following 
cardiac surgery. This PhD focuses on the relationship between depression symptoms and 
adaptation over time, and the underlying mechanistic pathways. Two main mechanisms are 
explored here in detail: biological and psychosocial.  Chapter 6 presented results pertaining to 
early-term outcomes, as measured at baseline and T2. This chapter focuses on predictors of 
short-term recovery outcomes, occurring up to two months following surgery at T3. In this 
chapter, the demographic statistics are described, followed by descriptive statistics of 
predictor and outcome variables, covariates, and candidate mechanisms. Lastly, mediation 
analyses of associations between depression symptoms and recovery are presented. In 
particular, this chapter assesses the role of three possible mechanistic pathways: social-
behavioural factors, cognition, and biology.    
 The specific hypotheses to be tested in this chapter are: 
(1) Depression symptoms are associated with impaired adaptation following CABG surgery 
i. Somatic/affective depression, persistent depression and post-CABG onset depression will 
carry greater risk than no depression symptoms, cognitive/affective depression symptoms 
and resolved depression for poor adaptation up to two months following surgery, 
including: 
a) Short-term emotional recovery such as anxiety,   
b) Short-term surgical recovery such as pain, physical symptom reporting, 
c) Short-term physical and mental adaptation,  
and these associations will be independent of demographic and clinical factors.  
(2) Social-behavioural factors affect the depression symptoms-poor adaptation relationship 
i. Patients who show more negative health behaviours and lower social support before 
surgery will be more likely to have poorer emotional adaptation and recovery up to two 
months following surgery, including: 
a) Short-term emotional recovery, 
b) Short-term surgical recovery, 
c) Short-term physical and mental adaptation, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
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ii. Patients who show lower social support before surgery will be more likely to have poorer 
emotional adaptation and recovery up to two months following surgery, including: 
a) Short-term emotional recovery, 
b) Short-term surgical recovery, 
c) Short-term physical and mental adaptation, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
(3) Cognitive factors affect the depression symptoms-poor adaptation relationship 
i. Patients who show more neurocognitive impairment before surgery will be more likely to 
have poorer emotional adaptation and recovery up to two months following surgery, 
including: 
a) Short-term emotional recovery, 
b) Short-term surgical recovery, 
c) Short-term physical and mental adaptation, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
ii. Patients who show more negative illness perceptions before surgery will be more likely to 
have poorer emotional adaptation and recovery up to two months following surgery, 
including: 
a) Short-term emotional recovery, 
b) Short-term surgical recovery, 
c) Short-term physical and mental adaptation, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
(4) Biological factors affect the depression symptoms-poor adaptation relationship 
i. Patients who show a flatter diurnal cortisol profile before surgery will be more likely to 
show poorer emotional and physical recovery up to two months following surgery, 
including: 
a) Short-term emotional recovery, 
b) Short-term surgical recovery, 
c) Short-term physical and mental adaptation, 
and this will partly mediate the association between baseline depression symptoms and 
adaptation following cardiac surgery.  
ii. Patients who show greater inflammatory responses in the days after surgery will be more 
likely to show poorer emotional and physical recovery up to two months following surgery, 
including: 
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a) Short-term emotional recovery; 
b) Short-term surgical recovery; 
c) Short-term physical and mental adaptation; 
and these factors will partly mediate the association between baseline depression 
symptoms and adaptation following cardiac surgery.  
iii. Patients who show greater inflammatory responses in the days after surgery will be more 
likely to display greater depression symptoms up to two months following surgery. 
7.2 Uptake, attrition and missing data 
Due to attrition, the final total of participants who completed the questionnaires at all three 
time points was 154. On average, participants completed their baseline questionnaire 27.55 
(SD = 27.92) days prior to surgery, had their T2 assessment on the cardiac care ward 4.45 (SD = 
4.94) days after surgery, and filled in their T3 questionnaire approximately two months (mean 
= 60.77 days, SD = 28.62) following surgery. The time delay variables were not associated with 
either depression symptoms or recovery outcomes in regression analyses. Missing data on 
questionnaires meant analyses were performed on a reduced number of participants for some 
measures.  
Details of the types of missing questionnaire data are provided in Table 7.1. This table 
(Table 7.1) also displays the Cronbach’s alphas for each questionnaire measure, as applicable. 
As in Chapter 6, in questionnaires where respondents had provided valid responses on at least 
half the questionnaire items, data were scaled up (see Table 7.1). All analyses in this chapter 
were performed using the scaled-up data, to increase power. As discussed in Chapter 6, 
questions that were sensitive in nature, such as household income and libido on the BDI, may 
partly account for high levels of missing data on these scales. High rates of missing data on the 
MPQ-SF may be due to participants having difficulty completing this measure.  
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TABLE 7.1 MISSING QUESTIONNAIRE DATA IN T1-T3 ANALYTIC SAMPLE  
Measure 
T1 T2 T3 
n α S* n α S* n α S* 
Socio-demographics          
Education 2 - - - - - - - - 
Income 7 - - - - - - - - 
Emotional distress          
Depression 
symptoms (BDI) 
16 0.82 2 - - - 14 0.85 1 
Anxiety (HADS 
subscale) 
7 0.88 2 1 0.76 0 7 0.87 0 
Health status          
Health status (SF-12) 
– Physical 
0 0.65 - - - - 1 0.47 1 
Health status (SF-12) 
– Mental 
1 0.53 1 - - - 1 0.65 1 
Health behaviour          
Physical activity 
(IPAQ – walking) 
11 - - - - - 7 - - 
Sleep (Jenkins Scale) 1 0.81 1 - - - 3 0.88 1 
Cognitive factors          
Illness perceptions 
(BIPQ) 
5 0.64 0 - - - 1 0.81 0 
Cognitive screen 
(MoCA) 
8 0.57 8 - - - - - - 
Social support          
Social support (ESSI) 4 0.90 2 - - - 5 0.91 5 
Physical symptoms          
Pain (MPQ-SF) - 
Sensory 
- - - 3 0.73 1 29 0.93 10 
Pain (MPQ-SF) - 
Affective 
- - - 1 0.50 1 16 0.81 11 
Symptoms (CROQ-
CABG) 
- - - 10 0.57 0 6 0.79 0 
*S: Scaled-up data to account for missing values. 
 
7.3 Sample characteristics 
Table 7.2 describes the characteristics of the T1-T3 analytic sample (n = 154), respectively, at 
baseline. Please refer to Table 4.3 in Chapter 6 for details of the entire sample. The analytic 
sample had an age range between 44 to 88 years, was predominantly male (85.1%) and 
overweight (body mass index, BMI, >25.0 = 77.9%). The majority of participants were retired 
(63.4%), three participants were registered disabled and seven participants were unemployed. 
The majority of the analytic sample had either no or only secondary educational qualifications 
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(70.5%). Over 50% of participants were past-smokers, but only a minority were current 
smokers (7.2%). The majority of participants (90.0% of men and 95.7% of women) adhered to 
UK government guidelines concerning alcohol consumption which for men equates to a 
maximum of 28 units per week and for women are no more than 21 units per week. 
 
TABLE 7.2: CHARACTERISTICS OF THE T1-T3 ANALYTIC SAMPLE AT BASELINE  
Characteristic N Mean ± SD or n (%) 
Age (years) 154 68.31±9.11 
Female 154 23 (14.9) 
BMI (kg/m
2
) 154 27.97±3.76 
Married/cohabiting 154 118 (76.6) 
Ethnicity – White British/other White 154 134 (87.0) 
Tobacco smoking 
Never 
Past 
Current 
153 
 
55 (35.9) 
87 (56.9) 
11 (7.2) 
Alcohol consumption (units/week) 153 9.63±13.86 
Currently employed 153 46 (30.1) 
Employment grade of current/last major occupation 
Unemployed/disabled 
Managers, directors and senior officials 
Professional 
Associate professional and technical 
Administrative and secretarial 
Skilled trades 
Caring, leisure and other service 
Sales and customer service 
Process, plant and machine operatives 
Elementary 
148 
 
10 (6.8) 
28 (18.9) 
32 (21.6) 
19 (12.8) 
9 (6.1) 
11 (7.4) 
8 (5.4) 
8 (5.4) 
14 (9.5) 
9 (6.1) 
Yearly household income 
≤ 10,000 GBP 
10,000 – 20,000 GBP 
20,000 – 30,000 GBP 
30,000 – 40,000 GBP 
≥40,000 
147 
 
21 (14.3) 
44 (29.9) 
35 (23.8) 
20 (13.6) 
27 (18.4)  
Education 
None 
Secondary 
Higher secondary 
Degree 
146 
 
44 (30.1) 
59 (40.4) 
19 (13.0) 
24 (16.4) 
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TABLE 7.3: CLINICAL CHARACTERISTICS OF THE T1-T3 ANALYTIC SAMPLE AT BASELINE  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristic N n (%) 
Co-morbidities*  
 
Diabetes 154 36 (23.4) 
Renal failure (requiring dialysis) 154 2 (1.3) 
Chronic respiratory disease 154 9 (5.8) 
Cancer (self-reported) 
Colon 
Prostate 
Breast 
Bladder 
149 
 
1 (0.7) 
2 (1.3) 
1 (0.7) 
1 (0.7) 
Psychiatric history*   
History of depression 145 23 (15.9) 
History of anxiety disorder 146 19 (13.0) 
Current treatment for depression 145 5 (3.4) 
Current treatment for anxiety 146 1 (0.7) 
Cardiac morbidity   
Hypertension 154 122 (79.2) 
Angina 
None 
No limitation 
Slight limitation 
Marked limitation 
Symptoms at rest 
154 
 
5 (3.2) 
38 (24.7) 
84 (54.5) 
26 (16.9) 
1 (0.6) 
Dyspnoea 
None 
Slight 
Moderate 
154 
 
34 (22.1) 
96 (62.3) 
24 (15.6) 
Previous MI 
None 
1 
2 or more 
154 
 
107 (69.5) 
45 (29.2) 
2 (1.3) 
Disease severity  
 
Ejection fraction < 50 154 18 (11.7) 
Logistic euroSCORE (%) 
<3.0 
3.0-6.0 
6.1-9.0 
9.1-12.0 
>12.0 
154 
 
63 (40.9) 
55 (35.7) 
24 (15.6) 
5 (3.2) 
7 (4.5) 
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*Absolute number of cases in sample. 
 
Clinical data of the analytic sample is displayed in Table 7.3. Co-morbidities were 
prevalent in the analytic sample, with almost a quarter (23.4%) of participants having a 
diagnosis of diabetes. In terms of psychiatric morbidity, 15.9% of participants reported a 
history of depression, but only 3.4% were being treated for depression symptoms in the four 
weeks prior to CABG surgery. The association between depression symptoms and use of 
antidepressant medication was checked in Pearson’s correlations, but there were no 
significant associations between total BDI scores, somatic/affective depression symptom 
scores, cognitive affective depression symptom scores and use of antidepressant medications 
at T1 or T3. Therefore, these participants were retained in analyses. The majority of 
participants had on-pump (cardiopulmonary bypass) surgery (78.6%) in isolation. Three 
participants required dialysis post-operatively. All participants were alive on discharge. No 
deaths occurred between the in-hospital follow-up at T2 and the two-month post-surgery 
follow-up at T3.  
Cross-tabulations were performed on age, total yearly household income, education and 
sex, to compare the characteristics of those who completed all three time points (n = 154) to 
those who did not (n = 89). Age was converted to a categorical variable for chi-squared analysis 
(<50 years, 50-60 years, 60-70 years, 70-80 years, >80 years). There was no statistical 
difference between completers and non-completers in terms of age groups (2 = 3.847, df = 4, 
n = 243, p = 0.427). This was confirmed in an independent t-test of mean age (t = 0.789, p = 
0.420).  There was no significant difference between completers and non-completers in terms 
Surgical details  
 
Off-pump 154 33 (21.4) 
CABG in isolation 154 118 (76.6) 
Graft sites 
1-2 
3-4 
5+ 
154 
 
52 (33.8) 
88 (57.1) 
14 (9.1) 
Post-operative recovery  
 
Intensive care stay > 2 days 154 15 (9.7) 
Intensive care re-admittance 154 2 (1.3) 
Length of post-operative stay 
≤7 days 
>7 days 
154 
 
113 (73.4) 
41 (26.6) 
Reoperation necessary 154 6 (3.9) 
Post-operative complications 
Post-operative dialysis 
154 
 
3 (1.9) 
Cardiac rehabilitation   
Attended cardiac rehabilitation 149 44 (29.5) 
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of income groups (2 = 3.805, df = 4, n = 228, p = 0.433), education groups (2 = 0.554, df = 3, n 
= 228, p = 0.907), and sex (2 = 0.658, df = 1, n = 243, p = 0.417). Markers of disease severity 
did also not significantly differ between completers and non-completers in terms of both 
euroSCORE groups (2 = 2.331, df = 4, n = 223, p = 0.675) and LVEF (2 = 0.114, df = 1, n = 223, 
p = 0.736); cut-offs for these variables are displayed in Table 7.3. In addition, an independent 
samples t-test for mean euroSCORE values, using the continuous score, confirmed this lack of 
difference between completers (M: 4.47, SD: 2.98) and non-completers (M: 4.47, SD: 3.61) (t = 
0.008, p = 0.994). 
Kolmogorov-Smirnov tests were performed revealing scores on all continuous measures 
apart from the BIPQ (T1 and T3) and the SF-12 physical (T1) to be non-normally distributed (p > 
0.05). Both non-parametric and parametric tests were performed on the data, but since results 
were similar, the parametric results are presented here.  Distribution of the biological data was 
also tested using Kolmogorov-Smirnov tests and raw data were assessed for log 
transformation, however in order to keep in the full range of responses on the biological 
measures, and to retain those participants who had extreme responses, the raw data was used 
for both cortisol and inflammatory  marker measures. In addition, this ensures the unit of 
measurement is preserved, maintaining the clinical relevance of the results. Correlation 
analyses were used throughout to assess the assumption of multicollinearity, prior to using 
regression analyses. Multicollinearity assumptions were not violated since all correlation 
coefficients were <0.80.   
7.4 Descriptive analyses of depression symptom and recovery measures 
7.4.1 Depression symptoms at T1 and T3 
A summary of the depression symptom scores are displayed in Table 7.4, with p representing 
the significance value of dependent t-tests. Total, somatic/affective and cognitive/affective 
scores on the BDI were used as predictor variables in analyses of the relationship between 
depression symptoms and recovery over time. Please note that this table displays the values 
on the BDI in accordance with the BDI handbook severity cut-offs. Baseline (>10 = 27.8%) and 
T3 (>10 = 20.4%) values of the BDI revealed the majority of participants were within the 
normal range for depression symptom scores. Dependent t-tests were performed to examine 
the change in depression symptom scores over time, with results showing a significant 
decrease in depression symptoms for BDI total, somatic/affective and cognitive/affective 
scores. However, as described in the method chapter (Chapter 3), to examine caseness on the 
BDI, a binary cut-off was implemented at a conservative ≥13 to maximise the specificity of this 
measure (Gutierrez & Davis, 1999). Using this cut-off, 18.4% of participants were classified as 
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depressed at baseline, and 15.0% of participants were depressed at T3. To examine caseness 
depression on the BDI over time, four groups were created in order to examine the pattern of 
depression symptoms from T1 to T3. Results from these analyses are shown in Table 7.5, 
revealing that 8.0% of participants can be classified as having depression that persists to T3. A 
further 10.0% of participants had depression that had resolved by T3, and 7.3% of participants 
had post-CABG onset depression. 
 In conjunction with scores on the BDI, self-reported history of depression was also 
examined, in order to assess the frequency of depression caseness on the BDI and a positive 
history of diagnosed depression. Fourteen participants (12.5%) who were never depressed 
according to the BDI reported a history of depression. In addition, three participants in each of 
the depressed groups, resolved (20.0%), persistent (25.0%), post-CABG onset (27.2%), had a 
positive depression history.    
 
TABLE 7.4: T1 AND T3 DEPRESSION SYMPTOM SCORES 
Measure N 
T1 T3 
p 
Mean ± SD or n (%) Mean ± SD or n (%) 
Total BDI 151 8.43±6.05 7.04±5.98 0.008 
Total cognitive/affective 
BDI 
153 2.78±3.75 2.21±3.33 0.043 
Total somatic/affective 
BDI 
150 6.91±4.40 5.48±4.55 <0.001 
Normal (0-10) 151 109 (72.2) 121 (79.6)* - 
Mild (11-16) 151 29 (19.2) 19 (12.5)* - 
Borderline clinical (17-20) 151 7 (4.6) 6 (3.9)* - 
Moderate (21-30) 151 5 (3.3) 5 (3.3)* - 
Severe (31-40) 151 1 (0.7) 1 (0.7)* - 
Extreme (41-63) 151 - - - 
*N = 152 
 
TABLE 7.5: DEPRESSION TYPE ACCORDING TO TIME POINT 
Depression  type 
BDI ≥ 13 
n (%) 
T1 T3 
Never depressed x x 112 (74.7) 
Post-CABG onset X  11 (7.3) 
Persistent   12 (8.0) 
Resolved  x 15 (10.0) 
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7.4.2 Short-term recovery outcome variables 
Three different types of recovery were assessed at T3: emotional distress, physical symptom 
measures and health status. Descriptive analyses of these measures at T1, T2 and T3 are 
presented in Table 7.6. Although data are presented at each time point a measure was used, 
this is merely to describe these measures; only the T3 data were used as a recovery endpoint 
in this chapter. The in-hospital endpoints were included as early-term outcomes in Chapter 6, 
and will not be covered here. Dependent t-tests were performed to assess change in variables 
over time.  
 
TABLE 7.6: RECOVERY OUTCOME MEASURES ACROSS TIME 
Measure N 
T1 T2 T3 
p 
Mean ± SD Mean ± SD Mean ± SD 
Emotional distress      
Anxiety total (T1-T2) 152 5.83±4.22 4.53±3.86 - <0.001 
Anxiety total (T1-T3) 152 5.83±4.22 - 4.06±3.68 <0.001 
Anxiety total (T2-T3) 154 - 4.51±3.84 4.03±3.66 0.159 
Anxiety normal (≤7) 152 106 (69.7) 123 (79.9)* 133 (86.4)* - 
Anxiety borderline (8-10) 152 25 (16.4) 20 (13.0)* 8 (95.2)* - 
Anxiety caseness (≥11) 152 21 (13.8) 11 (7.1)* 13 (8.4)* - 
Physical symptoms      
Pain - Sensory 143 - 5.26±4.61 4.76±6.32 0.378 
Pain  - Affective 142 - 1.22±1.78 1.26±2.13 0.845 
Pain – Numerical rating 
scale 
152 - 3.44±2.47 2.41±2.23 <0.001 
Pain – Current descriptor 151 - 1.55±0.96 1.00±0.94 <0.001 
Symptoms (CROQ-CABG) 154 - 8.75±4.58 14.68±7.58 <0.001 
Health status      
Health status (SF-12) – 
Physical 
153 39.35±10.61 - 35.36±8.35 0.001 
Health status (SF-12) – 
Mental 
152 56.67±6.27 - 57.83±6.97 0.059 
N = 154. 
 
The emotional distress measure used in these analyses was anxiety. Dependent t-tests 
were performed on means scores for anxiety over time, revealing a significant decrease from 
T1 to T2 and from T1 to T3. T2 and T3 anxiety scores did not significantly differ.  The majority 
of participants were free from anxiety at all three time points, with only 7.1% and 8.4% of 
participants being clinically anxious (≥11) at T2 and T3, respectively. To examine borderline to 
caseness anxiety on the HADS, a binary cut-off was implemented in accordance with previous 
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literature at ≥8. Four groups were created in order to examine the pattern of anxiety across 
time. Results from these analyses are shown in Table 7.7, revealing that 9.9% of participants 
can be classified as having anxiety that persists to T3. A further 20.4% of participants had 
anxiety that had resolved by T2. Only nine (3.9%) participants had post-CABG onset anxiety.  
Physical symptoms were measured using the CROQ symptom subscale and the MPQ-
SF. In terms of physical recovery, the majority of participants experienced physical pain and 
discomfort at T2, with only 10.5% of participants reporting no sensory pain at T2. Affective 
pain was reported in just under half (42.5%) of participants. At T3, mean pain scores were 
lower than at T2 on sensory measures, but this did not reach statistical significance. In 
addition, affective pain did not significantly change from T2 to T3. The reduction in pain over 
time was, however, reflected in scores on the numerical rating scale and the current pain 
descriptor score. Since the sensory and affective pain scores capture a wide array of pain 
symptoms, these scores were used in all further analyses, rather than the numerical rating 
scale and the current pain descriptor scores. Physical symptoms, as measured by the CROQ, 
were also frequently reported following surgery, with significantly higher mean scores at T3 
than at T2 (Table 7.8). Feelings of pain around the surgical wound sites were frequently 
reported at both time points, and at T3 participants were likely to report bruising, infection 
and numbness and tingling.  This observed increase in physical symptom reporting over time 
corroborates the findings from the pilot study.  
Health status was measured using the SF-12 to generate mental and physical health 
status scores. These scores show that participants reported significantly poorer physical health 
status at T3, compared with T1. Mental health status slightly improved following surgery, but 
this was not significant. This latter finding is in line with the data showing a decrease in BDI 
mean score over time (see Table 7.4).   
 
TABLE 7.7: ANXIETY TYPE ACCORDING TO TIME POINT 
Anxiety type 
HADS ≥ 8 
n (%) 
T1 T3 
Never anxious x x 100 (65.8) 
Post-CABG onset X  9 (3.9) 
Persistent   15 (9.9) 
Resolved  x 31 (20.4) 
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TABLE 7.8: FREQUENCY OF CROQ PHYSICAL SYMPTOMS AT T2 AND T3 
Symptom severity (Moderate to A lot) 
T2  T3 
N n (%) N n (%) 
Pain in chest wound 154 94 (61.0) 154 83 (53.9) 
Infection in chest wound 154 4 (2.6) 154 15 (9.7) 
Tenderness around chest wound 154 87 (56.5) 154 87 (56.5) 
Numbness/tingling around chest wound 154 10 (6.5) 154 54 (35.1) 
Bruising around chest wound 154 14 (9.1) 154 29 (18.8) 
Pain in arm/leg wound 147 55 (37.4) 153 75 (49.0) 
Other pain in arm/leg due to operation 147 8 (5.4) 153 52 (34.0) 
Infection in arm/leg wound 147 1 (0.7) 153 42 (27.5) 
Numbness/tingling in arm/leg due to 
operation 
146 14 (9.6) 153 81 (52.9) 
Bruising arm/leg where vein was 
removed 
147 35 (23.8) 153 62 (40.5) 
Swollen feet/ankles 154 66 (42.9) 149 82 (55.0) 
 
7.4.3 Covariates of the depression symptoms-recovery relationship 
Covariates are factors associated with the outcome variable, other than the predictor variable 
of interest. Potential covariates of the depression symptoms-recovery relationship were 
identified in the literature review and include both demographic and clinical factors. For ease 
of reference the demographic covariates are presented again here in Table 7.9; they include 
age, sex, and socioeconomic status as measured by education, occupation level and household 
income. Disease severity, including LVEF and euroSCORE were also considered as covariates, 
and are again presented in Table 7.9. To clarify, LVEF was used as a binary variable (<50 or ≥50) 
and logistic euroSCORE was used as a continuous variable. Other clinical factors such as 
medication use and co-morbidities may also play a role in recovery and were also considered 
as potential covariates. Pre- and post-operative medication usage is displayed in Table 7.10, 
demonstrating ACE inhibitors, aspirin, statins and beta-blockers were frequently prescribed 
both before and after CABG surgery. In addition, following surgery roughly one-third (30.7%) of 
patients were taking prescribed analgesic medication.  
 Although primary identification of covariates has been theory driven, in order to 
create a parsimonious model of the depression symptoms-recovery relationship, some 
tailoring was required to identify those covariates applicable to recovery in my sample. This 
was necessary since the ARCS study was powered to include nine predictor variables. The 
potential covariates were entered into correlation analyses in order to identify those variables 
which were strongly related to the T3 outcome variables. 
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TABLE 7.9: CHARACTERISTICS OF THE T1-T3 ANALYTIC SAMPLE AT BASELINE  
Characteristic N Mean ± SD or n (%) 
Age (years) 154 68.31±9.11 
Female 154 23 (14.9) 
Employment grade of current/last major occupation 
Unemployed/disabled 
Managers, directors and senior officials 
Professional 
Associate professional and technical 
Administrative and secretarial 
Skilled trades 
Caring, leisure and other service 
Sales and customer service 
Process, plant and machine operatives 
Elementary 
148 
 
10 (6.8) 
28 (18.9) 
32 (21.6) 
19 (12.8) 
9 (6.1) 
11 (7.4) 
8 (5.4) 
8 (5.4) 
14 (9.5) 
9 (6.1) 
Yearly household income 
≤ 10,000 GBP 
10,000 – 20,000 GBP 
20,000 – 30,000 GBP 
30,000 – 40,000 GBP 
≥40,000 
147 
 
21 (14.3) 
44 (29.9) 
35 (23.8) 
20 (13.6) 
27 (18.4)  
Education 
None 
Secondary 
Higher secondary 
Degree 
146 
 
44 (30.1) 
59 (40.4) 
19 (13.0) 
24 (16.4) 
Ejection fraction < 50 154 18 (11.7) 
Logistic euroSCORE (%) 154 4.49±3.00 
 
  Results of the correlation analyses offer some insight into the covariates applicable to 
the depression symptoms-recovery relationship in this sample. In correlation analyses, age, 
sex, occupation level, euroSCORE and LVEF failed to show any significant associations with T3 
recovery. Out of the three markers of socioeconomic position considered as potential 
covariates (education, occupation level and household income), total household income (r = -
0.227, p = 0.006) and education (r = -0.183, p = 0.027) were both significantly related to T3 
physical symptoms; these associations were negative such that those participants with lower 
income/education had greater symptoms. Associations between use of medications and co-
morbidities and outcome variables were also performed, with no significant associations 
found.  
Household income was used as a proxy measure of socioeconomic status in analyses, 
rather than education or occupation level, since this produced the strongest significant 
association with T3 physical symptoms and because it was significantly correlated to both 
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education (r = 0.223, p = 0.008) and occupation (r = -0.357, p <0.001). Due to the fact that 
euroSCORE and LVEF were correlated (r = 0.247, p = 0.002) and euroSCORE actually takes into 
account LVEF, only euroSCORE was included in mediation models as a marker of disease 
severity.  
 
TABLE 7.10: PRE- AND POST-OPERATIVE PRESCRIBED MEDICATION USE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Medication N n (%) 
Pre-operative (T1)   
ACE inhibitors 142 76 (53.5) 
Angiotensin II receptor antagonist 142 18 (12.7) 
Anti-arrhythmia 142 3 (2.1) 
Antibiotic 142 2 (1.4) 
Anticoagulant 142 6 (4.2) 
Antiplatelet 142 42 (29.6) 
Aspirin 148 119 (80.4) 
Beta-blockers 142 88 (62.0) 
Calcium channel blocker 142 44 (31.0) 
Nitrate 142 45 (31.7) 
NSAID 142 22 (15.5) 
Sleeping tablet 142 4 (2.8) 
Statins 142 125 (88.0) 
Post-operative (T3)   
ACE inhibitors 137 64 (46.7) 
Angiotensin II receptor antagonist 137 16 (11.7) 
Anti-arrhythmia 137 25 (18.2) 
Antibiotic 137 13 (9.5) 
Anticoagulant 137 24 (17.5) 
Antiplatelet 137 13 (9.5) 
Aspirin 141 118 (83.7) 
Beta-blockers 137 111 (81.0) 
Calcium channel blocker 137 11 (8.0) 
Nitrate 137 3 (2.2) 
NSAID 137 42 (30.7) 
Sleeping tablet 137 1 (0.7) 
Statins 137 120 (87.6) 
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7.5 Depression symptoms predicting short-term recovery  
In order to examine the recovery outcomes in relation to depression, analyses were performed 
between depression symptom subtype scores at baseline and the emotional distress, health 
status and physical symptom recovery outcomes at T3. Depression symptoms were coded into 
three types: total BDI score, somatic/affective BDI symptom score and cognitive/affective BDI 
symptom score. Multiple regression analyses were performed in order to assess the 
relationship between depression symptom subtype and recovery outcomes after controlling 
for demographic and disease severity covariates, as well as baseline measures of the outcome 
variable for the anxiety and health status outcomes. 
7.5.1 Emotional distress 
Multiple regression analyses were performed using T3 anxiety (two months following surgery), 
as measured on the HADS, as the outcome variable. Total BDI (t = 1.202, p = 0.231) and 
cognitive/affective (t = 0.389, p = 0.698) depression symptom scores were not significant 
predictors of T3 anxiety after controlling for baseline anxiety and demographic and disease 
severity covariates. However, baseline somatic/affective depression symptoms (t = 1.953, p = 
0.053) reached borderline statistical significance; results are displayed in Table 7.11. The 
significant predictors in this model were baseline anxiety (t = 5.213, p <0.001) and household 
income (t = -2.300, p = 0.023), such that those participants with greater pre-operative anxiety 
and a lower annual income, had greater anxiety two months after their surgery. The final 
model accounted for 35.3% of variance (R2 = 0.353) in T3 anxiety scores. In summary, these 
results suggest that greater pre-operative somatic/affective depression symptoms were a 
borderline predictor of T3 emotional distress.  
  
TABLE 7.11: MULTIPLE REGRESSION OF T3 ANXIETY ON T1 SOMATIC/AFFECTIVE BDI SCORE  
Model B SE ß p 
Age -0.030 0.043 -0.076 0.486 
Sex -1.050 0.820 -0.099 0.203 
Household income -0.455 0.198 -0.167 0.023 
euroSCORE 0.100 0.140 0.082 0.475 
T1 Anxiety 0.386 0.074 0.443 <0.001 
T1 BDI somatic 0.137 0.070 0.166 0.053 
R
2
 = 0.353, N = 143 
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7.5.2 Physical symptoms 
Pain 
Multiple regression analyses were performed using T3 sensory pain, as measured on the MPQ-
SF, as the outcome variable. Total BDI (t = 1.838, p = 0.068) and cognitive/affective (t = 0.551, p 
= 0.582) depression symptom scores were not significant predictors of T3 sensory pain after 
controlling for demographic and disease severity covariates. However, baseline 
somatic/affective depression symptoms (t = 2.212, p = 0.029) reached statistical significance; 
results are displayed in Table 7.12. There were no other significant predictors in this model. 
The final model accounted for 6.3% of variance (R2 = 0.063) in T3 sensory pain scores. In 
summary, these results suggest that only baseline somatic/affective depression symptom 
subtype was an important predictor of T3 sensory pain. 
 
TABLE 7.12: MULTIPLE REGRESSION OF T3 SENSORY PAIN ON T1 SOMATIC/AFFECTIVE BDI 
SCORE 
Model B SE ß p 
Age 0.032 0.098 0.046 0.744 
Sex 2.192 1.823 0.111 0.232 
Household income -0.501 0.430 -0.104 0.246 
euroSCORE -0.115 0.310 -0.054 0.711 
T1 BDI somatic 0.300 0.136 0.193 0.029 
R
2
 = 0.063, N = 136 
 
Multiple regression analyses were also performed using T3 affective pain, as measured 
on the MPQ-SF, as the outcome variable. Total BDI (t = 1.870, p = 0.064) and 
cognitive/affective (t = 0.695, p = 0.488) depression symptom scores at baseline were not 
significant predictors of T3 affective pain after controlling for demographic and disease 
severity covariates. However, baseline somatic/affective depression symptoms (t = 2.672, p = 
0.009) reached statistical significance; results are displayed in Table 7.13. There were no other 
significant predictors in this model. The final model accounted for a relatively small amount of 
variance (R2 = 0.029) in T3 affective pain scores. In summary, these results suggest that only 
the somatic/affective depression symptom subtype was an important predictor of T3 affective 
pain. 
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TABLE 7.13: MULTIPLE REGRESSION OF T3 AFFECTIVE PAIN ON T1 SOMATIC/AFFECTIVE 
BDI SCORE 
Model B SE ß p 
Age 0.000 0.033 0.002 0.991 
Sex -0.476 0.629 -0.069 0.451 
Household income -0.135 0.146 -0.083 0.355 
euroSCORE -0.023 0.106 -0.031 0.827 
T1 BDI somatic 0.123 0.046 0.233 0.009 
R
2
 = 0.029, N = 135 
 
Physical symptoms 
Multiple regression analyses were also performed using T3 physical symptoms, as measured 
on the CROQ, as the outcome variable. Baseline total BDI (t = 1.846, p = 0.067) and 
cognitive/affective (t = 0.856, p = 0.393) depression symptom scores were not significant 
predictors of T3 physical symptoms after controlling for demographic and disease severity 
covariates. However, baseline somatic/affective depression symptoms (t = 2.352, p = 0.020) 
reached statistical significance; results are displayed in Table 7.14. The only other significant 
predictor in this model was household income (t = -2.477, p = 0.014), such that participants 
with a lower annual income had greater physical symptoms after surgery. The final model 
accounted for 9.1% of variance (R2 = 0.091) in T3 CROQ physical symptom scores.  
In summary, these results suggest that somatic/affective depression symptoms prior 
to surgery were the most important for predicting greater physical symptoms two months 
after surgery. Neither total BDI score, nor cognitive/affective depression symptom score were 
significant predictors of any of the physical symptom recovery endpoints at T3.  
 
TABLE 7.14: MULTIPLE REGRESSION OF T3 PHYSICAL SYMPTOMS ON T1 
SOMATIC/AFFECTIVE BDI SCORE 
Model B SE ß p 
Age 0.068 0.108 0.081 0.528 
Sex 0.351 2.046 0.015 0.864 
Household income -1.230 0.496 -0.212 0.014 
euroSCORE -0.126 0.340 -0.050 0.712 
T1 BDI somatic 0.351 0.149 0.197 0.020 
R
2
 = 0.091, N = 145  
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7.5.3 Health status 
Multiple regression analyses were performed using T3 physical health status, as measured on 
the SF-12, as the outcome variable. Total BDI (t = -1.939, p = 0.055) and cognitive/affective (t = 
-1.084, p = 0.280) depression symptom scores at baseline were not significant predictors of T3 
physical health status after controlling for baseline physical health status and demographic and 
disease severity covariates. However, baseline somatic/affective depression symptoms (t = -
2.511, p = 0.013) reached statistical significance; results are displayed in Table 7.15. This 
association was negative such that higher depression symptom scores predicted lower health 
status following surgery. Interestingly, there were no other significant predictors in this model, 
not even baseline SF-12 scores (t = 0.177, p = 0.860). The final model accounted for 9.8% of 
variance (R2 = 0.098) in T3 physical health status scores. No significant associations were found 
between baseline depression symptoms and mental health status scores at T3, after 
controlling for covariates and baseline measures of these scales.  
 
TABLE 7.15: MULTIPLE REGRESSION OF T3 PHYSICAL HEALTH STATUS ON T1 
SOMATIC/AFFECTIVE BDI SCORE 
Model B SE ß p 
Age -0.176 0.119 -0.195 0.144 
Sex -4.221 2.241 -0.174 0.062 
Household income 0.132 0.536 0.021 0.806 
euroSCORE 0.875 0.369 0.326 0.019 
T1 Physical health status 0.013 0.071 0.016 0.860 
T1 BDI somatic -0.431 0.172 -0.227 0.013 
R
2
 = 0.098, N = 144 
 
7.6 Depression onset predicting short-term recovery  
In order to examine the recovery outcomes in relation to depression, analyses were also 
performed between depression onset subtypes and the emotional distress, health status and 
physical symptom recovery outcomes at T3. Depression caseness was categorised into binary 
variables (yes/no) based on the timing and recurrence of the depressive episode: resolved, 
persistent and post-CABG onset. To recapitulate, resolved depression participants were 
depressed at T1 (BDI ≥13), but not at T3, indicating a transient depressive episode. Persistent 
depressed participants were depressed at both T1 and T3 (BDI ≥13), indicating a persistent or 
chronic depressive episode. Finally, post-CABG depressed participants were depressed at T3 
but not at T1. These were all coded as dummy variables based on the presence or absence of 
the depression subtype (yes/no).  
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Multiple regression analyses were performed in order to assess the relationship 
between depression symptoms onset subtype and recovery outcomes after controlling for 
demographic and disease severity covariates, as well as baseline measures of the outcome 
variable for the anxiety and health status outcomes. Importantly, each onset subtype was 
studied in turn; for example, in the resolved depression analyses, participants with persistent 
and post-CABG onset depression were excluded. This enabled comparisons to be made 
between the presence of each depression subtype and never depressed participants.  
7.6.1 Emotional distress 
Multiple regression analyses were performed using T3 anxiety, as measured on the HADS, as 
the outcome variable. Resolved depression (t = -1.177, p = 0.242) was not significantly 
associated with T3 anxiety after controlling for baseline anxiety and demographic and disease 
severity covariates. However, persistent depression (t = 5.952, p <0.001) was statistically 
significant; results are displayed in Table 7.16. This relationship was positive such that the 
presence of persistent depression was significantly associated with greater anxiety two 
months after surgery, compared to those who were never depressed. The only other 
significant predictors in this model were baseline anxiety (t = 6.863, p <0.001) and household 
income (t = -2.015, p = 0.046), such that those participants with greater pre-operative anxiety 
and a lower annual income had greater anxiety two months after their surgery. The model 
accounted for 59.0% of variance (R2 = 0.590) in T3 anxiety scores. 
 
TABLE 7.16: MULTIPLE REGRESSION OF T3 ANXIETY ON PERSISTENT DEPRESSION  
Model B SE ß p 
Age 0.023 0.035 0.061 0.519 
Sex -0.358 0.651 -0.038 0.583 
Household income -0.326 0.162 -0.130 0.046 
euroSCORE -0.033 0.110 -0.030 0.766 
T1 Anxiety 0.387 0.056 0.470 <0.001 
Depression persistent 4.613 0.775 0.414 <0.001 
R
2
 = 0.590, N = 116 
 
In addition, post-CABG onset depression (t = 8.921, p <0.001) was also statistically 
significant in regression models; results are displayed in Table 7.17. This relationship was 
positive such that the presence of post-CABG onset depression was significantly associated 
with greater anxiety two months after surgery, compared to those who were never depressed. 
The only other significant predictors in this model were baseline anxiety (t = 7.196, p <0.001) 
and household income (t = -2.751, p = 0.007), such that those participants with greater pre-
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operative anxiety and a lower annual income had greater anxiety two months after their 
surgery. The model accounted for 58.3% of variance (R2 = 0.583) in T3 anxiety scores.  
 
TABLE 7.17: MULTIPLE REGRESSION OF T3 ANXIETY ON POST-CABG ONSET DEPRESSION  
Model B SE ß p 
Age 0.009 0.034 0.024 0.796 
Sex -0.185 0.687 -0.019 0.788 
Household income -0.450 0.163 -0.179 0.007 
euroSCORE -0.055 0.109 -0.050 0.618 
T1 Anxiety 0.417 0.058 0.452 <0.001 
Depression post-CABG onset 6.175 0.692 0.558 <0.001 
R
2
 = 0.583, N = 116 
 
7.6.2 Physical symptoms 
Sensory pain 
Multiple regression analyses were performed using T3 sensory pain, as measured on the MPQ-
SF, as the outcome variable. Resolved depression (t = 1.161, p = 0.248) was not significantly 
associated with T3 sensory pain after controlling for demographic and disease severity 
covariates. However, persistent depression (t = 2.458, p = 0.016) was statistically significant; 
results are displayed in Table 7.18. This relationship was positive such that the presence of 
persistent depression was significantly associated with greater sensory pain two months after 
surgery, compared to those who were never depressed. There were no other significant 
predictors in this model. The model accounted for 10.0% of variance (R2 = 0.100) in T3 sensory 
pain scores. 
 
TABLE 7.18: MULTIPLE REGRESSION OF T3 SENSORY PAIN ON PERSISTENT DEPRESSION  
Model B SE ß p 
Age 0.095 0.093 0.153 0.312 
Sex 1.721 1.650 0.104 0.299 
Household income -0.592 0.411 -0.141 0.152 
euroSCORE -0.339 0.282 -0.186 0.231 
Depression persistent 4.568 1.858 0.238 0.016 
R
2
 = 0.100, N = 112 
 
In addition, post-CABG onset depression (t = 4.908, p <0.001) was also statistically 
significant in regression models; results are displayed in Table 7.19. This relationship was 
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positive such that the presence of post-CABG onset depression was significantly associated 
with greater sensory pain two months after surgery, compared to those who were never 
depressed. There were no other significant predictors in this model. The model accounted for 
24.0% of variance (R2 = 0.240) in T3 sensory pain scores.  
 
TABLE 7.19: MULTIPLE REGRESSION OF T3 SENSORY PAIN ON POST-CABG ONSET 
DEPRESSION  
Model B SE ß p 
Age 0.118 0.093 0.170 0.206 
Sex 4.090 1.751 0.220 0.021 
Household income -0.797 0.428 -0.167 0.065 
euroSCORE -0.553 0.286 -0.271 0.056 
Depression post-CABG onset 9.055 1.845 0.420 <0.001 
R
2
 = 0.240, N = 112 
 
Affective pain 
Multiple regression analyses were performed using T3 affective pain, as measured on the 
MPQ-SF, as the outcome variable. Resolved depression (t = 0.841, p = 0.402) was not 
significantly associated with T3 affective pain after controlling for demographic and disease 
severity covariates. However, persistent depression (t = 3.628, p <0.001) was statistically 
significant; results are displayed in Table 7.20. This relationship was positive such that the 
presence of persistent depression was significantly associated with greater affective pain two 
months after surgery, compared to those who were never depressed. There were no other 
significant predictors in this model. The model accounted for 13.7% of variance (R2 = 0.137) in 
T3 affective pain scores. 
In addition, post-CABG onset depression (t = 5.782, p <0.001) was also statistically 
significant in regression models; results are displayed in Table 7.21. This relationship was 
positive such that the presence of post-CABG onset depression was significantly associated 
with greater affective pain two months after surgery, compared to those who were never 
depressed. There were no other significant predictors in this model. The model accounted for 
26.1% of variance (R2 = 0.261) in T3 affective pain scores.  
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TABLE 7.20: MULTIPLE REGRESSION OF T3 AFFECTIVE PAIN ON PERSISTENT DEPRESSION  
Model B SE ß p 
Age 0.003 0.032 0.014 0.923 
Sex -0.155 0.574 -0.026 0.788 
Household income -0.132 0.143 -0.088 0.359 
euroSCORE -0.016 0.098 -0.025 0.868 
Depression persistent 2.347 0.647 0.344 <0.001 
R
2
 = 0.137, N = 112 
 
TABLE 7.21: MULTIPLE REGRESSION OF T3 AFFECTIVE PAIN ON POST-CABG ONSET 
DEPRESSION  
Model B SE ß p 
Age 0.025 0.030 0.112 0.401 
Sex 0.222 0.568 0.036 0.698 
Household income -0.176 0.136 -0.115 0.198 
euroSCORE -0.143 0.091 -0.216 0.120 
Depression post-CABG onset 3.560 0.616 0.492 <0.001 
R
2
 = 0.261, N = 111 
 
 
Physical symptoms 
Next, multiple regression analyses were performed using T3 physical symptoms, as measured 
on the CROQ, as the outcome variable. Resolved depression (t = 0.030, p = 0.976) was not 
significantly associated with T3 physical symptoms after controlling for demographic and 
disease severity covariates. However, persistent depression (t = 0.191, p = 0.042) was 
statistically significant; results are displayed in Table 7.22. This relationship was positive such 
that the presence of persistent depression was significantly associated with greater physical 
symptoms two months after surgery, compared to those who were never depressed. 
Household income (t = -2.526, p = 0.013) was the only other significant predictor in this model, 
with a negative association such that those participants with a lower annual income reported 
greater physical symptoms. The model accounted for 11.2% of variance (R2 = 0.112) in T3 
physical symptom scores. 
In addition, post-CABG onset depression (t = 3.084, p = 0.003) was also statistically 
significant in regression models; results are displayed in Table 7.23. This relationship was 
positive such that the presence of post-CABG onset depression was significantly associated 
with greater physical symptoms two months after surgery, compared to those who were never 
depressed. Household income (t = -2.765, p = 0.013) was the only other significant predictor in 
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this model, with a negative association such that those participants with a lower annual 
income reported greater physical symptoms. The model accounted for 14.9% of variance (R2 = 
0.149) in T3 physical symptom scores.  
 
TABLE 7.22: MULTIPLE REGRESSION OF T3 PHYSICAL SYMPTOMS ON PERSISTENT 
DEPRESSION  
Model B SE ß p 
Age 0.114 0.115 0.137 0.322 
Sex 0.560 2.128 0.026 0.793 
Household income -1.346 0.533 -0.238 0.013 
euroSCORE -0.235 0.346 -0.098 0.498 
Depression persistent 4.872 2.372 0.191 0.042 
R
2
 = 0.112, N = 118 
 
TABLE 7.23: MULTIPLE REGRESSION OF T3 PHYSICAL SYMPTOMS ON POST-CABG ONSET 
DEPRESSION  
Model B SE ß p 
Age 0.116 0.112 0.135 0.301 
Sex 1.521 2.246 0.067 0.500 
Household income -1.489 0.539 -0.254 0.007 
euroSCORE -0.258 0.345 -0.105 0.455 
Depression post-CABG onset 7.084 2.297 0.271 0.003 
R
2
 = 0.149, N = 118 
 
7.6.3 Health status 
Physical health status 
Multiple regression analyses were next performed using T3 physical health status, as 
measured on the SF-12, as the outcome variable. Both resolved depression (t = 0.465, p = 
0.643) and persistent depression (t = -0.759, p = 0.450) were not significantly associated with 
T3 physical health status after controlling for demographic and disease severity covariates and 
baseline SF-12 physical scores. However, post-CABG onset depression (t = -3.598, p <0.001) 
was statistically significant in a regression model; results are displayed in Table 7.24. This 
relationship was negative such that the presence of post-CABG onset depression was 
significantly associated with lower physical health status two months after surgery, compared 
to those who were never depressed. Interestingly, baseline SF-12 physical score (t = 0.750, p = 
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0.455) was not a significant predictor in this model. The model accounted for 15.5% of 
variance (R2 = 0.155) in T3 physical health status scores.  
 
TABLE 7.24: MULTIPLE REGRESSION OF T3 PHYSICAL HEALTH STATUS ON POST-CABG 
ONSET DEPRESSION  
Model B SE ß p 
Age -0.204 0.130 -0.212 0.120 
Sex -5.391 2.602 -0.213 0.041 
Household income 0.082 0.610 0.013 0.893 
euroSCORE 1.052 0.394 0.386 0.009 
T1 Physical health status 0.056 0.074 0.069 0.455 
Depression post-CABG onset -9.250 2.571 -0.319 <0.001 
R
2
 = 0.155, N = 117 
 
Mental health status 
Multiple regression analyses were performed using T3 mental health status, as measured on 
the SF-12, as the outcome variable. Resolved depression (t = 0.798, p = 0.427) was not 
significantly associated with T3 mental health status after controlling for demographic and 
disease severity covariates and baseline SF-12 mental scores. However, persistent depression 
(t = -3.419, p = 0.001) was statistically significant; results are displayed in Table 7.25. This 
relationship was negative such that the presence of persistent depression was significantly 
associated with lower mental health status two months after surgery, compared to those who 
were never depressed. Baseline SF-12 mental score (t = 4.198, p <0.001) was the only other 
significant predictor in this model, with a positive association such that those participants with 
higher mental health status prior to surgery also had higher mental health status after surgery. 
The model accounted for 29.3% of variance (R2 = 0.293) in T3 mental health status scores. 
In addition, post-CABG onset depression (t = 4.226, p <0.001) was also statistically 
significant in regression models; results are displayed in Table 7.26. This relationship was 
negative such that the presence of post-CABG onset depression was significantly associated 
with lower mental health status two months after surgery, compared to those who were never 
depressed. Baseline SF-12 mental health status score (t = 3.823, p <0.001) was the only other 
significant predictor in this model, with a positive association such that those participants with 
higher mental health status prior to surgery also had higher mental health status after surgery. 
The final model accounted for 24.7% of variance (R2 = 0.247) in T3 mental health status scores.  
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TABLE 7.25: MULTIPLE REGRESSION OF T3 MENTAL HEALTH STATUS ON PERSISTENT 
DEPRESSION  
Model B SE ß p 
Age -0.081 0.102 -0.103 0.428 
Sex -1.119 1.813 -0.055 0.538 
Household income -0.276 0.458 -0.052 0.548 
euroSCORE 0.004 0.303 0.002 0.989 
T1 Mental health status 0.430 0.103 0.369 <0.001 
Depression persistent -7.226 2.113 -0.302 0.001 
R
2
 = 0.293, N = 117 
 
TABLE 7.26: MULTIPLE REGRESSION OF T3 MENTAL HEALTH STATUS ON POST-CABG ONSET 
DEPRESSION  
Model B SE ß p 
Age -0.078 0.102 -0.099 0.449 
Sex -1.476 1.952 -0.071 0.451 
Household income -0.282 0.472 -0.053 0.552 
euroSCORE -0.017 0.311 -0.008 0.957 
T1 Mental health status 0.405 0.106 0.328 <0.001 
Depression post-CABG onset -8.355 1.977 -0.353 <0.001 
R
2
 = 0.247, N = 117 
 
7.6.4 Summary 
The results using depression onset subtypes have consistently shown that persistent and post-
CABG onset depression subtypes were significantly associated with poorer recovery outcomes 
at T3. In contrast, resolved depression cases were not significantly associated with recovery 
following CABG surgery. However, several caveats need to be borne in mind in summarising 
these results. Firstly, these analyses involved only a small number of depression cases, for each 
of the subtypes respectively. Therefore, these results only indicate preliminary findings and 
warrant further investigation when the full sample becomes available. Secondly, these 
analyses do not demonstrate a prospective relationship between depression and recovery, but 
rather reveal the importance of the cross-sectional association between T3 depression 
symptoms and T3 recovery outcomes. These analyses will benefit from the 12-month follow-
up data to test the effect of depression onset on physical and mental adaptation up to one 
year post-CABG. As such, while these analyses have produced some interesting findings, 
depression onset subtypes will not be investigated in the analyses of mediation. Instead the 
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mediation analyses will be limited to the prospective association between depression 
symptom subtypes, as measured at baseline, and later recovery.  
7.7 Mechanisms  
Candidate mechanisms were identified in the literature review and in Chapter 6 to involve 
several biopsychosocial pathways. This PhD tests the role of three possible mechanistic 
pathways: social-behavioural factors, cognitive factors and biology. All of these candidate 
mechanisms were based on measures taken at T1, except for inflammatory markers which 
were assessed at T1 and T2. Although descriptive data are presented at each time point a 
measure was used, this is merely to characterise these measures; only the T1 (and T2 for 
inflammatory markers) measurement point was used as a mechanism variable in this chapter. 
Each of the mechanisms are described in turn below, followed by analyses of their association 
with depression symptoms and the outcome variables, before finally including them in 
multivariate regression models.   
In order to directly test mediation, the Sobel test method was implemented using the 
method set out by Preacher and Hayes (Preacher & Hayes, 2004, 2008). This method has 
previously been described in Chapter 6 (Section 6.6). The models included depression 
symptoms subtype score as the independent variable and the T3 recovery outcome as the 
dependent variable, with candidate mechanisms entered as the mediator. Covariates included 
age, sex, household income, euroSCORE, and for models predicting T2 anxiety and health 
status, baseline scores on these measures were also controlled for. A second approach was 
also taken to estimate the significance of the indirect effect. The change in the amount of 
variance explained by depression symptoms before and after the addition of the candidate 
mechanism in the models was estimated by calculating the percentage change: 1-(T3 β/ T1 β). 
Since depression symptoms were significant predictors of affective and sensory pain, physical 
symptoms and health status, these outcomes were used in analyses of mediation.  
7.7.1 Behavioural and social mechanisms 
7.7.1.1 Descriptive statistics 
As shown in Chapter 6, social-behavioural factors were relevant to both depression symptoms 
and poorer recovery outcomes. In particular, physical activity and smoking were identified as 
important predictors of poorer early-term recovery. Therefore, this chapter will again examine 
the role of social-behavioural factors to include: physical activity, smoking, alcohol intake, 
sleep and social support. Importantly, sleep must be remembered as a symptom of depression, 
and therefore there are conceptual difficulties in describing sleep as a candidate mediator of 
the depression symptoms-recovery relationship. Given that cognitive/affective depression 
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symptoms were not a significant predictor of any of the T3 recovery outcomes, sleep was not 
assessed as a mediator, but instead has been included here to show associations with the 
recovery outcomes. 
 
TABLE 7.27: SOCIAL-BEHAVIOURAL MECHANSIMS AT T1 AND T3 
Measures N 
T1 T3 
p Mean ± SD 
or   n (%) 
Mean ± SD or   
n (%) 
Health behaviour     
BMI (kg/m
2
) 154 27.97±3.76 - - 
Current smoker 151 11 (7.3) 3 (2.0) <0.001* 
Alcohol consumption (units/week) 153 9.63±13.86 6.61±14.52 <0.001 
Physical activity (hours/week) 138 3.30±4.02 3.43±3.06 0.700 
Sleep total 152 9.61±6.87 10.39±7.11 0.166 
Sleep  items     
1. Trouble falling asleep 152 1.16±1.59 1.39±1.61 0.070 
2. Waking during night 152 2.65±1.87 2.88±1.79 0.146 
3. Trouble staying asleep 152 2.16±1.99 2.24±1.83 0.562 
4. Waking feeling tired/ worn out 152 1.55±1.69 1.59±1.55 0.787 
5. Disturbed/restless sleep 152 2.11±1.88 2.30±1.80 0.223 
Social support     
Social support (ESSI) 152 28.99±5.58 29.78±5.22 0.024 
*Chi-square statistic 
 
The descriptive statistics for the social-behavioural candidate mechanisms are 
displayed in Table 7.27; dependent t-tests were performed to compare mean baseline and 
follow-up scores, with chi-square analysis for frequency comparisons. The majority of the 
sample was overweight at baseline, with a mean BMI of 27.97 kg/m2. The majority of the 
sample drank alcohol moderately, within the UK government recommended guidelines, 
however one participant reported drinking heavily with an estimated 148 units of alcohol per 
week. Overall, there was a significant decline in mean alcohol intake from T1 to T3. Only 7.3% 
of participants were current smokers prior to surgery and this fell to just 2.0% after surgery; a 
chi-square analysis showed this to be a significant decline (2 = 38.956, df = 1, n = 151, p 
<0.001). On average, participants walked for 3.30 hours per week at T1 and this did not 
significantly change following surgery.  Data from the Jenkins sleep questionnaire show that 
participants frequently experienced sleep disturbances prior to surgery, with the symptoms of 
waking several times during the night, trouble staying asleep and disturbed or restless sleep 
being most commonly reported. Sleep symptom reporting did not significantly differ following 
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surgery compared to before. Finally, social support scores significantly increased over time, 
suggesting participants generally perceived higher levels of social support after surgery than 
before. 
7.7.1.2 Associations with depression symptoms and recovery variables 
Pearson’s correlation analyses were performed to assess whether the candidate mechanisms 
were associated with depression symptoms (Table 7.28). To clarify, smoking was entered as a 
binary value (yes/no) to reflect current smoking status in these analyses. Although only 
somatic/affective depression symptoms were associated with T3 recovery outcomes, 
associations between social-behavioural factors and all the depression symptom scores on the 
BDI and recovery outcomes were tested to explore the data in detail. Results of these 
correlation analyses show smoking status, sleep problems and social support were all 
associated with depression symptom subtypes. However, physical activity, alcohol intake and 
BMI were not significantly associated with depression symptoms. Independent t-tests 
confirmed the difference between depressed/non-depressed participants (BDI ≥13) on sleep 
scores (t(136) = -3.519, p = 0.001), and social support scores (t(135) = 2.265, p = 0.025), but 
chi-square tests found no difference in smoking status (2 = 2.66, df = 1, p = 0.103). In addition, 
independent t-tests found no difference between depressed/non-depressed participants in 
terms of BMI (t(136) = 0.091, p = 0.927) and weekly alcohol intake (t(135)= 0.998, p = 0.320), 
but did find a significant difference in physical activity levels (t(128)= 2.270, p = 0.025). The 
latter finding shows that non-depressed participants were more physically active than 
depressed participants.  
Pearson’s correlation analyses were also performed to assess the association of these 
social-behavioural factors with the recovery outcomes. However, no significant associations 
were found for any of the social-behavioural factors. Regression analyses were also performed 
to assess whether the social-behavioural factors predicted any of the recovery outcomes after 
controlling for demographic and disease severity covariates. Anxiety and health status models 
also controlled for baseline scores on these measures. Statistically, the correlation coefficient 
represents the linear dependence between the predictor and outcome variable, but it does not 
control for the fact that other factors may also account for the relationship, potentially 
producing a biased estimate.  
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TABLE 7.28: PEARSON’S CORRELATIONS OF T1 SOCIAL-BEHAVIOURAL FACTORS AND T1 
DEPRESSION SYMPTOMS 
Measure 
T1 BDI 
total 
T1 BDI 
somatic 
T1 BDI 
cognitive 
Health behaviour    
T1 BMI  
r 
p 
0.112 
0.168 
0.101 
0.215 
0.069 
0.394 
T1 Smoking 
r 
p 
-0.210
 
0.010 
-0.239
 
0.003 
-0.184
 
0.023 
T1 Alcohol consumption 
r 
p 
-0.126 
0.122 
-0.140 
0.086 
-0.046 
0.572 
T1 Physical activity – walking 
r 
p 
-0.130 
0.123 
-0.141 
0.096 
-0.143 
0.089 
T1 Sleep  
r 
p 
0.396
 
<0.001 
0.422
 
<0.001 
0.290
 
<0.001 
Social support    
T1 Social support  
r 
p 
-0.378
 
<0.001 
-0.369
 
<0.001 
-0.369
 
<0.001 
 
 
Results found that baseline BMI was a significant predictor of T3 sensory pain (t = 
2.450, p = 0.016) after controlling for covariates, with a positive relationship such that a higher 
BMI was associated with greater pain following surgery. Physical activity was significantly 
associated with anxiety at T3 (t = 2.149, p = 0.034) and was borderline significantly associated 
with affective pain at T3 (t = 1.963, p = 0.052), with greater time spent walking per week being 
predictive of greater anxiety and more affective pain. This is an interesting finding and not easy 
to interpret, given lower physical activity was related to greater emotional distress at T2 
(Chapter 6). Finally, baseline sleep problems were a significant predictor of CROQ physical 
symptoms at T3 (t = 3.120, p = 0.002) and physical health status at T3 (t = -3.175, p = 0.002). 
The association with physical symptoms was positive such that greater sleep problems were 
associated with more physical symptoms, while the association with health status was 
negative such that greater sleep problems were predictive of poorer physical health status. No 
other significant predictors of recovery were found. These significant predictors were 
examined as potential mediators of the depression symptoms-recovery relationship. 
 
 
249 
 
7.7.1.3 Mediation models of T3 emotional distress 
 
TABLE 7.29: HIERARCHICAL REGRESSION OF T3 ANXIETY ON T1 PHYSICAL ACTIVITY AND T1 
TOTAL BDI SCORE  
Model B SE ß p 
Step 1     
Age -0.038 0.047 -0.093 0.422 
Sex -0.969 0.855 -0.093 0.259 
Household income -0.373 0.213 -0.134 0.082 
euroSCORE 0.125 0.148 0.103 0.400 
T1 anxiety 0.398 0.081 0.443 <0.001 
T1 BDI total score 0.090 0.058 0.140 0.125 
Step 2     
Age -0.028 0.046 -0.070 0.542 
Sex -0.700 0.847 -0.067 0.410 
Household income -0.372 0.209 -0.134 0.077 
euroSCORE 0.116 0.145 0.095 0.427 
T1 anxiety 0.398 0.080 0.443 <0.001 
T1 BDI total score 0.104 0.057 0.163 0.072 
T1 Physical activity - walking 0.161 0.068 0.173 0.019 
Step 1 R
2
 = 0.336; Step 2 R
2
 = 0.365; N = 134 
 
A regression model was built using the hierarchical method in which predictor variables were 
entered in steps, to assess the relative contribution of physical activity to the depression 
symptoms-T3 anxiety relationship. Depression symptom subtypes were used in separate 
models. The final model using total BDI score, is displayed in Table 7.29 confirming the earlier 
presented results that T1 total BDI score (t = 1.814, p = 0.072) was not a significant predictor of 
T3 anxiety. However, T1 physical activity was a significant predictor (t = 2.374, p = 0.019), with 
a positive association such that the most active participants at baseline, had greater anxiety 
following surgery. This is counterintuitive and does not support the findings demonstrated in 
Chapter 6 whereby greater physical activity at T1 was predictive of lower anxiety levels at T2. 
Similar findings were also found using T1 cognitive/affective depression symptom scores as a 
predictor of T3 anxiety, such that baseline physical activity (t = 2.275, p = 0.025) was a 
significant predictor in the final model, but not T1 cognitive/affective depression symptoms (t 
= 1.814, p = 0.311). Since baseline total BDI and cognitive/affective depression symptoms were 
not significant predictors of T3 anxiety, Sobel tests of mediation were not conducted.   
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TABLE 7.30: HIERARCHICAL REGRESSION OF T3 ANXIETY ON T1 PHYSICAL ACTIVITY AND T1 
SOMATIC/AFFECTIVE BDI SCORE  
Model B SE ß p 
Step 1     
Age -0.040 0.046 -0.099 0.386 
Sex -1.044 0.847 -0.100 0.220 
Household income -0.359 0.210 -0.129 0.090 
euroSCORE 0.118 0.146 0.097 0.423 
T1 anxiety 0.374 0.078 0.416 <0.001 
T1 BDI somatic 0.172 0.076 0.198 0.025 
Step 2     
Age -0.031 0.045 -0.077 0.494 
Sex -0.771 0.838 -0.074 0.359 
Household income -0.359 0.206 -0.129 0.084 
euroSCORE 0.108 0.144 0.089 0.454 
T1 anxiety 0.374 0.077 0.417 <0.001 
T1 BDI somatic 0.190 0.074 0.219 0.012 
T1 Physical activity - walking 0.165 0.067 0.177 0.015 
Step 1 R
2
 = 0.350; Step 2 R
2
 = 0.380; N = 134 
 
Next, a hierarchical regression model was built adjusting for somatic/affective 
depression symptoms (Table 7.30). The model shows that T1 anxiety (t = 4.760, p <0.001) and 
T1 somatic/affective depression symptoms (t = 2.276, p = 0.025) were the only significant 
predictors of T3 anxiety in step 1 adjusted for covariates. After adding T1 hours spent walking 
per week into the model, T1 anxiety (t = 4.864, p <0.001) and T1 somatic/affective depression 
symptoms (t = 2.552, p = 0.012) remained significant predictors. In addition, T1 physical 
activity was also a significant predictor (t = 2.464, p = 0.015), with a positive association such 
that the most active participants at baseline, had greater anxiety following surgery. This is in 
line with results using baseline total BDI and cognitive/affective depression symptom scores. 
The final model accounted for 38.0% (R2 = 0.380) of variance in T3 anxiety scores. Looking at 
the standardised regression coefficient (β) for depression symptoms shows that with the 
inclusion of T1 physical activity in the model, the β for depression symptoms changed from 
0.198 to 0.219. This indicates that when physical activity was included in the model, there was 
a 10.6% increase in the size of β for T1 somatic/affective depression symptoms. However, 
since T1 somatic/affective depression symptoms (t = -1.116, p = 0.266) were not significantly 
associated with T1 physical activity in a covariate adjusted model, a Sobel test was not 
conducted.  
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7.7.1.4 Mediation models of T3 physical symptoms 
BMI 
TABLE 7.31: HIERARCHICAL REGRESSION OF T3 SENSORY PAIN ON T1 BMI AND T1 TOTAL 
BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.033 0.100 0.048 0.738 
Sex 2.193 1.834 0.111 0.234 
Household income -0.508 0.432 -0.106 0.241 
euroSCORE -0.091 0.311 -0.042 0.770 
T1 BDI total score 0.185 0.100 0.164 0.068 
Step 2     
Age 0.024 0.098 0.034 0.808 
Sex 1.136 1.865 0.057 0.544 
Household income -0.627 0.429 -0.130 0.146 
euroSCORE 0.024 0.311 0.011 0.939 
T1 BDI total score 0.166 0.099 0.147 0.096 
T1 BMI 0.339 0.150 0.201 0.025 
Step 1 R
2
 = 0.052; Step 2 R
2
 = 0.089; N = 136 
 
The next regression model to be built used the hierarchical method in which predictor 
variables were entered in steps, to assess the relative contribution of baseline BMI to the 
depression symptoms-T3 sensory pain relationship. Depression symptom subtypes were used 
in separate models. The final model using T1 total BDI score is displayed in Table 7.31 and 
confirms the earlier presented results that T1 total BDI score (t = 1.675, p = 0.096) was not a 
significant predictor of T3 sensory pain. However, T1 BMI was a significant predictor (t = 2.266, 
p = 0.025), with a positive association such that the participants with higher BMIs, had greater 
sensory pain after surgery. There were no other significant predictors in this model. Similar 
findings were also found using T1 cognitive/affective depression symptom scores as a 
predictor of T3 sensory pain, such that BMI (t = 2.432, p = 0.016) was a significant predictor in 
the final model, but not cognitive/affective depression symptoms (t = 0.510, p = 0.611). Since, 
baseline total BDI and cognitive/affective depression symptoms were not significant predictors 
of sensory pain, Sobel tests of mediation were not conducted.  
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TABLE 7.32: HIERARCHICAL REGRESSION OF T3 SENSORY PAIN ON T1 BMI AND T1 
SOMATIC/AFFECTIVE BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.032 0.098 0.046 0.744 
Sex 2.192 1.823 0.111 0.232 
Household income -0.501 0.430 -0.104 0.246 
euroSCORE -0.115 0.310 -0.054 0.711 
T1 BDI somatic 0.300 0.136 0.193 0.029 
Step 2     
Age 0.024 0.096 0.034 0.805 
Sex 1.145 1.854 0.058 0.538 
Household income -0.618 0.426 -0.129 0.149 
euroSCORE -0.001 0.309 -0.001 0.996 
T1 BDI somatic 0.278 0.134 0.178 0.040 
T1 BMI 0.336 0.149 0.199 0.025 
Step 1 R
2
 = 0.063; Step 2 R
2
 = 0.099; N = 136 
 
A hierarchical regression model was also built adjusting for baseline somatic/affective 
depression symptoms (Table 7.32). The model shows that T1 somatic/affective depression 
symptoms (t = 2.212, p = 0.029) were the only significant predictor of T3 sensory pain in step 1 
adjusted for covariates. After adding BMI into the model, T1 somatic/affective depression 
symptoms (t = 2.071, p = 0.040) remained a significant predictor. In addition, BMI was also a 
significant predictor (t = 2.263, p = 0.025), with a positive association such that the most 
overweight participants at baseline, had greater sensory pain following surgery. The final 
model accounted for 9.9% (R2 = 0.099) of variance in T3 sensory pain scores. Looking at the 
standardised regression coefficient (β) for depression symptoms shows that with the inclusion 
of BMI in the model, the β for depression symptoms changed from 0.193 to 0.178. This 
indicates that when T1 physical activity was included in the model, there was a 7.8% reduction 
in the size of β for T1 somatic/affective depression symptoms. However, in a separate 
regression model using baseline BMI as the dependent variable to assess the association with 
T1 somatic/affective depression symptoms, after adjusting for disease severity and 
demographic covariates, T1 somatic/affective depression symptom score (t = 0.930, p = 0.350) 
was not significant. Therefore, a Sobel test of mediation was not performed. 
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Physical activity 
 
TABLE 7.33: HIERARCHICAL REGRESSION OF T3 AFFECTIVE PAIN ON T1 PHYSICAL ACTIVITY 
AND T1 TOTAL BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.001 0.035 0.004 0.977 
Sex -0.529 0.652 -0.077 0.419 
Household income -0.136 0.156 -0.082 0.385 
euroSCORE -0.015 0.110 -0.020 0.892 
T1 BDI total score 0.074 0.038 0.177 0.057 
Step 2     
Age 0.009 0.035 0.036 0.805 
Sex -0.345 0.647 -0.050 0.595 
Household income -0.137 0.153 -0.082 0.373 
euroSCORE -0.024 0.108 -0.032 0.825 
T1 BDI total score 0.084 0.038 0.202 0.028 
T1 Physical activity 0.111 0.049 0.201 0.026 
Step 1 R
2
 = 0.045; Step 2 R
2
 = 0.083; N = 127 
 
The hierarchical regression method was again used to assess the relative contribution of 
physical activity to the depression symptoms-T3 affective pain relationship. Depression 
symptom subtypes were used in separate models. First, total BDI score was used; results are 
displayed in Table 7.33. Step 1 of the model confirms the earlier presented results that total 
BDI score was not a significant predictor of affective pain (t = 1.924, p = 0.057). However, in 
step 2, after the addition of physical activity to the model, total BDI score (t = 2.217, p = 0.028) 
was a significant predictor of T3 affective pain. In addition, T1 hours spent walking per week 
was a significant predictor (t = 2.250, p = 0.026), with a positive association such that the most 
active participants had greater affective pain two months after surgery. Although 
counterintuitive, this finding is in line with the results previously presented which showed 
greater physical activity at T1 was associated with greater anxiety at T3 (Section 7.7.1.3). There 
were no other significant predictors in this model. Looking at the standardised regression 
coefficient (β) for depression symptoms shows that with the inclusion of physical activity in the 
model, the β for depression symptoms changed from 0.177 to 0.202. This indicates that when 
physical activity was included in the model, there was a 14.1% increase in the size of β for total 
BDI depression symptom score. However, in a separate regression model using baseline 
physical activity as the dependent variable to assess the association with T1 total BDI 
depression symptoms, after adjusting for disease severity and demographic covariates, total 
254 
 
BDI depression symptoms (t = -1.401, p = 0.163) were not significant. Therefore, a Sobel test of 
mediation was not performed.  
Next, a hierarchical regression model was built adjusting for somatic/affective 
depression symptoms (Table 7.34). The model shows that T1 somatic/affective depression 
symptoms (t = 2.633, p = 0.010) were the only significant predictor of T3 sensory pain in step 1 
adjusted for covariates. After adding T1 physical activity into the model, T1 somatic/affective 
depression symptoms (t = 2.949, p = 0.004) remained a significant predictor. In addition, 
physical activity was also a significant predictor (t = 2.365, p = 0.020), again with a positive 
association such that the most active participants at baseline, had greater affective pain 
following surgery. The final model accounted for 11.0% (R2 = 0.110) of variance in T3 affective 
pain scores. Looking at the standardised regression coefficient (β) for depression symptoms 
shows that with the inclusion of physical activity in the model, the β for depression symptoms 
changed from 0.236 to 0.261. This indicates that when physical activity was included in the 
model, there was a 10.6% increase in the size of β for T1 somatic/affective BDI depression. 
However, in a separate regression model using baseline physical activity as the dependent 
variable to assess the association with T1 somatic/affective depression symptoms, after 
adjusting for disease severity and demographic covariates, T1 somatic/affective depression 
symptoms (t = -1.369, p = 0.173) were not significant. Therefore, a Sobel test of mediation was 
not performed.  
 
TABLE 7.34: HIERARCHICAL REGRESSION OF T3 AFFECTIVE PAIN ON T1 PHYSICAL ACTIVITY 
AND T1 SOMATIC/AFFECTIVE BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.001 0.034 0.006 0.968 
Sex -0.518 0.644 -0.076 0.423 
Household income -0.124 0.154 -0.074 0.422 
euroSCORE -0.027 0.109 -0.036 0.806 
T1 BDI somatic 0.133 0.051 0.236 0.010 
Step 2     
Age 0.009 0.034 0.036 0.798 
Sex -0.328 0.637 -0.048 0.607 
Household income -0.125 0.151 -0.075 0.408 
euroSCORE -0.036 0.107 -0.049 0.734 
T1 BDI somatic 0.148 0.050 0.261 0.004 
T1 Physical activity 0.115 0.049 0.208 0.020 
Step 1 R
2
 = 0.069; Step 2 R
2
 = 0.110; N = 127 
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Findings using T1 cognitive/affective depression symptom scores as a predictor of T3 
affective pain, showed that T1 physical activity (t = 2.123, p = 0.036) was a significant predictor 
in the final model, but not cognitive/affective depression symptoms (t = 1.105, p = 0.271). 
Since, T1 cognitive/affective depression symptoms were not a significant predictor of affective 
pain, a Sobel test was not conducted.   
 
Sleep 
To reiterate, since sleep is a symptom of depression, the Jenkins score was only included in 
these analyses to assess its association with the recovery outcomes. A regression model was 
built to assess the contribution of baseline self-reported sleep problems in explaining T3 
physical symptoms (Table 7.35). The model shows that T1 sleep was a significant predictor (t = 
2.493, p = 0.014) after controlling for baseline depression symptoms and demographic and 
disease severity covariates. The only other significant predictor in the final model was 
household income (t = -2.206, p = 0.029). This model suggests that those participants with 
poorer T1 sleep and lower annual income had greater physical symptoms two months after 
surgery. The final model accounted for 11.2% (R2 = 0.112) of variance in CROQ physical 
symptom scores. Individual regression models were also built entering each of the T1 Jenkins 
items individually to predict physical symptoms at T3. In these analyses, after controlling for 
demographic and disease severity covariates as well as baseline total BDI score, only items 3 
(trouble staying asleep) (t = 2.141, p = 0.034) and 5 (disturbed or restless sleep) (t = 2.988, p = 
0.003) were significant independent predictors of greater physical symptoms after surgery.  
Similar results were also found using T1 somatic/affective depression symptoms, such 
that T1 sleep (t = 2.228, p = 0.028) and household income (t = -2.206, p = 0.029) were 
significant predictors after controlling for baseline depression symptoms and demographic and 
disease severity covariates. The model using T1 cognitive/affective depression symptoms was 
also in line with these results, such that T1 sleep (t = 3.008, p = 0.003) and household income (t 
= -2.240, p = 0.027) were significant predictors after controlling for baseline depression 
symptoms and demographic and disease severity covariates. Interestingly, using the individual 
T1 Jenkins items in separate regression models found only item 5 (disturbed or restless sleep) 
(t = 2.769, p = 0.006) to be a significant independent predictor of greater physical symptoms at 
T3, after adjusting for demographic, disease severity and T1 somatic/affective BDI score 
covariates. In contrast, in the models adjusting for demographic and disease severity 
covariates and T1 cognitive/affective BDI score, all the items except item 1 (trouble falling 
asleep) were significant predictors of greater physical symptoms at T3: item 2 (waking during 
the night) (t = 2.136, p = 0.034), item 3 (trouble staying asleep) (t = 2.491, p = 0.014), item 4  
(waking feeling tired/worn out) (t = 2.394, p = 0.018), and item 5 (disturbed or restless sleep) (t 
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= 3.428, p = 0.001). In summary, greater sleep problems at T1 were significantly associated 
with greater physical symptoms two months after surgery in models controlling for covariates 
and baseline total BDI, somatic/affective, cognitive/affective depression symptom scores. In 
particular, the individual sleep problems specifically related to physical symptoms varied 
according to the depression subtype included in the model. Nevertheless, it appeared that 
items related to difficulty in maintaining sleep were the best predictors of physical symptoms, 
as opposed to problems initiating sleep.  
 
TABLE 7.35: MULTIPLE REGRESSION OF T3 PHYSICAL SYMPTOMS ON T1 SLEEP PROBLEMS 
AND T1 TOTAL BDI SCORE  
Model B SE ß p 
Age 0.056 0.108 0.066 0.607 
Sex 1.159 2.032 0.051 0.569 
Household income -1.090 0.494 -0.188 0.029 
euroSCORE -0.127 0.336 -0.051 0.705 
T1 BDI total score 0.072 0.120 0.056 0.546 
T1 Sleep 0.253 0.102 0.225 0.014 
R
2
 = 0.112; N = 144 
 
7.7.1.5 Mediation models of T3 health status 
Sleep was next assessed as an independent predictor of T3 physical health status (Table 7.36). 
The model shows that T1 sleep was a significant predictor (t = -2.330, p = 0.021) after 
controlling for baseline depression symptoms and demographic and disease severity 
covariates. The only other significant predictors in the final model were sex (t = -2.242, p = 
0.027) and euroSCORE (t = 2.476, p = 0.015). This model suggests that those participants with 
poorer sleep, female sex and lower mortality risk had lower physical health status two months 
after surgery. The final model accounted for 11.7% (R2 = 0.117) of variance in physical health 
status scores. Separate regression analyses were also performed entering each of the baseline 
Jenkins items individually to predict T3 physical health status, controlling for demographic and 
disease severity covariates and baseline total BDI score. These analyses showed that item 2 
(waking during the night) (t = -2.737, p = 0.007) was a significant predictor, and item 3 (trouble 
staying sleep) (t = -1.967, p = 0.051) approached being a significant predictor, of lower physical 
health status following CABG.   
Similar results were also found using T1 somatic/affective depression symptoms, such 
that T1 sleep (t = -2.082, p = 0.039) and euroSCORE (t = 2.557, p = 0.012) were significant 
predictors after controlling for baseline depression symptoms and demographic and disease 
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severity covariates. Again, the euroSCORE relationship was positive suggesting those 
participants with lower mortality risk had poorer physical health status. The model using T1 
cognitive/affective depression symptoms were also in line with these results, such that T1 
sleep (t = -2.968, p = 0.004), sex (t = -2.763, p <0.001) and euroSCORE (t = 2.443, p = 0.016) 
were significant predictors after controlling for baseline depression symptoms and 
demographic and disease severity covariates. Separate regression analyses using the individual 
items of the T1 Jenkins questionnaire in covariate adjusted models were also performed. 
These analyses showed that the baseline score on item 2 (waking during the night) (t = -2.737, 
p = 0.007) was the only significant predictor of lower physical health status following CABG in 
models using somatic/affective depression symptoms. However, in the models using 
cognitive/affective depression symptoms, both items 2 (waking during the night) (t = -3.291, p 
= 0.001) and 3 (trouble staying sleep) (t = -2.421, p = 0.017) at T1 were significant predictors of 
lower physical health status at T3. In summary, these results suggest that poorer pre-CABG 
sleep was a significant independent predictor of lower T3 physical health status, in models 
adjusting for all depression symptom subtypes. In particular, problems maintaining sleep prior 
to surgery were particularly important for predicting poorer physical health status after 
surgery.  
 
TABLE 7.36: MULTIPLE REGRESSION OF T3 PHYSICAL HEALTH STATUS ON T1 SLEEP 
PROBLEMS AND T1 TOTAL BDI SCORE  
Model B SE ß p 
Age -0.192 0.122 -0.211 0.116 
Sex -5.079 2.265 -0.210 0.027 
Household income 0.066 0.539 0.011 0.902 
euroSCORE 0.915 0.369 0.340 0.015 
T1 BDI total score -0.003 0.071 -0.004 0.963 
T1 Physical health status -0.131 0.132 -0.095 0.323 
T1 Sleep -0.263 0.113 -0.218 0.021 
R
2
 = 0.117; N = 143 
 
7.7.2 Cognitive mechanisms 
7.7.2.1 Descriptive statistics 
Chapter 6 identified the importance of negative illness perceptions for mediating the 
relationship between greater pre-operative depression symptoms and poorer early-term 
recovery. The following analyses sought to replicate these findings using the two month post-
surgery recovery endpoints.  
258 
 
Cognitive function and illness perceptions were considered as cognitive mechanisms of 
the depression symptoms-recovery relationship; descriptive statistics of these measures are 
displayed in Table 7.37, p represents the significance value in dependent t-tests for total BIPQ 
scores and individual BIPQ items. The mean score on the MoCA was below the cut-off of 26, 
with 43.2% of the sample scoring ≤25. Scores on the individual items of the BIPQ are also 
displayed in Table 7.37. Please note that items 3, 4 and 7 have been reverse coded, so higher 
means reflect a more negative illness perception for all items. Total scores on the BIPQ reveal 
that participants held a less negative view of their illness over time, with significant decreases 
in items 3 (personal control), 5 (identity), 6 (concern) and 8 (emotional response). These items 
reflect that participants perceived more control over their illness experienced less symptoms 
from their illness, were less concerned about their illness, and were less emotionally affected 
by their illness, two months after surgery than before. Interestingly, a significant increase was 
found for item 4 (treatment control), suggesting participants had a more negative view of 
treatment for their illness after surgery than before.   
 
TABLE 7.37: COGNITIVE MECHANISMS AT T1 AND T3 
Cognitive factors N 
T1 T3 
p 
Mean ± SD Mean ± SD 
Cognitive screen (MoCA) 146 25.20±3.43 - - 
Illness perceptions total 154 34.88±11.18 27.85±14.01 <0.001 
Illness perceptions items     
1. Consequences 153 5.58±2.91 5.19±2.91 0.182 
2. Timeline 153 4.22±2.90 4.36±3.00 0.623 
3. Personal control 154 5.86±2.87 4.31±2.81 <0.001 
4. Treatment control 154 1.11±1.45 1.56±1.74 0.005 
5. Identity 154 4.81±2.73 3.49±2.81 <0.001 
6. Concern 153 7.08±2.79 4.38±3.15 <0.001 
7. Understanding 151 1.48±1.91 1.79±2.07 0.072 
8. Emotional response 152 4.66±3.05 2.86±2.82 <0.001 
 
7.7.2.2 Associations with depression symptoms and recovery variables 
Pearson’s correlation analyses were performed to analyse the association between depression 
symptoms subtypes and the candidate cognitive mechanisms. Results are displayed in Table 
7.38 and show illness perceptions were associated with all depression symptom subtypes, 
while MoCA scores were not significantly associated with any of the depression subtype 
scores. Independent t-tests confirmed the difference between depressed/non-depressed 
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participants (BDI ≥13) on illness perceptions (t(136) = -4.618, p <0.001), and confirmed the lack 
of difference in cognitive function scores on the MoCA (t(129) = -0.261, p = 0.794).  
 
TABLE 7.38: PEARSON’S CORRELATIONS BETWEEN T1 COGNITIVE MECHANISMS AND T1 
DEPRESSION SYMPTOMS 
Cognition  T1 BDI 
T1 BDI 
somatic 
T1 BDI 
cognitive 
T1 Cognitive function (MoCA) 
r 
p 
-0.080 
0.339 
-0.076 
0.363 
-0.020 
0.811 
T1 Illness perceptions(BIPQ) 
r 
p 
0.452
 
<0.001 
0.499
 
<0.001 
0.365
 
<0.001 
 
 
Next, Pearson’s correlation analyses were performed to assess the association of the 
cognitive measures with the T3 recovery outcomes. These correlations are displayed in Table 
7.39 and show that illness perception score was significantly associated with all outcomes 
except sensory pain. Cognitive function on the other hand was not associated with any of the 
T3 recovery outcomes. These null findings for the MoCA were also confirmed in regression 
models controlling for covariates.  As such, illness perception score was the only cognitive 
mechanism that was assessed for mediation of the depression symptoms-short-term recovery 
relationship.  
 
TABLE 7.39: PEARSON’S CORRELATIONS BETWEEN T1 COGNITIVE MECHANISMS AND T3 
RECOVERY OUTCOMES 
Cognition  
T3 
Anxiety 
 
T3 
Affective 
pain 
T3 
Sensory 
pain 
T3 
Physical 
symptoms  
T3 
Physical 
health 
status 
T3 Mental 
health 
status 
T1 Cognitive function  
r 
p 
-0.154 
0.064 
-0.068 
0.427 
-0.135 
0.114 
-0.089 
0.284 
0.018 
0.829 
-0.005 
0.954 
T1 Illness perceptions 
r 
p 
0.420
 
<0.001 
0.317
 
<0.001 
0.159 
0.057 
0.236
 
0.003 
-0.222
 
0.006 
-0.341
 
<0.001 
 
7.7.2.3 Mediation models of T3 emotional distress 
The first regression model was built using the hierarchical method to assess the relative 
contribution of illness perceptions to the depression symptoms-T3 anxiety relationship. 
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Depression symptom subtypes were used in separate models. The final model using baseline 
total BDI score, confirmed the earlier presented results that T1 total BDI score (t = 0.853, p = 
0.395) was not a significant predictor of T3 anxiety. In addition, T1 illness perceptions were 
also not a significant predictor (t = 1.830, p = 0.069). Similar findings were also found using T1 
somatic/affective depression symptom scores as a predictor of T3 anxiety, such that neither 
somatic/affective depression symptoms (t = 1.466, p = 0.145) nor illness perceptions (t = 1.558, 
p = 0.122) were a significant predictor in the final model. This lack of association was 
confirmed in individual covariate adjusted models using each of the BIPQ items entered 
separately to predict T3 anxiety.   Since illness perceptions were not a significant predictor of 
T3 anxiety, Sobel tests of mediation were not conducted.  
 
TABLE 7.40: HIERARCHICAL REGRESSION OF T3 ANXIETY ON T1 ILLNESS PERCEPTIONS AND 
T1 COGNITIVE/AFFECTIVE BDI SCORE  
Model B SE ß p 
Step 1     
Age -0.032 0.044 -0.081 0.464 
Sex -0.713 0.803 -0.069 0.376 
Household income -0.467 0.199 -0.171 0.020 
euroSCORE 0.106 0.140 0.086 0.450 
T1 anxiety 0.451 0.076 0.518 <0.001 
T1 BDI cognitive 0.034 0.088 0.035 0.698 
Step 2     
Age -0.039 0.043 -0.097 0.375 
Sex -0.861 0.797 -.083 0.282 
Household income -0.427 0.198 -0.156 0.033 
euroSCORE 0.140 0.139 0.114 0.317 
T1 anxiety 0.371 0.085 0.426 <0.001 
T1 BDI cognitive 0.029 0.087 0.030 0.736 
T1 Illness perceptions 0.054 0.027 0.169 0.044 
Step 1 R
2
 = 0.339; Step 2 R
2
 = 0.358; N = 145 
 
A hierarchical regression model using T1 cognitive/affective depression symptoms 
(Table 7.40) showed that in step 2, lower household income (t = -2.157, p = 0.033) and greater 
T1 anxiety (t = 4.347, p <0.001) were significant predictors of anxiety. In addition, T1 illness 
perception score was also a significant predictor (t = 2.030, p = 0.044), with a positive 
association such that the participants with the most negative view of their illness at baseline, 
had greater anxiety following surgery. However, in separate covariate adjusted analyses 
entering each of the BIPQ items individually to predict T3 anxiety, none were significant. In 
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summary, these results suggest that baseline illness perceptions were not consistently related 
to T3 anxiety and none of the baseline depression symptom subtypes were significant 
predictors of T3 anxiety after including illness perceptions in the models. 
7.7.2.4 Mediation models of T3 physical symptoms 
Sensory pain 
Regression models were built using the hierarchical method in which predictor variables were 
entered in steps, to assess the relative contribution of illness perceptions to the depression 
symptoms-T3 sensory pain relationship, controlling for covariates. Baseline depression 
symptom subtypes were used in separate models, however no significant findings were found. 
Illness perceptions were not a significant predictor in models using T1 total BDI, 
cognitive/affective and somatic/affective depression symptom scores. Baseline 
somatic/affective depression symptom score (t = 2.212, p = 0.029) was a significant predictor 
in step 1 controlling for covariates, but not in step 2 (t = 1.546, p = 0.125) when illness 
perceptions were added to the model. Furthermore, the lack of association between baseline 
illness perceptions and T3 sensory pain was confirmed in covariate adjusted models using each 
of the BIPQ items individually.  
Affective pain 
A regression model was built using the hierarchical method in which predictor variables were 
entered in steps, to assess the relative contribution of illness perceptions to the depression 
symptoms-T3 affective pain relationship. Depression symptom subtypes were used in separate 
models. The final model using baseline total BDI score, confirmed the earlier presented results 
that total BDI score (t = 0.211, p = 0.833) was not a significant predictor of T3 affective pain. 
However, T1 illness perceptions were a significant predictor (t = 3.386, p = 0.001). The 
individual items of the BIPQ that were found to be significant predictors of T3 affective pain 
when entered into separate covariate adjusted regression models were: item 1 
(consequences) (t = 2.133, p = 0.035), item 2 (timeline) (t = 1.980, p = 0.050), item 5 (identity) 
(t = 2.197, p = 0.030) and item 6 (concern) (t = 2.025, p = 0.045). Similar findings were also 
found using T1 cognitive/affective depression symptom scores in the model, such that 
cognitive/affective depression symptoms (t = 0.615, p = 0.540) were not a significant predictor, 
but T1 illness perceptions (t = 3.888, p <0.001) were. In individual item analyses of the baseline 
BIPQ, item 1 (consequences) (t = 2.532, p = 0.013), item 2 (timeline) (t = 2.268, p = 0.025), item 
5 (identity) (t = 2.522, p = 0.013) and item 6 (concern) (t = 2.323, p = 0.022) and item 8 
(emotional response) (t = 2.321, p = 0.022) were all significant independent predictors of 
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greater affective pain after adjusting for covariates. These results suggest that those 
participants prior to surgery who saw their illness as having more severe consequences, a 
longer duration, and greater symptoms, as well as having greater concern about their illness, 
were more likely to experience greater distress from physical pain following surgery. However, 
since baseline total depression symptoms and cognitive/affective depression symptoms were 
not a significant predictor of T3 affective pain in step 1 of these models, Sobel tests of 
mediation were not conducted.  
 
TABLE 7.41: HIERARCHICAL REGRESSION OF T3 AFFECTIVE PAIN ON T1 ILLNESS 
PERCEPTIONS AND T1 SOMATIC/AFFECTIVE BDI SCORE 
Model B SE ß p 
Step 1     
Age 0.000 0.033 0.002 0.991 
Sex -0.476 0.629 -0.069 0.451 
Household income -0.135 0.146 -0.083 0.355 
euroSCORE -0.023 0.106 -0.031 0.827 
T1 BDI somatic 0.123 0.046 0.233 0.009 
Step 2     
Age 0.004 0.032 0.016 0.906 
Sex -0.590 0.613 -0.086 0.337 
Household income -0.079 0.143 -0.048 0.583 
euroSCORE -0.018 0.103 -0.025 0.861 
T1 BDI somatic 0.045 0.052 0.086 0.386 
T1 Illness perceptions 0.055 0.019 0.287 0.004 
Step 1 R
2
 = 0.066; Step 2 R
2
 = 0.124; N = 135 
 
A hierarchical regression model was also built adjusting for T1 somatic/affective 
depression symptoms (Table 7.41). The model shows that T1 somatic/affective depression 
symptom score (t = 2.672, p = 0.009) was the only significant predictor of T3 affective pain in 
step 1 adjusted for covariates. After adding T1 illness perception total score into the model, T1 
somatic/affective depression symptoms were no longer a significant predictor (t = 0.870, p = 
0.386). However, T1 illness perception score was a significant predictor (t = 2.914, p = 0.004), 
with a positive association such that the participants with the most negative view of their 
illness at baseline, had greater affective pain following surgery. The final model accounted for 
12.4% (R2 = 0.124) of variance in T3 affective pain scores. Looking at the standardised 
regression coefficient (β) for depression symptoms shows that with the inclusion of illness 
perceptions in the model, the β for depression symptoms changed from 0.233 to 0.086. This 
indicates that when illness perceptions were included in the model, there was a 63.1% 
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reduction in the size of β for somatic/affective depression symptoms. In regression models 
using the individual illness perceptions as predictors of T3 affective pain, adjusting for 
covariates and T1 somatic/affective depression symptoms, none of the individual perceptions 
were significant predictors, suggesting that having a general negative perception of the illness 
was more important than any individual cognition. 
A Sobel test was used on these data to assess the significance of the indirect effect. 
The model included T1 somatic/affective BDI score as the independent variable and T3 
affective pain as the dependent variable, with illness perceptions entered as the mediator. 
Covariates included age, sex, household income and euroSCORE. The results of this Sobel test 
are illustrated in Figure 7.1, showing a significant total effect (pathway c) for the T1 
somatic/affective depression symptoms and T3 affective pain relationship (B = 0.123, SE = 
0.046, p = 0.009). However, the direct pathway (pathway c’) (B = 0.045, SE = 0.052, p = 0.386) 
was not significant after taking the mediator into account. The indirect pathway (pathway ab) 
was significant in this model (B = 0.078, SE = 0.033, 95% CI = 0.022-0.154), confirming illness 
perceptions to be a significant mediator. Full mediation was shown since the direct effect, 
pathway c’, was not significant after illness perceptions were taken into account. 
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FIGURE 7.1: MEDIATION MODEL OF T1 SOMATIC/AFFECTIVE DEPRESSION SYMPTOMS 
AND T3 AFFECTIVE PAIN THROUGH T1 ILLNESS PERCEPTIONS 
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In summary, these results suggest that illness perceptions were a significant mediator 
of the somatic/affective depression symptoms-affective pain relationship, with full mediation 
found. Interestingly none of the individual illness perceptions were found to be significant in 
this model. Illness perceptions were also a significant predictor of T3 affective pain in models 
using baseline total BDI and cognitive/affective depression symptom scores, with the T1 
individual negative perceptions being widely predictive of greater affective pain following 
surgery. 
 
Physical symptoms 
The next regression model built used the hierarchical method to assess the relative 
contribution of baseline illness perceptions to the depression symptoms-T3 physical symptoms 
relationship. Depression symptom subtypes were used in separate models. The final model 
using baseline total BDI score is displayed in Table 7.42, confirming the earlier presented 
results that baseline total BDI score (t = 0.592, p = 0.555) was not a significant predictor of T3 
CROQ physical symptoms. However, T1 illness perceptions were a significant predictor (t = 
2.546, p = 0.012), with a positive relationship, which meant the participants with the most 
negative view of their illness reported the most physical symptoms after surgery. The only 
other significant predictor in this model was household income (t = -2.245, p = 0.026), with a 
negative association such that those participants with the lowest income reported the most 
physical symptoms. In separate regression models, entering each of the T1 illness perception 
items individually to predict T3 physical symptoms, item 5 (symptoms) (t = 2.055, p = 0.042) 
and item 6 (concern) (t = 2.911, p = 0.004) were both significant predictors. Similar findings 
were also found using T1 cognitive/affective depression symptom scores as a predictor of T3 
physical symptoms, such that T1 cognitive/affective depression symptom score (t = -0.186, p = 
0.852) was not a significant predictor of T3 physical symptoms, but T1 illness perceptions (t = 
2.976, p = 0.003) were. Again this association was positive, such that those participants who 
held a more negative view of their illness prior to surgery had greater physical symptoms up to 
two months after surgery. Separate regression models were also used to enter each of the T1 
illness perception items individually to predict T3 physical symptoms, finding item 1 
(consequences) (t = 2.108, p = 0.037), item 5 (symptoms) (t = 2.308, p = 0.022) and item 6 
(concern) (t = 3.103, p = 0.002) were all significant predictors. These results suggest that those 
participants, prior to surgery, who saw their illness as having more severe consequences and 
greater symptoms, and who felt most concerned by their illness, experienced greater physical 
symptoms up to two months after surgery. However, since total BDI and cognitive/affective 
depression symptoms were not significant predictors of T3 physical symptoms, Sobel tests of 
mediation were not conducted.  
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TABLE 7.42: HIERARCHICAL REGRESSION OF T3 PHYSICAL SYMPTOMS ON T1 ILLNESS 
PERCEPTIONS AND T1 TOTAL BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.067 0.110 0.079 0.543 
Sex 0.485 2.060 0.021 0.814 
Household income -1.246 0.500 -0.214 0.014 
euroSCORE -0.096 0.342 -0.038 0.780 
T1 BDI total score 0.204 0.110 0.157 0.067 
Step 2     
Age 0.059 0.108 0.069 0.588 
Sex 0.282 2.022 0.012 0.889 
Household income -1.108 0.494 -0.191 0.026 
euroSCORE -0.033 0.336 -0.013 0.923 
T1 BDI total score 0.071 0.120 0.055 0.555 
T1 Illness perceptions 0.158 0.062 0.230 0.012 
Step 1 R
2
 = 0.078; Step 2 R
2
 = 0.119; N = 145 
 
 
The succeeding hierarchical regression analyses used baseline somatic/affective 
depression symptoms (Table 7.43). The model shows that household income (t = -2.477, p = 
0.014) and T1 somatic/affective depression symptoms (t = 2.352, p = 0.020) were the only 
significant predictors of T3 CROQ physical symptoms in step 1 adjusted for covariates. After 
adding T1 illness perception total score into the model, household income (t = -2.254, p = 
0.026) remained a significant predictor, but not T1 somatic/affective depression symptoms (t = 
0.979, p = 0.329). T1 illness perception score was also a significant predictor (t = 2.232, p = 
0.027), with a positive association such that the participants with the most negative view of 
their illness at baseline, had greater physical symptoms following surgery. The final model 
accounted for 12.3% (R2 = 0.123) of variance in T3 physical symptom scores. Looking at the 
standardised regression coefficient (β) for depression symptoms shows that with the inclusion 
of illness perceptions in the model, the β for depression symptoms changed from 0.197 to 
0.093. This indicates that when physical activity was included in the model, there was a 52.8% 
reduction in the size of β for somatic/affective BDI depression. In regression models using the 
individual illness perceptions as predictors of T3 physical symptoms, adjusting for covariates 
and T1 somatic/affective depression, only the T1 illness perception of concern (t = 2.812, p = 
0.006) was a significant predictor, such that those participants who were most concerned 
about their illness prior to surgery had greater physical symptoms after surgery.  
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TABLE 7.43: HIERARCHICAL REGRESSION OF T3 PHYSICAL SYMPTOMS ON T1 ILLNESS 
PERCEPTIONS AND T1 SOMATIC/AFFECTIVE BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.068 0.108 0.081 0.528 
Sex 0.351 2.046 0.015 0.864 
Household income -1.230 0.496 -0.212 0.014 
euroSCORE -0.126 0.340 -0.050 0.712 
T1 BDI somatic 0.351 0.149 0.197 0.020 
Step 2     
Age 0.063 0.106 0.075 0.553 
Sex 0.225 2.019 0.010 0.911 
Household income -1.110 0.492 -0.191 0.026 
euroSCORE -0.058 0.336 -0.023 0.864 
T1 BDI somatic 0.165 0.169 0.093 0.329 
T1 Illness perceptions 0.143 0.064 0.208 0.027 
Step 1 R
2
 = 0.091; Step 2 R
2
 = 0.123; N = 145 
 
Mediation was assessed by using a Sobel test on the data. The model included T1 
somatic/affective BDI score as the independent variable and T3 CROQ physical symptoms as 
the dependent variable, with T1 illness perceptions entered as the mediator. Covariates 
included age, sex, household income and euroSCORE. The results of this Sobel test are 
illustrated in Figure 7.2, showing a significant total effect (pathway c) for the T1 
somatic/affective depression symptoms and T3 CROQ physical symptom relationship (B = 
0.351, SE = 0.149, p = 0.020). However, the direct pathway (pathway c’) (B = 0.165, SE = 0.169, 
p = 0.330) was not significant after taking the mediator into account. The indirect pathway 
(pathway ab) was significant in this model (B = 0.185, SE = 0.091, 95% CI = 0.028-0.391), 
confirming baseline illness perceptions to be a significant mediator. Full mediation was shown 
since the direct effect, pathway c’, was not significant after illness perceptions were taken into 
account.  
In summary, baseline illness perceptions were a significant predictor of T3 physical 
symptoms in models using all depression symptom subtypes. Moreover, the association 
between somatic/affective depression symptoms and T3 physical symptoms was mediated by 
illness perceptions. The individual illness perception that was of particular importance in this 
relationship was concern.  
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7.7.2.5 Mediation models of T3 health status 
Physical health status 
A hierarchical regression model was built to assess the relative contribution of baseline illness 
perceptions to the depression symptoms-T3 physical health status relationship. Depression 
symptom subtypes were used in separate models. The final model using T1 total BDI score, 
confirmed the earlier presented results that T1 total BDI score (t = -1.203, p = 0.231) was not a 
significant predictor of T3 physical health status. T1 total illness perceptions were also not a 
significant predictor (t = -1.906, p = 0.059) in this model. However, in separate regression 
models using each of the BIPQ items entered individually to predict physical health status at 
T3, item 3 (personal control) (t = -1.906, p = 0.059) and item 5 (identity) (t = -1.906, p = 0.059)  
were both significant. These results suggest that those participants prior to surgery who felt 
least control over their illness and experienced most physical symptoms, had poorer physical 
health status at T3. In models using somatic/affective depression symptom scores as a 
predictor of T3 physical health status, somatic/affective depression symptoms (t = -1.716, p = 
0.088) and total illness perceptions (t = -1.627, p = 0.106) were both not significant predictors 
of T3 physical health status. Moreover, none of the individual illness perceptions were found 
to be significant when entered into separate regression models. Since illness perceptions were 
T1 Somatic 
BDI 
T3 Physical 
symptoms c 
B = 0.351 
p = 0.020 
 
T1 Somatic 
BDI 
T3 Physical 
symptoms 
T1 Illness 
perceptions 
B = 1.296 
p <0.001 
 
B = 0.165 
p = 0.330 
 
B = 0.143 
p = 0.027 
 a b 
c' 
FIGURE 7.2: MEDIATION MODEL OF T1 SOMATIC/AFFECTIVE DEPRESSION SYMPTOMS 
AND T3 PHYSICAL SYMPTOMS THROUGH T1 ILLNESS PERCEPTIONS 
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not significant predictors of T3 physical health status, Sobel tests of mediation were not 
conducted.  
 
TABLE 7.44: HIERARCHICAL REGRESSION OF T3 PHYSICAL HEALTH STATUS ON T1 ILLNESS 
PERCEPTIONS AND T1 TOTAL BDI SCORE 
Model B SE ß p 
Step 1     
Age -0.137 0.124 -0.148 0.269 
Sex -5.189 2.240 -0.213 0.022 
Household income 0.225 0.554 .035 0.686 
euroSCORE 0.787 0.378 0.285 0.039 
T1 Physical health status 0.046 0.067 0.060 0.491 
T1 BDI cognitive -0.217 0.200 -0.095 0.280 
Step 2     
Age -0.147 0.122 -0.159 0.230 
Sex -5.186 2.204 -0.213 0.020 
Household income 0.102 0.548 0.016 0.852 
euroSCORE 0.734 0.373 0.266 0.051 
T1 Physical health status -0.030 0.074 -0.039 0.682 
T1 BDI cognitive -0.066 0.207 -0.029 0.751 
T1 Illness perceptions -0.171 0.073 -0.229 0.020 
Step 1 R
2
 = 0.069; Step 2 R
2
 = 0.104; N = 146 
 
A hierarchical regression model was subsequently built adjusting for 
cognitive/affective depression symptoms (Table 7.44). The model shows that sex (t = -2.317, p 
= 0.022) and euroSCORE (t = 2.081, p = 0.039) were the only significant predictors of T3 
physical health status in step 1 adjusted for covariates, such that female sex and greater 
mortality risk were associated with poorer physical health status. After adding T1 illness 
perception total score into the model, female sex (t = -2.352, p = 0.020) remained a significant 
predictor. In addition, T1 illness perception score was also a significant predictor (t = -2.349, p 
= 0.044), with a negative association such that the participants with the most negative view of 
their illness at baseline, had poorer physical health status following surgery. In particular, in 
individual analyses entering each of the T1 BIPQ items separately to predict physical health 
status at T3, item 2 (timeline) (t = -2.102, p = 0.037), item 3 (personal control) (t = -2.071, p = 
0.040) and item 5 (concern) (t = -2.139, p = 0.034) were significant independent predictors. 
These results suggest that those participants who felt their illness would last longer and who 
perceived less personal control and greater concern prior to surgery, experienced lower 
physical health status two months after surgery. In summary, these results suggest that 
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baseline illness perceptions were inconsistently associated with physical health status at T3, 
after taking baseline depression scores into account. 
Mental health status 
A regression model was built using the hierarchical method to assess the relative contribution 
of illness perceptions to the depression symptoms-T3 mental health status relationship. 
Depression symptom subtypes were used in separate models. The final model using T1 total 
BDI score, confirmed the earlier presented results that baseline total BDI score (t = -0.554, p = 
0.581) was not a significant predictor of T3 mental health status. T1 illness perceptions were, 
however, a significant predictor (t = -2.798, p = 0.006) in this model, with a negative 
association such that a more negative view of one’s illness prior to surgery was related to 
lower mental health status at T3. Individual item analyses showed that the only T1 illness 
perception that was significantly associated with lower mental health status at T3, was item 1 
(consequences) (t = -2.752, p = 0.007). Similar findings were also found using T1 
somatic/affective depression symptom scores in models to predict T3 physical health status, 
such that baseline somatic/affective depression symptom score (t = -0.505, p = 0.614) was not 
a significant predictor, but illness perceptions (t = -2.700, p = 0.008) were. Again, the only 
individual illness perception to predict lower mental health status was item 1 (consequences) 
(t = -2.634, p = 0.009). This result suggests that those participants who, prior to surgery, felt 
their illness had more negative consequences, reported lower mental health status two 
months after surgery. Results using cognitive/affective depression symptoms also supported 
this trend, such that cognitive/affective depression symptom score (t = -0.692, p = 0.490) was 
not a significant predictor of T3 mental health status, but illness perceptions (t = -2.974, p = 
0.003) were. Individual item analyses showed that two of the illness perceptions experienced 
prior to surgery were predictive of lower mental health status at T3: item 1 (consequences) (t = 
-2.948, p = 0.004) and item 5 (concern) (t = -1.984, p = 0.049). However, since depression 
symptom subtypes were not significant predictors of T3 mental health status, Sobel tests of 
mediation were not conducted.  
In summary, these results suggest that illness perceptions were a significant predictor 
of T3 mental health status in models controlling for all depression symptom subtypes. 
However, since depression symptoms subtypes were not a significant predictor of T3 mental 
health status, mediation did not occur, instead illness perceptions were an independent 
predictor.  
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7.7.3 Biological mechanisms – cortisol 
7.7.3.1 Descriptive statistics 
 
TABLE 7.45: T1 AND T3 NON-TRANSFORMED SALIVARY CORTISOL DATA 
Cortisol (nmol/l) N 
T1 T3 
p 
Mean ± SD Mean ± SD 
Waking 135 21.11±10.80 19.37±10.50 0.102 
Waking + 30 minutes 136 25.88±12.90 23.68±11.07 0.094 
10:00am 143 13.32±7.52 13.08±7.12 0.735 
12:00noon 141 9.64±5.58 9.58±7.14 0.926 
4:00 pm 145 6.76±3.31 7.17±5.06 0.402 
8:00 pm 145 4.82±4.70 4.93±5.64 0.850 
Bedtime 143 3.97±3.41 3.82±3.83 0.713 
Slope 73 0.02±0.01 0.02±0.01 0.876 
CAR  122 5.02±13.66 3.64±11.14 0.465 
AUC 146 9220.02±2986.10 9184.03±3838.90 0.925 
Waking-bedtime difference 132 17.39±10.28 15.91±10.48 0.153 
 
 
 
 
FIGURE 7.3: T1 AND T3 MEAN SALIVARY CORTISOL ACROSS THE DAY  
N.B. Bars represent standard error of the means 
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The first biological pathway to be tested in this PhD was the role of the neuroendocrine 
hormone, cortisol. Descriptive statistics for cortisol at T1 and T3 are displayed in Table 7.45, 
with p representing the significance value in dependent t-tests. Missing cortisol data was due 
to some participants declining to provide samples and some outliers being removed. Data 
show that there were no significant differences in participants’ cortisol samples at T3 
compared to T1. Figure 7.3 represents the mean T1 and T3 cortisol data at the seven 
measurement points for participants across the course of the day, showing at T3 there was a 
smaller peak in cortisol at 30 minutes after waking compared to T1.   
Cross-sectional associations between cardiac medication, including aspirin, beta-
blockers, statins and antiplatelets, and cortisol responses, were not found using T1 or T3 data; 
multiple regression models supported these findings. Therefore, the regression models shown 
in the following sections adjust for the demographic and disease severity covariates only.  
7.7.3.2 Associations with depression symptom variables 
Pearson’s correlation analyses were performed to assess the relationship between the 
different cortisol scores (CAR, AUC, slope, waking-bedtime difference) and baseline depression 
symptom scores. Results showed no significant correlations between cortisol and the 
depression symptom scores. Regression analyses were also performed to assess whether 
cortisol predicted any of the recovery outcomes after controlling for demographic and disease 
severity covariates; anxiety and health status models also controlled for baseline scores. 
Statistically, the correlation coefficient represents the linear dependence between variables, 
but it does not control for the fact that other factors may also account for the relationship, 
potentially producing a biased estimate. Results found that depression symptoms caseness 
(BDI ≥13) (t = 2.639, p = 0.009) was significantly associated with T1 cortisol AUC after 
controlling for covariates; see Table 7.46. This association was positive such that depressed 
participants had a larger total cortisol output over the course of the day than their non-
depressed counterparts. This model accounted for 8.8% (R2 = 0.088) of variance in T1 cortisol 
AUC. The difference in cortisol scores by depression caseness at T1 is represented in Figure 
7.4, with independent t-tests confirming the difference between depressed and non-
depressed participants in terms of AUC (t(121) = -2.105, p = 0.037). 
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TABLE 7.46: MULTIPLE REGRESSION OF T1 CORTISOL AUC ON T1 DEPRESSION CASENESS  
Model B SE ß p 
Age 37.183 42.448 0.115 0.383 
Sex -1214.514 851.458 -0.136 0.156 
Household income 218.143 207.512 0.097 0.295 
euroSCORE 96.347 133.806 0.099 0.473 
T1 Depression symptoms 
caseness 
1791.017 678.675 0.233 0.009 
R
2
 = 0.088, N = 128 
 
 
FIGURE 7.4: MEAN T1 SALIVARY CORTISOL ACROSS THE DAY BY T1 DEPRESSION SYMPTOMS 
CASENESS 
N.B. Bars represent standard error of the means 
 
Next, Pearson’s correlation analyses were performed to assess the relationship 
between the different cortisol scores at baseline (CAR, AUC, slope, waking-bedtime difference) 
and the T3 recovery outcomes scores. Results showed no significant correlations between 
baseline cortisol and the outcomes measures. Multiple regression analyses were also 
performed using baseline cortisol to predict T3 recovery outcomes, adjusting for demographic 
and disease severity covariates and baseline scores on anxiety and health status outcome 
measures, where applicable. Results found that T1 cortisol AUC (t = 2.082, p = 0.039) was a 
significant predictor of mental health status at T3, after controlling for demographic and 
disease severity covariates (see Table 7.47). This relationship was positive, which meant that 
those participants with higher cortisol output across the day had higher mental health status. 
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This suggests that participants with a blunted cortisol output, had lower mental health status. 
This is contradictory to the depression symptom results which showed depression caseness 
was associated with greater cortisol output. The only other significant predictor in this model 
was baseline mental health status score (t = 4.724, p < 0.001). This model accounted for 19.6% 
(R2 = 0.196) of variance in T3 mental health status scores. Cortisol was not significantly related 
to any other recovery outcomes in regression models controlling for covariates.  
 
TABLE 7.47: MULTIPLE REGRESSION OF T1 CORTISOL AUC ON T3 MENTAL HEALTH STATUS 
Model B SE ß p 
Age 0.023 0.098 0.031 0.812 
Sex 1.231 1.896 0.059 0.517 
Household income 0.074 0.461 0.014 0.873 
euroSCORE -0.355 0.302 -0.156 0.242 
T1 Mental health status 0.436 0.092 0.399 <0.001 
T1 Cortisol AUC 0.000 0.000 0.172 0.039 
R
2
 = 0.196, N = 129 
 
7.7.3.3 Mediation models of T3 health status 
A regression model was built using the hierarchical method in which predictor variables were 
entered in steps, to assess the relative contribution of baseline cortisol AUC to the depression 
symptoms-T3 mental health status relationship. In order to explore the data fully, cortisol AUC 
was entered into regression models with each of the depression symptom scores in turn. The 
final model using total BDI score, confirmed the earlier presented results that T1 total BDI 
score (t = -1.840, p = 0.068) was not a significant predictor of T3 mental health status. T1 
cortisol AUC was however a significant predictor (t = 2.363, p = 0.020) in this model. Similar 
findings were also found using cognitive/affective depression symptom scores as a predictor of 
T3 mental health status, such that T1 cognitive/affective depression symptoms (t = -1.623, p = 
0.107) were not a significant predictor in the final model but T1 cortisol AUC (t = 2.269, p = 
0.025) was. Since baseline total BDI depression, cognitive/affective depression symptoms were 
not significant predictors of T3 mental health status, Sobel tests of mediation were not 
conducted.  
Next a hierarchical regression model was built adjusting for baseline somatic/affective 
depression symptoms (Table 7.48). This model shows that baseline mental health status (t = 
3.686, p <0.001) was the only significant predictor of T3 mental health status in step 1 adjusted 
for covariates, such that higher baseline mental health status was associated with greater 
mental health status at T3. After adding T1 cortisol AUC into the model, T1 mental health 
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status (t = 3.698, p <0.001) remained a significant predictor and T1 somatic/affective 
depression symptoms (t = -2.028, p = 0.045) became significant. In addition, T1 cortisol AUC 
was also a significant predictor (t = 2.403, p = 0.018), with a positive association such that the 
participants with the highest cortisol responses, had the highest mental health status following 
surgery. The final model accounted for 22.3% (R2 = 0.223) of variance in T3 mental health 
status scores. However, since somatic/affective depression symptoms were not a significant 
predictor in step 1 of this model, a Sobel test of mediation was not conducted.  
In summary, these results suggest that cortisol AUC was a significant predictor of T3 
mental health status in models controlling for total BDI, cognitive/affective and 
somatic/affective depression. These results demonstrated that lower cortisol output across 
the day was associated with lower mental health status after surgery.  
 
TABLE 7.48: HIERARCHICAL REGRESSION OF T3 MENTAL HEALTH STATUS ON T1 CORTISOL 
AUC AND T1 TOTAL BDI SCORE  
Model B SE ß p 
Step 1     
Age 0.011 0.100 0.015 0.909 
Sex 0.770 1.899 0.037 0.686 
Household income 0.149 0.465 0.028 0.750 
euroSCORE -0.259 0.306 -0.114 0.399 
T1 Mental health status 0.369 0.100 0.337 <0.001 
T1 BDI somatic -0.238 0.147 -0.147 0.107 
Step 2     
Age 0.000 0.098 0.000 0.999 
Sex 1.387 1.881 0.066 0.462 
Household income 0.070 0.458 0.013 0.879 
euroSCORE -0.305 0.301 -0.134 0.313 
T1 Mental health status 0.364 0.098 0.332 <0.001 
T1 BDI somatic -0.296 0.146 -0.182 0.045 
T1 Cortisol AUC 0.000 0.000 0.200 0.018 
Step 1 R
2
 = 0.185; Step 2 R
2
 = 0.223; N = 128 
  
7.7.3.4 T1 depression symptoms predicting T3 cortisol 
Although not part of the primary hypotheses of this PhD, additional regression analyses were 
also performed to assess whether depression symptom subtypes at T1 were able to predict 
cortisol at T3, after controlling for demographic and disease severity covariates. Anxiety and 
health status models also controlled for baseline scores on these measures. These analyses 
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were performed in order to further explore the cortisol data. Results found that T1 total BDI 
score (t = -1.988, p = 0.049) was a significant predictor of T3 waking-bedtime difference in 
cortisol after controlling for covariates; see Table 7.49. This association was negative such that 
greater baseline depression symptoms were associated with a lower change in cortisol output 
from the waking to bedtime response. This smaller change is suggestive of a flatter cortisol 
response across the day. This model accounted for 5.4% (R2 = 0.054) of variance in T3 waking-
bedtime cortisol difference. 
 
TABLE 7.49: MULTIPLE REGRESSION OF T3 CORTISOL WAKING-BEDTIME DIFFERENCE ON T1 
TOTAL BDI SCORE  
Model B SE ß p 
Age -0.099 0.162 -0.087 0.541 
Sex 3.308 3.030 0.103 0.277 
Household income 1.175 0.731 0.147 0.111 
euroSCORE 0.217 0.511 0.061 0.673 
T1 BDI total score -0.313 0.157 -0.181 0.049 
R
2
 = 0.054, N = 131 
 
TABLE 7.50: MULTIPLE REGRESSION OF T3 CORTISOL WAKING-BEDTIME DIFFERENCE ON T1 
COGNITIVE/AFFECTIVE BDI SCORE  
Model B SE ß p 
Age -0.126 0.160 -0.109 0.433 
Sex 2.504 2.908 0.080 0.391 
Household income 1.187 0.724 0.149 0.104 
euroSCORE 0.232 0.501 0.066 0.645 
T1 BDI cognitive -0.571 0.254 -0.205 0.026 
R
2
 = 0.059, N = 133 
 
Results also found that T1 cognitive/affective depression symptom score (t = -2.250, p 
= 0.026) was a significant predictor of T3 waking-bedtime difference in cortisol after 
controlling for covariates; see Table 7.50. This association was negative such that greater 
depression symptoms were associated with a smaller change in cortisol output from their 
waking to bedtime response. This suggests that participants with the greatest depression 
symptoms experienced a flatter cortisol response across the day. This model accounted for 
5.9% (R2 = 0.059) of variance in T3 waking-bedtime cortisol difference. However, in models 
using somatic/affective depression symptoms to predict T3 waking-bedtime cortisol 
difference, T1 somatic/affective depression score was not a significant predictor (t = -1.921, p = 
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0.057) after adjusting for covariates. In summary, these findings demonstrate that baseline 
total and cognitive/affective depression symptoms were significant independent predictors of 
a flatter cortisol response two months after surgery.  
Next, regression models were built to assess the relationship of baseline depression 
symptoms on cortisol AUC at T3. Results found that T1 cognitive/affective depression 
symptom score (t = -2.026, p = 0.045) was a significant predictor of T3 cortisol AUC after 
controlling for covariates; see Table 7.51. This association was negative such that participants 
with greater cognitive/affective depression symptoms had a smaller cortisol output across the 
day compared to those with fewer depression symptoms. This model accounted for 15.3% (R2 
= 0.153) of variance in T3 cortisol AUC. This contradicts the findings looking at the associations 
between baseline depression symptoms and T1 cortisol, whereby greater depression 
symptoms were associated with greater cortisol AUC. Interestingly, neither total BDI score (t = 
-1.519, p = 0.131) nor somatic/affective depression symptom score (t = -1.001, p = 0.319) at 
baseline were able to significantly predict cortisol AUC at T3. In summary, these findings 
demonstrate that baseline cognitive/affective depression symptoms were a significant 
independent predictor of a lower cortisol output across the day, two months after surgery. 
 
TABLE 7.51: MULTIPLE REGRESSION OF T3 CORTISOL AUC ON T1 COGNITIVE/AFFECTIVE 
BDI SCORE  
Model B SE ß p 
Age -95.952 54.317 -0.238 0.080 
Sex -765.111 1042.716 -0.067 0.465 
Household income 381.545 248.064 0.135 0.127 
euroSCORE 638.200 170.036 0.518 <0.001 
T1 BDI cognitive -177.772 87.729 -0.180 0.045 
R
2
 = 0.153, N = 127 
   
7.7.3.5 Cross-sectional associations between T3 cortisol and T3 recovery 
The following analyses are again not related to the primary hypotheses of this PhD, which 
focus on prospective relationships over time, but instead are included here in order to 
demonstrate the cross-sectional relationship between cortisol responses and recovery at T3. 
These analyses were performed since there was only limited evidence of baseline cortisol 
affecting post-operative recovery; therefore, the cortisol data warranted exploring in greater 
detail. 
 To this effect, multiple regression analyses were performed to assess the relationship 
between T3 cortisol and T3 recovery, after controlling for baseline demographic and disease 
277 
 
severity covariates. In addition, models of anxiety and health status also controlled for baseline 
scores on these measures. Since these models were assessing the cross-sectional association 
between variables and not the temporal relationship across time, depression symptom scores 
at T3 were also used as a covariate in the models, including total T3 BDI score, 
somatic/affective and cognitive/affective depression symptom scores.  
Anxiety 
Results using T3 total BDI depression, found that T3 cortisol slope (t = 2.583, p = 0.011) was a 
significant predictor of T3 anxiety after controlling for covariates; see Table 7.52. This 
association was negative such that a flatter slope was associated with greater anxiety. The only 
other significant predictors in this model were household income (t = -2.365, p = 0.020), T1 
anxiety (t = 6.547, p <0.001), and T3 total BDI score (t = 9.428, p <0.001), such that lower 
household income, higher baseline anxiety and higher depression symptoms at T3 were 
associated with greater anxiety at T3. This model accounted for 64.9% (R2 = 0.649) of variance 
in T3 anxiety. Cortisol slope remained significant in models adjusting for T3 somatic/affective 
depression symptoms (slope: t = -2.769, p = 0.006) and cognitive/affective depression 
symptoms (slope: t = -2.707, p = 0.008).   
 
TABLE 7.52: MULTIPLE REGRESSION OF T3 ANXIETY ON T3 CORTISOL SLOPE AND T3 TOTAL 
BDI SCORE 
Model B SE ß p 
Age -0.025 0.032 -0.065 0.438 
Sex -0.617 0.569 -0.064 0.281 
Household income -0.341 0.144 -0.130 0.020 
euroSCORE 0.072 0.100 0.063 0.475 
T1 Anxiety 0.307 0.047 0.378 <0.001 
T3 BDI total score 0.342 0.036 0.538 <0.001 
T3 Cortisol slope -36.259 14.036 -0.139 0.011 
R
2
 = 0.649, N = 136 
  
In summary, cross-sectional analyses showed that cortisol slope was significantly 
related to T3 anxiety after controlling for covariates in models adjusted for T3 total depression, 
T3 somatic/affective depression and T3 cognitive/affective depression symptoms. This 
relationship was such that those participants with a flatter cortisol slope across the day had 
greater anxiety symptoms. The direction of causality in this relationship is not clear.  
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Physical symptoms 
 
The following analyses assessed the cross-sectional association between T3 CAR and T3 
physical symptoms. Results using T3 total BDI depression, found that T3 CAR (t = -2.409, p = 
0.018) was significantly associated with T3 physical symptoms after controlling for covariates; 
see Table 7.53. This association was negative such that a smaller awakening response was 
associated with greater physical symptoms. The only other significant variable in this model 
was T3 total BDI score (t = 2.760, p = 0.007), such that higher depression symptoms at T3 were 
associated with greater physical symptoms at T3. This model accounted for 17.0% (R2 = 0.170) 
of variance in T3 physical symptoms. CAR remained significant in models adjusting for T3 
somatic/affective depression symptoms (CAR: t = -2.418, p = 0.018) and cognitive/affective 
depression symptoms (CAR: t = -2.345, p = 0.021).   
 
TABLE 7.53: MULTIPLE REGRESSION OF T3 PHYSICAL SYMPTOMS ON T3 CAR AND T3 TOTAL 
BDI SCORE 
Model B SE ß p 
Age 0.026 0.128 0.033 0.840 
Sex 0.008 2.119 0.000 0.997 
Household income -0.871 0.596 -0.157 0.148 
euroSCORE 0.005 0.426 0.002 0.990 
T3 BDI total score 0.381 0.138 0.287 0.007 
T3 CAR -0.172 0.071 -0.251 0.018 
R
2
 = 0.170, N = 91 
 
In summary, these results have shown that the T3 awakening response in cortisol is 
significantly related to physical symptoms at T3, such that those participants who had a lower 
cortisol peak half an hour after waking also reported greater physical symptoms. This 
relationship was maintained in models adjusting for total BDI depression symptom score at T3, 
somatic/affective and cognitive/affective depression symptoms at T3.  
7.7.4 Biological mechanisms – inflammatory markers 
7.7.4.1 Descriptive statistics 
The second biological pathway tested in the PhD was the role of inflammatory markers, 
including IL-6, hs-CRP and TNF-α. Inflammatory markers were measured both before CABG and 
post-CABG, during the post-surgery hospital stay. Due to the variability in collection day for the 
post-operative bloods, two summary scores were created. The first summary score used the 
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mean for the inflammatory marker values on days one, two and three post-surgery, and the 
second used the mean for the inflammatory marker values on days four, five, six, seven and 
eight post-surgery. These scores were termed ‘early’ and ‘late’ T2 bloods.  Change scores were 
also computed by deducting baseline from follow-up values; larger change scores indicate a 
greater response from T1 to T2.  
The change in the inflammatory markers over time was presented in Chapter 6, but for 
ease of reference are shown in Table 7.54 using participants who completed T1-T3 
assessments. Dependent t-tests were used to assess change over time. Data confirm the same 
trend shown with the larger sample used in Chapter 6, such that for IL-6 and hs-CRP there was 
a significant increase from T1 to T2, for both early and late samples. In addition, there was a 
significant decrease from T2 early to T2 late samples for these inflammatory markers. The TNF-
α data reveals that no significant changes occurred over time.  
 
TABLE 7.54: BASELINE INFLAMMATORY MARKER NON-TRANSFORMED DATA 
Inflammatory 
marker 
Pair N Mean ± SD t p 
IL-6 (pg/mL) 
T1  
104 
5.40±1.76 
-38.148 <0.001 
T2 Early 218.22±56.98 
T1  
99 
5.17±1.69 
-32.122 <0.001 
T2 Late 96.12±28.51 
T2 Early  
74 
216.03±64.74 
14.995 <0.001 
T2 Late 98.13±25.43 
hs-CRP 
(mg/mL) 
T1  
107 
7.75±6.95 
-12.243 <0.001 
T2 Early 76.97±58.33 
T1  
100 
8.95±10.04 
-9.551 <0.001 
T2 Late 69.53±66.56 
T2 Early  
74 
81.67±65.27 
2.213 0.030 
T2 Late 65.02±60.05 
TNF-α (pg/mL) 
T1  
107 
5.65±2.72 
-1.032 0.305 
T2 Early 6.04±2.68 
T1 
100 
5.79±2.79 
-0.443 0.658 
T2 Early  5.97±2.62 
T2 Early 
74 
6.07±2.75 
-0.637 0.526 
T2 Late 6.36±2.75 
 
7.7.4.2 Associations with depression symptom variables 
Pearson’s correlation analyses were first performed to assess the relationship between the 
different inflammatory markers (IL-6, hs-CRP, TNF-α) at baseline, T2 early and T2 late, with 
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baseline depression symptom scores. Results showed no significant associations between any 
of the inflammatory markers and the depression symptom scores. 
Regression analyses were next performed to assess whether depression symptoms 
were able to predict the inflammatory marker responses after controlling for covariates. 
Results found only one model was significant; this is displayed in Table 7.55 and shows that 
cognitive/affective depression symptoms (t = 2.031, p = 0.045) were a significant predictor of 
T2 early IL-6 responses, with greater depression symptoms being associated with greater IL-6 
levels in the days following surgery, after controlling for demographic and disease severity 
covariates. This model accounted for 7.0% (R2 = 0.070) of variance in IL-6 T2 early responses.  
 
TABLE 7.55: MULTIPLE REGRESSION OF IL-6 T2 EARLY ON T1 COGNITIVE/AFFECTIVE BDI 
SCORE  
Model B SE ß p 
Age 1.141 1.046 0.167 0.278 
Sex 33.754 19.290 0.188 0.083 
Household income -0.501 4.692 -0.011 0.915 
euroSCORE -4.362 3.198 -0.220 0.176 
T1 BDI cognitive 3.535 1.740 0.205 0.045 
R
2
 = 0.070, N = 105 
 
7.7.5 Associations with recovery variables 
Next, Pearson’s correlations were performed to assess the associations between the 
inflammatory markers at baseline, T2 early and T2 late, with the T3 recovery outcomes. Results 
found no significant correlations between the inflammatory markers and T3 recovery 
outcomes. However, regression models were also used to assess the relationship between 
inflammatory markers and the T3 recovery outcomes controlling for demographic, disease 
severity and depression symptom covariates. The results from these analyses are described 
below, but since none of the inflammatory markers associated with the recovery outcomes 
were also associated with depression symptoms, mediation analyses were not performed.   
Anxiety 
A multiple regression model was built to assess the relative contribution of inflammation to T3 
anxiety. There were no significant results using hs-CRP or IL-6 responses. Instead, results 
showed that TNF-α T2 early response was a significant predictor. The model is displayed in 
Table 7.56 and shows that T1 anxiety (t = 4.992, p <0.001) and TNF-α T2 early (t = -2.727, p = 
0.008) were the only significant predictors of T3 anxiety after adjusting for covariates. This 
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association was such that those participants, who had higher anxiety prior to surgery and a 
lower level of TNF-α one to three days after surgery, had greater anxiety up to two months 
after surgery. The model accounted for 41.3% (R2 = 0.413) of variance in T3 anxiety scores. 
TNF-α T2 early was also a significant predictor of T3 anxiety in models using somatic/affective 
(TNF-α: t = -2.815, p = 0.006) and cognitive/affective (TNF-α: t = -2.633, p = 0.010) depression. 
These negative associations were an unexpected finding and it is not clear why a lower TNF-α 
response was predictive of greater anxiety. In summary, these results show that TNF-α in the 
days shortly following surgery was an important independent predictor of greater anxiety two 
months after surgery.  
 
TABLE 7.56: MULTIPLE REGRESSION OF T3 PHYSICAL SYMPTOMS ON T2 TNF-α EARLY  
Model B SE ß p 
Age -0.027 0.050 -0.067 0.595 
Sex -1.779 0.927 -0.173 0.058 
Household income -0.389 0.221 -0.148 0.081 
euroSCORE 0.127 0.159 0.105 0.428 
T1 Anxiety 0.409 0.082 0.502 <0.001 
T1 BDI total score 0.071 0.062 0.113 0.257 
T2 TNF-α early -0.292 0.107 -0.217 0.008 
R
2
 = 0.413, N = 103 
 
Physical symptoms 
 
The following analyses were performed to assess the relative contribution of inflammation to 
T3 physical symptoms. There were no significant results using hs-CRP or TNF-α responses. 
Instead, results showed that IL-6 T2 late response and change in IL-6 from baseline to T2 late, 
were both significant predictors. The model using IL-6 T2 late response is displayed in Table 
7.57 and shows that T2 late IL-6 (t = 2.746, p = 0.007) was the only significant predictor of T3 
physical symptoms after adjusting for covariates and baseline total BDI score. This association 
was positive such that those participants who had a higher level of IL-6 four to eight days after 
surgery, had greater physical symptoms up to two months after surgery. The model accounted 
for 12.6% (R2 = 0.126) of variance in T3 physical symptom scores. T2 late IL-6 response was 
also a significant predictor of T3 physical symptoms in models using T1 somatic/affective (t = 
2.837, p = 0.006) and cognitive/affective (t = 2.738, p = 0.007) depression symptom scores. 
Only T1 somatic/affective depression symptoms (t = 2.023, p = 0.046) also remained a 
significant predictor of T3 physical symptoms in models using T2 IL-6 late.  
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TABLE 7.57: MULTIPLE REGRESSION OF T3 PHYSICAL SYMPTOMS ON T2 IL-6 LATE  
Model B SE ß p 
Age 0.047 0.154 0.053 0.761 
Sex 2.217 2.711 0.084 0.416 
Household income -0.945 0.613 -0.156 0.126 
euroSCORE -0.112 0.475 -0.041 0.814 
T1 BDI total score 0.168 0.142 0.125 0.241 
T2 IL-6 late 0.077 0.028 0.278 0.007 
R
2
 = 0.126, N = 96 
 
TABLE 7.58: MULTIPLE REGRESSION OF T3 PHYSICAL SYMPTOMS ON T1 TO T2 LATE IL-6 
CHANGE  
Model B SE ß p 
Age 0.004 0.165 0.004 0.983 
Sex 2.202 2.768 0.085 0.429 
Household income -0.957 0.653 -0.154 0.146 
euroSCORE 0.045 0.517 0.016 0.930 
T1 BDI total score 0.167 0.149 0.122 0.265 
IL-6 change T1-T2 late 0.075 0.030 0.264 0.014 
R
2
 = 0.124, N = 91 
 
The model using IL-6 change from T1 to T2 late is displayed in Table 7.58 and shows 
that IL-6 change (t = 2.520, p = 0.014) was the only significant predictor of T3 physical 
symptoms after adjusting for covariates and baseline total BDI score. This association was 
positive such that those participants who had a higher change in IL-6 from before CABG to four 
to eight days after surgery, had greater physical symptoms up to two months after surgery. 
The model accounted for 12.4% (R2 = 0.124) of variance in T3 physical symptom scores. T2 late 
IL-6 was also a significant predictor of T3 physical symptoms in models using T1 
somatic/affective (t = 2.583, p = 0.012) and cognitive/affective (t = 2.500, p = 0.014) depression 
symptom scores. Somatic/affective depression symptoms (t = 1.981, p = 0.051) was borderline 
significant in the model, but cognitive/affective depression symptoms were not significant.   
In summary, these results show that the IL-6 response four to eight days following 
surgery was an important independent predictor of physical symptoms experienced up to two 
months after surgery. In particular, those participants with the greatest increase in IL-6 from 
baseline to four to eight days after surgery had the greatest physical symptoms at T3.  
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Health status 
 
TABLE 7.59: MULTIPLE REGRESSION OF T3 MENTAL HEALTH STATUS ON T2 TNF-α EARLY  
Model B SE ß p 
Age -0.176 0.113 -0.220 0.125 
Sex 1.506 2.092 0.071 0.473 
Household income -0.170 0.505 -0.032 0.736 
euroSCORE 0.172 0.346 0.074 0.621 
T1 Mental health status 0.355 0.105 0.334 0.001 
T1 BDI total score -0.265 0.127 -0.207 0.040 
T2 TNF-α early 0.706 0.244 0.259 0.005 
R
2
 = 0.245, N = 105 
 
TABLE 7.60: MULTIPLE REGRESSION OF T3 MENTAL HEALTH STATUS ON T1 TO T2 EARLY 
TNF-α CHANGE  
Model B SE ß p 
Age -0.180 0.119 -0.226 0.135 
Sex 2.284 2.193 0.107 0.300 
Household income -0.187 0.519 -0.035 0.719 
euroSCORE 0.114 0.370 0.049 0.758 
T1 Mental health status 0.367 0.107 0.345 0.001 
T1 BDI total score -0.301 0.130 -0.232 0.023 
Change TNF-α T1-T2 early 0.459 0.174 0.241 0.010 
R
2
 = 0.256, N = 99 
 
A multiple regression model was next built to assess the relative contribution of inflammation 
to T3 health status. There were no significant results using IL-6 or hs-CRP responses. Results 
did however show that TNF-α T2 early response and change in TNF-α from T1 to T2 early were 
significant predictors. The model using TNF-α T2 early is displayed in Table 7.59 and shows that 
T1 mental health status (t = 3.384, p = 0.001), total BDI score (t = -2.085, p = 0.040), and TNF-α 
T2 early (t = 2.890, p = 0.005) were all significant predictors of T3 mental health status in this 
model. This association was such that those participants who had higher baseline mental 
health status, fewer baseline depression symptoms, and a higher level of TNF-α one to three 
days after surgery, had better mental health status up to two months after surgery. The model 
accounted for 24.5% (R2 = 0.245) of variance in T3 mental health status scores. TNF-α T2 early 
was also a significant predictor of T3 mental health status in models using somatic/affective 
(TNF-α: t = 2.917, p = 0.004) and cognitive/affective (TNF-α: t = 2.764, p = 0.007) depression. In 
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summary, these results show that TNF-α in the days shortly following surgery was an 
important predictor in models using depression symptom subtypes. Interestingly, it was those 
participants who had a lower TNF-α response who had poorer mental health status; the reason 
for this is not clear, but is in line with the findings described earlier showing lower TNF-α was 
predictive of greater anxiety at T3.  
The model using change in TNF-α from T1 to T2 early is displayed in Table 7.60 and 
shows that T1 mental health status (t = 3.422, p = 0.001), total BDI score (t = -2.310, p = 0.023), 
and TNF-α T2 early (t = 2.636, p = 0.010) were all significant predictors of T3 mental health 
status in this model. This association was such that those participants, who had higher mental 
health status and low depression symptoms prior to surgery, and a higher level of change in 
TNF-α, had better mental health status up to two months after surgery. The model accounted 
for 25.6% (R2 = 0.256) of variance in T3 mental health status scores. Change in TNF-α T2 early 
was also a significant predictor of T3 mental health status in models using somatic/affective 
(TNF-α: t = 2.610, p = 0.011) and cognitive/affective (TNF-α: t = 2.497, p = 0.014) depression 
symptom scores. In summary, these results show that change in TNF-α from baseline to the 
days shortly following CABG surgery was an independent predictor of mental health status as 
T3. However, it is not clear why a smaller change in the inflammatory response was predictive 
of poorer mental health status. 
7.7.6 Post-operative inflammation and greater T3 depression symptoms 
The final model to be tested in this PhD was the association between inflammation occurring 
in the days after surgery and depression symptoms at T3. This relationship was assessed using 
both the total BDI continuous score at T3 and the post-CABG depression categorical variable 
(yes/no). No significant results were found using any of the IL-6 or hs-CRP responses. However, 
significant findings were found using TNF-α responses in the days after surgery. The model 
using TNF-α T2 early response is shown in Table 7.61, whereby after controlling for 
demographic and disease severity covariates and baseline total BDI score, TNF-α T2 early (t = -
2.661, p = 0.009)  was a significant predictor of greater depression symptoms at T3. This 
association was negative, such that greater inflammation was predictive of lower depression 
symptoms. The only other significant predictor in this model was baseline depression 
symptoms (t = 4.859, p <0.001). The model accounted for 27.0% (R2 = 0.140) of variance in T3 
BDI scores. This result was also replicated in models to predict T3 somatic/affective (t = -2.369, 
p = 0.020) and cognitive/affective (t = -2.447, p = 0.016) depression symptoms. This negative 
association between TNF-α and depression symptoms is in line with findings reported earlier 
showing greater TNF-α at T2 early was associated with better mental health status at T3.  
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TABLE 7.61: MULTIPLE REGRESSION OF T3 BDI SCORE ON T2 EARLY TNF-α  
Model B SE ß p 
Age -0.031 0.095 -0.046 0.741 
Sex -0.489 1.753 -0.027 0.781 
Household income -0.621 0.426 -0.135 0.148 
euroSCORE -0.020 0.291 -0.010 0.945 
T1 BDI total  0.484 0.100 0.440 <0.001 
T2 early TNF-α  -0.548 0.206 -0.234 0.009 
R
2
 = 0.270, N = 104 
 
Significant findings were also found using TNF-α responses in the days following 
surgery to predict post-CABG onset depression. Results showed that the TNF-α T2 late 
response was a significant predictor. The model is displayed in Table 7.62 and shows that TNF-
α T2 late (t = -2.210, p = 0.030) was the only significant predictor of post-CABG onset 
depression after adjusting for covariates. In line with the results to predict greater total BDI 
scores at T3, this association was negative such that those participants who had a lower level 
of TNF-α four to eight days after surgery were significantly more likely to have post-CABG 
depression up to two months after surgery. The model accounted for 14.0% (R2 = 0.140) of 
variance in post-CABG onset depression. In summary, these results show that TNF-α in the 
days following surgery was an important predictor of depression symptoms two months 
following surgery.  
 
 
TABLE 7.62: MULTIPLE REGRESSION OF POST-CABG ONSET DEPRESSION ON T2 LATE TNF-α   
Model B SE ß p 
Age -0.015 0.006 -0.416 0.020 
Sex 0.042 0.118 0.042 0.721 
Household income -0.004 0.027 -0.015 0.894 
euroSCORE 0.025 0.019 0.237 0.194 
T2 late TNF-α  -0.030 0.013 -0.247 0.030 
R
2
 = 0.140, N = 75 
 
7.8 Discussion 
7.8.1 Summary of results 
The table (Table 7.63) displays a summary of the main findings presented in this chapter. 
Somatic/affective and post-CABG onset depression symptoms were related to all the recovery 
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outcomes after controlling for covariates. Persistent depression symptoms were related to all 
the recovery outcomes except physical health status. Total, cognitive/affective and resolved 
depression symptoms were not significantly related to any of the T3 recovery outcomes after 
adjustment for covariates. However, due to the small number of depression cases for resolved, 
persistent and post-CABG onset depression, the role of mechanistic variables was only 
examined for the prospective relationship between baseline depression symptom subtypes 
and recovery outcomes at T3.  
Health behaviours including physical activity, sleep and BMI were predictive of 
recovery outcomes. Physical activity was an important predictor of T3 emotional distress and 
affective pain, such that participants who walked for a greater number of hours per week prior 
to CABG were most anxious and experienced more affective pain two months after surgery. 
Notably, baseline depression symptoms were not related to baseline physical activity and so 
physical activity was shown to exert an independent effect on T3 anxiety and affective pain. 
The positive association was an unexpected result, but perhaps shows that the most physically 
able participants prior to surgery were most affected by the limitations imposed by undergoing 
a major procedure. Baseline BMI was another health behaviour that was able to predict 
recovery, with the most overweight participants prior to surgery reporting greater sensory 
pain after surgery. The reason for this is not clear, but perhaps suggests that overweight 
participants recovered more slowly from the physical symptoms of surgery than those 
participants who had a lower BMI. Depression symptoms were unrelated to BMI, and 
therefore this effect was independent of baseline depression symptom status. Lastly, poorer 
sleep prior to surgery, and in particular difficulty maintaining sleep, was a significant predictor 
of greater physical symptoms after surgery and poorer physical health status. This suggests 
that good sleep was an important factor for predicting better functional recovery after surgery. 
Sleep was not considered to be a mediator of the depression symptoms-recovery relationship, 
since poor sleep is in itself a symptom of depression.  
Baseline illness perceptions were broadly predictive of the T3 recovery outcomes. 
Indeed, greater negative illness perceptions prior to surgery mediated the relationship 
between somatic/affective depression symptoms and greater affective pain and greater 
physical symptoms. In particular, in models using somatic/affective depression, the specific 
illness perception of concern was most relevant in predicting greater physical symptoms at T3, 
but none of the individual illness perceptions were independent predictors of affective pain. 
The perception of concern captures a distress element of illness perceptions, suggesting those 
participants who were most emotionally affected by their illness, were particularly vulnerable 
to poor physical and emotional adaptation following surgery. Perhaps more notable is the fact 
that illness perceptions did not mediate all the relationships between depression and recovery, 
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with somatic/affective depression symptoms exerting an independent effect on some of the 
recovery outcomes, including anxiety, sensory pain and physical and mental health status.   
 
TABLE 7.63: SUMMARY OF SHORT-TERM OUTCOME RESULTS 
Main findings  Supported using depression symptom models? 
1. Pre-operative total BDI scores were not able to 
predict any of the recovery outcomes at T3.  
 Pre-operative cognitive/affective depression 
scores were not able to predict any of the 
recovery outcomes at T3. 
 Pre-operative somatic/affective depression score 
was a significant predictor of greater sensory and 
affective pain, greater physical symptoms and 
lower physical health status at T3. It was a 
borderline significant predictor of T3 anxiety. 
2. Resolved depression was not significantly related 
to any of the recovery outcomes at T3. Post-
CABG onset depression was associated with 
greater anxiety, greater sensory and affective 
pain, greater physical symptoms and lower 
physical and mental health status at T3; 
persistent depression was associated with all the 
outcomes except physical health status.  
- 
3. Greater pre-operative physical activity was 
significantly associated with greater anxiety and 
greater affective pain at T3, in models using total 
BDI score.    
 The same findings were found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
4. Greater pre-operative BMI was significantly 
associated with greater sensory pain at T3, in 
models using total BDI score.    
 The same finding was found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
5. Greater pre-operative sleep problems were 
significantly associated with greater physical 
symptoms and lower mental health status at T3, 
in models using total BDI score.    
 The same findings were found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
6. Baseline illness perceptions were associated with 
greater affective pain, greater physical 
symptoms and lower mental health status at T3 
in models using total BDI score.   
 Baseline illness perceptions mediated the 
relationship between T1 somatic/affective 
depression score and greater affective pain and 
physical symptoms at T3. T1 illness perceptions 
were a significant predictor of lower mental 
health status at T3 after including 
somatic/affective depression score in the model.  
 Greater pre-operative illness perceptions were 
associated with greater anxiety, greater physical 
symptoms and lower physical and mental health 
status in models using cognitive/affective 
depression scores.    
7. T1 lower cortisol AUC was significantly 
associated with lower mental health status at T3, 
in models using total BDI score.     
 The same finding was found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
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8. Pre-operative total BDI scores were able to 
predict a lower change in cortisol output from 
waking to bedtime at T3.  
 The same finding was found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
 Pre-operative cognitive/affective depression 
scores also predicted a lower cortisol AUC at T3.  
9. T3 cortisol slope was significantly associated with 
greater anxiety at T3, and T3 CAR was 
significantly associated with greater physical 
symptoms at T3, in models using total BDI score.    
 The same findings were found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
10. Greater T2 late IL-6 response and greater change 
in IL-6 from baseline to T2 late was significantly 
associated with greater physical symptoms at T3, 
in models using total BDI score.      
 The same finding was found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
11. Lower T2 early TNF-α response was significantly 
associated with greater anxiety and lower 
mental health status at T3, and a smaller change 
in TNF-α from baseline to T2 early was 
associated with lower mental health status at T3, 
in models using total BDI score.         
 The same findings were found adjusting for both 
somatic/affective and cognitive/affective 
depression symptoms. 
12. Lower T2 early TNF-α and lower T2 late TNF-α 
were associated with greater total BDI scores at 
T3 and post-CABG onset depression respectively.   
 Lower T2 early TNF-α was associated with greater 
somatic/affective and cognitive/affective 
depression symptoms at T3.  
 
Biological factors were also assessed as mediators of the depression-recovery 
relationship. The baseline AUC of cortisol was significantly related to the recovery outcome, 
mental health status. This effect was independent of all the depression symptom subtypes; 
however it was not in the predicted direction. Depression symptoms were associated with an 
increase in cortisol output across the day, but lower mental health status was associated with 
lower AUC. This suggests that cortisol AUC was not a mediator of the relationship between 
depression symptoms and mental health status. 
The inflammatory markers also produced interesting results, with IL-6 and TNF-α 
responses both predicting recovery outcomes. It was hypothesised that heightened 
inflammatory responses would lead to poorer recovery. IL-6 results were in line with this 
hypothesis. For example, the participants who had the highest IL-6 response four to eight days 
after surgery and the greatest change from baseline to four to eight days post-surgery had the 
greatest physical symptoms. This is in contrast to results found in Chapter 6, whereby lower IL-
6 responses in the days after surgery were predictive of longer hospital stays. TNF-α results 
also add to the inconsistent picture, such that lower TNF-α in the days shortly after surgery 
were predictive of greater anxiety and poorer mental health status. It is not clear why a 
greater inflammatory response for IL-6, but a lower TNF-α response, was predictive of better 
recovery outcomes at T3. More work is needed to delineate the independent effects the 
different inflammatory markers exert on recovery outcomes in this patient group.  These 
results do however suggest that the extent of the inflammatory response is an important 
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independent predictor of emotional adaptation and adjustment after CABG surgery, even after 
taking depression symptoms into account. Nonetheless, it is important to note that the 
inflammatory responses were not shown to mediate the depression symptoms-recovery 
relationship, since while depression caseness was found to be associated with inflammatory 
responses, these did not correspond to the inflammatory markers predictive of recovery 
outcomes.  
The inflammatory responses after surgery (T2 early and T2 late) were also tested to 
see if they were able to predict greater depression symptoms at T3, including the onset of 
post-CABG depression. Results showed that a lower TNF-α response in the days following 
surgery were predictive of greater depression symptoms and post-CABG onset depression. In 
particular, it was found that a lower TNF-α response one to three days following surgery was 
an independent predictor of greater depression symptoms at T3, even after controlling for 
baseline depression symptoms. What is more, lower TNF-α responses four to eight days after 
surgery were also found to predict post-CABG onset depression symptoms independently from 
demographic and disease severity covariates.  
7.8.2 Analysis of results 
7.8.2.1 Hypothesis 1: Depression symptoms and recovery 
This hypothesis stated that depression symptoms would be associated with impaired 
adaptation following CABG surgery. In particular it stated that somatic/affective depression, 
persistent depression symptoms and post-CABG onset depression symptoms would carry 
greater risk than no depression, cognitive/affective depression symptoms and resolved 
depression symptoms for poor adaptation up to two months following surgery. This hypothesis 
was upheld since the only depression symptom subtypes significantly related to the recovery 
outcomes at T3 were somatic/affective, persistent and post-CABG onset depression 
symptoms. Indeed, total BDI depression score, cognitive/affective depression symptoms and 
resolved depression were not significantly related to any of the T3 recovery outcomes. 
However, since persistent and post-CABG onset depression capture T3 depression symptoms, 
it is probable that the associations with recovery outcomes for these depression subtypes 
were driven by the cross-sectional associations between greater T3 depression symptoms and 
poorer T3 recovery.  All recovery endpoints were associated with these depression subtypes, 
including poorer emotional recovery in terms of anxiety, longer surgical recovery including 
greater sensory and affective pain and greater physical symptom reporting, and poorer 
physical and mental adaptation as measured by health status on the SF-12.  
These results partially support recent evidence which has shown the greater cardiac 
risk associated with post-ACS depression symptoms may be in large part attributable to an 
290 
 
increase in depression symptoms following MI, rather than the prolongation of recurrent 
depressive symptoms from before the MI (Zuidersma, Ormel, Conradi, & de Jonge, 2012). In 
particular these authors reported that each new depression symptom experienced post-MI 
carried an increased risk of new cardiac events of 15%, remaining significant even after 
adjusting for baseline disease severity and demographic confounders. However, this PhD 
found that persistent depression symptoms, as well as post-CABG depression symptoms, were 
important predictors of recovery outcomes in CABG patients up to two months after surgery, 
but it is not clear to what extent this effect would continue in the longer term. Moreover, the 
effect of persistent and post-CABG onset depression was not assessed in relation to cardiac 
morbidity.  
Previous studies using CABG patients have also examined the risk of mortality 
associated with the onset of depression in relation to the surgical procedure.  For example, 
Connerney and colleagues (Connerney, Sloan, Shapiro, Bagiella, & Seckman, 2010) found post-
CABG depression symptoms were significantly associated with elevated cardiac mortality. 
Moreover, in models adjusted for sex, age, ejection fraction and diabetes, those patients with 
new onset depression symptoms (n = 39) (HR 2.12, 95% CI 1.09-4.15, p = 0.03) had twice the 
risk of cardiac mortality compared with those patients who had never been depressed (n = 
198). The recurrent depression group (n = 24) was not significantly different to the never 
depressed group (HR 1.72, 95% CI 0.78-3.80, p = 0.18). This PhD was not able to assess 
mortality and further work is needed to understand the cardiac risk associated with the timing 
and recurrence of a depressive episode.  
In addition, this PhD has shown somatic/affective depression symptoms to be 
particularly damaging, which is in line with previous literature using MI patients. Analyses 
performed on two large datasets comprising more than 2000 patients compared three 
dimensions of depression symptoms derived from the BDI in relation to cardiovascular risk 
markers, mortality and readmissions over an average of 2.5 years after ACS (De Jonge, Ormel, 
et al., 2006). Cox regression analyses found somatic/affective symptoms (e.g. fatigue, 
pessimism) to predict cardiovascular events and mortality, even after controlling for cardiac 
risk factors (LVEF, Killip class, and previous myocardial infarction), while cognitive/affective 
(e.g. social withdrawal, work difficulty) and appetitive symptoms (e.g. loss of appetite, weight 
loss) did not. Other studies have reported similar findings (Doyle, Conroy, McGee, & Delaney, 
2010; Hoen et al., 2010; Linke et al., 2009; Martens, Hoen, Mittelhaeuser, de Jonge, & 
Denollet, 2010; McGowan et al., 2004). Somatic depression symptoms have also shown to be 
positively correlated to intima-media thickness of the carotid artery, a marker of 
atherosclerotic disease progression (Bus et al., 2011). However, this trend of results has not 
been supported using CABG patients. For example, Connerney and colleagues (Connerney, 
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Sloan, Shapiro, Bagiella, & Seckman, 2010) found cognitive-affective but not somatic 
symptoms to be predictive of cardiac mortality in models adjusted for confounders. These 
results have been supported by another recent study of morbidity and mortality in CABG 
patients, which also found cognitive depressive symptoms to be particularly damaging (Tully et 
al., 2011). However, this PhD was only able to study the effect of depression symptom 
subtypes on impaired adaptation, and not mortality, which may partly explain the discrepant 
findings.  
7.8.2.2 Hypothesis 2: Social-behavioural mechanisms 
This hypothesis stated that social-behavioural factors would affect the depression symptoms-
poor adaptation relationship and that those patients who showed more negative health 
behaviours and lower social support before surgery would be more likely to have poorer 
emotional adaptation and recovery up to two months following surgery. In fact, the results 
only partially supported this hypothesis. Physical activity, sleep and BMI were all related to 
recovery endpoints, but no significant findings were found for alcohol intake, smoking status 
or social support.  
 Physical activity was associated with anxiety, but as previously discussed this was not 
in the anticipated direction, such that lower physical activity predicted greater anxiety. This 
was found to be the case even after adjusting for depression symptoms. Physical activity has 
been shown to be an important component of cardiac rehabilitation, being associated with 
reduced total and cardiovascular mortality and hospital readmission (Heran et al., 2011). A 
recent study showed that the relationship between depressive symptoms and future cardiac 
events in patients with CHD was largely accounted for by poor health behaviours, particularly 
physical inactivity (Whooley et al., 2008). Few studies have investigated these effects in CABG 
patients although physical activity is thought to have important protective effects in these 
patients (Nery & Barbisan, 2010). Therefore, the finding that the most active participants had 
the greatest anxiety at T3 is surprising. This can possibly be interpreted as the most active 
participants prior to surgery finding it the hardest to adapt to the limitations imposed on their 
lifestyle due to the CABG procedure.  
 BMI was found to be significantly related to greater sensory pain following surgery and 
this was independent from the depression symptom subtypes.  Obesity is a cardiac risk factor 
that has been associated with depression symptoms (Luppino et al., 2010), and although many 
studies using CABG patients do not report body mass index (BMI) statistics, the few that have 
do not show BMI or obesity to be associated with depression symptoms (Blumenthal et al., 
2003; Burg, Benedetto, Rosenberg, et al., 2003; Dunkel et al., 2009). The results from this PhD 
confirm that depression symptoms were not associated with BMI; however, these findings do 
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suggest that BMI is an important factor for predicting the amount of pain participants 
experience up to two months after CABG surgery, with the most overweight participants 
having a slower recovery process.  
 Sleep was a significant predictor of greater physical symptoms and poorer physical 
health status up to two months following surgery. This was confirmed in all models including 
the depression symptom subtypes. This is in line with results presented using the pilot data in 
Chapter 3. Sleep duration and quality have been associated with both cardiovascular disease 
and events (Leineweber et al., 2003; Sabanayagam & Shankar, 2010; Schwartz et al., 1998). 
Poor sleep is also thought to have negative consequences for emotional wellbeing and 
research has shown an association between poor sleep quality and depression symptoms 
(Almeida et al., 2011; Benca et al., 1992). While depression symptoms were associated with 
poor sleep, mediation analyses were not performed since sleep is a symptom of depression. 
Instead, this PhD assessed the relationship between sleep and recovery outcomes, 
independent from covariates and depression symptom subtypes. Although sleep is recognised 
to be an important issue in post-CABG recovery (Jenkins et al., 1996; Redeker & Hedges, 2002), 
very few studies have investigated the impact of poor sleep on physical and emotional 
adaptation and recovery following cardiac surgery. Hunt and colleagues (Hunt et al., 2000) 
assessed 108 CABG patients 12-months after surgery and used cross-sectional analyses to test 
for associations between poor self-reported sleep quality and poor health status. These 
authors found patients reporting poor sleep were 4.8 times more likely to also report poor 
health status. Redeker and colleagues (Redeker et al., 2004) studied 72 cardiac surgery 
patients in a study which implemented both self-report and objective measures of sleep on 
quality of life after surgery. They reported cross-sectional associations between poor sleep and 
worsened physical and emotional quality of life at four and eight weeks after surgery. The 
results from this PhD furthered these findings with results showing that poor sleep prior to 
surgery was not only predictive of worse physical health status after surgery, but also greater 
physical symptoms after surgery. In particular, this PhD found that problems maintaining 
sleep, as opposed to difficulty initiating sleep, were most important for recovery.  
7.8.2.3 Hypothesis 3: Cognitive mechanisms 
This hypothesis stated that cognitive factors would affect the depression symptoms-poor 
adaptation relationship, such that patients who had lower cognitive function and who showed 
more negative illness perceptions before surgery would be more likely to have poorer 
emotional adaptation and recovery up to two months following surgery. In line with findings 
presented in Chapter 6, baseline cognitive function was again not related to either T1 
depression symptoms or recovery outcomes at T3. Previous literature has not assessed 
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cognition in relation to adaptation following surgery, but instead has demonstrated low levels 
of cognitive function to be associated with greater all-cause (Bosworth & Siegler, 2002) and 
cardiac mortality (Batterham et al., 2012). This latter study followed-up 592 community-
dwelling participants for up to 17 years, and showed that while initial cognitive function was 
the better predictor, deterioration in cognition function over time was also predictive of future 
mortality, after adjustment for demographic, physical functioning and depression symptoms 
and anxiety scores. This association was not tested in this PhD. Moreover, the ARCS study did 
not assess cognitive function over time, and therefore could not test whether deterioration in 
neurocognition was associated with poorer recovery.  
Illness perceptions were found to be implicated in linking depression symptoms to 
poorer physical and emotional adaptation following CABG surgery. The illness perception 
perspective emphasises the importance of patients’ beliefs about their treatment and the 
course of their illness. The majority of the work in this area has used MI patients, and negative 
illness perceptions have been associated with an array of poorer outcomes for this population. 
In addition, more negative illness perceptions have also been related to poorer emotional 
responses to ACS, such as greater depression symptoms (Grace, Krepostman, et al., 2005; 
Stafford et al., 2009). In a study which assessed illness perceptions in the days following 
hospital admission for MI, more negative beliefs were associated with the development of new 
onset depression symptoms in particular (Dickens et al., 2008b). This finding was not tested in 
this PhD. However, previous research has also suggested a mediation model (Dickens, 
Cherrington, & McGowan, 2011) whereby the negative illness perceptions of consequences, 
identity, illness concern and emotional representation have been shown to partly mediate the 
prospective, negative, relationship between baseline depression symptoms and follow-up 
health related health status. Results from the ARCS study are in line with this hypothesis, since 
illness perceptions were shown to mediate the relationship between greater somatic/affective 
depression symptoms and greater affective pain and physical symptoms two months after 
surgery. However, illness perceptions did not mediate the relationship between greater 
somatic/affective depression symptoms and anxiety, sensory pain, physical and mental health 
status. Therefore it seems while illness perceptions are important for some recovery outcomes 
two months following CABG surgery, the effects are not consistent. 
7.8.2.4 Hypothesis 4: Biological mechanisms 
Hypothesis 4 stated that biological factors would affect the depression symptoms-poor 
adaptation relationship. This hypothesis was split into three sub-hypotheses. First, patients 
who showed a flatter cortisol response before surgery would be more likely to show poorer 
emotional and physical recovery up to two months following surgery. Second, patients who 
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showed greater inflammatory responses in the days after surgery would be more likely to 
show poorer emotional and physical recovery up to two months following surgery. Lastly, 
patients who showed greater inflammatory responses in the days after surgery would be more 
likely to experience greater depression symptoms and develop post-CABG onset depression up 
to two months following surgery. 
  The first of these sub-hypotheses only received limited support. Depressed 
participants were found to have greater cortisol output across the day (AUC) compared to non-
depressed participants, but there was no difference between groups in terms of cortisol slope. 
Moreover, baseline cortisol slope was not related to any of the recovery outcomes after 
controlling for covariates. The only baseline marker of cortisol response to be related to 
recovery was in fact the AUC. Cortisol AUC prior to surgery was related to mental health status 
two months after surgery, but this association was not in the predicted direction, such that 
lower cortisol output predicted lower mental health status. It is not clear why those 
participants with higher cortisol had better mental health status, since this is incongruent with 
the association with depression symptoms. It may suggest that the BDI and SF-12 are capturing 
different dimensions of affect. Further exploratory analyses were performed in order to assess 
the relationship between baseline depression symptoms and cortisol responses at T3. Results 
from these analyses showed that greater pre-operative depression symptoms were associated 
with a flatter cortisol response, from waking to bedtime, up to two months after surgery. 
Moreover, cognitive/affective depression symptoms prior to surgery were associated with a 
lower cortisol output across the day at T3, but these findings were not replicated in models 
using total BDI score or somatic/affective depression symptom score; therefore it is not clear 
to what extent this may be a spurious finding. Cross-sectional associations were also found, 
with T3 cortisol slope being associated with T3 anxiety and T3 CAR being associated with T3 
physical symptoms. Therefore, there is some indication that cortisol dysregulation is important 
for recovery. There have been very limited studies investigating cortisol in CABG surgery 
patients, although there is some evidence that there is heightened cortisol output in the post-
operative period (Roth-Isigkeit & Schmucker, 1997; Tønnesen et al., 1987) and one study found 
this pattern to be associated with post-operative complications, in particular delirium (Mu et 
al., 2010). Cortisol responses were not, however, found to mediate the relationship between 
depression symptoms and the recovery outcomes in the ARCS study. 
 The second of these sub-hypotheses was also only partially upheld, with TNF-α and IL-
6 responses, but not hs-CRP, being associated with recovery outcomes. Greater inflammation 
was shown to be linked to poorer recovery using IL-6 data. Specifically, greater IL-6 responses 
four to eight days after surgery were associated with greater physical symptoms two months 
after surgery. However, lower TNF-α one to three days after surgery was found to be 
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associated with greater anxiety and lower mental health status at T3. It is not clear why there 
were inconsistencies in the direction of the inflammatory effect on recovery, since this is not in 
line with previous research. For example, an observational study of 29 cardiopulmonary bypass 
patients by Holmes and colleagues (Holmes et al., 2002) used a median split to compare 
outcomes between those patients who showed a heightened inflammatory response at four 
hours post-CABG, to those who did not. Findings showed that hyper-responders in IL-8, IL-6 
and CR3 (an anaphylatoxin) had greater risk of adverse clinical outcomes. Therefore, it was 
expected that a higher inflammatory response would be associated with poorer recovery in 
ARCS. A key finding from the early-term outcome results presented in Chapter 6 was that 
lower IL-6 responses were associated with longer hospital stays. The direction of the IL-6 
response was not in line with this finding using the T3 data. Instead, greater IL-6 responses 
were associated with greater physical symptoms. The reason for this discrepancy is not clear, 
but suggests that the relationship between IL-6 and recovery may change over time. These 
findings need careful interpretation and corroboration using the full ARCS dataset once 
recruitment has finished. 
  Finally, the last of these sub-hypotheses was not upheld, since lower, rather than 
greater, TNF-α was predictive of greater depression symptoms at T3 and post-CABG onset 
depression. These findings are in line with the aforementioned findings in which lower TNF-α 
was also associated with greater anxiety and lower mental health status. This rationale for a 
positive association was based on the literature which has suggested depression symptoms in 
cardiac patients may be induced by a faulty sickness behaviour response to surgery. Sickness 
behaviour is thought to be adaptive in organising bodily responses that fight infection, 
promoting cellular immunity  which targets intracellular organisms through activation of 
macrophages, cytotoxic T lymphocytes and natural killer cells (Dantzer, Castanon, Lestage, 
Moreau, & Capuron, 2006). A sickness behaviour model of depression symptoms posits that, in 
the case of ACS and CABG, the extent of tissue trauma invokes a large inflammatory response, 
capable of triggering a series of sickness behaviours. In these vulnerable individuals, where the 
immune response is exacerbated in duration and intensity, decompensation (i.e., functional 
deterioration) occurs, causing a shift in balance between pro-inflammatory and anti-
inflammatory markers towards one of inflammation. However, this PhD found results 
incongruent with this hypothesis, such that lower TNF-α was predictive of greater depression 
symptoms. Only one other study to date has assessed the association between depression 
symptoms and inflammation in CABG patients (Yang et al., 2012). These authors studied 232 
patients undergoing CABG surgery and found that higher pre-operative hs-CRP was predictive 
of depression symptoms up to six months following surgery, after controlling for covariates.  
There was no evidence of hs-CRP being associated with T3 recovery outcomes, but the sickness 
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behaviour model of depression does warrant further investigation using the full data once 
recruitment has finished.  
7.9 Chapter summary 
This chapter has assessed the relationship between pre-operative depression symptoms and 
recovery up to two months following surgery. Depression symptoms were classified as 
symptom subtypes including somatic/affective and cognitive/affective symptom subtypes, and 
onset subtypes including resolved, persistent and post-CABG onset. The recovery outcomes 
included emotional distress, physical symptoms and health status. In addition, mechanisms 
accounting for this relationship between baseline depression symptom subtypes and recovery 
were explored, finding little evidence of social-behavioural or biological mediation. Illness 
perceptions were found to mediate the relationship between somatic/affective depression 
symptoms and affective pain and physical symptoms. It appears that depression symptoms 
exert a unique influence on short-term recovery not entirely explained by the mechanisms 
explored in this PhD. Further research is needed to clarify why depression symptom and onset 
subtypes differentially affect recovery.  
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Chapter 8. Discussion 
8.1 Introduction 
Individual discussion sections for the results of this PhD were presented in the respective 
chapters. My PhD had two aims, firstly to develop the ARCS research study and secondly, to 
use this study to test my hypotheses. The pilot study was developed to meet the first aim of 
this thesis and will only be briefly discussed here. Instead, the primary discussion will relate to 
the second part of my PhD, which involved the testing of the hypotheses. As such, this 
discussion chapter will offer a broad view of the literature in which this PhD is nested and will 
highlight the strengths and limitations of the ARCS study, before suggesting the clinical 
implications of this work and areas for further research.  
8.2 Discussion of findings 
8.2.1 Developing ARCS 
The P-ARCS study was performed to enable the development of the main study; in particular 
the aim of P-ARCS was to assess the feasibility of the study design and the suitability of the 
chosen measures. The results from the pilot work informed the design of the ARCS study and 
established the clinical collaboration for data collection at St. George’s Hospital, London. As a 
result of the pilot, several amendments were made to the study protocol and questionnaire 
packs. These included the addition of a 12-month follow-up assessment point for the study of 
long-term outcomes in CABG surgery patients, collection of biological data to include cortisol 
sampling and blood for the analysis of inflammatory cytokines, and a partner study to assess 
the influence of the dyadic relationship between patient and partner on recovery outcomes. 
Adjustments were also made to the questionnaire packs, in particular the CPQ (Stansfeld & 
Marmot, 1992) was included in the main ARCS study instead of the marital functioning 
questionnaire. The only measure removed from the questionnaire pack as a result of P-ARCS 
was the BDI from T2. It was concluded that the length of the BDI and the nature of the 
questions, which often overlap with the physical symptoms experienced as a result of the 
surgery and the hospital environment, made it an inappropriate choice.  
 Preliminary analyses were also performed on the data to explore the associations 
between variables. In particular, models identified pre-surgical sleep and illness perceptions to 
be important independent predictors of recovery outcomes. These findings were used to guide 
the analyses using data from the main ARCS dataset. The development and undertaking of P-
ARCS was a crucial element in preparing for recruitment of participants into the ARCS study. 
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However, the analyses to test the central hypotheses of this thesis were performed using data 
from the main ARCS study.   
8.2.2 Depression symptoms prevalence 
CABG surgery is a surgical intervention aimed to improve life expectancy and quality of life in 
patients with CHD. Therefore, it is surprising that CABG is now understood to have negative 
emotional effects, and both severe depression in the clinical range and subclinical milder 
depression are both commonly experienced by patients (Pignay-Demaria et al., 2003). 
Depression has been found to be common in patients prior to scheduled surgery (Blumenthal 
et al., 2003; Borowicz et al., 2002; Burg, Benedetto, Rosenberg, & Soufer, 2003; Connerney, 
Shapiro, McLaughlin, Bagiella, & Sloan, 2001; Krannich et al., 2007; Tully, Baker, & Knight, 
2008) as well as afterwards (Blumenthal et al., 2003; Borowicz et al., 2002; Connerney et al., 
2001; Krannich et al., 2007).   
Previous literature has shown that the prevalence of depression symptoms varies 
widely both before and after CABG surgery; a full review was provided in Chapter 1 of this 
thesis. This review found that before CABG the prevalence of depression symptoms was 
between 14.3% and 43.1%, while after surgery estimates were between 12.8% and 50%. These 
data were used to calculate weighted means: on average 28.22% of patients were depressed 
pre-surgery and post-surgery 28.17% of patients were depressed. Therefore, overall estimates 
suggest very similar prevalence rates both pre- and post-operatively. 
In the ARCS study, depression was measured using the BDI, which assesses the extent 
to which symptoms have been experienced in the previous two-week period, rather than as a 
clinical categorisation. Using this questionnaire, participants were grouped according to two 
severity cut-offs, >10 in accordance with the BDI handbook and ≥13 in accordance with 
previous work using cardiac patients (Gutierrez & Davis, 1999). Using a cut-off of >10, 29.2% 
(27.2% using T1-T3 sample) of participants were classified as depressed in the ARCS study at 
baseline; this compares to 24.2% of participants in P-ARCS. However, when the more 
conservative cut-off was implemented at ≥13, only 18.4% of participants were classified as 
depressed in the main ARCS study; this compares to 21.4% of participants in P-ARCS. 
Therefore, the prevalence rates using the respective cut-offs were similar in both P-ARCS and 
ARCS. Overall, these results suggest that depression symptoms are commonly experienced 
prior to surgery in CABG patients.  
Depression symptoms were also assessed two months after surgery using the BDI. 
Again, prevalence was captured using the two cut-offs. After surgery at T3, 20.4% of 
participants scored >10 on the BDI in P-ARCS, which was identical to the main study where 
20.4% of participants also scored >10. Using the higher cut-off, P-ARCS showed only 9.2% of 
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participants scored ≥13 after surgery at T3, while 15.0% of participants in the main ARCS study 
were depressed at T3. These findings suggest that fewer participants were depressed at T3 
than before surgery, although depression symptoms were still frequently reported. In terms of 
the prevalence rates using the ≥13 cut-off, compared to the weighted means from previous 
studies, the ARCS study had lower levels of depression symptoms both pre and post-
operatively. Details of participants’ psychiatric history were also obtained in the main ARCS 
study, showing that 15.8% of participants had a history of depression symptoms and a further 
12.9% had a history of anxiety. 
The BDI prevalence findings reflect the importance of using an appropriate cut-off for 
depression. The cut-off implemented by researchers to determine caseness varies greatly 
between studies, even among those using the same instrument. In particular, the study by 
Timberlake and colleagues (Timberlake et al., 1997) used a cut-off of ≥9 on the BDI, which in 
large part may account for their finding of 50% depression cases in the days following surgery. 
Therefore, this study likely over-estimated the effect. This example highlights the difficulty in 
comparing prevalence rates across studies. In fact, the analyses described in this PhD are the 
only study to date which has implemented the BDI cut-off of ≥13 in a sample of CABG patients. 
However, this step was taken in order to increase the specificity of the measure and to 
increase the salience of the findings.  Indeed the results using this conservative cut-off are in 
line with prevalence rates from Mitchell and colleagues (Mitchell et al., 2005) who used both 
questionnaires and diagnostic clinical interviews to measure depression.  For example, in 
terms of pre-CABG surgery estimates, they showed using the MINI (Mini International 
Neuropsychiatric Interview) that 28.2% of participants were depressed compared to 39.0% 
classified as depressed using the BDI cut-off ≥10. In addition, these same authors also 
estimated depression symptoms prevalence after CABG, finding the MINI diagnosed 16.4% of 
participants with depression symptoms compared to 30.0% on the BDI (≥10). Despite the 
variation in use of cut-offs, this PhD largely side-stepped this issue by assessing depression 
symptoms along a continuum rather than demarking participants as depressed or not 
depressed.   
Besides the use of cut-offs, other reasons for the difference in prevalence rates for 
depression found between ARCS and the previous literature are likely to involve dissimilarities 
in the patient demographic and the pre-operative environment. For example, some of the 
studies included urgent (Baker, Andrew, Schrader, & Knight, 2001; Burg et al., 2003; 
Connerney et al., 2001) and re-do (Borowicz et al., 2002; Burg et al., 2003; Connerney et al., 
2001; McKhann, Borowicz, Goldsborough, Enger, & Selnes, 1997) cases in their sample, while 
ARCS was restricted to first-time elective patients. Moreover, since the 1980s, the use of 
medications for the prevention and treatment of CHD has risen in an exponential fashion, and 
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even since the late 1990s the UK has seen a fifteen-fold increase in the prescription of lipid-
lowering medications (Scarborough et al., 2011). These differences in pre-surgical medication 
use may therefore partly account for the differences in depression prevalence, particularly 
since there is some evidence for the depression-protective effects of statins (Otte et al., 2012; 
Stafford & Berk, 2011). Furthermore, the use of antidepressant medication has been 
inconsistently taken into account across studies, with only the studies by Blumenthal and 
colleagues excluding those who were taking antidepressants on study entry (Blumenthal et al., 
2003; Phillips-Bute et al., 2008); this may have lead some studies to underestimate the 
prevalence of depressive symptoms, although this was not supported in the ARCS data. 
Variation in depression prevalence may also be due to differences in the surgical procedure 
such as the use of cardiopulmonary bypass, the duration of surgery and the number of grafts 
performed, alongside differences in post-operative care such as between hospital variations in 
analgesic protocols and the length of in-hospital minimum stay. These factors are not routinely 
disclosed in published findings, making it difficult to draw comparisons between studies. 
Moreover, cross-cultural differences may also play a role, since the majority of work has been 
performed in the USA and Australia, with Timberlake and colleagues (Timberlake et al., 1997) 
providing the only UK data of depression prevalence in CABG patients.    
8.2.3 Depression symptoms and recovery 
8.2.3.1 Impaired adaptation 
This PhD tested the hypothesis that greater depressive symptoms prior to surgery would lead 
to impaired adaptation and slower recovery after surgery. The majority of previous literature 
has focussed on the role of post-operative depression in predicting poorer outcomes after 
CABG (Wellenius et al., 2008) (Tully, Baker, Turnbull, et al., 2008) (Doering et al., 2005) 
(Doering et al., 2008, 2005; Kendel et al., 2010), and few studies have studied the prospective 
relationship using pre-operative measures of depression symptoms. The results presented in 
this thesis showed that pre-operative depression symptoms were associated with greater 
emotional distress, greater physical symptoms, longer hospital stays, and poorer quality of life, 
both in the days and months following surgery. This is in line with work by Burg and colleagues 
(Burg, Benedetto, Rosenberg, & Soufer, 2003) who showed that patients who were depressed 
pre-surgery had higher levels of medical complications during the six months following 
surgery, and were more likely to report poor quality of life and worse recovery.  
In addition, my results have demonstrated that more information can be gleaned by 
examining depression according to its different symptom and onset subtypes, since these were 
predictive of different recovery endpoints. In addition, these associations varied according to 
the point at which recovery was measured after surgery (T2 or T3). These findings suggest care 
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needs to be taken when making comparisons across studies. The depression subtypes will be 
discussed in turn in the following sections.   
8.2.3.2 Depression symptom subtypes 
Depression is an illness without discrete boundaries, encompassing an array of symptoms and 
having a heterogeneous diagnosis. Indeed there is little consensus amongst clinicians and 
researchers about how best to categorise depressive disorders (Wakefield, 2011). The ICD-10 
and DSM-IV classifications of depression symptoms both require a series of symptoms to be 
present most days for at least two weeks and at least one of these symptoms must include low 
mood or loss of interest and pleasure; the ICD-10 also includes loss of energy as one of the key 
diagnostic symptoms. Further symptoms also need to be reported such as feelings of 
guilt/worthlessness, appetitive changes, sleep disruption, suicidal ideation, loss of 
concentration and psychomotor agitation or retardation. Following the work of de Jonge and 
colleagues (De Jonge, Ormel, et al., 2006) this PhD has demonstrated that different depression 
symptoms can predict different recovery outcomes. In particular, two different symptom 
clusters were analysed: somatic/affective and cognitive/affective. The only BDI item not to be 
included in either of these clusters is item 19 pertaining to weight loss, all other symptoms of 
depression were captured.  
As discussed in the literature review, the symptom profile of patients with post-ACS 
depression symptoms seems to affect the risk of future cardiac events. Some types of 
symptoms are thought to be more cardiotoxic than others, with somatic symptoms found to 
be particularly damaging in ACS patients (de Jonge, Ormel, et al., 2006; Doyle, Conroy, McGee, 
& Delaney, 2010; Hoen et al., 2010; Linke et al., 2009; Martens, Hoen, Mittelhaeuser, de Jonge, 
& Denollet, 2010; McGowan et al., 2004). The CABG literature has little studied depression 
symptom subtypes in relation to recovery and the results have generally not tallied with the 
ACS studies. For example, Connerney and colleagues (Connerney, Sloan, Shapiro, Bagiella, & 
Seckman, 2010) found cognitive/affective but not somatic symptoms to be predictive of 
cardiac mortality in models adjusted for confounders. These results have been supported by 
another recent study of morbidity and mortality in CABG patients, which also found cognitive 
depressive symptoms to be particularly damaging (Tully et al., 2011). It is not clear why ACS 
and CABG surgery should have these differences in the cardiotoxicity of the depression 
symptom subtypes, but issues surrounding the different methods of grouping the items of BDI 
into different clusters and differences in the patient demographic, may partly contribute to the 
discrepancy. The difference may also be related to the phenomenology of the experience.  
CABG is planned, somewhat predictable, and optional (the patient can choose whether to have 
surgery), while on the other hand an ACS is unplanned, unexpected, unpredictable and 
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uncontrollable.  Cardiac function over the recovery period may also be different in the two 
situations, so somatic correlates could differ. 
Since the weight of evidence in cardiac patients supports the cardiotoxicity of 
somatic/affective depression, this PhD hypothesised that somatic/affective symptoms would 
lead to more adverse outcomes than cognitive/affective symptoms. In fact, I found mixed 
evidence to support this hypothesis, showing that the recovery timeframe was a critical 
determinant of the relationship between depression symptoms and the recovery outcome. For 
example, somatic/affective, but not cognitive/affective depression symptoms, were a 
significant predictor of greater anxiety and affective pain in the days following surgery, but 
neither symptom subtypes were predictive of sensory pain and both were predictive of greater 
physical symptoms in hospital and longer post-operative hospital stays. In comparison, by two 
months post-surgery, only somatic/affective depression symptoms were a significant predictor 
of recovery outcomes after adjusting for covariates. Cognitive/affective depression symptoms 
prior to surgery were not significantly related to any of the two-month post-surgery endpoints, 
including emotional distress, sensory and affective pain, physical symptom reporting and 
quality of life.  Therefore, both symptom dimensions of the BDI were important predictors of 
early-term physical recovery, but there were differences between subtypes in predicting early-
term emotional recovery and physical and emotional short-term recovery. Therefore, it 
appears the relationship between depression symptoms and recovery is not static, but rather 
dynamic, changing and shifting over time.  
The reason why greater pre-operative somatic/affective depression symptoms, but not 
cognitive/affective symptoms, predicted poorer recovery two months after surgery is not 
clear. Since euroSCORE was a covariate in all analyses, it does not seem that the difference was 
due to differences in underlying disease severity. Nevertheless, somatic depression symptoms 
have been shown to be positively correlated to intima-media thickness of the carotid artery, a 
marker of atherosclerotic disease progression (Bus et al., 2011). Therefore, it is possible that 
the different depression symptoms subtypes have different underlying physiological 
correlates. However, disease severity has been investigated in another recent study by Meurs 
and colleagues (Meurs, Zuidersma, Dickens, & de Jonge, in press) who used data from 494 MI 
patients and studied associations of somatic/affective and cognitive/affective depression 
symptoms with recurrent cardiac events, before and after controlling for GRACE scores. 
Findings showed that controlling for GRACE score did not affect the relationship of total 
depression symptom score nor cognitive/affective depression symptoms on prognosis and 
only partly attenuated the risk of somatic/affective depression symptoms on prognosis. 
Therefore, it appears somatic/affective depression symptoms exert an effect on cardiac 
morbidity largely independent of disease severity.  
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Another related concept to somatic/affective depression symptoms is vital exhaustion, 
which is commonly defined as symptoms of excessive tiredness, increased irritability and a 
sense of demoralisation (Appels et al., 1987). Vital exhaustion has been shown to be predictive 
of cardiac prognosis in MI and heart failure patients (Smith et al., 2010). Although depression 
symptoms and vital exhaustion are often considered to be separate constructs (Kopp et al., 
1998), in a recent study this was only observed in men and not women (Lindeberg et al., 2012). 
Another study used principal component analyses on questionnaire responses of 528 MI 
patients on the BDI and Maastricht Questionnaire (a measure of vital exhaustion) (Vroege et 
al., 2012).  These authors showed strong conceptual overlap between the two scales, with all 
but two items from the Maastricht Questionnaire loading on the somatic/affective dimension 
of the BDI. Moreover, this somatic/affective dimension was able to predict recurrent events, 
but not the cognitive/affective dimension. Therefore, the reason why somatic/affective 
symptoms appeared to lead to poorer outcomes at T3 in this PhD may reflect the effect of 
greater levels of vital exhaustion, as opposed to greater depression. Interestingly, these 
authors also reported individual item analyses of the BDI and Maastricht Questionnaire in 
relation to recurrent cardiac events, showing no specific cardiotoxic items; instead, greater risk 
was attributed to nearly all the items.  More work is needed in order to study the effect of the 
different somatic symptoms in detail, to demark the two syndromes.  
It was hypothesised that the different depression symptom subtypes may actually 
reflect a manifestation of underlying biological processes, in particular differences in 
inflammation. I analysed the role of the inflammatory response to surgery in predicting T3 
depression symptoms and post-CABG onset depression in order to assess the evidence for a 
sickness behaviour model of depression in CABG surgery patients (Dantzer et al., 2008; Poole, 
Dickens, & Steptoe, 2011). This model posits that, in the case of ACS and CABG, the extent of 
tissue trauma invokes a large inflammatory response, capable of triggering a series of sickness 
behaviours. In these vulnerable individuals, where the immune response is exacerbated in 
duration and intensity, decompensation (i.e., functional deterioration) occurs, causing a shift in 
balance between pro-inflammatory and anti-inflammatory cytokines towards one of 
inflammation. Only one previous study to date has assessed the association between 
depression and inflammation in CABG patients, finding that higher pre-operative hs-CRP was 
predictive of depression symptoms up to six months following surgery, after controlling for 
covariates (Yang et al., 2012). However, this PhD tested the inflammatory response to surgery 
and its impact on later depression symptoms; results showed that a lower TNF-α response was 
associated with greater depression symptoms two months after surgery and post-CABG onset 
depression. Therefore, while inflammation was shown to play a role, it was not in the 
anticipated direction, limiting the interpretation of this finding. While the sickness behaviour 
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model offers a strong conceptual basis for interpreting the new onset depression literature in 
cardiac patients, further work is needed in order to substantiate this hypothesis.   
8.2.3.3 Onset subtypes 
There is now a large body of evidence suggesting that different subtypes of depression exist 
according to the timing, duration and recurrence of the depression symptoms in relation to the 
cardiac event. These definitions relate to the chronicity of the depressive episode as well as 
pointing towards different underlying aetiology. This has been well studied in ACS patients, but 
has been little explored in CABG surgery patients.  
Recent evidence indicates there is a stronger association with mortality and recurrent 
cardiac events in patients with new onset depression symptoms (post-ACS depressed with no 
prior history of depression) (Carney et al., 2009; de Jonge, van den Brink, et al., 2006; Dickens 
et al., 2007, 2008a; Grace, Abbey, et al., 2005; Lespérance et al., 1996; Parker et al., 2008).  
However, as with the study of symptom subtypes, little work has explored the importance of 
depression onset subtypes in relation to CABG surgery recovery. One of the few studies to 
date which has begun to address these issues was published recently (Connerney, Sloan, 
Shapiro, Bagiella, & Seckman, 2010). These authors found post-CABG depression was 
significantly associated with elevated cardiac mortality. Moreover, in models adjusted for sex, 
age, ejection fraction and diabetes, those patients with new onset depression symptoms had 
twice the risk of cardiac mortality compared with those patients who had never been 
depressed. Recurrent depression was not significantly different to the never depressed group.  
 Due to a lack of new onset cases, this PhD was restricted to studying post-CABG onset 
depression symptoms (i.e. pre-CABG BDI <13, but post-CABG depression symptoms ≥13) in 
comparison to resolved depression symptoms (i.e. pre-CABG BDI ≥13, but post-CABG BDI <13) 
and persistent depression symptoms (i.e. pre- and post-CABG BDI ≥13). By stratifying 
depression caseness according to these onset subtypes, results demonstrated that patients 
who had resolved depression symptoms had no poorer recovery outcomes at two months 
post-CABG than those who were never depressed. In contrast, both persistent and post-CABG 
depressed participants experienced poorer recovery compared to their never depressed 
counterparts. These results need to be interpreted with caution due to the small number of 
positive cases in each of these groups, but it appears there is some preliminary evidence to 
suggest the chronicity of the depressive episode and the timing of depression symptoms in 
relation to the surgical procedure affects recovery. However, it is likely that these differences 
between the onset subtypes in this PhD were driven by cross-sectional associations between 
depression and recovery outcomes at T3. Further work will be needed to assess these effects 
on recovery at 12 months post-CABG.  
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Previous research has shown the greater cardiac risk associated with post-ACS 
depression may be in large part attributable to an increase in depressive symptoms following 
MI, rather than the prolongation of recurrent depressive symptoms from before the MI 
(Zuidersma, Ormel, Conradi, & de Jonge, 2012). In particular these authors reported that each 
new depression symptom experienced post-MI carried a 15% increased risk of new cardiac 
events, remaining significant even after adjusting for baseline disease severity and 
demographic confounders. While this PhD supports the evidence for the negative effects of 
post-CABG depression, it also suggests that persistent depression is also damaging. However, 
as already described, it will be necessary to explore whether these effects remain at the 12-
month follow-up, when the full ARCS dataset becomes available for analysis.  
8.2.4 Early- and short-term outcomes 
8.2.4.1 T1 depression symptoms and post-operative recovery 
Pre-operative depression symptoms were assessed in relation to recovery in the days following 
surgery (T2) and up to two months later (T3). This allowed for longitudinal examination of the 
relationship between depression symptoms and CABG recovery over time. With regards to the 
early-term outcomes, pre-operative somatic/affective depression symptoms and 
cognitive/affective depression symptoms were not related to the same recovery outcomes at 
T2. Somatic/affective and cognitive/affective depression symptom subtypes were both 
relevant for predicting physical recovery at T2, whereas somatic/affective depression 
symptoms were the better predictor of distress at T2.  In terms of the short-term outcomes, 
somatic/affective depression, but not total or cognitive/affective depression symptoms were 
predictive of recovery outcomes. In addition, persistent and post-CABG, but not resolved 
depression, were predictive of the T3 recovery outcomes.  
Previous literature has also shown the importance of the timing of assessments in 
understanding the relationship between depression symptoms and poorer adaptation 
following CABG. For example, Burg and colleagues found that pre-operative depression was 
able to predict greater risk of cardiac hospitalisations, continued surgical pain and failure to 
return to previous functioning up to six months after surgery (Burg, Benedetto, Rosenberg, et 
al., 2003). However, the course of this prospective relationship over time has received little 
attention in previous research, and my results are the first to show the negative sequelae of 
pre-operative depression symptoms for recovery in both the early- and short-term stages of 
the post-CABG period. In order to understand why and how depression symptoms affect 
recovery, the role of possible covariates and mediating variables were explored. Each of these 
will be discussed in turn below.  
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8.2.4.2 Covariates  
Covariates were identified based on a priori assumptions, but were then selected for inclusion 
in regression models based on results from correlation analyses. This approach was taken in 
order to limit the number of variables in models and so to maximise power, especially in the 
case of the biological data where there were a reduced number of cases. Age, sex, household 
income and euroSCORE were used as covariates in all statistical models. In addition, baseline 
measures of anxiety and quality of life were included in models, where appropriate, to take 
into account pre-existing scores on these variables. Notably, while co-morbidities and other 
clinical factors such as use of medication were not included in regression models, these factors 
were not found to be related to either depression or the recovery outcomes. Moreover, 
euroSCORE is a composite risk marker and takes into account multiple clinical risk indices such 
as diabetes, LVEF and recent MI among others.  
 Several significant findings were found for the covariates across the statistical models. 
Male sex was associated with greater anxiety at T2 and female sex was significantly associated 
with greater sensory pain at T3 and lower physical health status at T3.  Significant findings 
were also found for household income, with the participants from the lowest income 
households being more likely to have an extended post-operative hospital stay, greater 
anxiety, sensory pain and physical symptoms at T3 and lower physical health status also at T3.  
Age and euroSCORE were found to be less important, with older age only being associated 
with greater physical symptoms at T2 and euroSCORE only predicting greater sensory pain at 
T3.  
Gender and age were included as covariates in analyses since these demographic 
factors are established risk factors for both depression (Dunkel et al., 2009; McKenzie et al., 
2010) and mortality (Lehmkuhl et al., 2012; Sen et al., 2012) in CABG patients. In fact, in ARCS, 
few associations were found between gender and age and post-operative recovery. Male sex 
was associated with greater anxiety in the early term post-CABG period and female sex was 
significantly associated with greater sensory pain and lower physical health status two months 
after surgery.  Older age was only associated with greater physical symptoms in the days 
following surgery, but not with any of the other recovery outcomes.  
Interestingly, household income was associated with a range of recovery outcomes, 
including length of post-operative hospital stay, anxiety, sensory pain and physical symptoms 
and lower physical health status; these associations were such that the participants from the 
lowest income households had the poorest recovery outcomes. These findings are in line with 
previous research which has shown the importance of socioeconomic position for cardiac 
health and longevity (Ferrie, Martikainen, Shipley, & Marmot, 2005; Sacker et al., 2008; 
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Stringhini et al., 2010) and prognosis following CABG (Gibson et al., 2009). For example, Britton 
and colleagues (Britton, Shipley, Marmot, & Hemingway, 2004) reported an inverse social 
gradient for CHD within the Whitehall II cohort of UK civil servants, such that the lowest 
employment grades experienced higher rates of cardiac morbidity and mortality than those 
participants from the higher employment bands. The importance of the socioeconomic 
environment in which one resides has also been shown to be an important risk factor for 
recurrent cardiac events in a longitudinal analysis of over 1000 MI survivors (Koren, Steinberg, 
Drory, & Gerber, 2012), with those from the poorest neighbourhoods having the greatest risk 
of adverse outcomes. In addition, previous research has also studied the extent to which 
socioeconomic status is related to depression in CABG patients. For example, some have 
shown that low education is associated with greater risk of pre-operative depression (Dunkel 
et al., 2009; Pirraglia et al., 1999), but not others (Burg, Benedetto, Rosenberg, et al., 2003). In 
terms of post-operative depression, Connerney and colleagues (Connerney et al., 2001) 
reported no difference in education levels between depressed and non-depressed CABG 
patients and this has been found by others (Pirraglia et al., 1999).  The mixed results may be a 
result of education being a weak marker of socioeconomic position in this patient group, since 
most will have completed formal education several decades prior to the onset of cardiac 
disease (Steptoe et al., 2011). The results of this PhD did not examine whether socioeconomic 
position moderates or mediates the relationship between depression and recovery, so this will 
be an important line of enquiry in future analyses, with the added advantage that several 
measures of socioeconomic position can be explored.  
8.2.4.3 Causal pathways – Social-behavioural factors 
Several mechanisms were explored in order to try and explain why participants experiencing 
greater depression symptoms had poorer recovery over and above the covariates. The 
relationship between greater depression symptoms and poor recovery was first attempted to 
be attributed to a higher preponderance of unhealthy behaviours among those participants 
reporting greater depressive symptomatology. Social-behavioural factors included BMI, 
physical activity, smoking status, alcohol intake, sleep and social support. In fact, this 
hypothesis was not supported, since while health behaviours were found to exert independent 
effects on recovery, these were not associated with depression symptoms. These findings do 
however suggest that behaviour modification is an important part of cardiac rehabilitation, but 
the reach of such programmes is not entirely clear in ARCS, since less than half the sample 
actually participated in a cardiac rehabilitation programme. Despite this, alcohol intake did 
decrease following surgery and several participants quit smoking, though the extent to which 
cardiac rehabilitation contributed to these lifestyle changes is uncertain.  
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While the results of this PhD were compelling for the negative effect of smoking on 
length of hospital stay, the protective effect of physical activity was less clear. Specifically, 
greater physical activity was associated with reduced anxiety in the days following surgery, but 
greater anxiety in the months following surgery. This is surprising since there has been recent 
interest in the use of physical exercise as a treatment for mental illness (Blumenthal, 2011; 
Phillips et al., 2003) and our own work has supported the mood-enhancing benefits of physical 
activity, both in terms of reducing negative mood symptoms (Poole, Hamer, et al., 2011) and 
promoting positive wellbeing (Poole, Steptoe, et al., 2011). Therefore, more work is needed to 
delineate these effects in greater detail and to determine the mechanisms through which 
exercise affects recovery, including greater understanding of the timeline over which the 
beneficial effects of exercise are able to impact wellbeing in these patients. It is possible that 
the physical activity measure used in ARCS was not able to capture the frequency and intensity 
of exercise bouts most applicable for wellbeing as it was restricted to time spent walking only. 
Participants may have been engaging in physical activities not screened, including both 
recreational sports, such as swimming, and activities of daily living, such as housework and 
gardening. A recent randomised controlled trial to assess the effectiveness of exercise therapy 
for depression in cardiac patients showed that aerobic exercise performed at 70-85% of a 
participant’s maximal heart rate conferred a mood benefit (Blumenthal et al., 2012); the effect 
of less vigorous activity in this patient group is not well understood. 
Obesity is another cardiac risk factor that has also been associated with depression 
(Luppino et al., 2010), but the effects in CABG patients have not been fully investigated, with 
only a handful of studies reporting BMI statistics in papers of depression in CABG patients 
(Blumenthal et al., 2003; Burg, Benedetto, Rosenberg, et al., 2003; Dunkel et al., 2009). This 
PhD was able to show no differences in BMI in relation to depression symptom reporting, but 
those participants who were more overweight were shown to experience greater sensory pain 
two months after surgery. The association between pain and obesity has been established 
previously using a large-scale birth cohort study (Lake, Power, & Cole, 2000), though it has not 
been previously established in CABG patients and it is not clear to what extent this relationship 
is causal.    
Sleep was also assessed as a behavioural factor predicting poor recovery since a recent 
meta-analysis of prospective studies found that both short and long sleep duration was 
associated with increased risk of developing or dying from CHD and stroke (Francesco P 
Cappuccio et al., 2011). The research in this area has previously been discussed in relation to 
results from P-ARCS (Chapter 4) so will only be briefly outlined again here. Sleep is recognised 
to be an important issue in post-CABG recovery (Jenkins et al., 1996; Redeker & Hedges, 2002), 
but very few studies have investigated the impact of poor sleep on physical and emotional 
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adaptation and recovery following cardiac surgery. To date, two studies have reported cross-
sectional associations between poor sleep and reduced quality of life after CABG surgery (Hunt 
et al., 2000; Redeker et al., 2004). One other study showed that the pre-surgery sleep 
symptom of feeling unrefreshed on awakening explained 44.5% of variance in quality of life 
scores six months after surgery (Edéll-Gustafsson & Hetta, 1999). This PhD also found that 
specific pre-operative sleep symptoms were differentially predictive of recovery outcomes and 
in particular that problems with sleep maintenance, as opposed to sleep initiation, were most 
important for predicting greater physical symptoms and lower mental health status up to two 
months after surgery. Interestingly, these effects were only observed at T3 and not at T2, 
suggesting that different processes are in operation at these time points. Understanding the 
impact of different sleep problems on adaptation and recovery is an important line of enquiry 
for guiding future intervention studies.   
The role of social processes has been little studied in the CABG population and the 
results of this PhD found that while depression symptoms were associated with social support, 
social support was not related to recovery outcomes. Therefore, the mediation hypothesis was 
not upheld.  This hypothesis was based on research which has shown positive effects of social 
support in CABG patients. For example, Okkonen and colleagues found that lower perceived 
family support prior to surgery was associated with greater depression symptoms, feelings of 
hopelessness and anxiety (Okkonen & Vanhanen, 2006). Another study found that 
instrumental social support was associated with positive improvements in mental health but 
not physical functioning at six months following CABG (Barry et al., 2006). As in P-ARCS, the 
ESSI questionnaire showed a skewed response profile, with the majority of participants 
reporting high levels of social support. Therefore, measurement issues may partly account for 
the lack of observed findings. In addition, it is possible that perceived support is less important 
for predicting recovery compared to other forms of support, such as instrumental support.  
Instrumental support captures the practical aspect of social support, with help engaging in 
healthy lifestyle behaviours (Kouvonen et al., 2012) and adherence to medication regimes 
(Molloy, Perkins-Porras, Bhattacharyya, et al., 2008) being potentially relevant to CABG 
patients. Further work is also needed to evaluate the effects of other social support measures 
used in ARCS on the recovery outcomes, such as social networks, attachment style and marital 
functioning.   
In summary, evidence from the ARCS study does suggest that having an unhealthy 
lifestyle prior to surgery has a negative impact on physical recovery after CABG. However, in 
the case of physical activity, this benefit was restricted to the early term and actually caused 
greater distress in the months following surgery in the ARCS sample. It is not clear to what 
extent this effect would persist up to a year following surgery. Moreover, health behaviours 
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exerted their effect on recovery independent from depression, demographic and disease 
severity covariates, and so while not mediators of the depression-recovery relationship, they 
were important independent predictors.  
8.2.4.4 Causal pathways – cognitive factors 
Cognitive factors were described in the literature review as a potential mechanism linking pre-
operative depression to impaired adaptation following CABG.  The first cognitive mechanism to 
be explored in this PhD was the role of neurocognitive function. Lower cognitive function was 
hypothesised to be associated with greater depression symptoms and poorer recovery. In fact, 
no evidence was found in support of this hypothesis. There has been marked interest and 
debate in the role of neurocognitive processes following CABG, such as memory loss and 
difficulties with concentration and problem-solving and both short- and long-term deficits in 
neurocognition have been observed in CABG patients (van Dijk et al., 2000). Unfortunately, the 
ARCS study was unable to observe any deterioration in CABG over time since the MoCA was 
only administered prior to surgery. However, low levels of cognitive function have previously 
been associated with greater all-cause (Bosworth & Siegler, 2002) and cardiac mortality 
(Batterham et al., 2012). This latter study showed the importance of initial cognitive function, 
not just deterioration in cognitive function over time, on cardiac mortality. Cognitive 
difficulties are also well-established in depression, among the geriatric depressed (Butters et 
al., 2004; Rapp et al., 2005) and also younger adults (Castaneda et al., 2008; Herrmann et al., 
2007; Thomas et al., 2009), but have been inconsistently reported in CABG samples (Andrew et 
al., 2000; McKhann et al., 1997; Tsushima et al., 2005; Tully et al., 2009). Therefore, more work 
is needed in order to explore the effects of neurocognition on depression and recovery 
following CABG surgery.  
The second cognitive factor to be explored in my thesis was the role of illness 
perceptions. Illness perceptions were found to mediate some of the relationships depression 
symptoms had with recovery outcomes in the early- and short-term follow-ups.  This is 
consistent with previous literature which has shown negative illness perceptions to be 
associated with an array of poorer outcomes in ACS patients, including greater illness related 
disability at home and at work (Petrie et al., 1996), reduced quality of life (French et al., 2005; 
Stafford et al., 2009) and greater risk of in-hospital complications (Cherrington et al., 2004), 
among others. In addition, more negative illness perceptions have also been related to poorer 
emotional responses in CABG surgery patients (Hermele et al., 2007; Juergens et al., 2010).  
 Results from this PhD were able to show that depression and illness perceptions were 
associated, and while causality was not ascertained, these results are consistent with the 
cognitive vulnerability theory of depression. This theory suggests that negative cognitive 
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appraisals, or negative schemas, are triggered during stressful situations and consequently are 
then capable of leading to depression onset, maintenance and relapse/recurrence (Scher et al., 
2005). Not only was this PhD able to show a cross-sectional relationship between greater 
depression symptoms and greater negative illness perceptions, but also that there was 
evidence in favour of a mediation model, whereby baseline illness perceptions fully mediated 
the relationship between greater baseline depression symptoms and greater anxiety and 
greater physical symptoms in the days following surgery. Interestingly, only partial mediation 
was shown for the relationship between baseline somatic/affective depression symptoms and 
T2 anxiety. Mediation also extended to the two month recovery outcomes, such that greater 
negative illness perceptions fully mediated the relationship between somatic/affective 
depression symptoms at baseline and greater affective pain and physical symptoms two 
months after surgery. These findings are in keeping with results from a recent study by Dickens 
and colleagues (Dickens, Cherrington, & McGowan, 2011) of stable CHD outpatients who 
completed baseline and six-month follow-up assessments. They showed the negative illness 
perceptions of consequences, identity, illness concern and emotional representation partly 
mediated the prospective, negative, relationship between baseline depression and follow-up 
health related quality of life.  
Understanding why illness perceptions are predictive of recovery involves 
identification of the specific perceptions that were significant in the models. For example, in 
the ARCS study, the emotional distress illness perceptions were most predictive of the T2 
recovery outcomes, suggesting that illness specific distress prior to surgery accounted for the 
relationship between greater pre-operative depression and greater anxiety and physical 
symptom reporting. Negative perceptions more generally, rather than any of the individual 
items, were related to greater affective pain at T3, while concern was the only significant 
predictor of greater physical symptoms at T3. These results seem to suggest that those 
participants who were more depressed prior to surgery, were also likely to perceive their 
illness to be more threatening and more worrisome, and this illness specific distress was 
particularly important for some of the self-reported outcomes. Interestingly, depression 
symptoms, but not illness perceptions, were an important independent predictor of length of 
hospital stay, suggesting while these concepts may be similar, they are not one and the same. 
An important future line of enquiry for work in this area is in understanding the extent to 
which the emotional distress aspects of illness perceptions are a separate construct to 
depression and anxiety. It is plausible that the worry and concern invoked by the surgical 
procedure actually reflects a manifestation of an underlying mood disorder.   
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8.2.4.5 Causal pathways – biological factors 
Two different biological pathways were tested in this PhD: cortisol and the inflammatory 
markers IL-6, hs-CRP and TNF-α. Baseline levels of cortisol were not significantly related to the 
recovery outcomes at T2. Depressed participants did, however, have a higher cortisol output 
over the course of the day, but this did not mediate the relationship depression symptoms had 
with the T2 recovery outcomes. At T3, baseline AUC of cortisol was significantly related to the 
recovery outcome, mental health status. This effect was independent of all the depression 
symptom subtypes; however it was not in the predicted direction. Depression symptoms were 
associated with an increase in cortisol output across the day, but lower mental health status 
was associated with lower AUC. This suggests that cortisol AUC was not a mediator of the 
relationship between depression symptoms and mental health status. Cross-sectional 
associations were found to be more consistent with the hypothesised effect, such that a flatter 
cortisol slope at T3 was associated with greater anxiety at T3 and a smaller T3 CAR was 
associated with greater physical symptoms at T3.  
Elevated cortisol has been linked to cardiac risk factors such as hypercholesterolemia, 
abdominal obesity and hypertension, by some (Brown, Varghese, & McEwen, 2004), but not all 
(Otte et al., 2004), authors. In addition, flatter cortisol rhythms across the day have been 
linked with the progression of coronary calcification (Matthews, Schwartz, Cohen, & Seeman, 
2006). In line with the hypothesis that the pattern of the diurnal response, as opposed to the 
total output, would be important for recovery, this PhD found cross-sectional associations 
between flatter cortisol slope and greater anxiety and a smaller morning awakening response 
and greater physical symptoms two months following surgery.   
Cortisol has also been implicated in the pathophysiology of depression (Zunszain et al., 
2011). HPA axis abnormalities have been observed in patients with major depression, including 
increased secretion and reactivity of cortisol (Cowen, 2010). Moreover, Steptoe’s group 
recently showed that alterations in the diurnal profile of cortisol were associated with 
depressed mood in patients with CHD. This PhD found no significant differences between 
depressed and non-depressed participants in terms of the diurnal profile of cortisol; however 
results did show a significant difference in cortisol AUC, such that depressed participants had a 
higher cortisol output across the day than non-depressed participants.  The long-term effects 
of this higher cortisol level on recovery was not observed, therefore future work is needed to 
understand the consequences of these changes to the neuroendocrine system in greater 
detail. More work is needed to understand the effects of the chronicity of the depressive 
episode on the neuroendocrine system. For example, a recent study found that disturbances in 
CAR were only observed among post-ACS patients whose depression was diagnosed through a 
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clinical interview as opposed to a questionnaire measure (Messerli-Bürgy et al., 2012). 
Therefore, problems with the measurement of depression may partly account for my findings. 
In addition, the cortisol sampling method used in ARCS may also play a role, with problems 
surrounding the non-completion of samples, non-adherence to the pre-sampling procedure 
such as not eating or taking any medication, and the short assessment period, all potentially 
compromising the results.  
An extensive review of inflammatory processes was provided in Chapter 2, so only a 
brief summary will be provided again here. Two recent meta-analyses have concluded that 
depression is associated with an increased inflammatory response, including  CRP, IL-1, IL-6 
and TNF-α (Dowlati et al., 2010; Howren et al., 2009). Epidemiological evidence for the 
directionality of the depression-inflammation relationship is mixed, with some studies 
suggesting that depression precedes inflammation (Stewart et al., 2009), while others show 
that inflammation precedes depression (Gimeno et al., 2008). Results from this PhD were able 
to show that participants who had greater depression symptoms pre-operatively had a higher 
post-operative IL-6 response in the days shortly following surgery. While CABG surgery is 
known to be associated with an acute inflammatory response (Biglioli et al., 2003), which 
indeed was supported in the ARCS data, the extent of the inflammatory response is thought 
largely to reflect the amount of trauma derived from the surgical procedure itself. However, 
this PhD showed that the relationship between pre-operative depression and post-operative 
IL-6 was independent from euroSCORE, which is partly comprised of perioperative risk factors. 
 The inflammatory response was not consistently related to recovery outcomes in 
ARCS. For example, lower IL-6, but higher CRP, was associated with poorer recovery at T2, but 
higher IL-6 and lower TNF-α, were associated with poorer recovery at T3. Previous research 
has shown a positive relationship between the extent of the inflammatory response to surgery 
and clinical outcomes (Holmes et al., 2002; Kaireviciute et al., 2010). The baseline CRP findings 
shown in ARCS were congruent with previous research (De Lorenzo et al., 2012; Perry et al., 
2010), such that those participants with higher CRP prior to surgery had greater anxiety, 
greater pain and greater physical symptoms during the in-hospital period.  Some authors 
(Hemingway et al., 2010; Kushner, Broder, & Karp, 1978) have argued that the literature 
relating elevated CRP with poor prognosis in CHD patients is seriously flawed, with poor 
control for confounders, poor methodology and publication bias. Our results would certainly 
suggest that the picture is not as clear-cut as previous research would suggest, and greater 
work is needed to explore the inflammatory response to CABG surgery in greater detail. This 
may include analysis of a greater array of inflammatory markers and greater consideration of 
other contributing factors, such as the use of in-hospital medications, which were not 
measured in ARCS and therefore not controlled for in these analyses. 
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8.2.5 Defining depression 
The results of my PhD have implications for our understanding of depression, how to 
characterise depressive episodes and the relevance of depression symptoms for predicting 
outcomes in cardiac patients. In fact, one of the key findings of this PhD has been that 
depression is not a homogenous disorder in cardiac patients, and lacks discrete boundaries. 
Moreover, my work has highlighted the conceptual problems with the nosology of depression. 
For example, depression symptoms can present different symptom clusters in different 
individuals and symptoms of major depression overlap with other disorders such as anxiety.  
Moreover, patients also differ according to the severity of the depressive disorder, which is 
based both on the number and intensity of an individual’s symptoms and the level of distress 
and impairment in normal functioning. This causes difficulty in studying depression symptoms 
and comparing across individuals, since different patients present differently.  
Some studies have compared whether the way depression is measured affects its 
association with recovery. This has been investigated in ACS patients, but not in CABG 
populations. A recent study has examined this question in detail (Zuidersma et al., 2012) using  
data from 2704 post-MI patients who were administered the BDI and the Composite 
International Diagnostic Interview at three months after their cardiac event, and who were 
followed for up to 10 years post-MI for all cause and cardiac mortality and cardiac 
readmissions. Results found that those scoring ≥19 on the BDI had more than two times 
greater risk of all-cause mortality (HR: 2.47, 95% CI: 1.64-3.70, p <0.001) and almost three 
times greater risk of cardiac mortality (HR: 2.70, 95% CI: 1.38-5.27, p <0.01) than those 
participants who scored <5, after controlling for age, sex, LVEF, previous MI, diabetes and 
smoking. These analyses were also performed using recurrent cardiac events and a lower BDI 
cut-off of 10-18, with the significant effect also being confirmed. In comparison, participants 
with a clinical diagnosis of depression had a lower risk of all-cause (HR: 1.48, 95% CI: 1.12-1.96, 
p <0.01) but not cardiac mortality, in fully adjusted models. However, after adjusting for scores 
on the BDI, this effect actually became non-significant. Therefore, these authors concluded 
that after MI, self-reported BDI symptoms were a better predictor of cardiac outcomes than 
clinically diagnosed depression. Other studies have supported this finding (Frasure-
Smith, Lespérance, & Talajic, 1995; Whooley et al., 2008), but two other studies have shown 
that depression as measured using a diagnostic interview was associated with greater risk of 
adverse cardiac outcomes than depression symptoms measured by questionnaire (Frasure-
Smith & Lespérance, 2008; Penninx et al., 2001). Therefore, further work is needed to explore 
the effect of measurement on morbidity and mortality risk in cardiac patients. In particular, it 
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will be important to determine why and how these measurement methods generate different 
risk profiles.  
In addition, measurement problems are not restricted to the instrument used to 
capture depression, but also relate to difficulties teasing apart the relative contribution of 
depression symptoms from other diagnoses such as anxiety and vital exhaustion. The vital 
exhaustion literature has already been described in Section 8.2.3.2 above, so the following 
section will focus on anxiety.  
8.2.5.1 Anxiety 
Common to all anxiety disorders are intense and excessive feelings of fear and worry that 
impact on an individual’s ability to function as usual in everyday life. According to the DSM-IV, 
GAD refers to chronic feelings of anxiety and worry that are not specific to a single object or 
situation, that are difficult to control, and that persist on more days than not for at least six 
months. At least three accompanying symptoms must also be present, to include: feelings of 
restlessness or being ‘on edge’, fatigue, difficulty in concentrating, irritability, muscle tension 
and sleep disturbance. Therefore, anxiety and depression symptoms share some common 
symptoms, and it is not clear to what extent these symptoms operate under two higher order 
constructs or whether they represent features of a more generalised disorder of distress.  
There is growing evidence surrounding the role of anxiety in predicting poorer 
prognosis in those patients with CHD (Player & Peterson, 2011). For example, in patients with 
stable heart disease, anxiety was able to predict increased risk of cardiac events in two large-
scale prospective studies (Martens, de Jonge, et al., 2010; Moser et al., 2011). Moreover in ACS 
patients, a recent meta-analysis concluded that anxiety following MI is associated with a 36% 
increased risk of adverse cardiac outcomes (Roest, Martens, Denollet, & de Jonge, 2010).  
These observations in MI patients were recently confirmed in a 10-year follow-up study of MI 
patients showing that three months after MI, those patients with GAD were almost twice as 
likely to experience adverse events (mortality or cardiac-related hospital readmissions) than 
those without GAD, even after controlling for baseline disease severity, demographic and 
depression symptom variables (Roest, Zuidersma, & de Jonge, 2012). Similar observations have 
also been reported in CABG patients. Tully and colleagues (Tully, Baker, & Knight, 2008) found 
that those patients with higher levels of pre-operative anxiety were at greater risk of mortality 
(HR 1.88, 95% CI 1.12–3.17, p = 0.02). Another study has also confirmed the effect of anxiety 
on mortality in patients who had previously undergone CABG surgery (Rosenbloom et al., 
2009). Oxlad and colleagues showed anxiety in the immediate post-operative period was 
associated with greater hospital readmissions six months after CABG (Oxlad et al., 2006).  
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My PhD did not directly test the role of pre-operative anxiety in predicting poorer 
recovery. Instead analyses were performed to assess anxiety as an outcome measure of 
emotional stress after surgery. Indeed, the results were able to show that pre-operative 
depression symptoms were a significant predictor of greater anxiety symptoms in the days 
shortly following CABG and up to two months later. Theories have been proposed in which 
anxiety and depressive disorders should be viewed collectively as part of a higher-order 
diagnosis of negative affectivity, characterised by heightened levels of distress, negative 
emotionality and neuroticism (Andrews et al., 2009; Brown & Barlow, 2009; Prenoveau et al., 
2010; Watson, 2009). In this PhD only somatic/affective depression symptoms were predictive 
of anxiety both in the days and months following surgery, and not cognitive/affective 
symptoms. Therefore, it is possible that the somatic/affective depression symptoms partly 
reflect the somatic manifestations of anxiety, particularly problems sleeping, restlessness and 
appetitive changes. However, these effects were shown even after controlling for baseline 
anxiety, and so it seems that while similar, the two are not quite the same. As such, more work 
is needed to explore the differential effects of anxiety and depression symptoms in greater 
detail, as it is unclear whether negative affectivity is more important than either depression 
symptoms or anxiety alone. 
8.2.6 Cardiac populations 
The majority of research investigating depression symptoms in cardiac patients has been 
restricted to the ACS population. One difficulty in interpreting findings from ACS patients is 
that mental health before the cardiac event is assessed retrospectively. The ARCS study was 
able to address this issue, since measures of mood were taken both before and after surgery. 
Another problem with ACS studies is that the temporal relationship of depression symptoms 
and CHD is not clear. However, by using a CABG population, the prospective relationship 
between depression symptoms and recovery was demonstrated, showing that pre-operative 
depression symptoms were able to partially account for variation in recovery outcomes after 
surgery.  However, there are several distinctions that were highlighted in the literature review, 
which need to be borne in mind when making comparisons between the ACS and CABG 
literature.  
First, even though we can measure depression symptoms pre-operatively, this does 
not mean patients are being tested in a disease-free state. For example, in ARCS approximately 
one-third of patients had experienced at least one previous MI. Therefore, it is possible for 
pre-CABG depressed patients to also be classified as post-ACS depressed. It was not possible to 
disentangle the relative risk associated with post-CABG depression symptoms over and above 
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post-ACS depression symptoms in the ARCS study, although it is interesting that persistent and 
post-CABG onset depression symptoms was both associated with poorer recovery.  
Second, although the post-ACS depression literature provides a useful model on which 
we could base the research rationale and hypotheses, this does not amount to post-ACS and 
post-CABG depression symptoms being one in the same, even in new onset cases. Only a 
minority of participants with either resolved, persistent or post-CABG onset depression were 
found to have a positive history of depression, and due to the limited cases it was not possible 
to classify participants as having new onset or recurrent depression, nor pinpoint the initial 
onset of recurrent cases.  While, some participants in the ARCS study did develop post-CABG 
onset depression, the underlying aetiology is not clear; while there were some preliminary 
results which pointed towards the possible contribution of the inflammatory response to 
surgery, the small number of cases limits the inferences that can be drawn. Further work is 
needed to delineate the differences between post-ACS and post-CABG depressed patients and 
the underlying mechanistic pathways related to new onset depression episodes.  
The final caveat is that it is not yet clear whether CABG surgery patients tell us 
anything over and above patients undergoing other major surgery. Nor is it clear to what 
extent CABG surgery differs from other types of cardiac surgery. While the majority of work 
has focussed on depression symptoms in CABG surgery patients, recent evidence suggests 
similar effects of depression symptoms on mortality in percutaneous coronary intervention 
patients too (Damen et al., in press). Unfortunately, ARCS was not able to address this issue, 
but my findings remain relevant since cardiac disease and revascularisation treatment are so 
common. These findings are able to contribute to the cardiac literature as well as the dialogue 
on the commonality of disease processes (Field, 2001; Southerland et al., 2006), suggesting 
mind and body are inextricably linked. 
8.3 Methodological shortcomings 
The ARCS study is able to make a significant contribution to the current literature based on 
several key methodological features. Firstly, its longitudinal design allows for multiple 
assessment points for the analysis of temporal relationships between variables. Importantly, 
this also allowed for the collection of baseline and follow-up measures of depression 
symptoms using the BDI. Secondly, the multidisciplinary approach allowed recruitment to be 
supported by the pre-assessment clinic nurses, for blood to be collected by the ward 
phlebotomists and for clinical data to be obtained from the clinical research analyst at St. 
George’s hospital. Thirdly, we were able to collect a wide range of repeated measures, 
including biological samples and questionnaire data; the latter included measures of 
behavioural, psychological, social and cognitive factors potentially relevant to recovery after 
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CABG surgery.  However, there are a number of limitations that also need consideration; 
these will be described in turn below.  
8.3.1 Uptake and attrition 
Refusal to participate and attrition warrant consideration as a limitation of the ARCS study. 
Four hundred and six participants were invited to participate, with only 243 participants 
returning their T1 assessment. In total, 104 patients refused to take part in the ARCS study and 
while some participants were unable to take part due to inadequate English or because they 
were too unwell, 59 participants stated they were not interested. This raises several issues.  
Firstly, since non-English speaking participants were not included in the study, the 
sample is not entirely representative of the community from which participants were drawn. 
St. George’s Hospital is situated in an ethnically diverse area of South West London, with 
approximately 22% of the borough stating their ethnicity as non-White in the UK 2001 census, 
and 27% of respondents stating a non-UK country of birth (Wandsworth Council, 2001). In 
total, 12.3% of the entire ARCS sample stated their ethnicity to be non-White. Previous 
research has shown that south Asians are less likely to confer the same long-term 
improvements after revascularisation procedures compared to white Europeans (Zaman et al., 
2009). However, the analyses performed in this thesis did not take into account variation in 
ethnicity and culture not captured by household income, therefore future analyses should 
explore the impact of religious and ethnic status on the recovery outcomes.  
Secondly, refusal to participate because participants were not interested or too 
stressed or anxious potentially means that those patients who were most relevant to the 
hypotheses of my PhD may not have been recruited. Therefore, it is possible that my results 
have underestimated the effect of emotional distress on recovery outcomes. Moreover, in 
terms of attrition, it is possible that the participants who withdrew from the study were those 
who were most affected by the procedure, either physically or mentally, and therefore again 
there is a chance the effect size has been underestimated in this data. However, in order to 
maintain full ethical compliance and to ensure the wellbeing of participants, right to withdraw 
at any time was one of the safeguards put in place to protect participants. Given the length of 
the questionnaire booklets, it is feasible that some participants felt undergoing a stressful life 
experience such as CABG surgery, was not conducive to the additional burden of participating 
in a research study. The resulting drop-out has implications in terms of power. The ARCS study 
was designed to recruit 200 participants. Due to the timescale of this PhD, 216 participants 
were included in analyses of early-term outcomes, but only 154 participants provided data for 
the short-term analyses. Due to missing biological samples, the analyses using the cortisol and 
inflammatory cytokine data were performed on a reduced number of participants, again 
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affecting the power of this study to detect an effect and increasing the risk of committing type 
I and II errors. When recruitment and data collection has completed, this issue can be 
addressed in future analyses using the full dataset.  
8.3.2 Inclusion criteria 
With regards to the inclusion criteria there are several potential problems. Participants were 
included in the ARCS study if they were elective, first-time CABG patients. Therefore we 
excluded any participants who were having a repeat procedure or were admitted via Accident 
and Emergency for an emergency procedure. Therefore, the ARCS sample does not capture the 
full breadth of clinical presentations for patients undergoing a CABG procedure, particularly 
the most unwell. In addition, participants with co-morbidities were permitted to take part in 
ARCS, and in line with the average age of the sample, many different conditions were self-
reported including diabetes, osteoarthritis and cancer. These participants were maintained in 
the sample in order to strengthen the ecological validity of the sample. However, these co-
morbidities were all considered during data analysis with no associations with the predictor or 
recovery variables found. Similarly, participants who were undergoing current treatment for 
psychiatric disorders were also allowed to participate, but again during data analysis 
associations were not found between antidepressant or anxiolytic treatment and scores on the 
BDI; therefore, these participants were retained in analyses.  
8.3.3 Gender 
There was a preponderance of male participants in the ARCS study and this was reflected in 
both P-ARCS and the main ARCS study, with 24.3% and 13.6% of the sample being female 
respectively. This male majority is characteristic of the CABG surgical population more 
generally, with men more likely to receive a revascularisation procedure than women in the 
UK. For example, in the ARCS study 406 patients were invited to participate, out of these only 
55 patients (13.5%) were female. Therefore, the total number or women recruited to the 
sample is representative of the targeted clinical population. Moreover, sex was included in all 
analyses as a covariate, in order to assess whether any of the recovery outcomes were 
particularly relevant for men or women, since some studies have shown greater mortality risk 
for women after CABG (Lehmkuhl et al., 2012). However, due to the lack of female participants 
it is difficult to draw any firm conclusions about a gender effect in these data.  
8.3.4 Time intervals between assessments 
Another possible limitation is with regards to the difference between participants in terms of 
the time intervals between assessments. This is arguably a problem with all research that 
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occurs in a naturalistic setting where control over extraneous variables is reduced. Participants 
were recruited at the pre-assessment clinic, which the hospital aims to schedule approximately 
two weeks prior to surgery. In fact, on average participants completed their T1 questionnaire 
29 days prior to surgery. Similarly, after surgery, the researchers aimed to conduct the T2 
interview between three and five days after surgery, at a time convenient to the participant. 
On average, the T2 assessment did indeed take place approximately 4.5 days after surgery. 
Finally, with regards to the T3 assessment all participants were contacted and posted their T3 
questionnaire pack six weeks after surgery, with the mean completion date being 60 days after 
surgery. The problem is that variation in these time points may have affected participants’ 
responses, in particular with regards to the recovery outcomes and depression scores. 
Regression analyses were performed to assess the relationship between the time lag and BDI 
and recovery variables, with no significant findings found; however this needs greater 
consideration in future analyses.  
8.3.5 Length of follow-up 
Since analyses were restricted to the two-month follow-up of participants, clinical endpoints 
such as recurrent cardiac events, post-operative complications and mortality could not be 
investigated. Instead, my PhD was limited to investigate self-reported outcomes including 
emotional distress, pain and physical symptoms and quality of life. The only objective measure 
of recovery used was length of post-operative stay. It is possible that the associations between 
depression symptoms and the self-report outcomes were due to a reporting bias, such that 
participants with low mood were more likely to over-report negative symptoms. Nevertheless, 
it is interesting that the effect of depression on recovery was corroborated using the length of 
post-operative hospital stay outcome. Further analyses using the one-year follow-up data will 
be useful to verify the findings of this thesis with analyses of the associations between 
depression symptoms and other clinical endpoints.  
8.3.6 Questionnaire measures 
The next limitation of the ARCS study is the reliance on questionnaire measures of emotional 
distress, including depression symptoms and anxiety. The main issue is that clinical diagnosis of 
these conditions can only be given through administration of a clinical interview. As such, 
questionnaire measures are said to capture depression symptoms and not depression per se. 
Therefore, care must be taken when making inferences using results from the BDI and this 
thesis implemented a conservative cut-off of ≥13 in order to maximise the sensitivity and 
specificity of the measure. In addition, continuous variables were predominantly used in 
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analyses to make comparisons according to the degree of depression symptoms rather than 
depression caseness.  
In terms of anxiety, the validity of the HADS has recently been questioned, with 
concerns regarding its latent structure and its ability to differentiate between cases of 
depression symptoms and anxiety (Cosco et al., 2012; Coyne & van Sonderen, 2012). These 
latter authors also point out issues surrounding use of colloquialisms in the HADS such as 
“butterflies in the stomach” and the subtlety of the reverse phrasing of some items such as “I 
can sit at ease and feel relaxed”, which they argue may cause response errors. Issues of 
interpretation are inherent with all questionnaire measures where the researcher relies on the 
participant to comprehend the written instructions. In the ARCS study it is likely to have been 
the cause of missing data on some of the questionnaires, but it is not clear to what extent 
questions were misinterpreted. Inferences can be drawn using the internal consistency values 
in the form of the Cronbach’s alpha coefficient, which for the BDI and anxiety were good 
across all three time points (>0.75).   However, the criticism charged at the HADS regarding its 
latent structure requires consideration, and has been addressed in this work by terming 
anxiety an ‘emotional distress’ outcome. Moreover, the HADS score was used as a continuous 
measure in all regression models, again sidestepping the issue of caseness.  
Ceiling effects on questionnaire measures were assessed during P-ARCS with the ESSI 
showing a high positive skew, such that the majority of participants reported high levels of 
social support. This was also the case in the ARCS study and creates issues surrounding the 
estimation of central tendency. This is possibly why no difference was observed between 
depressed and non-depressed participants in terms of social support. Future analyses will 
benefit from making use of the other social measures included in ARCS, such as social 
networks and marital functioning.   
8.3.7 Confounders and covariates 
Adequate control for confounders is crucial for interpreting of any relationship between a 
predictor and an outcome variable. One of the major concerns with the research in this field 
relates to the issue of reverse causality, which questions whether rather than depression 
causing poor cardiac prognosis, poor cardiac prognosis actually causes depression. In 
considering how to unpick this relationship, proper control for confounders becomes of crucial 
importance since both depression and poor cardiac prognosis could in fact be the product of a 
separate underlying disease process, like, for example, inflammation. A randomised trial would 
be able to test this hypothesis by assessing the extent to which treatment of the possible 
confounder, in this example inflammation, was able to reduce both depression and improve 
cardiac prognosis. Careful examination of all possible confounders will enable future research 
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to illuminate the direction of the causal relationship between depression and cardiac 
prognosis.  
In ARCS, all analyses were adjusted for age, sex, socioeconomic status (household 
income), euroSCORE and where applicable, baseline measures of questionnaire outcomes. 
However, it is important to note that not all possible confounders of the depression-recovery 
relationship have been captured in ARCS, such as use of illicit drugs and aspects of people 
home environment such as the ambient temperature. In addition, problems surrounding the 
measurement of confounders also warrant consideration as a limitation of the ARCS study. For 
example, smoking was included in models as a binary variable, demarking participants 
according to their current smoking status. This does not take into account the nuances in 
smoking such as the duration of the smoking habit and the number of cigarettes typically 
smoked. Nor does it capture the influence of indirect tobacco effects through passive smoking. 
In addition, while some covariates were measured, the literature is yet to elucidate how they 
influence risk; an example being ethnicity (see Section 8.3.1).  A final point here is that while 
disease severity was captured by euroSCORE, this only takes into account coronary disease, 
and no measure of global cardiovascular disease (including cerebrovascular and peripheral 
arterial disease) was included in analyses; this needs to be addressed in future work using the 
ARCS sample. Comprehensive assessment of disease severity is an important step in 
understanding the causal relationship between depression and cardiac disease, particularly in 
understanding whether depression precedes atherosclerosis or incident ACS, or whether 
depression arises as a consequence of these underlying disease processes. Inclusion of 
multiple disease severity covariates will be important when studying post-CABG onset 
depression using the full ARCS dataset.  
8.3.8 Biological measures 
Another limitation of the ARCS study is with regards to the collection of the biological data. 
Cortisol was assessed using saliva samples, which was used as it has the advantage of being a 
non-invasive and convenient method of assessing diurnal variation of cortisol in a naturalistic 
setting (Kirschbaum & Hellhammer, 1989, 1994). However, this approach relies on participants 
taking the samples themselves and accurately reporting the time of assessment. This reflects a 
trade-off, since the control over the measurement is surrendered in order to gain ecological 
validity. Participants were instructed to choose one day prior to surgery in which to give seven 
samples at set time points: on awakening, 30 minutes after awakening, 10am, midday, 4pm, 
8pm and bedtime. Participants were told not to eat, drink caffeinated beverages, smoke 
cigarettes, take any medications, or brush their teeth, for the 30 minutes prior to giving the 
sample. However, non-adherence to this protocol meant that some samples were not given, 
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some were given at the incorrect time and outliers had to be removed, leaving a reduced 
number of cases on these analyses.  
 To assess inflammatory activity, a 20ml blood sample was drawn into plain serum 
tubes by venepuncture from the forearm at T1 and T2. However, although blood was planned 
to be drawn at days one and four after surgery, this was not always achieved due to 
inconsistencies in nursing staff. The reasons for the variability in collection day meant some 
participants had blood drawn on any combination of two days post-surgery. This led to a range 
of collection days between day one and day eight post-surgery. Although not foreseen during 
the planning stages of the ARCS study, this meant cytokine responses had to be averaged 
across two time periods: days one to three and days four to eight, to produce an early and late 
mean.  
8.3.9 Medication 
Problems interpreting the role of prescribed and non-prescribed medications on the 
depression-recovery relationship are another limitation of my analyses. Depression has been 
shown to be associated with cardiac medications such as statins and beta-blockers. Statins 
have actually been shown to have a protective effect for depression, with several longitudinal 
studies finding use of statins to confer a risk reduction for depression onset in CHD patients 
(Otte et al., 2012; Stafford & Berk, 2011). In contrast, the literature on beta-blockers and 
depression is less clear, with some early evidence suggesting they may be capable of inducing 
mood disturbance (Greenblatt & Koch-Weser, 1974). More recently, evidence from systematic 
reviews has not substantiated this link, although the popular misconception persists in 
prescription practice (Ko et al., 2002). In my results, analyses were performed to assess the 
relationship between medication use and the recovery outcomes and the biomarkers, with no 
significant findings found. Moreover, the cardiac medication usage of this patient group is 
largely standardised, following the prescription guidelines of NICE. While information was 
gathered from participants regarding their medications prior to surgery and at the T3 
assessment, no information was collected regarding the administration of drugs during the in-
hospital stay. It is possible that differences in the administration of medications at this time, 
particularly analgesics, affected responses given at the T2 assessment. More work is needed to 
understand how these medications may interact to affect the relationship between depression 
and later recovery in CABG patients. 
8.3.10 Cognitive function 
The next limitation is that cognitive function was only assessed pre-operatively, to assess 
baseline levels of neurocognition. Therefore, it was not possible to assess the effect of 
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cognitive deterioration from before to after the surgical procedure, and the effect of any 
change on the depression symptoms-recovery relationship. Previous research in this area is 
mixed, and while there is some evidence that cognitive decline is an important predictor of 
cardiac mortality  (Batterham et al., 2012), it is not yet clear how this interacts with depression 
to effect prognosis in CABG patients. For example, McKhann and colleagues (McKhann et al., 
1997) found no association between depression and cognitive decline in a one-year follow-up 
study of 124 CABG patients and a more recent study has shown cross-sectional associations 
between depression and cognitive function at six months and five years following CABG 
surgery, though the effects were only small and explained no more than 7.2% of variance in 
any of the cognitive domains (Tully et al., 2009). In addition, since levels of cognitive function 
were already below normative values in the ARCS sample at baseline, it is unclear to what 
extent a further deterioration over time would have contributed to the depression symptoms-
recovery relationship.     
8.3.11 Causality 
The final limitation of the ARCS study is with regards to the issue of causality. Mediation 
analyses were performed on the data to assess the extent to which the candidate mechanisms 
accounted for the relationship between depression symptoms and the recovery outcomes. 
However, given the timeline of the study it is difficult to assess the direction of the causal 
relationship between depression symptoms and the candidate mechanisms. For example, it is 
not clear to what extent depression symptoms caused physical inactivity or vice versa. 
Nevertheless, the prospective relationship between depression symptoms and the recovery 
outcomes was established in this study, showing the effect of pre-operative depression 
symptoms on post-operative recovery. 
8.4 Clinical implications and suggestions for further research 
The findings of this study have important clinical implications, primarily surrounding the 
identification of different depression symptom subtypes and mechanisms of the depression-
recovery relationship. My work has shown depression symptoms to be heterogeneous with 
different subtypes being predictive of different recovery outcomes. Depression symptoms 
were grouped into subtypes including total depression, cognitive/affective and 
somatic/affective depression, as well as depression onset subtypes including resolved, 
persistent and post-CABG onset depression. These findings are relevant at two stages of the 
clinical process: screening and treatment.  
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8.4.1 Screening 
One of the main problems with treating depression is the failure to identify cases of 
depression in primary care. The current UK Quality Outcome Framework incentivises the 
screening of depression in primary care, and advocates the use of the Patient Health 
Questionnaire-2 and -9 questionnaire measures of depression for this purpose. However, 
difficulty arises when one considers the fact that individuals often fail to consult with their GP 
about mood symptoms (Meltzer et al., 2003). Moreover, GPs are not currently required to 
routinely screen for depression in persons with known CHD; routine screening would eliminate 
the need for GPs to react to cues provided by the patient as to whether screening is required. 
The identification of different depression subtypes in my results has consequences for 
the identification and screening of depression. For example, traditional cut-off scores on 
depression screening instruments do not distinguish between different symptom clusterings of 
depression symptoms. Theoretically, a total depression symptom score above the threshold 
for caseness may not actually be clinically relevant for those patients who score lowly on both 
cognitive/affective and somatic/affective subscales. What seems to be more important than 
total score, in terms of short-term recovery, is the preponderance of somatic/affective but not 
cognitive/affective symptoms. Designing screening tools for depression symptom subtypes 
with appropriate cut-offs is an area for further research. However, having said this, greater 
work is still needed to explore the consequences of cognitive/affective depression. It could be 
that cognitive/affective depression symptoms have synergistic effects with somatic/affective 
symptoms that cannot be captured in a simple questionnaire. Care must be taken not to 
negate the importance of cognitive/affective depression symptoms in a screening instrument, 
as in my results of the early-term recovery outcomes they were similarly predictive as 
somatic/affective symptoms.  
Of course, screening for depression is not necessarily as straightforward as having a 
good and valid measurement. While the American Heart Association now recommends routine 
screening for depression in all heart disease patients (Bigger & Glassman, 2010; Lichtman et 
al., 2008), such guidelines have yet to be introduced in the UK. Moreover, screening for 
depression has yet to be shown to actually impact patient outcomes (Thombs et al., 2008). 
Therefore, it is not clear to what extent screening would actually have any added benefit for 
these patients. This issue is further complicated since even mild levels of depression 
symptoms, not just depression caseness, have been shown to confer cardiac risk (Zuidersma et 
al., 2012). Regardless, a standardised approach to depression screening in cardiac patients 
appears to be the most efficient way to ensure patients receive the support they require, and 
offers an effective way of identifying those patients who may be at greatest risk of adverse 
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events and poorer recovery after CABG. The lack of an effective treatment strategy does 
however limit the benefits of screening; this will be discussed below.  
8.4.2 Treatment 
The NICE guidelines for depression (National Collaborating Centre for Mental Health, 2010a) 
recognise that some cases of depression will remit spontaneously without treatment, while 
other cases will recur and take a more chronic course. The results of this PhD suggest that 
different depression subtypes of depression may exist and therefore strategies aimed to 
improve and treat depression as a homogenous disorder, and according to currently diagnostic 
criteria, may not necessarily confer clinical benefits. Indeed, intervention studies designed to 
improve emotional wellbeing after CABG have shown mixed results. Positive results were 
found by Freedland and colleagues (Freedland et al., 2009) who conducted a 12-week 
randomised controlled trial to assess the efficacy of two different types of non-
pharmacological treatment for depression symptoms after CABG, in comparison to usual care 
controls. Results showed significantly higher rates of remission in depressed patients who 
received cognitive behavioural therapy or supportive stress-management compared to usual 
care controls, at three- and nine-month follow-up.  A more recent intervention study, the 
Bypassing the Blues randomised controlled trial, investigated the impact of a telephone 
delivered collaborative care intervention in post-CABG depressed patients, compared to usual 
care depressed controls and non-depressed controls. The intervention group received a 
tailored nurse-led telephone delivered programme for up to eight months following CABG. 
Results showed significant improvements in health-related quality of life and mood in the 
intervention group compared to usual care controls, however the effect was stronger for men 
than women (Rollman & Herbeck Belnap, 2011; Rollman et al., 2009). Despite these studies 
demonstrating a positive impact on emotional wellbeing, three other randomised controlled 
trials have been less conclusive (Furze et al., 2009; Lie et al., 2007; Sebregts et al., 2005). 
Notably, these studies sought to improve emotional wellbeing, and the clinical consequences 
of such improvements were not assessed. Turning to the MI literature suggests the effect 
would not necessarily have extended to clinical endpoints such as mortality (Berkman et al., 
2003).  
Interestingly, another randomised controlled trial using cognitive behavioural therapy 
for post-ACS patients, not specifically targeting depression symptoms, but instead stress 
management, did show clinical benefits. These authors were able to show that participants in 
the intervention arm had a 41% lower rate of fatal and non-fatal first-time recurrent cardiac 
events compared to standard care controls (Gulliksson et al., 2011).  The reason why a stress 
management intervention programme should confer such large prognostic benefits over and 
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above a depression-centred intervention is likely multifaceted. For example, issues 
surrounding the timing of recruitment into the study, differences in the inclusion criteria, 
problems with spontaneous remission of some depression patients but onset or relapse of 
control patients, and use of out-of-study medications and therapies, are all likely to play a role. 
Understanding these differences is essential for directing future intervention studies.  If such 
benefits could be replicated in further work and could be translated into objective clinical 
results, such as shorter hospital stays, lower cardiac recurrence rates and lower use of GP and 
outpatient services, there would be a sustained health economics argument for investment in 
such work. 
The lack of clear findings are reflected in the European Society of Cardiology guidelines 
(Perk et al., 2012).These guidelines recognise and promote the management of psychosocial 
factors, including depression, but only as a means to promote healthy lifestyle choices. In 
reviewing the evidence for interventions aimed at reducing depression, these guidelines 
recognise the fact that studies which have shown a reduction in negative mood symptoms 
have not also seen improvements in cardiac outcomes. This highlights the need for further 
work to develop the field.  The recognition of the different predictive power of the different 
depression subtypes was crucial to understanding the relationship between depression 
symptoms and recovery in my results. In fact, in terms of predicting short-term outcomes, 
somatic/affective depression symptoms were the only significant depression subtype 
predictive of impaired adaptation, after controlling for demographic and disease severity 
covariates. This also has consequences for the design of tailored interventions.  More work is 
needed to investigate whether different treatment strategies are particularly effective for the 
different symptom subtypes.   
Based on the findings of this PhD I would propose a large, multi-centre randomised 
controlled trial to investigate the impact of a pre-CABG depression treatment programme on 
clinical, physical and psychological post-CABG recovery. Participants would be screened for 
trial inclusion on first notification of the need for elective CABG and, on meeting a depression 
diagnosis, would be randomised to either usual care or an intervention group. The content of 
the intervention itself would be determined by patient preference (Davidson et al., 2010), and 
would involve a mixed-treatment approach to depression including components of exercise, 
cognitive behavioural therapy and traditional pharmacotherapy. The length of the intervention 
prior to surgery would vary according to the amount of time each individual spent on the 
waiting list, but the intervention would continue post-CABG to ensure maximum benefit. In 
particular, careful attention would be paid to measuring depression symptoms and studying 
the effect of treatment on individual symptom remission. While the importance of recurrent 
cardiac events and mortality are obviously of critical importance when assessing the efficacy of 
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psychosocial interventions, other evaluative markers would also be included. For example, 
some authors argue that prognostic studies should not be limited to the assessment of cardiac 
endpoints, but should also include subjective markers of wellbeing and quality of life 
(Hemingway et al., 2009). This appraisal could also be extended to intervention trials. Results 
from the ARCS study suggest that an array of subjective parameters may be useful for 
assessing an intervention’s success, including pain, physical symptom reporting, physical and 
mental health status and other symptoms of emotional adjustment such as anxiety. Therefore, 
I would propose a trial powered to evaluate not only mortality, but also subjective outcomes 
such as quality of life. Such a distinction is also important for informing the next round of 
guidelines, and it could be suggested that organisations such as the European Society of 
Cardiology should recognise a more diverse range of endpoints, reducing the emphasis on 
‘hard’ clinical outcomes.  
While there is a need for more methodologically robust intervention work, greater 
attention also needs to be paid to how we make use of existing data. An alternative method 
for adding credence to the depression-cardiac prognosis literature could involve the pooling of 
data from existing depression treatment trials. This approach would allow a large sample of 
participants’ data to be analysed to assess whether depression treatment in a psychiatric 
population was associated with a reduction in cardiac events and/or mortality. In addition, it 
would also be possible to assess the type and level of depression treatment required to show 
an effect. Such a design could be strengthened by individual-level analysis, making use of 
resources such as the NHS’s hospital episode statistics data. While the pooling of data from 
depression treatment trials has yet to be carried out, an example of a large scale observation 
study is provided by Osborn and colleagues (Osborne et al., 2007) who conducted analyses 
using the General Practice Research Database of over 46 thousand individuals with severe 
mental illness. This retrospective cohort study was able to show that the hazard of CHD 
mortality among those with severe mental illness compared to controls was 2.88 (95% CI 1.77-
4.70) for 18 to 49 year olds, even after controlling for multiple risk factors. A significant effect 
was also found for older individuals aged 50 to 75 years (HR 1.76, 95% CI 1.54-2.01), but not 
among the very old (≥75 years) (HR 1.04, 95% CI 0.91-1.18). This study demonstrates the utility 
of large scale observations, although this evidence has yet to be replicated among those with 
major depression specifically. Such work presents a clear pathway for progression of the field, 
and while such large scale research lacks the detailed information about each individual that 
benefits the smaller trials, it offers a clear advantage in terms of the sample size increasing the 
power of the observations. 
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8.4.3 Other avenues for intervention 
My PhD has also produced results suggestive of other areas of further research. For example, 
behavioural factors such as smoking and physical activity were shown to have important 
effects on recovery. Working out the most effective way to disseminate knowledge regarding 
the health benefits of lifestyle improvements warrants further research. A recent longitudinal 
examination of smoking status in over 4.5 thousand post-ACS patients (Boggon et al., in press)  
found that smoking cessation advice, while advocated by NICE, was only provided by GPs to 
24% of patients after ACS. Moreover, less than half of the ARCS study actually partook in a 
cardiac rehabilitation scheme routinely offered to all patients under the NHS. Understanding 
adherence to lifestyle and medical advice is one way in which further research could help to 
advance our knowledge of this area.  
 Illness perceptions were also shown to be an important independent predictor of 
recovery in this PhD. This work has added relevance since research has shown that illness 
perceptions are amenable to change in several intervention studies, with results of one trial 
showing improvements in functional recovery, i.e. faster return to work, as a result of a brief 
in-hospital intervention to challenge and replace negative illness perceptions in MI patients 
(Broadbent, Ellis, Thomas, Gamble, & Petrie, 2009).  It is not clear to what extent such 
interventions could work to moderate the negative effect of depression symptoms on 
recovery, and further work is needed to investigate whether such interventions could affect 
clinical prognosis.  
 The results using the biological data in this thesis are also indicative of the need for 
further research. Biological and inflammatory marker research would benefit from being more 
widely investigated during intervention studies so that the underlying physiological pathways 
linking the psychological or cognitive behavioural intervention to later improvements could be 
delineated. Current trials are evaluating techniques for limiting acute inflammatory responses, 
for example, the MRC-ILA-HEART study (Crossman et al., 2008). If these trials are successful, 
they would provide the opportunity to test links between inflammation and the development 
of depression in ACS patients. 
8.5 Conclusion 
I studied the effect of pre-operative depression symptoms on impaired adaptation and 
physical recovery following CABG surgery and explored the underlying mechanistic pathways. 
Outcomes were studied in the early- and short-term stages of recovery, namely the days and 
months following surgery, showing that greater depression symptoms were predictive of 
greater emotional distress, greater physical symptoms and pain, longer in-hospital stays and 
impaired physical and mental health status, independent of demographic and disease severity 
330 
 
factors. Specifically, somatic/affective depression symptoms were predictive of the two-month 
post-operative outcomes, but not total or cognitive/affective depression symptoms. Social-
behavioural mediation of this relationship was not shown, but instead physical activity, BMI 
and smoking status all had independent effects on recovery outcomes. Cognitive mediation 
was found, showing that greater negative illness perceptions prior to surgery mediated the 
relationship between pre-operative depression symptoms and anxiety and physical symptoms 
in the early term and affective pain and physical symptoms in the short term.  Biological 
mediation was not shown, and although depression symptoms were related to 
neuroendocrine and inflammatory patterns suggestive of poorer physical functioning, these 
patterns did not consistently relate to any of the post-surgery recovery outcomes. Finally, 
there was little evidence in support of a sickness behavioural model of depression in this data. 
Further work is needed to translate these findings into new ways to approach the 
measurement, diagnosis and treatment of depressed cardiac surgery patients.   
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APPENDIX 4: EUROSCORE SCORING 
From: http://www.euroscore.org/euroscore_scoring.htm 
 Description Score 
Patient related factors 
Age (Per 5 years or part thereof over 60 years) 1 
Sex Female 1 
Chronic pulmonary disease  
 
Long-term use of bronchodilators or steroids 
for lung disease 
1 
Extracardiac arteriopathy  
 
Any one or more of the following: claudication, 
carotid occlusion or >50% stenosis, previous or 
planned intervention on the abdominal aorta, 
limb arteries or carotids 
2 
Neurological dysfunction disease  Severely affecting ambulation or day-to-day 
functioning 
2 
Previous cardiac surgery  
 
Requiring opening of the pericardium. 3 
Serum creatinine  >200m micromol/L preoperatively 2 
Active endocarditis  
 
Patient still under antibiotic treatment for 
endocarditis at the time of surgery 
3 
Critical preoperative state  
 
Any one or more of the following: ventricular 
tachycardia or fibrillation or aborted sudden 
death, preoperative cardiac massage, 
preoperative ventilation before arrival in the 
anaesthetic room, preoperative inotropic 
support, intraaortic balloon counterpulsation 
or preoperative acute renal failure (anuria or 
oliguria<10 ml/hour) 
3 
Cardiac related factors 
Unstable angina  
 
Rest angina requiring IV nitrates until arrival in 
the anaesthetic room 
2 
LV dysfunction  
 
Moderate or LVEF 30-50% 
Poor or LVEF <30 
1 
 
3 
Recent myocardial infarct  (<90 days) 2 
Pulmonary hypertension  Systolic PA pressure>60 mmHg 2 
Operation related factors 
Emergency  
 
Carried out on referral before the beginning of 
the next working day 
2 
Other than isolated CABG  Major cardiac procedure other than or in 
addition to CABG 
2 
Surgery on thoracic aorta  For disorder of ascending, arch or descending 
aorta 
3 
Post-infarct septal rupture  4 
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APPENDIX 7: EXAMPLE PAGE FROM CORTISOL SAMPLING DIARY 
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APPENDIX 8: LOGISTIC EUROSCORE   
From: http://www.euroscore.org/logisticEuroSCORE.htm 
 Description Beta weight 
Patient related factors 
Age (Per 5 years or part thereof over 60 years) 0.0666354 
Sex Female 0.3304052 
Chronic pulmonary disease  
 
Long-term use of bronchodilators or steroids 
for lung disease 
0.4931341 
Extracardiac arteriopathy  
 
Any one or more of the following: claudication, 
carotid occlusion or >50% stenosis, previous or 
planned intervention on the abdominal aorta, 
limb arteries or carotids 
0.6558917 
Neurological dysfunction disease  Severely affecting ambulation or day-to-day 
functioning 
0.841626 
Previous cardiac surgery  
 
Requiring opening of the pericardium. 1.002625 
Serum creatinine  >200m micromol/L preoperatively 0.6521653 
Active endocarditis  
 
Patient still under antibiotic treatment for 
endocarditis at the time of surgery 
1.101265 
Critical preoperative state  
 
Any one or more of the following: ventricular 
tachycardia or fibrillation or aborted sudden 
death, preoperative cardiac massage, 
preoperative ventilation before arrival in the 
anaesthetic room, preoperative inotropic 
support, intraaortic balloon counterpulsation 
or preoperative acute renal failure (anuria or 
oliguria<10 ml/hour) 
0.9058132 
 
Unstable angina  
 
Rest angina requiring IV nitrates until arrival in 
the anaesthetic room 
0.5677075 
LV dysfunction  
 
Moderate or LVEF 30-50% 
Poor or LVEF <30 
0.4191643 
 
1.094443 
Recent myocardial infarct  
(<90 days) 
0.5460218 
 
Pulmonary hypertension  Systolic PA pressure>60 mmHg 0.7676924 
 
Emergency  
 
Carried out on referral before the beginning of 
the next working day 
0.7127953 
Other than isolated CABG  Major cardiac procedure other than or in 
addition to CABG 
0.5420364 
Surgery on thoracic aorta  For disorder of ascending, arch or descending 
aorta 
1.159787 
Post-infarct septal rupture  1.462009 
 
 
